data_1hly_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hly _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.433 -1.321 1 N-CA-C 99.098 -4.408 . . . . 1.0 99.098 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.31 159.95 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 N-CA-C 102.403 -3.184 . . . . 1.0 102.403 169.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.27 49.16 1.58 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 124.651 2.167 . . . . 1.0 110.622 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.14 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 104.648 -2.352 . . . . 1.0 104.648 167.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.72 137.07 32.66 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.06 148.38 52.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 118.798 2.888 . . . . 1.0 118.798 -165.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -101.69 -14.45 17.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 113.283 -1.78 . . . . 1.0 110.902 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -169.95 167.33 5.03 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 -169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.38 -24.19 64.68 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.75 2.375 . . . . 1.0 114.258 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -47.58 -53.32 14.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 127.351 2.26 . . . . 1.0 112.349 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -70.73 -12.58 61.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.481 1.512 . . . . 1.0 114.547 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.9 t -100.68 -9.48 21.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.204 -0.935 . . . . 1.0 112.555 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -67.3 -45.11 49.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 119.94 -1.725 . . . . 1.0 114.148 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.97 -41.33 62.86 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 CA-C-O 114.106 -2.539 . . . . 1.0 115.902 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -68.84 -34.58 17.72 Favored 'Trans proline' 0 CA--C 1.505 -0.926 0 CA-C-N 127.283 3.637 . . . . 1.0 112.758 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -59.38 -51.47 69.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.575 -1.328 . . . . 1.0 112.01 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.272 0.0 OUTLIER -71.7 -2.32 16.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 115.444 1.646 . . . . 1.0 115.444 170.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -69.89 0.36 Allowed 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 118.934 -2.354 . . . . 1.0 111.173 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.63 -29.34 6.49 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 111.627 -2.533 . . . . 1.0 111.965 -160.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -88.48 -32.46 18.24 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.12 1.156 . . . . 1.0 114.12 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.88 178.16 47.43 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 117.958 -2.068 . . . . 1.0 115.811 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.88 -46.72 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 126.215 1.806 . . . . 1.0 113.896 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -122.25 20.57 10.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.511 -1.663 . . . . 1.0 106.511 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.44 143.47 40.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 115.994 1.85 . . . . 1.0 115.994 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.36 172.76 15.08 Favored Glycine 0 CA--C 1.478 -2.264 0 N-CA-C 108.574 -1.81 . . . . 1.0 108.574 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.13 138.71 18.69 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 -169.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.78 169.56 17.54 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 117.945 -1.502 . . . . 1.0 109.843 164.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.4 t -106.41 147.68 28.99 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.183 0.993 . . . . 1.0 109.956 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -160.15 148.2 16.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 105.827 -1.916 . . . . 1.0 105.827 159.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.312 0.9 OUTLIER 58.54 27.03 15.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.795 1.638 . . . . 1.0 113.435 177.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.36 14.62 77.06 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.134 -1.394 . . . . 1.0 115.936 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -144.85 153.98 42.16 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 119.695 -2.062 . . . . 1.0 109.123 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.1 t -70.55 157.63 37.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 116.552 2.056 . . . . 1.0 116.552 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 94.06 2.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.175 -3.639 . . . . 1.0 101.175 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.03 137.8 32.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.436 2.294 . . . . 1.0 112.313 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -108.11 98.28 25.67 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 125.5 1.52 . . . . 1.0 108.251 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--N 1.326 -0.619 0 C-N-CA 122.14 1.893 . . . . 1.0 112.441 -176.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 100.38 -3.933 . . . . 1.0 100.38 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.01 154.83 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 101.486 -3.524 . . . . 1.0 101.486 166.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 45.87 1.21 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.718 2.199 . . . . 1.0 111.16 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.2 t -84.12 113.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 103.766 -2.679 . . . . 1.0 103.766 163.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -93.06 143.02 26.65 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.165 0.983 . . . . 1.0 110.853 -169.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -141.04 158.31 44.11 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 117.57 2.433 . . . . 1.0 117.57 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.1 p -111.65 -16.8 13.16 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 112.939 -1.937 . . . . 1.0 110.799 161.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -135.72 151.23 73.87 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 125.033 1.333 . . . . 1.0 109.516 -171.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.99 -21.32 63.82 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 122.604 1.966 . . . . 1.0 112.289 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -57.51 -49.55 75.96 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 122.188 0.994 . . . . 1.0 112.79 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -70.18 -10.73 59.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.976 1.31 . . . . 1.0 114.323 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.72 -26.05 24.43 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.63 -1.294 . . . . 1.0 108.929 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.62 -49.64 60.14 Favored Pre-proline 0 C--N 1.352 0.682 0 CA-C-O 116.561 -1.685 . . . . 1.0 115.177 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.31 -40.01 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 CA-C-N 125.001 2.822 . . . . 1.0 115.391 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.54 -35.88 16.31 Favored 'Trans proline' 0 CA--C 1.502 -1.114 1 CA-C-N 128.491 4.068 . . . . 1.0 112.244 169.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -58.05 -43.21 86.76 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.822 1.296 . . . . 1.0 112.617 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -70.61 -11.56 61.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -67.34 0.53 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.967 2.318 . . . . 1.0 112.443 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.19 -27.83 8.54 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.36 -2.654 . . . . 1.0 111.649 -161.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.07 -20.3 18.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.65 149.75 5.11 Favored Glycine 0 CA--C 1.494 -1.271 0 O-C-N 120.53 -1.356 . . . . 1.0 114.457 160.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.08 -37.21 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 119.962 -1.904 . . . . 1.0 112.057 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -81.88 -24.02 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.737 -1.852 . . . . 1.0 111.578 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.7 161.76 1.02 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 117.868 2.544 . . . . 1.0 117.868 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.45 167.5 12.49 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 109.318 -1.513 . . . . 1.0 109.318 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.19 134.03 16.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.045 -1.268 . . . . 1.0 108.51 -167.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 156.77 41.44 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 120.913 -1.117 . . . . 1.0 110.427 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.4 t -98.98 129.17 45.26 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 161.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -158.63 134.5 8.97 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 121.137 -0.977 . . . . 1.0 110.558 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 56.54 40.76 29.32 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.741 2.016 . . . . 1.0 110.354 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.77 15.04 57.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 113.809 -1.542 . . . . 1.0 115.704 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.52 157.92 45.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 119.885 -1.95 . . . . 1.0 109.214 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.1 t -65.66 153.59 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 123.358 1.552 . . . . 1.0 113.056 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB2' ' HZ1' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -152.68 78.22 1.19 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 123.03 1.395 . . . . 1.0 108.45 -166.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.63 138.29 44.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.957 1.836 . . . . 1.0 115.957 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -105.79 95.13 9.97 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 105.828 -1.916 . . . . 1.0 105.828 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.464 -0.263 0 C-N-CA 122.963 2.442 . . . . 1.0 112.282 -172.08 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 N--CA 1.435 -1.219 1 N-CA-C 99.979 -4.082 . . . . 1.0 99.979 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.06 159.6 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 C-N-CA 129.495 3.118 . . . . 1.0 102.736 170.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.14 46.46 1.35 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 124.428 2.061 . . . . 1.0 110.919 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.17 128.66 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.69 135.83 53.72 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.72 0.772 . . . . 1.0 109.285 -163.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.09 161.77 41.72 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 115.848 1.796 . . . . 1.0 115.848 -164.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -107.17 -26.11 11.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 113.693 -1.594 . . . . 1.0 109.852 157.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -119.21 146.33 40.41 Favored Pre-proline 0 CA--C 1.512 -0.511 0 O-C-N 120.603 -1.311 . . . . 1.0 111.466 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.06 -19.49 63.44 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 122.032 1.821 . . . . 1.0 112.687 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.72 -41.23 85.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 121.423 -0.798 . . . . 1.0 112.742 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.32 -22.14 64.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.135 1.774 . . . . 1.0 113.879 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -91.61 -16.05 27.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.07 0.948 . . . . 1.0 111.899 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 tp -66.87 -51.59 37.34 Favored Pre-proline 0 C--N 1.35 0.607 0 CA-C-O 117.176 -1.393 . . . . 1.0 114.014 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.39 -36.98 52.33 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-O 113.1 -2.959 . . . . 1.0 115.623 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.62 -42.48 2.48 Favored 'Trans proline' 0 CA--C 1.502 -1.109 1 CA-C-N 129.232 4.333 . . . . 1.0 113.176 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.23 -48.42 81.7 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.783 -1.198 . . . . 1.0 110.956 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -70.84 -9.8 58.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 116.61 2.078 . . . . 1.0 116.61 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.76 -74.65 0.16 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 124.792 2.234 . . . . 1.0 112.353 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.5 -35.22 68.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 111.518 -2.583 . . . . 1.0 110.052 -164.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -107.82 -8.92 15.87 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.896 -1.502 . . . . 1.0 110.544 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 -161.9 26.83 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 124.539 2.188 . . . . 1.0 117.262 156.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -68.67 -28.24 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 119.715 -2.05 . . . . 1.0 112.591 -167.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -78.48 -30.59 47.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 120.631 -1.293 . . . . 1.0 110.72 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.49 43.65 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 117.447 2.388 . . . . 1.0 117.447 -164.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.18 179.23 16.49 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.93 127.7 8.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 120.547 -1.561 . . . . 1.0 111.203 -157.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.78 161.59 27.02 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 121.076 -1.015 . . . . 1.0 108.582 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.8 t -108.49 135.38 49.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.57 -1.195 . . . . 1.0 108.089 161.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -156.41 138.43 14.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.289 -0.882 . . . . 1.0 109.563 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.32 19.27 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.282 1.833 . . . . 1.0 110.447 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.96 8.56 69.17 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 124.557 1.075 . . . . 1.0 115.604 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -140.97 164.89 29.04 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 119.974 -1.898 . . . . 1.0 109.138 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -69.84 161.14 30.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 117.041 2.238 . . . . 1.0 117.041 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -150.82 82.25 1.34 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.1 m -75.09 129.13 37.05 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.629 -1.295 . . . . 1.0 114.138 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.84 150.68 36.92 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.788 1.235 . . . . 1.0 108.383 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 C--N 1.328 -0.502 0 CA-C-N 123.22 2.186 . . . . 1.0 111.85 162.606 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 101.767 -3.419 . . . . 1.0 101.767 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.86 -143.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 126.855 2.062 . . . . 1.0 108.043 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -139.29 48.19 1.87 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 124.782 2.229 . . . . 1.0 110.15 163.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.78 118.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 113.251 -1.795 . . . . 1.0 106.31 163.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -95.77 141.99 28.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.088 -1.449 . . . . 1.0 107.088 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.65 165.37 35.65 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -164.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -105.62 -32.8 8.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 123.421 1.581 . . . . 1.0 109.896 151.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -102.94 153.83 37.98 Favored Pre-proline 0 N--CA 1.452 -0.345 0 O-C-N 120.512 -1.368 . . . . 1.0 111.891 -166.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.73 -31.8 68.73 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 121.784 1.656 . . . . 1.0 112.812 159.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -62.42 -37.58 86.36 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.924 0.784 . . . . 1.0 112.981 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -57.22 -27.87 62.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.945 1.698 . . . . 1.0 113.922 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 t -96.41 -13.83 22.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.301 -0.874 . . . . 1.0 112.245 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.47 -46.87 69.64 Favored Pre-proline 0 C--N 1.345 0.401 0 CA-C-O 116.807 -1.568 . . . . 1.0 113.936 -164.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.15 -48.78 14.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-N 124.121 2.507 . . . . 1.0 115.895 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.85 -37.96 10.75 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 127.254 3.627 . . . . 1.0 112.648 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -59.48 -37.29 77.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 120.514 -1.367 . . . . 1.0 112.183 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -26.43 63.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.413 1.634 . . . . 1.0 115.413 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.89 -67.3 0.54 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 124.811 2.243 . . . . 1.0 113.14 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -84.86 -37.42 20.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.417 -2.629 . . . . 1.0 109.485 -166.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.61 -12.28 13.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.447 1.647 . . . . 1.0 115.447 -160.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.66 149.28 5.04 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 120.593 -1.317 . . . . 1.0 114.631 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.36 -40.5 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 O-C-N 119.845 -1.973 . . . . 1.0 112.837 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -84.14 -22.4 31.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.713 -1.867 . . . . 1.0 110.881 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.8 159.22 0.57 Allowed 'General case' 0 C--N 1.351 0.644 0 N-CA-C 117.788 2.514 . . . . 1.0 117.788 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.03 164.64 12.07 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.54 133.37 20.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.23 -1.767 . . . . 1.0 106.23 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -148.06 154.36 40.13 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.59 144.25 28.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.259 -1.525 . . . . 1.0 112.134 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -163.13 144.11 9.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.628 -1.295 . . . . 1.0 110.917 170.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.48 37.06 19.98 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.308 1.443 . . . . 1.0 110.419 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.01 -8.96 48.67 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.598 -1.183 . . . . 1.0 115.891 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -146.95 168.99 20.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.855 2.327 . . . . 1.0 111.63 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.47 162.51 17.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.336 1.976 . . . . 1.0 116.336 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -146.12 89.8 1.91 Allowed 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 130.113 3.365 . . . . 1.0 102.778 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.7 m -77.89 132.85 38.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.153 1.781 . . . . 1.0 112.195 173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -108.56 97.16 21.89 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.456 -0.724 0 C-N-CA 122.996 2.464 . . . . 1.0 111.338 -175.161 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.0 t . . . . . 0 N--CA 1.431 -1.411 1 N-CA-C 98.763 -4.532 . . . . 1.0 98.763 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.45 160.64 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 102.703 -3.073 . . . . 1.0 102.703 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 42.46 1.1 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 124.959 2.314 . . . . 1.0 110.831 172.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.2 t -87.11 115.1 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -101.94 139.92 36.93 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 122.182 0.991 . . . . 1.0 108.479 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 153.86 40.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 116.652 2.093 . . . . 1.0 116.652 -160.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -111.14 0.83 16.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 127.017 2.127 . . . . 1.0 110.449 172.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 m -171.18 153.68 3.8 Favored Pre-proline 0 CA--C 1.51 -0.594 0 O-C-N 120.714 -1.241 . . . . 1.0 108.782 -171.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.78 -32.08 47.25 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.009 2.472 . . . . 1.0 111.919 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -46.68 -45.76 19.6 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.403 2.281 . . . . 1.0 112.947 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -67.39 -17.59 64.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.761 1.224 . . . . 1.0 114.013 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.7 t -101.55 -7.32 22.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.405 -0.81 . . . . 1.0 112.698 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.93 -46.43 64.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 120.032 -1.667 . . . . 1.0 113.524 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.17 -45.7 29.88 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 CA-C-O 114.019 -2.576 . . . . 1.0 115.814 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.51 -35.86 21.71 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 CA-C-N 127.408 3.681 . . . . 1.0 112.722 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 m -56.93 -46.39 82.09 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.955 1.36 . . . . 1.0 112.119 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -9.84 58.77 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.315 2.339 . . . . 1.0 117.315 172.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -65.84 0.7 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 124.287 1.994 . . . . 1.0 110.58 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -114.8 -33.84 5.34 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 112.316 -2.22 . . . . 1.0 111.377 -169.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -94.08 -18.05 22.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.796 1.406 . . . . 1.0 114.796 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.76 168.09 41.05 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 116.662 -2.685 . . . . 1.0 116.234 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 tt -70.19 -50.07 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.339 1.456 . . . . 1.0 111.191 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -127.8 32.23 4.99 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.57 152.18 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 119.219 3.044 . . . . 1.0 119.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.47 12.34 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 108.713 -1.755 . . . . 1.0 108.713 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.19 130.74 9.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.294 -1.373 . . . . 1.0 107.294 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 166.69 26.69 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 120.455 -1.403 . . . . 1.0 109.361 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 t -120.78 135.99 55.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.242 0.617 . . . . 1.0 110.897 -164.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.23 145.67 19.51 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.39 1.076 . . . . 1.0 108.272 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.63 32.08 20.29 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 126.307 1.843 . . . . 1.0 110.419 -173.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.67 19.46 62.81 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 124.855 1.217 . . . . 1.0 115.468 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.53 151.87 37.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.662 -2.081 . . . . 1.0 108.876 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -69.17 162.7 26.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.069 2.248 . . . . 1.0 117.069 -169.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.74 95.7 2.55 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.324 -3.213 . . . . 1.0 102.324 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.34 132.68 33.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.557 2.343 . . . . 1.0 112.426 -174.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -102.67 111.57 64.9 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.458 -0.595 0 C-N-CA 122.382 2.054 . . . . 1.0 112.389 -167.352 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 102.019 -3.326 . . . . 1.0 102.019 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.64 154.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 101.472 -3.529 . . . . 1.0 101.472 160.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.64 41.9 1.06 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 124.369 2.033 . . . . 1.0 112.191 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.54 115.26 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.574 -2.38 . . . . 1.0 104.574 167.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -103.09 137.02 41.82 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -163.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 p -140.5 150.81 44.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 118.159 2.651 . . . . 1.0 118.159 -163.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 p -115.15 9.46 15.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 128.002 2.521 . . . . 1.0 109.639 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -167.49 150.31 5.72 Favored Pre-proline 0 CA--C 1.511 -0.534 0 O-C-N 119.608 -1.933 . . . . 1.0 108.536 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.65 -24.58 35.16 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.509 2.139 . . . . 1.0 111.93 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -48.86 -44.46 39.79 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.521 1.929 . . . . 1.0 112.84 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -65.86 -18.3 65.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.026 1.331 . . . . 1.0 113.553 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 40.1 t -83.64 -25.19 30.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.265 1.026 . . . . 1.0 111.344 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.06 -52.48 30.66 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 117.16 -1.4 . . . . 1.0 114.331 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.58 -38.79 39.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-O 113.127 -2.947 . . . . 1.0 115.433 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.94 -37.26 8.97 Favored 'Trans proline' 0 CA--C 1.502 -1.103 1 CA-C-N 129.365 4.38 . . . . 1.0 112.265 172.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.07 -44.3 82.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.379 1.085 . . . . 1.0 111.793 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -70.72 -17.73 62.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.461 2.023 . . . . 1.0 116.461 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -68.25 0.48 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 124.899 2.285 . . . . 1.0 113.005 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -102.08 -38.57 7.67 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.05 -2.796 . . . . 1.0 110.142 -161.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.06 -45.11 7.37 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.564 -166.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.94 142.87 4.41 Favored Glycine 0 CA--C 1.491 -1.426 0 C-N-CA 118.556 -1.783 . . . . 1.0 114.795 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.11 -38.03 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 120.082 -1.834 . . . . 1.0 112.393 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -81.49 -23.62 37.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.307 -1.496 . . . . 1.0 111.663 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.76 156.38 0.2 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 118.624 2.824 . . . . 1.0 118.624 -167.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.85 162.4 14.72 Favored Glycine 0 CA--C 1.475 -2.418 0 N-CA-C 107.854 -2.098 . . . . 1.0 107.854 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.66 6.05 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 119.911 -1.935 . . . . 1.0 107.56 -163.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.14 21.45 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.76 -1.576 . . . . 1.0 110.792 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.0 t -94.81 133.8 38.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.1 ttt -153.61 133.74 13.32 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 121.025 -1.047 . . . . 1.0 109.598 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.367 1.0 OUTLIER 53.48 32.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 128.473 2.709 . . . . 1.0 112.863 -172.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.74 10.02 86.56 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 113.712 -1.585 . . . . 1.0 115.403 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -136.85 157.31 47.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 120.298 2.049 . . . . 1.0 109.708 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.7 t -70.65 141.62 51.65 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 123.926 1.822 . . . . 1.0 113.819 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.72 84.25 2.09 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 102.125 -3.287 . . . . 1.0 102.125 -171.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.19 132.78 37.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.531 1.533 . . . . 1.0 110.551 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.98 95.05 19.31 Favored Pre-proline 0 N--CA 1.434 -1.238 0 C-N-CA 126.119 1.768 . . . . 1.0 106.248 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 N--CA 1.46 -0.461 0 C-N-CA 122.77 2.313 . . . . 1.0 112.389 -175.66 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 0 N--CA 1.431 -1.403 1 N-CA-C 97.697 -4.927 . . . . 1.0 97.697 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.84 156.27 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 101.547 -3.501 . . . . 1.0 101.547 176.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.71 51.31 1.55 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 125.08 2.372 . . . . 1.0 110.718 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -90.29 102.79 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 162.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER -74.36 136.12 42.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 123.765 1.745 . . . . 1.0 112.606 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.49 154.15 18.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.144 1.926 . . . . 1.0 114.165 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 3.18 5.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.6 1.96 . . . . 1.0 107.862 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -177.14 157.02 1.28 Allowed Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 104.032 -2.581 . . . . 1.0 104.032 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.4 -23.18 28.17 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 CA-C-N 123.277 2.206 . . . . 1.0 111.999 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -57.67 -42.15 82.96 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 122.082 0.944 . . . . 1.0 113.057 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -70.58 -7.41 43.79 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 114.973 1.472 . . . . 1.0 114.973 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -82.44 -25.71 33.38 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.95 -1.094 . . . . 1.0 110.297 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.86 -48.23 62.77 Favored Pre-proline 0 C--N 1.354 0.777 0 O-C-N 119.628 -1.92 . . . . 1.0 114.446 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.76 -37.5 55.62 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 CA-C-O 113.216 -2.91 . . . . 1.0 115.237 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -37.06 17.66 Favored 'Trans proline' 0 CA--C 1.503 -1.043 1 CA-C-N 129.054 4.269 . . . . 1.0 112.48 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.92 -39.17 77.35 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.81 -1.181 . . . . 1.0 112.335 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -13.34 62.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 116.917 2.192 . . . . 1.0 116.917 174.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.96 72.31 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 123.158 1.456 . . . . 1.0 113.558 -170.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -164.08 -27.79 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.074 -1.421 . . . . 1.0 111.719 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.79 -17.74 52.67 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 120.228 -1.545 . . . . 1.0 113.004 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 154.35 7.29 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 121.058 -1.026 . . . . 1.0 112.861 154.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.21 -43.17 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 O-C-N 119.914 -1.933 . . . . 1.0 112.554 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -75.91 -28.31 57.99 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.664 -1.897 . . . . 1.0 111.134 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.4 151.46 0.37 Allowed 'General case' 0 C--N 1.35 0.589 0 N-CA-C 118.811 2.893 . . . . 1.0 118.811 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.69 175.62 21.74 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.16 131.95 11.55 Favored 'General case' 0 N--CA 1.434 -1.255 0 O-C-N 121.33 -1.1 . . . . 1.0 110.06 -166.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 154.24 45.72 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.902 -1.123 . . . . 1.0 111.308 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.31 117.04 34.18 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 164.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -147.32 136.36 22.31 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.519 -1.363 . . . . 1.0 110.296 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.417 0.9 OUTLIER 53.23 30.4 9.92 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 128.106 2.562 . . . . 1.0 112.955 -170.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.45 6.28 89.0 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 113.744 -1.571 . . . . 1.0 115.647 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.58 152.4 51.89 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.855 1.827 . . . . 1.0 108.995 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.72 143.09 51.41 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 116.333 1.975 . . . . 1.0 116.333 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -137.98 81.59 1.87 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.34 2.256 . . . . 1.0 107.365 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.6 m -70.11 132.1 45.31 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.206 1.558 . . . . 1.0 115.206 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -96.63 101.08 8.23 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 CA-C-N 122.719 2.007 . . . . 1.0 111.745 -173.602 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 100.773 -3.788 . . . . 1.0 100.773 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.81 -149.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 126.279 1.832 . . . . 1.0 106.822 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -142.38 37.37 1.52 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 124.896 2.284 . . . . 1.0 110.389 167.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.14 119.03 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 112.241 -2.254 . . . . 1.0 106.622 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -102.23 143.16 32.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.828 0.823 . . . . 1.0 109.13 -170.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.5 149.67 41.19 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 117.574 2.435 . . . . 1.0 117.574 -162.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -110.44 3.31 19.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 127.642 2.377 . . . . 1.0 109.73 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -177.55 146.35 0.61 Allowed Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 105.723 -1.954 . . . . 1.0 105.723 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.03 -26.85 57.99 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 123.871 2.418 . . . . 1.0 112.846 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -54.74 -30.84 57.36 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.789 1.636 . . . . 1.0 113.802 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -62.32 -26.38 68.4 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.052 -1.03 . . . . 1.0 113.439 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -100.13 -1.15 37.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.302 -0.874 . . . . 1.0 112.567 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.52 -49.39 83.58 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 120.295 -1.503 . . . . 1.0 113.695 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.28 -34.13 56.91 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-O 113.15 -2.938 . . . . 1.0 115.477 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.38 -36.41 9.2 Favored 'Trans proline' 0 CA--C 1.507 -0.874 1 CA-C-N 129.094 4.284 . . . . 1.0 112.91 169.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.6 -52.37 65.93 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.542 -1.349 . . . . 1.0 111.558 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -71.76 -1.98 15.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.235 1.569 . . . . 1.0 115.235 171.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.67 -69.32 0.39 Allowed 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 118.981 -2.325 . . . . 1.0 111.003 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -115.41 -29.89 6.4 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 111.547 -2.569 . . . . 1.0 112.056 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -92.74 -23.38 18.92 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 115.063 1.505 . . . . 1.0 115.063 -167.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.33 47.91 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 119.842 -1.787 . . . . 1.0 115.231 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.53 -45.44 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.224 1.81 . . . . 1.0 114.136 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -120.61 13.61 11.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.736 1.614 . . . . 1.0 107.034 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 145.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.143 1.905 . . . . 1.0 116.143 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.57 178.17 22.64 Favored Glycine 0 CA--C 1.479 -2.158 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -163.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.42 141.89 31.02 Favored 'General case' 0 N--CA 1.423 -1.817 0 O-C-N 120.569 -1.548 . . . . 1.0 110.116 -163.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -111.85 139.91 46.94 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.5 t -101.14 130.76 47.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.4 ttt -150.06 137.82 20.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 120.751 -1.218 . . . . 1.0 109.59 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.44 27.26 16.22 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.558 1.543 . . . . 1.0 111.23 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.05 86.5 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 114.774 -1.103 . . . . 1.0 115.652 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.36 151.54 43.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.681 2.24 . . . . 1.0 110.536 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.4 t -70.32 153.75 42.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 118.025 2.602 . . . . 1.0 118.025 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -144.6 92.06 2.25 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 127.394 2.278 . . . . 1.0 105.016 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -77.96 137.35 38.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 128.55 2.74 . . . . 1.0 114.782 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -100.2 102.1 16.94 Favored Pre-proline 0 N--CA 1.441 -0.888 0 C-N-CA 126.595 1.958 . . . . 1.0 106.324 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo . . . . . 0 N--CA 1.448 -1.158 0 CA-C-N 121.978 1.742 . . . . 1.0 111.859 -173.102 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 N--CA 1.43 -1.461 1 N-CA-C 98.671 -4.566 . . . . 1.0 98.671 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 155.9 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 101.377 -3.564 . . . . 1.0 101.377 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.61 47.36 1.23 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 124.353 2.025 . . . . 1.0 110.946 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.96 122.88 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -93.8 144.24 25.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.137 0.97 . . . . 1.0 110.81 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.47 155.66 42.12 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.729 1.728 . . . . 1.0 115.395 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -110.71 -24.92 10.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.849 156.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -118.06 146.99 40.44 Favored Pre-proline 0 CA--C 1.512 -0.498 0 O-C-N 120.178 -1.576 . . . . 1.0 110.296 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.14 -17.0 57.67 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 C-N-CA 122.219 1.946 . . . . 1.0 112.049 166.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -59.41 -42.4 91.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.626 -1.296 . . . . 1.0 112.504 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.45 -16.78 63.03 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.04 1.736 . . . . 1.0 113.986 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -83.34 -28.25 29.13 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 121.114 -0.991 . . . . 1.0 111.063 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.3 -53.61 10.22 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 114.471 1.286 . . . . 1.0 114.471 -160.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -57.35 -46.11 30.13 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 CA-C-O 114.344 -2.44 . . . . 1.0 115.406 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -67.11 -37.48 18.61 Favored 'Trans proline' 0 CA--C 1.504 -1.017 0 CA-C-N 127.007 3.538 . . . . 1.0 112.398 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 t -64.41 -37.36 87.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 120.323 -1.485 . . . . 1.0 112.771 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -70.73 -11.63 61.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 116.827 2.158 . . . . 1.0 116.827 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.82 71.59 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 123.148 1.451 . . . . 1.0 113.416 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -164.4 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.911 -1.495 . . . . 1.0 111.378 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -78.5 -14.92 59.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.176 -1.578 . . . . 1.0 113.291 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.11 154.79 7.2 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 122.336 0.965 . . . . 1.0 113.108 149.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -70.19 -41.88 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 O-C-N 120.742 -1.446 . . . . 1.0 112.603 -174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -91.02 -18.56 24.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.961 -1.087 . . . . 1.0 110.978 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.78 144.35 1.76 Allowed 'General case' 0 C--N 1.352 0.703 0 N-CA-C 117.612 2.449 . . . . 1.0 117.612 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.35 25.9 Favored Glycine 0 CA--C 1.475 -2.407 0 N-CA-C 107.47 -2.252 . . . . 1.0 107.47 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.95 125.2 4.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.225 -1.162 . . . . 1.0 109.595 -168.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 169.65 22.04 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.723 -1.235 . . . . 1.0 109.65 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.8 t -100.2 139.29 36.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.609 -0.682 . . . . 1.0 112.443 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.8 ttt -162.94 148.4 11.91 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.343 1.057 . . . . 1.0 108.565 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 63.2 28.78 15.97 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 123.226 1.489 . . . . 1.0 110.208 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.16 12.38 57.73 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.602 1.096 . . . . 1.0 115.53 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.3 165.19 32.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 120.023 1.911 . . . . 1.0 110.536 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -69.52 153.96 42.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.144 1.535 . . . . 1.0 115.144 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 85.4 1.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.582 -2.747 . . . . 1.0 103.582 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.56 127.42 32.78 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.262 1.825 . . . . 1.0 112.681 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.56 102.41 14.57 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 105.729 -1.952 . . . . 1.0 105.729 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 N--CA 1.456 -0.71 0 C-N-CA 122.216 1.944 . . . . 1.0 112.141 -166.469 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.44 -0.944 1 N-CA-C 100.15 -4.019 . . . . 1.0 100.15 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 152.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 N-CA-C 100.824 -3.769 . . . . 1.0 100.824 154.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -99.23 50.11 0.95 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 124.268 1.985 . . . . 1.0 111.382 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.73 117.28 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 105.012 -2.218 . . . . 1.0 105.012 163.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.74 143.77 26.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.584 0.707 . . . . 1.0 111.291 -167.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.98 153.57 40.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 116.36 1.985 . . . . 1.0 116.36 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -94.0 -41.69 9.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 112.146 -2.297 . . . . 1.0 109.027 156.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -108.94 148.4 37.82 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.451 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.73 -23.92 74.61 Favored 'Trans proline' 0 CA--C 1.51 -0.704 0 C-N-CA 121.775 1.65 . . . . 1.0 112.656 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.95 -33.96 76.91 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 121.064 -1.023 . . . . 1.0 113.223 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -64.36 -15.32 60.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.549 1.14 . . . . 1.0 113.848 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -89.14 -21.68 23.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.841 -1.162 . . . . 1.0 111.477 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.95 -52.85 46.64 Favored Pre-proline 0 N--CA 1.439 -0.996 0 O-C-N 120.441 -1.412 . . . . 1.0 113.804 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.23 -36.59 45.63 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-O 112.877 -3.051 . . . . 1.0 115.263 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -69.86 -39.7 6.0 Favored 'Trans proline' 0 CA--C 1.504 -0.979 1 CA-C-N 129.456 4.413 . . . . 1.0 112.426 170.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.2 -49.73 75.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 123.71 1.719 . . . . 1.0 111.861 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -71.54 -8.78 56.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 115.905 1.817 . . . . 1.0 115.905 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -68.46 0.45 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 124.237 1.97 . . . . 1.0 110.986 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -106.83 -44.73 4.36 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 111.997 -2.365 . . . . 1.0 110.594 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -87.84 -24.89 23.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.427 0.899 . . . . 1.0 113.427 -154.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.0 167.22 39.99 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 115.297 -3.335 . . . . 1.0 118.314 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.21 -61.0 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 C-N-CA 124.772 1.229 . . . . 1.0 112.3 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -105.18 10.44 33.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.465 1.106 . . . . 1.0 109.659 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 146.2 39.25 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -168.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.86 167.25 19.62 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 107.754 -2.139 . . . . 1.0 107.754 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.18 127.02 4.96 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.963 -1.904 . . . . 1.0 109.674 -162.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 173.41 14.56 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 120.615 -1.303 . . . . 1.0 111.351 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -101.46 139.89 36.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.679 0.792 . . . . 1.0 110.112 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.5 ttt -164.68 145.9 7.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.249 1.42 . . . . 1.0 108.629 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 62.84 28.15 16.3 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 123.161 1.458 . . . . 1.0 110.368 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.72 62.25 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 124.246 0.927 . . . . 1.0 115.252 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.93 162.88 39.48 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 120.228 -1.748 . . . . 1.0 110.916 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 t -64.58 152.36 42.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.918 1.818 . . . . 1.0 115.023 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -142.89 85.88 1.9 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 104.357 -2.46 . . . . 1.0 104.357 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.91 128.28 33.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.075 0.95 . . . . 1.0 111.568 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -110.96 95.72 25.84 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.206 1.802 . . . . 1.0 109.125 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--N 1.33 -0.423 0 C-N-CA 122.776 2.318 . . . . 1.0 111.597 167.139 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.431 -1.406 1 N-CA-C 99.17 -4.382 . . . . 1.0 99.17 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.07 153.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 N-CA-C 100.7 -3.815 . . . . 1.0 100.7 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.575 ' CG ' ' HZ2' ' A' ' 6' ' ' LYS . 42.8 t0 -97.27 52.01 1.12 Allowed 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 124.64 2.162 . . . . 1.0 110.308 174.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.55 123.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 105.399 -2.075 . . . . 1.0 105.399 163.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.575 ' HZ2' ' CG ' ' A' ' 4' ' ' ASP . 41.1 mmtm -80.15 142.91 34.32 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.728 0.775 . . . . 1.0 110.524 -173.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -140.47 149.95 43.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 124.184 1.945 . . . . 1.0 116.088 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 m -114.25 -9.22 12.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 129.424 3.09 . . . . 1.0 107.97 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -174.18 158.15 2.66 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.568 1.547 . . . . 1.0 107.285 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.28 -28.76 33.18 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 C-N-CA 122.296 1.997 . . . . 1.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -55.0 -40.01 69.68 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.311 1.444 . . . . 1.0 113.313 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.2 -29.0 67.17 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.145 1.378 . . . . 1.0 114.079 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 t -99.21 -3.48 34.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.121 -0.987 . . . . 1.0 113.094 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.75 -51.55 75.3 Favored Pre-proline 0 N--CA 1.451 -0.418 0 O-C-N 120.247 -1.533 . . . . 1.0 113.851 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.99 -37.94 50.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-O 113.187 -2.922 . . . . 1.0 115.712 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -68.74 -38.31 10.58 Favored 'Trans proline' 0 CA--C 1.508 -0.825 1 CA-C-N 129.134 4.298 . . . . 1.0 112.701 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.1 t -58.63 -50.7 72.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.351 1.548 . . . . 1.0 111.747 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -0.9 12.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 116.762 2.134 . . . . 1.0 116.762 172.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.02 70.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 123.463 1.602 . . . . 1.0 112.316 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -156.26 -26.55 0.1 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.686 -1.597 . . . . 1.0 112.174 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.93 -19.75 51.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 119.959 -1.713 . . . . 1.0 113.19 -169.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.4 157.5 26.23 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 117.851 -2.119 . . . . 1.0 114.622 157.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -69.53 -35.45 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 O-C-N 120.511 -1.582 . . . . 1.0 112.249 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -112.76 10.76 19.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.695 1.598 . . . . 1.0 110.882 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.03 155.52 34.43 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 115.931 1.826 . . . . 1.0 115.931 -166.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.56 166.05 27.83 Favored Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.942 -2.463 . . . . 1.0 106.942 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.31 154.5 50.85 Favored 'General case' 0 N--CA 1.418 -2.027 0 O-C-N 120.568 -1.548 . . . . 1.0 107.792 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -149.36 165.8 30.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.984 167.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.5 t -97.39 140.53 31.7 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 113.445 0.905 . . . . 1.0 113.445 -169.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 ttt -155.83 136.72 13.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.888 -1.132 . . . . 1.0 109.66 167.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.01 31.08 18.09 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.294 1.521 . . . . 1.0 110.269 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.27 15.62 65.85 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 124.611 1.1 . . . . 1.0 115.012 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -146.91 158.14 43.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.319 -1.695 . . . . 1.0 110.081 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.68 156.62 38.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.677 2.473 . . . . 1.0 117.677 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -141.64 89.59 2.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 103.556 -2.757 . . . . 1.0 103.556 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.9 t -85.91 126.56 34.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.513 2.325 . . . . 1.0 112.854 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -115.8 108.07 47.34 Favored Pre-proline 0 N--CA 1.437 -1.089 0 C-N-CA 126.512 1.925 . . . . 1.0 108.501 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 C--N 1.317 -1.1 0 C-N-CA 122.608 2.206 . . . . 1.0 110.323 159.696 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.433 -1.315 1 N-CA-C 98.602 -4.592 . . . . 1.0 98.602 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.95 160.48 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.495 0 N-CA-C 103.787 -2.671 . . . . 1.0 103.787 172.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.51 44.05 1.18 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 124.672 2.177 . . . . 1.0 110.67 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.2 113.17 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 103.979 -2.6 . . . . 1.0 103.979 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -98.49 133.5 42.77 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -161.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 p -135.63 156.94 48.05 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 118.48 2.771 . . . . 1.0 118.48 -165.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -109.65 -23.43 11.45 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.972 -1.922 . . . . 1.0 110.404 156.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 t -131.59 151.82 79.35 Favored Pre-proline 0 CA--C 1.508 -0.661 0 O-C-N 120.192 -1.567 . . . . 1.0 109.655 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.42 -25.22 56.22 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 122.763 2.022 . . . . 1.0 111.953 164.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -58.49 -41.28 84.97 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 122.37 1.081 . . . . 1.0 113.482 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.42 -13.89 62.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.523 1.129 . . . . 1.0 113.445 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -90.59 -8.31 50.5 Favored 'General case' 0 N--CA 1.417 -2.087 0 O-C-N 120.629 -1.294 . . . . 1.0 111.72 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.08 -44.18 59.22 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 116.759 -1.591 . . . . 1.0 113.23 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.84 -46.77 21.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 124.13 2.511 . . . . 1.0 115.683 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.07 -34.91 21.36 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 CA-C-N 127.557 3.735 . . . . 1.0 112.722 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.3 m -58.95 -35.79 73.72 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.704 -1.248 . . . . 1.0 112.3 172.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -20.1 62.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 116.843 2.164 . . . . 1.0 116.843 172.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -69.88 0.36 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 125.074 2.369 . . . . 1.0 111.903 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -93.5 -38.4 11.43 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.35 -2.659 . . . . 1.0 110.254 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.4 -11.72 20.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 -167.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 174.04 18.53 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 123.202 1.445 . . . . 1.0 115.21 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -69.08 -33.61 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 119.452 -2.205 . . . . 1.0 113.123 -167.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -86.98 -12.66 46.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.457 -1.402 . . . . 1.0 112.027 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.44 158.12 18.48 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 116.737 2.125 . . . . 1.0 116.737 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.17 14.46 Favored Glycine 0 CA--C 1.492 -1.377 0 O-C-N 120.912 -1.117 . . . . 1.0 111.184 -170.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.38 149.08 27.44 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.565 -1.55 . . . . 1.0 111.19 -171.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.63 136.22 54.82 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 125.786 1.634 . . . . 1.0 108.362 167.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 t -89.7 130.05 36.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.393 -0.817 . . . . 1.0 110.597 167.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.9 ttt -155.13 137.24 14.71 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 121.049 -1.032 . . . . 1.0 109.612 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.27 29.03 18.66 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.232 1.813 . . . . 1.0 110.992 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.83 10.9 62.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 116.568 1.387 . . . . 1.0 116.568 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -143.91 127.31 16.83 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.739 2.269 . . . . 1.0 109.153 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 153.39 42.7 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 119.437 3.125 . . . . 1.0 119.437 -162.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -123.21 78.95 1.62 Allowed 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 128.579 2.752 . . . . 1.0 104.218 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 t -70.21 132.98 46.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.406 1.482 . . . . 1.0 114.122 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.98 103.86 46.57 Favored Pre-proline 0 N--CA 1.434 -1.27 0 C-N-CA 125.847 1.659 . . . . 1.0 106.852 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.324 -0.734 0 CA-C-N 123.194 2.176 . . . . 1.0 109.899 157.527 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 N--CA 1.439 -1.003 1 N-CA-C 99.95 -4.093 . . . . 1.0 99.95 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.445 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.4 mt -104.53 -146.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 126.695 1.998 . . . . 1.0 107.738 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.445 ' H ' HG22 ' A' ' 3' ' ' ILE . 1.3 t0 -124.31 46.34 2.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 124.956 2.312 . . . . 1.0 109.011 163.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.39 105.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 112.41 -2.177 . . . . 1.0 105.349 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.56 131.54 38.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.741 -1.577 . . . . 1.0 106.741 171.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.79 161.96 39.58 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.051 2.241 . . . . 1.0 117.051 -162.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -46.94 8.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 112.786 -2.006 . . . . 1.0 109.739 154.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 152.97 76.81 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.271 -1.331 . . . . 1.0 111.933 -149.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.29 -33.55 48.01 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.235 2.623 . . . . 1.0 112.034 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -44.85 -48.42 11.09 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 127.282 2.233 . . . . 1.0 112.371 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -63.71 -22.54 66.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.223 1.409 . . . . 1.0 113.978 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.5 t -106.5 -7.47 17.51 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.635 -0.665 . . . . 1.0 112.47 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 tp -64.67 -50.87 62.34 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 116.921 -1.514 . . . . 1.0 113.667 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.77 -41.16 40.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-O 112.918 -3.034 . . . . 1.0 115.543 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -69.03 -40.22 6.77 Favored 'Trans proline' 0 CA--C 1.508 -0.798 1 CA-C-N 129.369 4.382 . . . . 1.0 113.151 173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.1 t -56.89 -44.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.465 1.602 . . . . 1.0 111.627 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -21.01 62.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 174.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.21 -70.89 0.31 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 124.631 2.158 . . . . 1.0 112.89 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -90.58 -42.59 10.71 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.203 -2.726 . . . . 1.0 108.689 -159.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -96.53 -30.19 13.46 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.599 -1.637 . . . . 1.0 113.756 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.98 159.18 22.78 Favored Glycine 0 CA--C 1.484 -1.89 0 C-N-CA 114.798 -3.572 . . . . 1.0 115.016 165.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 tt -70.28 -34.51 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 C-N-CA 126.295 1.838 . . . . 1.0 113.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -98.12 -11.26 23.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.313 0.645 . . . . 1.0 111.801 172.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.39 152.12 11.91 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.812 2.523 . . . . 1.0 117.812 -167.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.4 167.92 29.68 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 109.039 -1.625 . . . . 1.0 109.039 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.98 154.43 42.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 123.286 1.517 . . . . 1.0 110.161 -164.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 175.7 10.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 107.485 -1.302 . . . . 1.0 107.485 166.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.3 t -107.53 147.08 31.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.782 -0.574 . . . . 1.0 110.513 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.1 ttt -164.01 142.01 7.26 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.378 1.471 . . . . 1.0 109.803 169.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.32 35.78 20.66 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 126.157 1.783 . . . . 1.0 110.48 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.87 -5.04 55.27 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 116.231 1.252 . . . . 1.0 116.231 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -135.39 165.26 25.88 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.686 2.243 . . . . 1.0 109.766 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.55 160.89 10.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 115.043 1.497 . . . . 1.0 115.043 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -142.74 90.53 2.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 100.289 -3.967 . . . . 1.0 100.289 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -92.46 128.68 38.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 126.261 1.824 . . . . 1.0 109.034 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.11 98.06 41.12 Favored Pre-proline 0 N--CA 1.436 -1.141 0 C-N-CA 125.212 1.405 . . . . 1.0 107.336 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 121.696 1.597 . . . . 1.0 111.078 173.793 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 98.543 -4.614 . . . . 1.0 98.543 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.79 158.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 101.68 -3.452 . . . . 1.0 101.68 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.85 42.06 1.09 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 124.091 1.901 . . . . 1.0 112.122 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.52 126.67 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 170.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -108.22 140.13 41.9 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.906 0.86 . . . . 1.0 110.958 -157.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.3 156.26 47.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -168.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.4 m -108.77 -26.55 10.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.709 1.719 . . . . 1.0 109.636 162.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -123.17 154.15 65.01 Favored Pre-proline 0 CA--C 1.515 -0.371 0 O-C-N 120.578 -1.326 . . . . 1.0 110.563 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.48 -27.11 54.43 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 121.816 1.677 . . . . 1.0 112.474 160.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.9 -49.63 74.05 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.623 -1.298 . . . . 1.0 112.651 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.93 -5.45 17.03 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.093 1.357 . . . . 1.0 113.633 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.56 -27.79 21.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.113 1.435 . . . . 1.0 109.533 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.9 tp -70.15 -47.3 21.29 Favored Pre-proline 0 C--N 1.355 0.835 0 CA-C-O 116.298 -1.811 . . . . 1.0 114.681 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.13 -35.87 61.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-O 113.23 -2.904 . . . . 1.0 115.288 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.43 -39.93 11.66 Favored 'Trans proline' 0 CA--C 1.502 -1.113 1 CA-C-N 128.98 4.243 . . . . 1.0 112.308 170.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.6 m -61.17 -33.47 73.49 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.744 -1.223 . . . . 1.0 113.379 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -12.2 61.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 116.417 2.006 . . . . 1.0 116.417 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.26 71.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 123.272 1.511 . . . . 1.0 113.518 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -163.05 -30.05 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.782 -1.554 . . . . 1.0 111.33 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.9 -15.46 59.0 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 120.23 -1.544 . . . . 1.0 113.038 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.23 153.3 6.3 Favored Glycine 0 CA--C 1.492 -1.394 0 CA-C-O 122.329 0.961 . . . . 1.0 113.887 150.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.3 -35.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 119.877 -1.955 . . . . 1.0 111.818 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -70.17 -37.44 75.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.996 1.718 . . . . 1.0 109.772 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.07 155.68 1.81 Allowed 'General case' 0 C--N 1.348 0.524 0 N-CA-C 118.163 2.653 . . . . 1.0 118.163 -162.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.18 174.13 15.09 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.361 -1.895 . . . . 1.0 108.361 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.35 137.59 9.34 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 120.879 -1.365 . . . . 1.0 109.386 -165.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -155.48 166.27 34.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.301 -0.96 . . . . 1.0 110.259 165.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.5 141.58 29.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.778 -0.576 . . . . 1.0 112.338 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -155.56 135.96 13.21 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.186 -0.946 . . . . 1.0 109.868 168.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.98 34.03 21.47 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.77 2.028 . . . . 1.0 110.42 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.47 15.27 68.06 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.76 -1.109 . . . . 1.0 115.669 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -145.85 150.76 36.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 119.8 -2.0 . . . . 1.0 110.057 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.0 156.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 -164.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.18 86.8 2.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.734 -2.691 . . . . 1.0 103.734 -175.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 62.1 m -75.31 131.03 40.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 125.967 1.707 . . . . 1.0 113.554 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.74 126.26 28.85 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 106.075 -1.824 . . . . 1.0 106.075 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 CA--C 1.509 -0.765 0 CA-C-N 124.641 2.693 . . . . 1.0 113.466 -168.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.433 -1.312 1 N-CA-C 98.686 -4.561 . . . . 1.0 98.686 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.53 158.76 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 103.284 -2.858 . . . . 1.0 103.284 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.23 50.85 1.56 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.115 2.166 . . . . 1.0 110.358 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.11 118.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 105.373 -2.084 . . . . 1.0 105.373 165.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 134.19 36.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -134.66 146.63 49.69 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 116.967 2.21 . . . . 1.0 116.967 -165.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -110.63 -17.78 13.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 112.433 -2.167 . . . . 1.0 109.176 167.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -140.3 147.62 50.69 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -60.71 -24.15 77.97 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 122.401 2.067 . . . . 1.0 112.88 167.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -37.67 70.72 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 122.716 1.246 . . . . 1.0 112.416 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -60.4 -24.66 65.32 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.543 1.537 . . . . 1.0 114.228 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.5 t -103.46 -5.02 23.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.164 0.983 . . . . 1.0 112.609 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.25 -48.65 75.89 Favored Pre-proline 0 C--N 1.345 0.411 0 O-C-N 120.186 -1.571 . . . . 1.0 114.299 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.61 -34.3 64.12 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-O 113.402 -2.832 . . . . 1.0 115.44 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.59 -36.55 14.5 Favored 'Trans proline' 0 CA--C 1.506 -0.89 1 CA-C-N 128.867 4.202 . . . . 1.0 112.54 169.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 m -59.29 -51.05 71.63 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.122 1.439 . . . . 1.0 112.37 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 2.36 5.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 116.777 2.14 . . . . 1.0 116.777 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.8 -50.93 30.38 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.752 1.739 . . . . 1.0 111.502 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 -12.71 0.24 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.447 -1.706 . . . . 1.0 113.036 -173.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -84.98 -20.74 30.09 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 120.031 -1.668 . . . . 1.0 113.384 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.88 -166.2 33.51 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 115.344 -3.312 . . . . 1.0 119.154 163.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.3 -62.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 C-N-CA 125.098 1.359 . . . . 1.0 112.295 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.69 13.51 14.23 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.906 1.682 . . . . 1.0 107.437 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.09 145.49 0.75 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 118.282 2.697 . . . . 1.0 118.282 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.8 170.8 21.07 Favored Glycine 0 CA--C 1.477 -2.311 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -162.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.16 135.44 24.05 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 -170.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.04 149.28 36.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.05 137.7 34.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 121.221 -0.924 . . . . 1.0 111.902 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -155.69 139.96 16.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 120.819 -1.176 . . . . 1.0 109.68 167.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.8 33.95 19.9 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 126.356 1.862 . . . . 1.0 110.141 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.12 16.7 60.3 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 124.382 0.991 . . . . 1.0 115.525 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -144.84 154.38 42.59 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 119.708 -2.054 . . . . 1.0 107.919 -173.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.35 158.49 31.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 119.675 -1.891 . . . . 1.0 115.987 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -144.09 89.69 2.05 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 101.625 -3.472 . . . . 1.0 101.625 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.2 t -85.64 129.3 34.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.798 2.039 . . . . 1.0 112.398 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -103.89 102.9 34.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 122.149 1.9 . . . . 1.0 111.865 -166.644 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t . . . . . 0 N--CA 1.43 -1.425 1 N-CA-C 98.551 -4.611 . . . . 1.0 98.551 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.21 157.39 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 167.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.61 41.6 1.03 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 125.401 2.525 . . . . 1.0 111.653 176.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -92.84 110.74 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.077 -1.874 . . . . 1.0 106.033 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 137.88 52.63 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.556 -1.34 . . . . 1.0 110.669 171.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -104.53 169.69 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.567 -1.333 . . . . 1.0 113.18 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 p -133.24 -0.75 3.28 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 126.803 2.041 . . . . 1.0 108.825 161.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -177.72 155.48 1.08 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 102.993 -2.966 . . . . 1.0 102.993 -167.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.71 -27.16 68.38 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 123.669 2.346 . . . . 1.0 111.748 163.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.37 -42.57 99.52 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.452 1.12 . . . . 1.0 112.893 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -7.05 41.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 t -99.89 -6.02 27.43 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.651 -1.28 . . . . 1.0 111.483 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.83 -39.59 54.92 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 119.703 -1.873 . . . . 1.0 114.303 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.85 -47.35 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 CA-C-O 113.8 -2.667 . . . . 1.0 115.792 169.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.31 -35.67 23.33 Favored 'Trans proline' 0 CA--C 1.507 -0.836 0 CA-C-N 127.995 3.891 . . . . 1.0 112.516 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.3 m -59.25 -34.36 72.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.954 -1.092 . . . . 1.0 112.5 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -25.25 63.05 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 117.01 2.226 . . . . 1.0 117.01 170.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -67.05 0.57 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 124.775 2.226 . . . . 1.0 113.256 -174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.48 -39.04 10.62 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 111.548 -2.569 . . . . 1.0 109.99 -166.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.19 -27.39 13.83 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.527 -1.215 . . . . 1.0 114.267 -162.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.45 171.27 19.83 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 119.98 -1.7 . . . . 1.0 115.758 163.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mp -69.51 -46.35 76.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 120.007 -1.878 . . . . 1.0 111.818 -175.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -83.83 -15.78 46.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.581 -1.324 . . . . 1.0 111.509 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.59 160.2 1.34 Allowed 'General case' 0 C--N 1.355 0.818 0 N-CA-C 117.833 2.531 . . . . 1.0 117.833 -166.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.01 177.4 20.95 Favored Glycine 0 CA--C 1.49 -1.469 0 O-C-N 120.718 -1.239 . . . . 1.0 111.881 -166.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.21 144.77 31.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.769 -1.43 . . . . 1.0 109.436 -170.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 153.46 35.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.39 1.076 . . . . 1.0 108.191 163.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.98 122.19 43.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.666 0.786 . . . . 1.0 110.346 167.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.7 tpp -154.95 140.71 18.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.847 -1.158 . . . . 1.0 112.034 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 33.37 17.35 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.143 1.777 . . . . 1.0 109.908 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.18 1.36 41.43 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 115.897 1.119 . . . . 1.0 115.897 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -132.6 151.61 51.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 120.021 -1.87 . . . . 1.0 107.831 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.0 t -67.33 156.95 35.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.358 -2.088 . . . . 1.0 114.713 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.16 81.15 1.84 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.435 -2.802 . . . . 1.0 103.435 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 t -81.56 140.67 34.36 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.448 1.099 . . . . 1.0 113.964 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.86 99.5 45.56 Favored Pre-proline 0 N--CA 1.437 -1.108 0 C-N-CA 125.554 1.542 . . . . 1.0 107.11 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--N 1.329 -0.466 0 C-N-CA 122.778 2.318 . . . . 1.0 110.841 169.369 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.4 t . . . . . 0 N--CA 1.429 -1.517 1 N-CA-C 98.241 -4.726 . . . . 1.0 98.241 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.75 158.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 102.49 -3.152 . . . . 1.0 102.49 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 39.03 0.91 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.635 2.636 . . . . 1.0 112.1 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -91.56 103.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.725 -1.58 . . . . 1.0 107.419 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 142.87 51.96 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.776 -1.202 . . . . 1.0 110.717 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.51 166.33 14.85 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.687 -1.258 . . . . 1.0 114.081 -170.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.9 p -126.7 -6.35 6.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.748 2.019 . . . . 1.0 109.325 150.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -178.98 154.91 0.81 Allowed Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 101.107 -3.664 . . . . 1.0 101.107 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.51 -28.37 77.58 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 CA-C-N 123.874 2.419 . . . . 1.0 112.189 162.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.8 -29.13 68.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.733 0.778 . . . . 1.0 112.801 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -9.93 57.82 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 120.723 -1.236 . . . . 1.0 114.3 175.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.3 t -93.36 -7.78 43.77 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.583 -1.323 . . . . 1.0 112.16 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -49.32 88.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 119.941 -1.724 . . . . 1.0 113.958 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.08 -32.92 63.5 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 CA-C-O 113.293 -2.878 . . . . 1.0 115.929 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.11 -36.3 10.11 Favored 'Trans proline' 0 CA--C 1.504 -0.976 1 CA-C-N 129.074 4.277 . . . . 1.0 112.632 167.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.83 -61.55 2.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.949 1.357 . . . . 1.0 111.749 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 21.24 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.921 -1.112 . . . . 1.0 113.873 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.07 -69.93 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 118.092 -2.88 . . . . 1.0 107.973 159.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.81 -20.89 2.21 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 127.435 2.294 . . . . 1.0 114.08 -163.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -87.97 -16.7 33.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.293 -1.505 . . . . 1.0 114.576 -165.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.26 178.67 38.8 Favored Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.226 -1.464 . . . . 1.0 111.35 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.01 -55.65 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 122.481 1.134 . . . . 1.0 112.776 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -122.89 25.08 8.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 123.45 1.595 . . . . 1.0 107.267 -175.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.48 143.89 0.19 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 119.166 3.025 . . . . 1.0 119.166 -163.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.09 163.59 13.23 Favored Glycine 0 CA--C 1.476 -2.368 0 N-CA-C 108.366 -1.893 . . . . 1.0 108.366 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.14 126.66 9.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.746 -1.205 . . . . 1.0 107.746 -172.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 150.95 39.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -96.61 139.66 32.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.951 -1.093 . . . . 1.0 112.115 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -156.93 144.81 19.24 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 166.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.341 0.7 OUTLIER 62.67 20.31 11.97 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.414 1.885 . . . . 1.0 113.381 -174.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.6 9.51 86.15 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 114.998 -1.001 . . . . 1.0 114.661 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.25 159.0 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.424 -1.633 . . . . 1.0 108.007 -170.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 t -70.05 159.04 34.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.214 -2.179 . . . . 1.0 116.409 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -144.48 90.35 2.08 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 102.034 -3.321 . . . . 1.0 102.034 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.3 t -84.45 130.26 34.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.734 2.014 . . . . 1.0 112.962 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -102.45 107.49 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.452 -0.932 0 C-N-CA 121.768 1.645 . . . . 1.0 112.365 -166.852 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.443 -0.815 0 N-CA-C 103.135 -2.913 . . . . 1.0 103.135 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.38 161.1 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 161.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.44 65.23 0.61 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.981 1.713 . . . . 1.0 107.508 160.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.9 t -84.64 109.2 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.673 -1.973 . . . . 1.0 105.673 160.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 124.17 41.32 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.9 1.28 . . . . 1.0 108.96 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -145.11 163.02 35.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.357 1.984 . . . . 1.0 116.357 -155.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -99.32 -36.15 9.71 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 123.646 1.688 . . . . 1.0 109.758 154.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -116.97 150.66 46.32 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.445 -1.252 . . . . 1.0 111.536 -156.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.8 -34.24 31.59 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.026 1.817 . . . . 1.0 111.776 170.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -54.85 -41.72 71.11 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.974 1.31 . . . . 1.0 113.021 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -54.75 -30.6 56.86 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.759 1.223 . . . . 1.0 114.149 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t -100.57 -9.37 22.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . 0.267 2.8 tm? -68.42 -49.21 32.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 120.402 -1.436 . . . . 1.0 113.192 -170.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.43 -44.29 43.85 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 CA-C-O 114.267 -2.472 . . . . 1.0 115.95 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.17 -37.73 13.78 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 CA-C-N 127.194 3.605 . . . . 1.0 112.981 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.93 -49.0 78.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.864 1.792 . . . . 1.0 111.414 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -71.31 -8.2 52.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.64 -54.92 10.06 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.605 1.669 . . . . 1.0 111.775 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.11 -23.26 1.03 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 113.146 -1.843 . . . . 1.0 112.597 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -84.64 -20.22 31.69 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 120.162 -1.586 . . . . 1.0 113.55 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.7 179.49 45.04 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 116.462 -2.78 . . . . 1.0 116.978 157.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 tt -70.72 -55.75 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 125.782 1.633 . . . . 1.0 112.434 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -121.31 19.19 11.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.476 1.911 . . . . 1.0 107.035 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.01 145.75 16.01 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.27 1.952 . . . . 1.0 116.27 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.35 162.29 22.68 Favored Glycine 0 CA--C 1.471 -2.659 0 N-CA-C 107.952 -2.059 . . . . 1.0 107.952 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.46 131.71 24.96 Favored 'General case' 0 N--CA 1.425 -1.701 0 O-C-N 120.678 -1.484 . . . . 1.0 107.456 -163.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -141.9 148.2 38.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -99.12 144.82 27.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.246 -1.533 . . . . 1.0 111.146 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -162.2 144.14 11.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.718 -1.239 . . . . 1.0 109.662 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.55 32.29 18.71 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.77 1.628 . . . . 1.0 110.855 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.11 65.98 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 114.636 -1.166 . . . . 1.0 115.885 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -142.67 153.27 43.26 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 120.175 1.987 . . . . 1.0 109.284 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.81 161.61 29.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 115.78 1.77 . . . . 1.0 115.78 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.45 95.38 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 101.738 -3.43 . . . . 1.0 101.738 168.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.7 t -82.56 116.6 22.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.117 1.767 . . . . 1.0 110.107 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -99.2 110.08 56.78 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 126.228 1.811 . . . . 1.0 107.681 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 122.115 1.877 . . . . 1.0 112.249 -175.739 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 N--CA 1.436 -1.127 1 N-CA-C 98.039 -4.801 . . . . 1.0 98.039 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.72 -155.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.39 52.57 2.01 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.606 2.146 . . . . 1.0 109.311 170.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 115.81 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 171.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 137.65 36.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.916 0.887 . . . . 1.0 109.449 -169.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.92 159.19 42.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.842 1.793 . . . . 1.0 115.842 -167.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -103.63 -33.98 8.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.379 -1.737 . . . . 1.0 109.492 154.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -108.98 145.38 31.6 Favored Pre-proline 0 CA--C 1.512 -0.508 0 O-C-N 120.547 -1.346 . . . . 1.0 111.065 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.94 -28.38 50.17 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.403 2.069 . . . . 1.0 111.633 175.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -56.8 -35.99 69.4 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 124.103 0.961 . . . . 1.0 113.461 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.36 -23.33 66.73 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.866 1.266 . . . . 1.0 114.181 177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -84.04 -23.89 30.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.493 1.117 . . . . 1.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 tp -70.15 -53.72 10.47 Favored Pre-proline 0 C--N 1.355 0.821 0 CA-C-O 116.841 -1.552 . . . . 1.0 114.853 -166.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.58 -35.38 81.61 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-O 113.366 -2.847 . . . . 1.0 115.113 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -69.79 -41.14 4.49 Favored 'Trans proline' 0 CA--C 1.508 -0.817 1 CA-C-N 128.532 4.083 . . . . 1.0 112.799 168.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.21 -50.08 73.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.655 1.693 . . . . 1.0 112.178 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -71.16 -8.51 54.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 115.139 1.533 . . . . 1.0 115.139 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.2 -64.27 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.198 1.952 . . . . 1.0 111.433 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -119.0 -28.81 5.43 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 111.989 -2.369 . . . . 1.0 111.574 -162.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -95.32 -26.95 15.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -166.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.39 171.14 42.5 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 115.884 -3.055 . . . . 1.0 117.605 171.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.87 -53.42 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 125.752 1.621 . . . . 1.0 113.039 -170.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -124.66 30.92 5.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 148.14 18.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.746 2.128 . . . . 1.0 116.746 -167.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.74 161.27 12.75 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 107.0 -2.44 . . . . 1.0 107.0 -172.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.77 121.17 3.6 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.967 -1.902 . . . . 1.0 108.047 -157.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -148.81 155.0 40.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.163 -1.421 . . . . 1.0 107.163 -168.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.2 t -97.4 139.93 32.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 121.249 -0.907 . . . . 1.0 111.23 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -155.52 138.48 15.42 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.29 -1.506 . . . . 1.0 109.583 169.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.5 28.82 13.44 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.161 1.385 . . . . 1.0 110.94 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.52 80.58 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 124.422 1.01 . . . . 1.0 115.186 -173.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -141.86 152.93 44.07 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 119.905 -1.938 . . . . 1.0 110.971 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -68.6 144.09 54.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.864 1.792 . . . . 1.0 114.815 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -140.82 91.83 2.45 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.245 -2.502 . . . . 1.0 104.245 -174.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.3 t -81.4 127.49 32.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.256 2.623 . . . . 1.0 112.106 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -103.04 101.77 23.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 126.574 1.95 . . . . 1.0 105.898 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 122.231 1.954 . . . . 1.0 112.382 -164.527 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.441 -0.893 1 N-CA-C 98.043 -4.799 . . . . 1.0 98.043 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.24 154.68 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 102.305 -3.22 . . . . 1.0 102.305 161.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.38 48.28 1.3 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 124.174 1.94 . . . . 1.0 110.871 177.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.35 129.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.606 -1.998 . . . . 1.0 105.606 171.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -97.06 142.77 28.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.2 152.25 35.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.499 2.037 . . . . 1.0 116.499 -172.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.4 m -100.39 -33.66 10.28 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.747 2.419 . . . . 1.0 109.135 159.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.2 t -120.26 146.6 43.01 Favored Pre-proline 0 CA--C 1.512 -0.483 0 O-C-N 120.951 -1.093 . . . . 1.0 110.295 -173.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.5 -24.47 78.13 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.951 1.767 . . . . 1.0 112.676 165.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.42 -28.71 69.99 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 122.002 0.906 . . . . 1.0 113.076 -176.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.75 -18.61 65.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.54 1.136 . . . . 1.0 114.059 177.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 68.0 m -85.3 -14.59 46.08 Favored 'General case' 0 N--CA 1.425 -1.718 0 O-C-N 120.799 -1.188 . . . . 1.0 113.538 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -49.38 75.28 Favored Pre-proline 0 C--N 1.351 0.655 0 O-C-N 120.603 -1.311 . . . . 1.0 114.444 -170.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.08 -39.35 50.19 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 CA-C-O 113.449 -2.813 . . . . 1.0 115.473 174.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.6 -36.92 10.3 Favored 'Trans proline' 0 CA--C 1.511 -0.667 1 CA-C-N 128.652 4.126 . . . . 1.0 113.096 172.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 m -59.52 -45.25 92.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.239 -1.538 . . . . 1.0 111.714 176.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -71.01 -13.4 61.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 171.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.9 -67.44 0.53 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 124.146 1.927 . . . . 1.0 112.287 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -105.36 -41.64 5.46 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 111.836 -2.438 . . . . 1.0 110.211 -163.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -87.32 -36.69 17.71 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -160.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.05 -177.24 46.65 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 115.934 -3.032 . . . . 1.0 117.922 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.9 -53.57 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 125.97 1.708 . . . . 1.0 113.394 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 16.12 15.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.718 2.407 . . . . 1.0 108.469 -174.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 148.8 10.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 116.946 2.202 . . . . 1.0 116.946 -172.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.71 -170.99 13.08 Favored Glycine 0 CA--C 1.475 -2.432 0 N-CA-C 108.486 -1.846 . . . . 1.0 108.486 -164.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.99 6.91 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 120.325 -1.691 . . . . 1.0 108.842 -175.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.31 0.0 OUTLIER -149.53 -177.86 6.1 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.694 143.52 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -115.13 135.78 53.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.896 1.678 . . . . 1.0 109.906 -176.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.09 151.43 21.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.306 -1.738 . . . . 1.0 106.306 168.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.346 0.5 OUTLIER 63.43 18.73 11.25 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.131 1.772 . . . . 1.0 113.439 -173.952 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.85 76.48 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.308 1.432 . . . . 1.0 114.729 -172.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -141.79 161.32 38.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.037 -1.861 . . . . 1.0 109.558 -177.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.1 t -69.75 163.83 24.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.952 2.204 . . . . 1.0 116.952 -168.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.88 90.26 1.82 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.212 -2.514 . . . . 1.0 104.212 167.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -78.17 140.17 38.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.266 2.226 . . . . 1.0 114.263 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -108.32 106.45 58.66 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 127.692 2.397 . . . . 1.0 107.156 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo . . . . . 0 C--N 1.324 -0.715 0 C-N-CA 122.619 2.213 . . . . 1.0 112.244 -179.073 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.439 -0.999 1 N-CA-C 99.326 -4.324 . . . . 1.0 99.326 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.2 mt -103.55 -149.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 126.815 2.046 . . . . 1.0 106.368 175.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -132.13 43.71 2.99 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 125.15 2.405 . . . . 1.0 109.644 164.706 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.51 120.02 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 112.81 -1.995 . . . . 1.0 106.014 166.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -94.78 141.12 29.0 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 105.399 -2.074 . . . . 1.0 105.399 172.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -122.48 149.83 43.35 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 117.639 2.459 . . . . 1.0 117.639 -164.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -114.08 -5.93 13.1 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.417 -2.174 . . . . 1.0 110.415 169.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -168.28 155.76 7.61 Favored Pre-proline 0 CA--C 1.504 -0.8 0 N-CA-C 105.129 -2.174 . . . . 1.0 105.129 -174.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.91 -26.87 51.38 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 124.315 2.577 . . . . 1.0 111.457 163.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -64.66 -36.07 83.06 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 113.598 0.962 . . . . 1.0 113.598 -168.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -13.82 62.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 176.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.6 t -96.18 -4.49 42.46 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.932 -1.105 . . . . 1.0 111.781 173.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.13 -50.97 83.65 Favored Pre-proline 0 C--N 1.349 0.578 0 O-C-N 120.303 -1.498 . . . . 1.0 113.5 177.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 -37.66 59.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-O 113.278 -2.884 . . . . 1.0 115.74 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -68.34 -38.18 12.25 Favored 'Trans proline' 0 CA--C 1.506 -0.898 1 CA-C-N 128.604 4.109 . . . . 1.0 112.771 169.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 m -58.37 -47.11 84.86 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.137 1.446 . . . . 1.0 112.745 177.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -4.46 27.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 117.189 2.292 . . . . 1.0 117.189 172.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.45 11.44 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 123.433 1.587 . . . . 1.0 111.257 -178.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.1 -11.5 0.19 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 113.906 -1.497 . . . . 1.0 114.253 -175.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -79.57 -25.58 41.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.797 -1.814 . . . . 1.0 112.751 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.37 159.93 27.29 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 117.188 -2.434 . . . . 1.0 115.317 162.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.94 -33.8 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 120.378 -1.66 . . . . 1.0 112.442 -173.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -115.04 13.66 16.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.906 1.682 . . . . 1.0 110.675 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 162.58 6.98 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 118.233 2.679 . . . . 1.0 118.233 -163.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.81 -171.27 15.92 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 107.187 -2.365 . . . . 1.0 107.187 -176.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.14 154.63 36.24 Favored 'General case' 0 N--CA 1.424 -1.747 0 O-C-N 120.925 -1.338 . . . . 1.0 108.408 -175.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -111.81 146.31 37.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.911 -1.515 . . . . 1.0 106.911 162.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.4 t -94.02 121.26 35.32 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 160.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.6 ttt -149.84 127.38 11.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.717 1.246 . . . . 1.0 111.497 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.17 31.19 17.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 126.824 2.05 . . . . 1.0 110.331 -177.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.95 9.31 79.61 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 115.3 0.88 . . . . 1.0 115.3 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -135.45 143.78 46.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 119.674 -2.074 . . . . 1.0 108.385 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.3 143.38 52.06 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -176.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.48 82.26 2.05 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 102.476 -3.157 . . . . 1.0 102.476 -174.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -71.34 135.41 47.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.388 2.275 . . . . 1.0 114.545 -173.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -120.45 103.46 44.16 Favored Pre-proline 0 N--CA 1.444 -0.766 0 C-N-CA 125.335 1.454 . . . . 1.0 110.038 -165.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo . . . . . 0 C--N 1.319 -1.018 0 C-N-CA 122.284 1.989 . . . . 1.0 110.137 151.732 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.446 -0.629 1 N-CA-C 96.627 -5.323 . . . . 1.0 96.627 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.74 145.76 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 N-CA-C 102.933 -2.988 . . . . 1.0 102.933 172.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.267 13.1 t70 -91.52 45.56 1.24 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.642 2.163 . . . . 1.0 112.551 -173.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.53 107.0 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 164.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -87.99 144.48 26.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.319 1.057 . . . . 1.0 112.556 -164.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.92 142.6 51.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.467 2.395 . . . . 1.0 117.467 -162.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -115.97 1.47 13.31 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.056 2.542 . . . . 1.0 108.231 173.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -173.65 153.95 2.31 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 118.621 -2.549 . . . . 1.0 105.414 -174.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.66 -21.82 38.59 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 123.698 2.357 . . . . 1.0 112.653 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -55.78 -31.4 62.58 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.281 1.432 . . . . 1.0 113.699 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -62.73 -23.13 67.02 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 124.622 1.169 . . . . 1.0 113.784 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.2 t -82.83 -20.99 34.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.005 0.922 . . . . 1.0 112.059 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 tp -68.54 -51.8 21.69 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-O 116.984 -1.484 . . . . 1.0 114.31 -174.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.9 -29.74 58.0 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-O 113.099 -2.959 . . . . 1.0 115.618 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.14 -39.79 2.02 Favored 'Trans proline' 0 CA--C 1.503 -1.031 1 CA-C-N 129.374 4.384 . . . . 1.0 112.456 166.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 t -62.61 -59.05 5.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.263 1.506 . . . . 1.0 111.617 -178.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 22.04 0.06 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.763 1.625 . . . . 1.0 113.435 165.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.59 -76.76 0.1 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 118.328 -2.733 . . . . 1.0 107.859 158.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -117.68 -34.21 4.3 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 111.498 -2.592 . . . . 1.0 113.189 -159.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -76.85 -30.28 56.24 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 120.823 -1.173 . . . . 1.0 112.535 -166.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.42 156.42 9.9 Favored Glycine 0 CA--C 1.494 -1.262 0 C-N-CA 118.166 -1.969 . . . . 1.0 115.748 166.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -71.14 -25.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.135 1.374 . . . . 1.0 112.075 159.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -81.89 -21.97 37.11 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.398 2.679 . . . . 1.0 110.455 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.46 153.59 42.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 116.036 1.865 . . . . 1.0 116.036 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.79 170.91 16.09 Favored Glycine 0 CA--C 1.489 -1.578 0 N-CA-C 108.351 -1.899 . . . . 1.0 108.351 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.84 129.62 10.12 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 119.421 -2.223 . . . . 1.0 108.841 -159.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.1 12.35 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 120.271 -1.518 . . . . 1.0 111.999 174.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.59 132.27 44.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.568 1.547 . . . . 1.0 109.752 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.2 ttt -161.47 140.23 9.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.136 1.374 . . . . 1.0 110.213 173.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 59.54 34.91 22.58 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 124.489 2.09 . . . . 1.0 110.759 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.92 57.15 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 114.075 -1.421 . . . . 1.0 116.143 -176.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 176.92 8.27 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 120.199 1.999 . . . . 1.0 112.877 -177.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.01 145.69 49.84 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 124.763 2.22 . . . . 1.0 114.538 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -137.38 92.9 2.75 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 102.841 -3.022 . . . . 1.0 102.841 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 131.3 40.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.051 -1.431 . . . . 1.0 112.084 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -111.79 82.83 4.2 Favored Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 127.734 2.414 . . . . 1.0 109.254 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 C--N 1.33 -0.397 0 CA-C-N 124.187 2.531 . . . . 1.0 109.049 154.162 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.432 -1.365 1 N-CA-C 99.891 -4.115 . . . . 1.0 99.891 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.58 156.24 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 102.244 -3.243 . . . . 1.0 102.244 170.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -94.59 54.01 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 124.156 1.931 . . . . 1.0 109.182 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.59 117.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -87.18 140.84 29.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.54 1.162 . . . . 1.0 109.235 -175.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.78 148.59 50.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 117.327 2.343 . . . . 1.0 117.327 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -114.59 1.13 14.17 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 124.925 2.298 . . . . 1.0 108.416 172.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -174.11 154.43 2.16 Favored Pre-proline 0 N--CA 1.444 -0.742 0 O-C-N 118.744 -2.473 . . . . 1.0 105.774 -174.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.71 -26.41 45.71 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 CA-C-N 123.221 2.186 . . . . 1.0 111.872 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -44.56 -46.7 10.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 128.644 2.778 . . . . 1.0 112.181 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -61.76 -28.42 69.43 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.629 1.572 . . . . 1.0 113.316 -174.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.9 t -94.28 -8.45 39.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.931 0.872 . . . . 1.0 112.412 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.93 -41.71 29.29 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 119.72 -1.863 . . . . 1.0 114.426 -178.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.13 -46.86 22.83 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-O 113.934 -2.611 . . . . 1.0 115.472 168.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.05 -36.03 23.49 Favored 'Trans proline' 0 CA--C 1.51 -0.697 0 CA-C-N 127.795 3.82 . . . . 1.0 112.507 174.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.3 m -63.54 -26.71 68.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 121.033 -1.042 . . . . 1.0 112.698 172.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -33.69 70.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 117.34 2.348 . . . . 1.0 117.34 162.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -66.97 0.56 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 124.687 2.184 . . . . 1.0 112.394 -169.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.8 -38.13 23.53 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 111.826 -2.443 . . . . 1.0 109.407 -172.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -112.78 -3.95 14.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.407 -1.27 . . . . 1.0 113.563 -164.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -178.58 37.49 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 124.34 2.078 . . . . 1.0 116.602 161.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -70.36 -33.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 O-C-N 119.465 -2.197 . . . . 1.0 114.108 -165.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -77.06 -33.86 57.17 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 120.913 -1.117 . . . . 1.0 110.439 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 137.51 58.09 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 116.548 2.055 . . . . 1.0 116.548 -161.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.67 174.4 25.69 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -175.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.83 131.43 8.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 120.556 -1.555 . . . . 1.0 108.901 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.1 168.96 21.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.713 -1.242 . . . . 1.0 109.87 174.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.22 129.73 55.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.617 0.767 . . . . 1.0 112.306 -168.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 125.06 43.43 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 126.904 2.082 . . . . 1.0 111.371 166.339 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.53 25.88 15.4 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 123.405 1.574 . . . . 1.0 112.128 170.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.21 77.42 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.624 -1.171 . . . . 1.0 115.682 -175.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -136.52 155.25 50.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 120.358 2.079 . . . . 1.0 108.946 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -70.55 160.63 32.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 118.557 2.799 . . . . 1.0 118.557 -175.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -148.24 99.75 3.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 104.144 -2.539 . . . . 1.0 104.144 165.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.6 t -80.78 130.79 35.26 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.515 2.726 . . . . 1.0 111.53 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -98.98 138.94 20.7 Favored Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 119.479 -2.013 . . . . 1.0 107.64 -178.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo . . . . . 0 CA--C 1.507 -0.834 0 CA-C-N 123.96 2.45 . . . . 1.0 111.802 171.679 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.513 2.714 0 CA-C-O 121.113 0.482 . . . . 1.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -138.95 137.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 1 N-CA-C 99.098 -4.408 . . . . 1.0 99.098 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.31 159.95 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 N-CA-C 102.403 -3.184 . . . . 1.0 102.403 169.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.27 49.16 1.58 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 124.651 2.167 . . . . 1.0 110.622 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.14 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 104.648 -2.352 . . . . 1.0 104.648 167.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.72 137.07 32.66 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.06 148.38 52.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 118.798 2.888 . . . . 1.0 118.798 -165.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -101.69 -14.45 17.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 113.283 -1.78 . . . . 1.0 110.902 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -169.95 167.33 5.03 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 -169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -64.38 -24.19 64.68 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.75 2.375 . . . . 1.0 114.258 174.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -47.58 -53.32 14.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 127.351 2.26 . . . . 1.0 112.349 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -70.73 -12.58 61.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.481 1.512 . . . . 1.0 114.547 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.9 t -100.68 -9.48 21.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.204 -0.935 . . . . 1.0 112.555 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -67.3 -45.11 49.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 119.94 -1.725 . . . . 1.0 114.148 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.97 -41.33 62.86 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 CA-C-O 114.106 -2.539 . . . . 1.0 115.902 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -68.84 -34.58 17.72 Favored 'Trans proline' 0 CA--C 1.505 -0.926 0 CA-C-N 127.283 3.637 . . . . 1.0 112.758 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -59.38 -51.47 69.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.575 -1.328 . . . . 1.0 112.01 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.272 0.0 OUTLIER -71.7 -2.32 16.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 115.444 1.646 . . . . 1.0 115.444 170.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -69.89 0.36 Allowed 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 118.934 -2.354 . . . . 1.0 111.173 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.63 -29.34 6.49 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 111.627 -2.533 . . . . 1.0 111.965 -160.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -88.48 -32.46 18.24 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.12 1.156 . . . . 1.0 114.12 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.88 178.16 47.43 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 117.958 -2.068 . . . . 1.0 115.811 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.88 -46.72 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 126.215 1.806 . . . . 1.0 113.896 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.48 HH22 ' CD2' ' A' ' 39' ' ' HIS . 35.6 ttp180 -122.25 20.57 10.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.511 -1.663 . . . . 1.0 106.511 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.44 143.47 40.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 115.994 1.85 . . . . 1.0 115.994 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.36 172.76 15.08 Favored Glycine 0 CA--C 1.478 -2.264 0 N-CA-C 108.574 -1.81 . . . . 1.0 108.574 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.13 138.71 18.69 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 -169.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.78 169.56 17.54 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 117.945 -1.502 . . . . 1.0 109.843 164.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.4 t -106.41 147.68 28.99 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.183 0.993 . . . . 1.0 109.956 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -160.15 148.2 16.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 105.827 -1.916 . . . . 1.0 105.827 159.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.312 0.9 OUTLIER 58.54 27.03 15.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.795 1.638 . . . . 1.0 113.435 177.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.36 14.62 77.06 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.134 -1.394 . . . . 1.0 115.936 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -144.85 153.98 42.16 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 119.695 -2.062 . . . . 1.0 109.123 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.1 t -70.55 157.63 37.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 116.552 2.056 . . . . 1.0 116.552 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 94.06 2.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.175 -3.639 . . . . 1.0 101.175 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.03 137.8 32.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.436 2.294 . . . . 1.0 112.313 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -108.11 98.28 25.67 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 125.5 1.52 . . . . 1.0 108.251 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.69 76.56 4.43 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.14 1.893 . . . . 1.0 112.441 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.48 ' CD2' HH22 ' A' ' 24' ' ' ARG . 35.0 t60 . . . . . 0 C--O 1.262 1.754 0 O-C-N 121.656 -0.652 . . . . 1.0 112.443 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.508 2.428 0 CA-C-O 121.044 0.45 . . . . 1.0 111.494 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.43 134.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 100.38 -3.933 . . . . 1.0 100.38 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.01 154.83 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 101.486 -3.524 . . . . 1.0 101.486 166.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 45.87 1.21 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.718 2.199 . . . . 1.0 111.16 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.2 t -84.12 113.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 103.766 -2.679 . . . . 1.0 103.766 163.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -93.06 143.02 26.65 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.165 0.983 . . . . 1.0 110.853 -169.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -141.04 158.31 44.11 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 117.57 2.433 . . . . 1.0 117.57 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.1 p -111.65 -16.8 13.16 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 112.939 -1.937 . . . . 1.0 110.799 161.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -135.72 151.23 73.87 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 125.033 1.333 . . . . 1.0 109.516 -171.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.99 -21.32 63.82 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 122.604 1.966 . . . . 1.0 112.289 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -57.51 -49.55 75.96 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 122.188 0.994 . . . . 1.0 112.79 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -70.18 -10.73 59.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.976 1.31 . . . . 1.0 114.323 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.72 -26.05 24.43 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.63 -1.294 . . . . 1.0 108.929 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.62 -49.64 60.14 Favored Pre-proline 0 C--N 1.352 0.682 0 CA-C-O 116.561 -1.685 . . . . 1.0 115.177 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.31 -40.01 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 CA-C-N 125.001 2.822 . . . . 1.0 115.391 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.54 -35.88 16.31 Favored 'Trans proline' 0 CA--C 1.502 -1.114 1 CA-C-N 128.491 4.068 . . . . 1.0 112.244 169.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -58.05 -43.21 86.76 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.822 1.296 . . . . 1.0 112.617 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -70.61 -11.56 61.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -67.34 0.53 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.967 2.318 . . . . 1.0 112.443 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.19 -27.83 8.54 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.36 -2.654 . . . . 1.0 111.649 -161.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.07 -20.3 18.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.65 149.75 5.11 Favored Glycine 0 CA--C 1.494 -1.271 0 O-C-N 120.53 -1.356 . . . . 1.0 114.457 160.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.08 -37.21 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 119.962 -1.904 . . . . 1.0 112.057 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.671 HH22 ' CD2' ' A' ' 39' ' ' HIS . 9.4 ttp180 -81.88 -24.02 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.737 -1.852 . . . . 1.0 111.578 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.7 161.76 1.02 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 117.868 2.544 . . . . 1.0 117.868 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.45 167.5 12.49 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 109.318 -1.513 . . . . 1.0 109.318 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.19 134.03 16.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.045 -1.268 . . . . 1.0 108.51 -167.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 156.77 41.44 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 120.913 -1.117 . . . . 1.0 110.427 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.4 t -98.98 129.17 45.26 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 161.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -158.63 134.5 8.97 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 121.137 -0.977 . . . . 1.0 110.558 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 56.54 40.76 29.32 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.741 2.016 . . . . 1.0 110.354 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.77 15.04 57.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 113.809 -1.542 . . . . 1.0 115.704 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.52 157.92 45.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 119.885 -1.95 . . . . 1.0 109.214 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.1 t -65.66 153.59 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 123.358 1.552 . . . . 1.0 113.056 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB2' ' HZ1' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -152.68 78.22 1.19 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 123.03 1.395 . . . . 1.0 108.45 -166.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.63 138.29 44.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.957 1.836 . . . . 1.0 115.957 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -105.79 95.13 9.97 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 105.828 -1.916 . . . . 1.0 105.828 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.76 70.2 7.49 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.963 2.442 . . . . 1.0 112.282 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.671 ' CD2' HH22 ' A' ' 24' ' ' ARG . 8.7 t60 . . . . . 0 C--O 1.258 1.508 0 C-N-CA 124.327 1.051 . . . . 1.0 108.716 176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.507 2.396 0 CA-C-O 120.96 0.41 . . . . 1.0 111.447 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.2 t -143.87 137.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 1 N-CA-C 99.979 -4.082 . . . . 1.0 99.979 -176.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.06 159.6 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 C-N-CA 129.495 3.118 . . . . 1.0 102.736 170.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.14 46.46 1.35 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 124.428 2.061 . . . . 1.0 110.919 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.17 128.66 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.69 135.83 53.72 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.72 0.772 . . . . 1.0 109.285 -163.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.09 161.77 41.72 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 115.848 1.796 . . . . 1.0 115.848 -164.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -107.17 -26.11 11.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 113.693 -1.594 . . . . 1.0 109.852 157.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -119.21 146.33 40.41 Favored Pre-proline 0 CA--C 1.512 -0.511 0 O-C-N 120.603 -1.311 . . . . 1.0 111.466 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.06 -19.49 63.44 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 122.032 1.821 . . . . 1.0 112.687 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.72 -41.23 85.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 121.423 -0.798 . . . . 1.0 112.742 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.32 -22.14 64.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.135 1.774 . . . . 1.0 113.879 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -91.61 -16.05 27.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.07 0.948 . . . . 1.0 111.899 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 tp -66.87 -51.59 37.34 Favored Pre-proline 0 C--N 1.35 0.607 0 CA-C-O 117.176 -1.393 . . . . 1.0 114.014 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.39 -36.98 52.33 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-O 113.1 -2.959 . . . . 1.0 115.623 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.62 -42.48 2.48 Favored 'Trans proline' 0 CA--C 1.502 -1.109 1 CA-C-N 129.232 4.333 . . . . 1.0 113.176 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.23 -48.42 81.7 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.783 -1.198 . . . . 1.0 110.956 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -70.84 -9.8 58.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 116.61 2.078 . . . . 1.0 116.61 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.76 -74.65 0.16 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 124.792 2.234 . . . . 1.0 112.353 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.5 -35.22 68.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 111.518 -2.583 . . . . 1.0 110.052 -164.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -107.82 -8.92 15.87 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.896 -1.502 . . . . 1.0 110.544 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 -161.9 26.83 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 124.539 2.188 . . . . 1.0 117.262 156.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -68.67 -28.24 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 119.715 -2.05 . . . . 1.0 112.591 -167.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -78.48 -30.59 47.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 120.631 -1.293 . . . . 1.0 110.72 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.49 43.65 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 117.447 2.388 . . . . 1.0 117.447 -164.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.18 179.23 16.49 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.93 127.7 8.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 120.547 -1.561 . . . . 1.0 111.203 -157.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.78 161.59 27.02 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 121.076 -1.015 . . . . 1.0 108.582 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.8 t -108.49 135.38 49.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.57 -1.195 . . . . 1.0 108.089 161.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -156.41 138.43 14.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.289 -0.882 . . . . 1.0 109.563 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.32 19.27 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.282 1.833 . . . . 1.0 110.447 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.96 8.56 69.17 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 124.557 1.075 . . . . 1.0 115.604 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -140.97 164.89 29.04 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 119.974 -1.898 . . . . 1.0 109.138 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -69.84 161.14 30.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 117.041 2.238 . . . . 1.0 117.041 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -150.82 82.25 1.34 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.1 m -75.09 129.13 37.05 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.629 -1.295 . . . . 1.0 114.138 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.84 150.68 36.92 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.788 1.235 . . . . 1.0 108.383 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -84.24 45.3 1.7 Allowed 'Trans proline' 0 C--N 1.328 -0.502 0 CA-C-N 123.22 2.186 . . . . 1.0 111.85 162.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.4 t60 . . . . . 0 C--O 1.258 1.525 0 C-N-CA 126.482 1.913 . . . . 1.0 109.189 -177.569 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 121.089 0.471 . . . . 1.0 111.445 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t -144.61 133.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 101.767 -3.419 . . . . 1.0 101.767 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.86 -143.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 126.855 2.062 . . . . 1.0 108.043 177.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -139.29 48.19 1.87 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 124.782 2.229 . . . . 1.0 110.15 163.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.78 118.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 113.251 -1.795 . . . . 1.0 106.31 163.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -95.77 141.99 28.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.088 -1.449 . . . . 1.0 107.088 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.65 165.37 35.65 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -164.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -105.62 -32.8 8.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 123.421 1.581 . . . . 1.0 109.896 151.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -102.94 153.83 37.98 Favored Pre-proline 0 N--CA 1.452 -0.345 0 O-C-N 120.512 -1.368 . . . . 1.0 111.891 -166.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.73 -31.8 68.73 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 121.784 1.656 . . . . 1.0 112.812 159.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -62.42 -37.58 86.36 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.924 0.784 . . . . 1.0 112.981 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -57.22 -27.87 62.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.945 1.698 . . . . 1.0 113.922 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 t -96.41 -13.83 22.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.301 -0.874 . . . . 1.0 112.245 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.47 -46.87 69.64 Favored Pre-proline 0 C--N 1.345 0.401 0 CA-C-O 116.807 -1.568 . . . . 1.0 113.936 -164.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.15 -48.78 14.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-N 124.121 2.507 . . . . 1.0 115.895 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.85 -37.96 10.75 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 127.254 3.627 . . . . 1.0 112.648 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -59.48 -37.29 77.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 120.514 -1.367 . . . . 1.0 112.183 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -26.43 63.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.413 1.634 . . . . 1.0 115.413 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.89 -67.3 0.54 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 124.811 2.243 . . . . 1.0 113.14 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -84.86 -37.42 20.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.417 -2.629 . . . . 1.0 109.485 -166.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.61 -12.28 13.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.447 1.647 . . . . 1.0 115.447 -160.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.66 149.28 5.04 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 120.593 -1.317 . . . . 1.0 114.631 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.36 -40.5 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 O-C-N 119.845 -1.973 . . . . 1.0 112.837 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.48 HH22 ' CD2' ' A' ' 39' ' ' HIS . 6.6 tmm_? -84.14 -22.4 31.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.713 -1.867 . . . . 1.0 110.881 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.8 159.22 0.57 Allowed 'General case' 0 C--N 1.351 0.644 0 N-CA-C 117.788 2.514 . . . . 1.0 117.788 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.03 164.64 12.07 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.54 133.37 20.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.23 -1.767 . . . . 1.0 106.23 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -148.06 154.36 40.13 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.59 144.25 28.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.259 -1.525 . . . . 1.0 112.134 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -163.13 144.11 9.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.628 -1.295 . . . . 1.0 110.917 170.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.48 37.06 19.98 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.308 1.443 . . . . 1.0 110.419 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.01 -8.96 48.67 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.598 -1.183 . . . . 1.0 115.891 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -146.95 168.99 20.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.855 2.327 . . . . 1.0 111.63 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.47 162.51 17.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.336 1.976 . . . . 1.0 116.336 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -146.12 89.8 1.91 Allowed 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 130.113 3.365 . . . . 1.0 102.778 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.7 m -77.89 132.85 38.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.153 1.781 . . . . 1.0 112.195 173.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -108.56 97.16 21.89 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.68 69.95 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.996 2.464 . . . . 1.0 111.338 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.48 ' CD2' HH22 ' A' ' 24' ' ' ARG . 11.7 t-160 . . . . . 0 C--O 1.257 1.487 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 170.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 121.507 0.67 . . . . 1.0 111.674 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.3 134.73 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 1 N-CA-C 98.763 -4.532 . . . . 1.0 98.763 169.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.45 160.64 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 102.703 -3.073 . . . . 1.0 102.703 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 42.46 1.1 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 124.959 2.314 . . . . 1.0 110.831 172.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.2 t -87.11 115.1 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -101.94 139.92 36.93 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 122.182 0.991 . . . . 1.0 108.479 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 153.86 40.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 116.652 2.093 . . . . 1.0 116.652 -160.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -111.14 0.83 16.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 127.017 2.127 . . . . 1.0 110.449 172.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 m -171.18 153.68 3.8 Favored Pre-proline 0 CA--C 1.51 -0.594 0 O-C-N 120.714 -1.241 . . . . 1.0 108.782 -171.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.78 -32.08 47.25 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.009 2.472 . . . . 1.0 111.919 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -46.68 -45.76 19.6 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.403 2.281 . . . . 1.0 112.947 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -67.39 -17.59 64.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.761 1.224 . . . . 1.0 114.013 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.7 t -101.55 -7.32 22.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.405 -0.81 . . . . 1.0 112.698 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.93 -46.43 64.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 120.032 -1.667 . . . . 1.0 113.524 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.17 -45.7 29.88 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 CA-C-O 114.019 -2.576 . . . . 1.0 115.814 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.51 -35.86 21.71 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 CA-C-N 127.408 3.681 . . . . 1.0 112.722 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 m -56.93 -46.39 82.09 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.955 1.36 . . . . 1.0 112.119 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -9.84 58.77 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.315 2.339 . . . . 1.0 117.315 172.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -65.84 0.7 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 124.287 1.994 . . . . 1.0 110.58 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -114.8 -33.84 5.34 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 112.316 -2.22 . . . . 1.0 111.377 -169.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -94.08 -18.05 22.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.796 1.406 . . . . 1.0 114.796 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.76 168.09 41.05 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 116.662 -2.685 . . . . 1.0 116.234 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 tt -70.19 -50.07 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.339 1.456 . . . . 1.0 111.191 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.5 HH12 ' CD2' ' A' ' 39' ' ' HIS . 3.7 ttp-105 -127.8 32.23 4.99 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.57 152.18 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 119.219 3.044 . . . . 1.0 119.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.47 12.34 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 108.713 -1.755 . . . . 1.0 108.713 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.19 130.74 9.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.294 -1.373 . . . . 1.0 107.294 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 166.69 26.69 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 120.455 -1.403 . . . . 1.0 109.361 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 t -120.78 135.99 55.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.242 0.617 . . . . 1.0 110.897 -164.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.23 145.67 19.51 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.39 1.076 . . . . 1.0 108.272 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.63 32.08 20.29 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 126.307 1.843 . . . . 1.0 110.419 -173.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.67 19.46 62.81 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 124.855 1.217 . . . . 1.0 115.468 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.53 151.87 37.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.662 -2.081 . . . . 1.0 108.876 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -69.17 162.7 26.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.069 2.248 . . . . 1.0 117.069 -169.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.74 95.7 2.55 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.324 -3.213 . . . . 1.0 102.324 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.34 132.68 33.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.557 2.343 . . . . 1.0 112.426 -174.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -102.67 111.57 64.9 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -86.98 59.36 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.382 2.054 . . . . 1.0 112.389 -167.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.5 ' CD2' HH12 ' A' ' 24' ' ' ARG . 35.4 t60 . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.942 1.697 . . . . 1.0 106.669 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.506 2.352 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -161.04 155.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 102.019 -3.326 . . . . 1.0 102.019 171.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.64 154.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 101.472 -3.529 . . . . 1.0 101.472 160.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.64 41.9 1.06 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 124.369 2.033 . . . . 1.0 112.191 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.54 115.26 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.574 -2.38 . . . . 1.0 104.574 167.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -103.09 137.02 41.82 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -163.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 p -140.5 150.81 44.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 118.159 2.651 . . . . 1.0 118.159 -163.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 p -115.15 9.46 15.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 128.002 2.521 . . . . 1.0 109.639 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -167.49 150.31 5.72 Favored Pre-proline 0 CA--C 1.511 -0.534 0 O-C-N 119.608 -1.933 . . . . 1.0 108.536 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.65 -24.58 35.16 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.509 2.139 . . . . 1.0 111.93 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -48.86 -44.46 39.79 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.521 1.929 . . . . 1.0 112.84 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -65.86 -18.3 65.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.026 1.331 . . . . 1.0 113.553 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 40.1 t -83.64 -25.19 30.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.265 1.026 . . . . 1.0 111.344 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.06 -52.48 30.66 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 117.16 -1.4 . . . . 1.0 114.331 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.58 -38.79 39.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-O 113.127 -2.947 . . . . 1.0 115.433 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.94 -37.26 8.97 Favored 'Trans proline' 0 CA--C 1.502 -1.103 1 CA-C-N 129.365 4.38 . . . . 1.0 112.265 172.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.07 -44.3 82.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.379 1.085 . . . . 1.0 111.793 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -70.72 -17.73 62.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.461 2.023 . . . . 1.0 116.461 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -68.25 0.48 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 124.899 2.285 . . . . 1.0 113.005 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -102.08 -38.57 7.67 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.05 -2.796 . . . . 1.0 110.142 -161.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.06 -45.11 7.37 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.564 -166.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.94 142.87 4.41 Favored Glycine 0 CA--C 1.491 -1.426 0 C-N-CA 118.556 -1.783 . . . . 1.0 114.795 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.11 -38.03 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 120.082 -1.834 . . . . 1.0 112.393 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.469 HH22 ' CD2' ' A' ' 39' ' ' HIS . 6.9 tmm_? -81.49 -23.62 37.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.307 -1.496 . . . . 1.0 111.663 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.76 156.38 0.2 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 118.624 2.824 . . . . 1.0 118.624 -167.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.85 162.4 14.72 Favored Glycine 0 CA--C 1.475 -2.418 0 N-CA-C 107.854 -2.098 . . . . 1.0 107.854 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.66 6.05 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 119.911 -1.935 . . . . 1.0 107.56 -163.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.14 21.45 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.76 -1.576 . . . . 1.0 110.792 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.0 t -94.81 133.8 38.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.1 ttt -153.61 133.74 13.32 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 121.025 -1.047 . . . . 1.0 109.598 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.367 1.0 OUTLIER 53.48 32.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 128.473 2.709 . . . . 1.0 112.863 -172.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.74 10.02 86.56 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 113.712 -1.585 . . . . 1.0 115.403 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -136.85 157.31 47.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 120.298 2.049 . . . . 1.0 109.708 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.7 t -70.65 141.62 51.65 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 123.926 1.822 . . . . 1.0 113.819 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.72 84.25 2.09 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 102.125 -3.287 . . . . 1.0 102.125 -171.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.19 132.78 37.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.531 1.533 . . . . 1.0 110.551 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.98 95.05 19.31 Favored Pre-proline 0 N--CA 1.434 -1.238 0 C-N-CA 126.119 1.768 . . . . 1.0 106.248 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.19 73.1 5.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.77 2.313 . . . . 1.0 112.389 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.469 ' CD2' HH22 ' A' ' 24' ' ' ARG . 11.5 t-160 . . . . . 0 C--O 1.259 1.592 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.51 2.525 0 CA-C-O 120.786 0.327 . . . . 1.0 111.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.0 t -134.53 138.56 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 1 N-CA-C 97.697 -4.927 . . . . 1.0 97.697 173.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.84 156.27 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 101.547 -3.501 . . . . 1.0 101.547 176.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.71 51.31 1.55 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 125.08 2.372 . . . . 1.0 110.718 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -90.29 102.79 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 162.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER -74.36 136.12 42.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 123.765 1.745 . . . . 1.0 112.606 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.49 154.15 18.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.144 1.926 . . . . 1.0 114.165 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 3.18 5.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.6 1.96 . . . . 1.0 107.862 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -177.14 157.02 1.28 Allowed Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 104.032 -2.581 . . . . 1.0 104.032 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.4 -23.18 28.17 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 CA-C-N 123.277 2.206 . . . . 1.0 111.999 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -57.67 -42.15 82.96 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 122.082 0.944 . . . . 1.0 113.057 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -70.58 -7.41 43.79 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 114.973 1.472 . . . . 1.0 114.973 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -82.44 -25.71 33.38 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.95 -1.094 . . . . 1.0 110.297 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.86 -48.23 62.77 Favored Pre-proline 0 C--N 1.354 0.777 0 O-C-N 119.628 -1.92 . . . . 1.0 114.446 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.76 -37.5 55.62 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 CA-C-O 113.216 -2.91 . . . . 1.0 115.237 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -37.06 17.66 Favored 'Trans proline' 0 CA--C 1.503 -1.043 1 CA-C-N 129.054 4.269 . . . . 1.0 112.48 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.92 -39.17 77.35 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.81 -1.181 . . . . 1.0 112.335 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -13.34 62.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 116.917 2.192 . . . . 1.0 116.917 174.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.96 72.31 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 123.158 1.456 . . . . 1.0 113.558 -170.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -164.08 -27.79 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.074 -1.421 . . . . 1.0 111.719 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.79 -17.74 52.67 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 120.228 -1.545 . . . . 1.0 113.004 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 154.35 7.29 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 121.058 -1.026 . . . . 1.0 112.861 154.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.21 -43.17 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 O-C-N 119.914 -1.933 . . . . 1.0 112.554 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.513 HH22 ' CE1' ' A' ' 39' ' ' HIS . 39.2 ttp180 -75.91 -28.31 57.99 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.664 -1.897 . . . . 1.0 111.134 173.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.4 151.46 0.37 Allowed 'General case' 0 C--N 1.35 0.589 0 N-CA-C 118.811 2.893 . . . . 1.0 118.811 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.69 175.62 21.74 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.16 131.95 11.55 Favored 'General case' 0 N--CA 1.434 -1.255 0 O-C-N 121.33 -1.1 . . . . 1.0 110.06 -166.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 154.24 45.72 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.902 -1.123 . . . . 1.0 111.308 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.31 117.04 34.18 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 164.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -147.32 136.36 22.31 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.519 -1.363 . . . . 1.0 110.296 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.417 0.9 OUTLIER 53.23 30.4 9.92 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 128.106 2.562 . . . . 1.0 112.955 -170.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.45 6.28 89.0 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 113.744 -1.571 . . . . 1.0 115.647 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.58 152.4 51.89 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.855 1.827 . . . . 1.0 108.995 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.72 143.09 51.41 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 116.333 1.975 . . . . 1.0 116.333 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -137.98 81.59 1.87 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.34 2.256 . . . . 1.0 107.365 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.6 m -70.11 132.1 45.31 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.206 1.558 . . . . 1.0 115.206 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -96.63 101.08 8.23 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.93 73.4 6.04 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 122.719 2.007 . . . . 1.0 111.745 -173.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.513 ' CE1' HH22 ' A' ' 24' ' ' ARG . 63.8 t60 . . . . . 0 C--O 1.261 1.703 0 CA-C-O 118.719 -0.658 . . . . 1.0 109.262 173.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 121.073 0.463 . . . . 1.0 110.499 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -135.65 127.42 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 100.773 -3.788 . . . . 1.0 100.773 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.81 -149.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 126.279 1.832 . . . . 1.0 106.822 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -142.38 37.37 1.52 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 124.896 2.284 . . . . 1.0 110.389 167.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.14 119.03 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 112.241 -2.254 . . . . 1.0 106.622 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -102.23 143.16 32.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.828 0.823 . . . . 1.0 109.13 -170.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.5 149.67 41.19 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 117.574 2.435 . . . . 1.0 117.574 -162.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -110.44 3.31 19.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 127.642 2.377 . . . . 1.0 109.73 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -177.55 146.35 0.61 Allowed Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 105.723 -1.954 . . . . 1.0 105.723 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.03 -26.85 57.99 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 123.871 2.418 . . . . 1.0 112.846 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -54.74 -30.84 57.36 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.789 1.636 . . . . 1.0 113.802 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -62.32 -26.38 68.4 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.052 -1.03 . . . . 1.0 113.439 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -100.13 -1.15 37.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.302 -0.874 . . . . 1.0 112.567 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.52 -49.39 83.58 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 120.295 -1.503 . . . . 1.0 113.695 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.28 -34.13 56.91 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-O 113.15 -2.938 . . . . 1.0 115.477 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.38 -36.41 9.2 Favored 'Trans proline' 0 CA--C 1.507 -0.874 1 CA-C-N 129.094 4.284 . . . . 1.0 112.91 169.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.6 -52.37 65.93 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.542 -1.349 . . . . 1.0 111.558 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -71.76 -1.98 15.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.235 1.569 . . . . 1.0 115.235 171.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.67 -69.32 0.39 Allowed 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 118.981 -2.325 . . . . 1.0 111.003 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -115.41 -29.89 6.4 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 111.547 -2.569 . . . . 1.0 112.056 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -92.74 -23.38 18.92 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 115.063 1.505 . . . . 1.0 115.063 -167.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.33 47.91 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 119.842 -1.787 . . . . 1.0 115.231 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.53 -45.44 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.224 1.81 . . . . 1.0 114.136 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.476 HH22 ' CD2' ' A' ' 39' ' ' HIS . 29.7 ttp180 -120.61 13.61 11.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.736 1.614 . . . . 1.0 107.034 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 145.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.143 1.905 . . . . 1.0 116.143 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.57 178.17 22.64 Favored Glycine 0 CA--C 1.479 -2.158 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -163.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.42 141.89 31.02 Favored 'General case' 0 N--CA 1.423 -1.817 0 O-C-N 120.569 -1.548 . . . . 1.0 110.116 -163.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -111.85 139.91 46.94 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.5 t -101.14 130.76 47.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.4 ttt -150.06 137.82 20.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 120.751 -1.218 . . . . 1.0 109.59 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.44 27.26 16.22 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.558 1.543 . . . . 1.0 111.23 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.05 86.5 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 114.774 -1.103 . . . . 1.0 115.652 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.36 151.54 43.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.681 2.24 . . . . 1.0 110.536 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.4 t -70.32 153.75 42.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 118.025 2.602 . . . . 1.0 118.025 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -144.6 92.06 2.25 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 127.394 2.278 . . . . 1.0 105.016 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -77.96 137.35 38.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 128.55 2.74 . . . . 1.0 114.782 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -100.2 102.1 16.94 Favored Pre-proline 0 N--CA 1.441 -0.888 0 C-N-CA 126.595 1.958 . . . . 1.0 106.324 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -85.12 72.38 4.62 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 121.978 1.742 . . . . 1.0 111.859 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.476 ' CD2' HH22 ' A' ' 24' ' ' ARG . 35.4 t60 . . . . . 0 C--O 1.259 1.601 0 O-C-N 121.59 -0.694 . . . . 1.0 112.468 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 121.173 0.511 . . . . 1.0 111.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.9 t -133.89 136.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 N-CA-C 98.671 -4.566 . . . . 1.0 98.671 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 155.9 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 101.377 -3.564 . . . . 1.0 101.377 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.61 47.36 1.23 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 124.353 2.025 . . . . 1.0 110.946 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.96 122.88 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -93.8 144.24 25.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.137 0.97 . . . . 1.0 110.81 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.47 155.66 42.12 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.729 1.728 . . . . 1.0 115.395 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -110.71 -24.92 10.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.849 156.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -118.06 146.99 40.44 Favored Pre-proline 0 CA--C 1.512 -0.498 0 O-C-N 120.178 -1.576 . . . . 1.0 110.296 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.14 -17.0 57.67 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 C-N-CA 122.219 1.946 . . . . 1.0 112.049 166.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -59.41 -42.4 91.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.626 -1.296 . . . . 1.0 112.504 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.45 -16.78 63.03 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.04 1.736 . . . . 1.0 113.986 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -83.34 -28.25 29.13 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 121.114 -0.991 . . . . 1.0 111.063 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.3 -53.61 10.22 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 114.471 1.286 . . . . 1.0 114.471 -160.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -57.35 -46.11 30.13 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 CA-C-O 114.344 -2.44 . . . . 1.0 115.406 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -67.11 -37.48 18.61 Favored 'Trans proline' 0 CA--C 1.504 -1.017 0 CA-C-N 127.007 3.538 . . . . 1.0 112.398 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 t -64.41 -37.36 87.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 120.323 -1.485 . . . . 1.0 112.771 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -70.73 -11.63 61.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 116.827 2.158 . . . . 1.0 116.827 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.82 71.59 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 123.148 1.451 . . . . 1.0 113.416 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -164.4 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.911 -1.495 . . . . 1.0 111.378 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -78.5 -14.92 59.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.176 -1.578 . . . . 1.0 113.291 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.11 154.79 7.2 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 122.336 0.965 . . . . 1.0 113.108 149.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -70.19 -41.88 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 O-C-N 120.742 -1.446 . . . . 1.0 112.603 -174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.431 HH22 ' CD2' ' A' ' 39' ' ' HIS . 5.8 tmm_? -91.02 -18.56 24.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.961 -1.087 . . . . 1.0 110.978 174.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.78 144.35 1.76 Allowed 'General case' 0 C--N 1.352 0.703 0 N-CA-C 117.612 2.449 . . . . 1.0 117.612 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.35 25.9 Favored Glycine 0 CA--C 1.475 -2.407 0 N-CA-C 107.47 -2.252 . . . . 1.0 107.47 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.95 125.2 4.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.225 -1.162 . . . . 1.0 109.595 -168.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 169.65 22.04 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.723 -1.235 . . . . 1.0 109.65 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.8 t -100.2 139.29 36.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.609 -0.682 . . . . 1.0 112.443 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.8 ttt -162.94 148.4 11.91 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.343 1.057 . . . . 1.0 108.565 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 63.2 28.78 15.97 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 123.226 1.489 . . . . 1.0 110.208 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.16 12.38 57.73 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.602 1.096 . . . . 1.0 115.53 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.3 165.19 32.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 120.023 1.911 . . . . 1.0 110.536 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -69.52 153.96 42.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.144 1.535 . . . . 1.0 115.144 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 85.4 1.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.582 -2.747 . . . . 1.0 103.582 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.56 127.42 32.78 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.262 1.825 . . . . 1.0 112.681 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.56 102.41 14.57 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 105.729 -1.952 . . . . 1.0 105.729 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.95 66.14 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.216 1.944 . . . . 1.0 112.141 -166.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.431 ' CD2' HH22 ' A' ' 24' ' ' ARG . 73.7 t60 . . . . . 0 C--O 1.259 1.602 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 170.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.256 0.551 . . . . 1.0 111.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.59 136.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -83.64 42.19 1.19 Allowed 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 . . . . . 0 N--CA 1.429 -1.525 0 C-N-CA 126.935 2.094 . . . . 1.0 109.715 -172.724 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.256 0.551 . . . . 1.0 111.38 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.59 136.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -83.64 42.19 1.19 Allowed 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 . . . . . 0 N--CA 1.429 -1.525 0 C-N-CA 126.935 2.094 . . . . 1.0 109.715 -172.724 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.517 2.879 0 N-CA-C 110.744 -0.095 . . . . 1.0 110.744 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -155.89 137.91 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 1 N-CA-C 100.15 -4.019 . . . . 1.0 100.15 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 152.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 N-CA-C 100.824 -3.769 . . . . 1.0 100.824 154.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -99.23 50.11 0.95 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 124.268 1.985 . . . . 1.0 111.382 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.73 117.28 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 105.012 -2.218 . . . . 1.0 105.012 163.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.74 143.77 26.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.584 0.707 . . . . 1.0 111.291 -167.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.98 153.57 40.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 116.36 1.985 . . . . 1.0 116.36 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -94.0 -41.69 9.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 112.146 -2.297 . . . . 1.0 109.027 156.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -108.94 148.4 37.82 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.451 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.73 -23.92 74.61 Favored 'Trans proline' 0 CA--C 1.51 -0.704 0 C-N-CA 121.775 1.65 . . . . 1.0 112.656 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.95 -33.96 76.91 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 121.064 -1.023 . . . . 1.0 113.223 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -64.36 -15.32 60.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.549 1.14 . . . . 1.0 113.848 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -89.14 -21.68 23.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.841 -1.162 . . . . 1.0 111.477 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.95 -52.85 46.64 Favored Pre-proline 0 N--CA 1.439 -0.996 0 O-C-N 120.441 -1.412 . . . . 1.0 113.804 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.23 -36.59 45.63 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-O 112.877 -3.051 . . . . 1.0 115.263 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -69.86 -39.7 6.0 Favored 'Trans proline' 0 CA--C 1.504 -0.979 1 CA-C-N 129.456 4.413 . . . . 1.0 112.426 170.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.2 -49.73 75.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 123.71 1.719 . . . . 1.0 111.861 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -71.54 -8.78 56.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 115.905 1.817 . . . . 1.0 115.905 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -68.46 0.45 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 124.237 1.97 . . . . 1.0 110.986 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -106.83 -44.73 4.36 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 111.997 -2.365 . . . . 1.0 110.594 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -87.84 -24.89 23.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.427 0.899 . . . . 1.0 113.427 -154.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.0 167.22 39.99 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 115.297 -3.335 . . . . 1.0 118.314 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.21 -61.0 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 C-N-CA 124.772 1.229 . . . . 1.0 112.3 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -105.18 10.44 33.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.465 1.106 . . . . 1.0 109.659 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 146.2 39.25 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -168.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.86 167.25 19.62 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 107.754 -2.139 . . . . 1.0 107.754 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.18 127.02 4.96 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.963 -1.904 . . . . 1.0 109.674 -162.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 173.41 14.56 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 120.615 -1.303 . . . . 1.0 111.351 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -101.46 139.89 36.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.679 0.792 . . . . 1.0 110.112 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.5 ttt -164.68 145.9 7.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.249 1.42 . . . . 1.0 108.629 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 62.84 28.15 16.3 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 123.161 1.458 . . . . 1.0 110.368 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.72 62.25 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 124.246 0.927 . . . . 1.0 115.252 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.93 162.88 39.48 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 120.228 -1.748 . . . . 1.0 110.916 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 t -64.58 152.36 42.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.918 1.818 . . . . 1.0 115.023 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -142.89 85.88 1.9 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 104.357 -2.46 . . . . 1.0 104.357 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.91 128.28 33.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.075 0.95 . . . . 1.0 111.568 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -110.96 95.72 25.84 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.206 1.802 . . . . 1.0 109.125 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.71 67.3 8.47 Favored 'Trans proline' 0 C--N 1.33 -0.423 0 C-N-CA 122.776 2.318 . . . . 1.0 111.597 167.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 . . . . . 0 C--O 1.26 1.631 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 176.698 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.512 2.642 0 CA-C-O 121.767 0.794 . . . . 1.0 112.285 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.44 127.9 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 N-CA-C 99.17 -4.382 . . . . 1.0 99.17 168.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.07 153.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 N-CA-C 100.7 -3.815 . . . . 1.0 100.7 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.575 ' CG ' ' HZ2' ' A' ' 6' ' ' LYS . 42.8 t0 -97.27 52.01 1.12 Allowed 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 124.64 2.162 . . . . 1.0 110.308 174.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.55 123.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 105.399 -2.075 . . . . 1.0 105.399 163.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.575 ' HZ2' ' CG ' ' A' ' 4' ' ' ASP . 41.1 mmtm -80.15 142.91 34.32 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.728 0.775 . . . . 1.0 110.524 -173.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -140.47 149.95 43.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 124.184 1.945 . . . . 1.0 116.088 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 m -114.25 -9.22 12.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 129.424 3.09 . . . . 1.0 107.97 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -174.18 158.15 2.66 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.568 1.547 . . . . 1.0 107.285 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.28 -28.76 33.18 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 C-N-CA 122.296 1.997 . . . . 1.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -55.0 -40.01 69.68 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.311 1.444 . . . . 1.0 113.313 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.2 -29.0 67.17 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.145 1.378 . . . . 1.0 114.079 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 t -99.21 -3.48 34.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.121 -0.987 . . . . 1.0 113.094 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.75 -51.55 75.3 Favored Pre-proline 0 N--CA 1.451 -0.418 0 O-C-N 120.247 -1.533 . . . . 1.0 113.851 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.99 -37.94 50.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-O 113.187 -2.922 . . . . 1.0 115.712 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -68.74 -38.31 10.58 Favored 'Trans proline' 0 CA--C 1.508 -0.825 1 CA-C-N 129.134 4.298 . . . . 1.0 112.701 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.1 t -58.63 -50.7 72.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.351 1.548 . . . . 1.0 111.747 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -0.9 12.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 116.762 2.134 . . . . 1.0 116.762 172.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.02 70.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 123.463 1.602 . . . . 1.0 112.316 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -156.26 -26.55 0.1 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.686 -1.597 . . . . 1.0 112.174 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.93 -19.75 51.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 119.959 -1.713 . . . . 1.0 113.19 -169.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.4 157.5 26.23 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 117.851 -2.119 . . . . 1.0 114.622 157.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -69.53 -35.45 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 O-C-N 120.511 -1.582 . . . . 1.0 112.249 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -112.76 10.76 19.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.695 1.598 . . . . 1.0 110.882 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.03 155.52 34.43 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 115.931 1.826 . . . . 1.0 115.931 -166.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.56 166.05 27.83 Favored Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.942 -2.463 . . . . 1.0 106.942 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.31 154.5 50.85 Favored 'General case' 0 N--CA 1.418 -2.027 0 O-C-N 120.568 -1.548 . . . . 1.0 107.792 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -149.36 165.8 30.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.984 167.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.5 t -97.39 140.53 31.7 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 113.445 0.905 . . . . 1.0 113.445 -169.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 ttt -155.83 136.72 13.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.888 -1.132 . . . . 1.0 109.66 167.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.01 31.08 18.09 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.294 1.521 . . . . 1.0 110.269 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.27 15.62 65.85 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 124.611 1.1 . . . . 1.0 115.012 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -146.91 158.14 43.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.319 -1.695 . . . . 1.0 110.081 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.68 156.62 38.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.677 2.473 . . . . 1.0 117.677 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -141.64 89.59 2.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 103.556 -2.757 . . . . 1.0 103.556 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.9 t -85.91 126.56 34.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.513 2.325 . . . . 1.0 112.854 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -115.8 108.07 47.34 Favored Pre-proline 0 N--CA 1.437 -1.089 0 C-N-CA 126.512 1.925 . . . . 1.0 108.501 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.94 56.7 5.96 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.608 2.206 . . . . 1.0 110.323 159.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.719 2.008 . . . . 1.0 105.661 -170.727 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.508 2.431 0 CA-C-O 120.604 0.24 . . . . 1.0 111.175 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.16 136.1 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 1 N-CA-C 98.602 -4.592 . . . . 1.0 98.602 173.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.95 160.48 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.495 0 N-CA-C 103.787 -2.671 . . . . 1.0 103.787 172.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.51 44.05 1.18 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 124.672 2.177 . . . . 1.0 110.67 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.2 113.17 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 103.979 -2.6 . . . . 1.0 103.979 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -98.49 133.5 42.77 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -161.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 p -135.63 156.94 48.05 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 118.48 2.771 . . . . 1.0 118.48 -165.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -109.65 -23.43 11.45 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.972 -1.922 . . . . 1.0 110.404 156.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 t -131.59 151.82 79.35 Favored Pre-proline 0 CA--C 1.508 -0.661 0 O-C-N 120.192 -1.567 . . . . 1.0 109.655 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.42 -25.22 56.22 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 122.763 2.022 . . . . 1.0 111.953 164.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -58.49 -41.28 84.97 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 122.37 1.081 . . . . 1.0 113.482 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.42 -13.89 62.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.523 1.129 . . . . 1.0 113.445 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -90.59 -8.31 50.5 Favored 'General case' 0 N--CA 1.417 -2.087 0 O-C-N 120.629 -1.294 . . . . 1.0 111.72 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.08 -44.18 59.22 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 116.759 -1.591 . . . . 1.0 113.23 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.84 -46.77 21.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 124.13 2.511 . . . . 1.0 115.683 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.07 -34.91 21.36 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 CA-C-N 127.557 3.735 . . . . 1.0 112.722 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.3 m -58.95 -35.79 73.72 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.704 -1.248 . . . . 1.0 112.3 172.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -20.1 62.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 116.843 2.164 . . . . 1.0 116.843 172.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -69.88 0.36 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 125.074 2.369 . . . . 1.0 111.903 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -93.5 -38.4 11.43 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.35 -2.659 . . . . 1.0 110.254 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.4 -11.72 20.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 -167.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 174.04 18.53 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 123.202 1.445 . . . . 1.0 115.21 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -69.08 -33.61 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 119.452 -2.205 . . . . 1.0 113.123 -167.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -86.98 -12.66 46.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.457 -1.402 . . . . 1.0 112.027 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.44 158.12 18.48 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 116.737 2.125 . . . . 1.0 116.737 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.17 14.46 Favored Glycine 0 CA--C 1.492 -1.377 0 O-C-N 120.912 -1.117 . . . . 1.0 111.184 -170.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.38 149.08 27.44 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.565 -1.55 . . . . 1.0 111.19 -171.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.63 136.22 54.82 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 125.786 1.634 . . . . 1.0 108.362 167.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 t -89.7 130.05 36.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.393 -0.817 . . . . 1.0 110.597 167.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.9 ttt -155.13 137.24 14.71 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 121.049 -1.032 . . . . 1.0 109.612 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.27 29.03 18.66 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.232 1.813 . . . . 1.0 110.992 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.83 10.9 62.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 116.568 1.387 . . . . 1.0 116.568 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -143.91 127.31 16.83 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.739 2.269 . . . . 1.0 109.153 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 153.39 42.7 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 119.437 3.125 . . . . 1.0 119.437 -162.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -123.21 78.95 1.62 Allowed 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 128.579 2.752 . . . . 1.0 104.218 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 t -70.21 132.98 46.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.406 1.482 . . . . 1.0 114.122 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.98 103.86 46.57 Favored Pre-proline 0 N--CA 1.434 -1.27 0 C-N-CA 125.847 1.659 . . . . 1.0 106.852 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.44 91.71 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.734 0 CA-C-N 123.194 2.176 . . . . 1.0 109.899 157.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 . . . . . 0 C--O 1.263 1.811 0 C-N-CA 124.318 1.047 . . . . 1.0 109.56 171.26 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.31 134.93 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 1 N-CA-C 99.95 -4.093 . . . . 1.0 99.95 175.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.445 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.4 mt -104.53 -146.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 126.695 1.998 . . . . 1.0 107.738 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.445 ' H ' HG22 ' A' ' 3' ' ' ILE . 1.3 t0 -124.31 46.34 2.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 124.956 2.312 . . . . 1.0 109.011 163.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.39 105.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 112.41 -2.177 . . . . 1.0 105.349 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.56 131.54 38.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.741 -1.577 . . . . 1.0 106.741 171.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.79 161.96 39.58 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.051 2.241 . . . . 1.0 117.051 -162.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -46.94 8.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 112.786 -2.006 . . . . 1.0 109.739 154.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 152.97 76.81 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.271 -1.331 . . . . 1.0 111.933 -149.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.29 -33.55 48.01 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.235 2.623 . . . . 1.0 112.034 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -44.85 -48.42 11.09 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 127.282 2.233 . . . . 1.0 112.371 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -63.71 -22.54 66.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.223 1.409 . . . . 1.0 113.978 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.5 t -106.5 -7.47 17.51 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.635 -0.665 . . . . 1.0 112.47 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 tp -64.67 -50.87 62.34 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 116.921 -1.514 . . . . 1.0 113.667 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.77 -41.16 40.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-O 112.918 -3.034 . . . . 1.0 115.543 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -69.03 -40.22 6.77 Favored 'Trans proline' 0 CA--C 1.508 -0.798 1 CA-C-N 129.369 4.382 . . . . 1.0 113.151 173.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.1 t -56.89 -44.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.465 1.602 . . . . 1.0 111.627 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -21.01 62.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 174.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.21 -70.89 0.31 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 124.631 2.158 . . . . 1.0 112.89 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -90.58 -42.59 10.71 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.203 -2.726 . . . . 1.0 108.689 -159.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -96.53 -30.19 13.46 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.599 -1.637 . . . . 1.0 113.756 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.98 159.18 22.78 Favored Glycine 0 CA--C 1.484 -1.89 0 C-N-CA 114.798 -3.572 . . . . 1.0 115.016 165.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 tt -70.28 -34.51 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 C-N-CA 126.295 1.838 . . . . 1.0 113.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.43 HH22 ' CE1' ' A' ' 39' ' ' HIS . 46.3 ttp180 -98.12 -11.26 23.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.313 0.645 . . . . 1.0 111.801 172.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.39 152.12 11.91 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.812 2.523 . . . . 1.0 117.812 -167.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.4 167.92 29.68 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 109.039 -1.625 . . . . 1.0 109.039 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.98 154.43 42.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 123.286 1.517 . . . . 1.0 110.161 -164.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 175.7 10.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 107.485 -1.302 . . . . 1.0 107.485 166.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.3 t -107.53 147.08 31.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.782 -0.574 . . . . 1.0 110.513 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.1 ttt -164.01 142.01 7.26 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.378 1.471 . . . . 1.0 109.803 169.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.32 35.78 20.66 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 126.157 1.783 . . . . 1.0 110.48 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.87 -5.04 55.27 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 116.231 1.252 . . . . 1.0 116.231 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -135.39 165.26 25.88 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.686 2.243 . . . . 1.0 109.766 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.55 160.89 10.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 115.043 1.497 . . . . 1.0 115.043 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -142.74 90.53 2.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 100.289 -3.967 . . . . 1.0 100.289 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -92.46 128.68 38.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 126.261 1.824 . . . . 1.0 109.034 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.11 98.06 41.12 Favored Pre-proline 0 N--CA 1.436 -1.141 0 C-N-CA 125.212 1.405 . . . . 1.0 107.336 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.94 78.29 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.696 1.597 . . . . 1.0 111.078 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.43 ' CE1' HH22 ' A' ' 24' ' ' ARG . 80.7 t60 . . . . . 0 C--O 1.26 1.606 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 167.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.194 0.521 . . . . 1.0 112.067 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t -136.63 138.07 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 98.543 -4.614 . . . . 1.0 98.543 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.79 158.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 101.68 -3.452 . . . . 1.0 101.68 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.85 42.06 1.09 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 124.091 1.901 . . . . 1.0 112.122 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.52 126.67 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 170.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -108.22 140.13 41.9 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.906 0.86 . . . . 1.0 110.958 -157.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.3 156.26 47.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -168.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.4 m -108.77 -26.55 10.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.709 1.719 . . . . 1.0 109.636 162.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -123.17 154.15 65.01 Favored Pre-proline 0 CA--C 1.515 -0.371 0 O-C-N 120.578 -1.326 . . . . 1.0 110.563 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.48 -27.11 54.43 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 121.816 1.677 . . . . 1.0 112.474 160.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.9 -49.63 74.05 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.623 -1.298 . . . . 1.0 112.651 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.93 -5.45 17.03 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.093 1.357 . . . . 1.0 113.633 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.56 -27.79 21.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.113 1.435 . . . . 1.0 109.533 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.9 tp -70.15 -47.3 21.29 Favored Pre-proline 0 C--N 1.355 0.835 0 CA-C-O 116.298 -1.811 . . . . 1.0 114.681 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.13 -35.87 61.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-O 113.23 -2.904 . . . . 1.0 115.288 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.43 -39.93 11.66 Favored 'Trans proline' 0 CA--C 1.502 -1.113 1 CA-C-N 128.98 4.243 . . . . 1.0 112.308 170.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.6 m -61.17 -33.47 73.49 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.744 -1.223 . . . . 1.0 113.379 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -12.2 61.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 116.417 2.006 . . . . 1.0 116.417 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.26 71.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 123.272 1.511 . . . . 1.0 113.518 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -163.05 -30.05 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.782 -1.554 . . . . 1.0 111.33 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.9 -15.46 59.0 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 120.23 -1.544 . . . . 1.0 113.038 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.23 153.3 6.3 Favored Glycine 0 CA--C 1.492 -1.394 0 CA-C-O 122.329 0.961 . . . . 1.0 113.887 150.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.3 -35.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 119.877 -1.955 . . . . 1.0 111.818 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -70.17 -37.44 75.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.996 1.718 . . . . 1.0 109.772 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.07 155.68 1.81 Allowed 'General case' 0 C--N 1.348 0.524 0 N-CA-C 118.163 2.653 . . . . 1.0 118.163 -162.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.18 174.13 15.09 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.361 -1.895 . . . . 1.0 108.361 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.35 137.59 9.34 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 120.879 -1.365 . . . . 1.0 109.386 -165.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -155.48 166.27 34.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.301 -0.96 . . . . 1.0 110.259 165.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.5 141.58 29.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.778 -0.576 . . . . 1.0 112.338 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -155.56 135.96 13.21 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.186 -0.946 . . . . 1.0 109.868 168.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.98 34.03 21.47 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.77 2.028 . . . . 1.0 110.42 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.47 15.27 68.06 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.76 -1.109 . . . . 1.0 115.669 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -145.85 150.76 36.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 119.8 -2.0 . . . . 1.0 110.057 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.0 156.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 -164.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.18 86.8 2.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.734 -2.691 . . . . 1.0 103.734 -175.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 62.1 m -75.31 131.03 40.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 125.967 1.707 . . . . 1.0 113.554 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.74 126.26 28.85 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 106.075 -1.824 . . . . 1.0 106.075 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.34 38.71 0.54 Allowed 'Trans proline' 0 CA--C 1.509 -0.765 0 CA-C-N 124.641 2.693 . . . . 1.0 113.466 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 t60 . . . . . 0 N--CA 1.426 -1.644 0 C-N-CA 125.965 1.706 . . . . 1.0 109.601 171.05 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.407 0 CA-C-O 121.033 0.444 . . . . 1.0 111.937 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.25 132.89 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 1 N-CA-C 98.686 -4.561 . . . . 1.0 98.686 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.53 158.76 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 103.284 -2.858 . . . . 1.0 103.284 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.23 50.85 1.56 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.115 2.166 . . . . 1.0 110.358 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.11 118.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 105.373 -2.084 . . . . 1.0 105.373 165.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 134.19 36.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -134.66 146.63 49.69 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 116.967 2.21 . . . . 1.0 116.967 -165.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -110.63 -17.78 13.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 112.433 -2.167 . . . . 1.0 109.176 167.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -140.3 147.62 50.69 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -60.71 -24.15 77.97 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 122.401 2.067 . . . . 1.0 112.88 167.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -37.67 70.72 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 122.716 1.246 . . . . 1.0 112.416 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -60.4 -24.66 65.32 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.543 1.537 . . . . 1.0 114.228 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.5 t -103.46 -5.02 23.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.164 0.983 . . . . 1.0 112.609 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.25 -48.65 75.89 Favored Pre-proline 0 C--N 1.345 0.411 0 O-C-N 120.186 -1.571 . . . . 1.0 114.299 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.61 -34.3 64.12 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-O 113.402 -2.832 . . . . 1.0 115.44 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.59 -36.55 14.5 Favored 'Trans proline' 0 CA--C 1.506 -0.89 1 CA-C-N 128.867 4.202 . . . . 1.0 112.54 169.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 m -59.29 -51.05 71.63 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.122 1.439 . . . . 1.0 112.37 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 2.36 5.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 116.777 2.14 . . . . 1.0 116.777 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.8 -50.93 30.38 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.752 1.739 . . . . 1.0 111.502 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 -12.71 0.24 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.447 -1.706 . . . . 1.0 113.036 -173.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -84.98 -20.74 30.09 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 120.031 -1.668 . . . . 1.0 113.384 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.88 -166.2 33.51 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 115.344 -3.312 . . . . 1.0 119.154 163.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.3 -62.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 C-N-CA 125.098 1.359 . . . . 1.0 112.295 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.474 HH22 ' CD2' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -117.69 13.51 14.23 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.906 1.682 . . . . 1.0 107.437 -176.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.09 145.49 0.75 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 118.282 2.697 . . . . 1.0 118.282 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.8 170.8 21.07 Favored Glycine 0 CA--C 1.477 -2.311 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -162.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.16 135.44 24.05 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 -170.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.04 149.28 36.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.05 137.7 34.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 121.221 -0.924 . . . . 1.0 111.902 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -155.69 139.96 16.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 120.819 -1.176 . . . . 1.0 109.68 167.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.8 33.95 19.9 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 126.356 1.862 . . . . 1.0 110.141 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.12 16.7 60.3 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 124.382 0.991 . . . . 1.0 115.525 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -144.84 154.38 42.59 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 119.708 -2.054 . . . . 1.0 107.919 -173.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.35 158.49 31.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 119.675 -1.891 . . . . 1.0 115.987 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -144.09 89.69 2.05 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 101.625 -3.472 . . . . 1.0 101.625 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.2 t -85.64 129.3 34.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.798 2.039 . . . . 1.0 112.398 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -103.89 102.9 34.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -87.0 63.4 4.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.149 1.9 . . . . 1.0 111.865 -166.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.474 ' CD2' HH22 ' A' ' 24' ' ' ARG . 58.2 t60 . . . . . 0 C--O 1.253 1.271 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.307 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 121.48 0.657 . . . . 1.0 111.011 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t -138.7 138.09 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 98.551 -4.611 . . . . 1.0 98.551 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.21 157.39 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 167.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.61 41.6 1.03 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 125.401 2.525 . . . . 1.0 111.653 176.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -92.84 110.74 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.077 -1.874 . . . . 1.0 106.033 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 137.88 52.63 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.556 -1.34 . . . . 1.0 110.669 171.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -104.53 169.69 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.567 -1.333 . . . . 1.0 113.18 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 p -133.24 -0.75 3.28 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 126.803 2.041 . . . . 1.0 108.825 161.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -177.72 155.48 1.08 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 102.993 -2.966 . . . . 1.0 102.993 -167.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.71 -27.16 68.38 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 123.669 2.346 . . . . 1.0 111.748 163.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.37 -42.57 99.52 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.452 1.12 . . . . 1.0 112.893 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -7.05 41.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 t -99.89 -6.02 27.43 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.651 -1.28 . . . . 1.0 111.483 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.83 -39.59 54.92 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 119.703 -1.873 . . . . 1.0 114.303 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.85 -47.35 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 CA-C-O 113.8 -2.667 . . . . 1.0 115.792 169.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.31 -35.67 23.33 Favored 'Trans proline' 0 CA--C 1.507 -0.836 0 CA-C-N 127.995 3.891 . . . . 1.0 112.516 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.3 m -59.25 -34.36 72.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.954 -1.092 . . . . 1.0 112.5 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -25.25 63.05 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 117.01 2.226 . . . . 1.0 117.01 170.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -67.05 0.57 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 124.775 2.226 . . . . 1.0 113.256 -174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.48 -39.04 10.62 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 111.548 -2.569 . . . . 1.0 109.99 -166.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.19 -27.39 13.83 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.527 -1.215 . . . . 1.0 114.267 -162.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.45 171.27 19.83 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 119.98 -1.7 . . . . 1.0 115.758 163.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mp -69.51 -46.35 76.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 120.007 -1.878 . . . . 1.0 111.818 -175.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.62 HH22 ' CD2' ' A' ' 39' ' ' HIS . 5.1 ttp180 -83.83 -15.78 46.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.581 -1.324 . . . . 1.0 111.509 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.59 160.2 1.34 Allowed 'General case' 0 C--N 1.355 0.818 0 N-CA-C 117.833 2.531 . . . . 1.0 117.833 -166.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.01 177.4 20.95 Favored Glycine 0 CA--C 1.49 -1.469 0 O-C-N 120.718 -1.239 . . . . 1.0 111.881 -166.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.21 144.77 31.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.769 -1.43 . . . . 1.0 109.436 -170.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 153.46 35.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.39 1.076 . . . . 1.0 108.191 163.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.98 122.19 43.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.666 0.786 . . . . 1.0 110.346 167.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.7 tpp -154.95 140.71 18.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.847 -1.158 . . . . 1.0 112.034 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 33.37 17.35 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.143 1.777 . . . . 1.0 109.908 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.18 1.36 41.43 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 115.897 1.119 . . . . 1.0 115.897 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -132.6 151.61 51.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 120.021 -1.87 . . . . 1.0 107.831 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.0 t -67.33 156.95 35.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.358 -2.088 . . . . 1.0 114.713 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.16 81.15 1.84 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.435 -2.802 . . . . 1.0 103.435 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 t -81.56 140.67 34.36 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.448 1.099 . . . . 1.0 113.964 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.86 99.5 45.56 Favored Pre-proline 0 N--CA 1.437 -1.108 0 C-N-CA 125.554 1.542 . . . . 1.0 107.11 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.27 73.28 4.53 Favored 'Trans proline' 0 C--N 1.329 -0.466 0 C-N-CA 122.778 2.318 . . . . 1.0 110.841 169.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.62 ' CD2' HH22 ' A' ' 24' ' ' ARG . 7.9 t60 . . . . . 0 N--CA 1.43 -1.438 0 C-N-CA 124.629 1.171 . . . . 1.0 108.242 -176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.511 2.591 0 CA-C-O 121.566 0.698 . . . . 1.0 111.485 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.56 135.12 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 1 N-CA-C 98.241 -4.726 . . . . 1.0 98.241 167.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.75 158.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 102.49 -3.152 . . . . 1.0 102.49 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 39.03 0.91 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.635 2.636 . . . . 1.0 112.1 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -91.56 103.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.725 -1.58 . . . . 1.0 107.419 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 142.87 51.96 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.776 -1.202 . . . . 1.0 110.717 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.51 166.33 14.85 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.687 -1.258 . . . . 1.0 114.081 -170.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.9 p -126.7 -6.35 6.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.748 2.019 . . . . 1.0 109.325 150.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -178.98 154.91 0.81 Allowed Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 101.107 -3.664 . . . . 1.0 101.107 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.51 -28.37 77.58 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 CA-C-N 123.874 2.419 . . . . 1.0 112.189 162.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.8 -29.13 68.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.733 0.778 . . . . 1.0 112.801 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.47 -9.93 57.82 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 120.723 -1.236 . . . . 1.0 114.3 175.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 45.3 t -93.36 -7.78 43.77 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.583 -1.323 . . . . 1.0 112.16 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -49.32 88.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 119.941 -1.724 . . . . 1.0 113.958 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.08 -32.92 63.5 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 CA-C-O 113.293 -2.878 . . . . 1.0 115.929 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.11 -36.3 10.11 Favored 'Trans proline' 0 CA--C 1.504 -0.976 1 CA-C-N 129.074 4.277 . . . . 1.0 112.632 167.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.83 -61.55 2.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.949 1.357 . . . . 1.0 111.749 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 21.24 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.921 -1.112 . . . . 1.0 113.873 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.07 -69.93 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 118.092 -2.88 . . . . 1.0 107.973 159.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.81 -20.89 2.21 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 127.435 2.294 . . . . 1.0 114.08 -163.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -87.97 -16.7 33.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.293 -1.505 . . . . 1.0 114.576 -165.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.26 178.67 38.8 Favored Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.226 -1.464 . . . . 1.0 111.35 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.01 -55.65 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 122.481 1.134 . . . . 1.0 112.776 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.489 HH22 ' CD2' ' A' ' 39' ' ' HIS 0.258 0.0 OUTLIER -122.89 25.08 8.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 123.45 1.595 . . . . 1.0 107.267 -175.42 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.48 143.89 0.19 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 119.166 3.025 . . . . 1.0 119.166 -163.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.09 163.59 13.23 Favored Glycine 0 CA--C 1.476 -2.368 0 N-CA-C 108.366 -1.893 . . . . 1.0 108.366 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.14 126.66 9.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.746 -1.205 . . . . 1.0 107.746 -172.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 150.95 39.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -96.61 139.66 32.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.951 -1.093 . . . . 1.0 112.115 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -156.93 144.81 19.24 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 166.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.341 0.7 OUTLIER 62.67 20.31 11.97 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.414 1.885 . . . . 1.0 113.381 -174.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.6 9.51 86.15 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 114.998 -1.001 . . . . 1.0 114.661 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.25 159.0 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.424 -1.633 . . . . 1.0 108.007 -170.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 t -70.05 159.04 34.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.214 -2.179 . . . . 1.0 116.409 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -144.48 90.35 2.08 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 102.034 -3.321 . . . . 1.0 102.034 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.3 t -84.45 130.26 34.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.734 2.014 . . . . 1.0 112.962 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -102.45 107.49 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.31 64.84 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.768 1.645 . . . . 1.0 112.365 -166.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.489 ' CD2' HH22 ' A' ' 24' ' ' ARG . 16.2 t-160 . . . . . 0 C--O 1.26 1.613 0 O-C-N 122.168 -0.332 . . . . 1.0 110.422 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.514 2.769 0 CA-C-O 118.852 -0.594 . . . . 1.0 109.664 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -154.92 127.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 103.135 -2.913 . . . . 1.0 103.135 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.38 161.1 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 161.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.44 65.23 0.61 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.981 1.713 . . . . 1.0 107.508 160.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.9 t -84.64 109.2 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.673 -1.973 . . . . 1.0 105.673 160.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 124.17 41.32 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.9 1.28 . . . . 1.0 108.96 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -145.11 163.02 35.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.357 1.984 . . . . 1.0 116.357 -155.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -99.32 -36.15 9.71 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 123.646 1.688 . . . . 1.0 109.758 154.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -116.97 150.66 46.32 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.445 -1.252 . . . . 1.0 111.536 -156.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.8 -34.24 31.59 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.026 1.817 . . . . 1.0 111.776 170.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -54.85 -41.72 71.11 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.974 1.31 . . . . 1.0 113.021 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -54.75 -30.6 56.86 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.759 1.223 . . . . 1.0 114.149 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t -100.57 -9.37 22.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . 0.267 2.8 tm? -68.42 -49.21 32.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 120.402 -1.436 . . . . 1.0 113.192 -170.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.43 -44.29 43.85 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 CA-C-O 114.267 -2.472 . . . . 1.0 115.95 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.17 -37.73 13.78 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 CA-C-N 127.194 3.605 . . . . 1.0 112.981 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.93 -49.0 78.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.864 1.792 . . . . 1.0 111.414 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -71.31 -8.2 52.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.64 -54.92 10.06 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.605 1.669 . . . . 1.0 111.775 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.11 -23.26 1.03 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 113.146 -1.843 . . . . 1.0 112.597 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -84.64 -20.22 31.69 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 120.162 -1.586 . . . . 1.0 113.55 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.7 179.49 45.04 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 116.462 -2.78 . . . . 1.0 116.978 157.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 tt -70.72 -55.75 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 125.782 1.633 . . . . 1.0 112.434 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -121.31 19.19 11.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.476 1.911 . . . . 1.0 107.035 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.01 145.75 16.01 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.27 1.952 . . . . 1.0 116.27 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.35 162.29 22.68 Favored Glycine 0 CA--C 1.471 -2.659 0 N-CA-C 107.952 -2.059 . . . . 1.0 107.952 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.46 131.71 24.96 Favored 'General case' 0 N--CA 1.425 -1.701 0 O-C-N 120.678 -1.484 . . . . 1.0 107.456 -163.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -141.9 148.2 38.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -99.12 144.82 27.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.246 -1.533 . . . . 1.0 111.146 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -162.2 144.14 11.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.718 -1.239 . . . . 1.0 109.662 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.55 32.29 18.71 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.77 1.628 . . . . 1.0 110.855 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.11 65.98 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 114.636 -1.166 . . . . 1.0 115.885 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -142.67 153.27 43.26 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 120.175 1.987 . . . . 1.0 109.284 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.81 161.61 29.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 115.78 1.77 . . . . 1.0 115.78 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.45 95.38 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 101.738 -3.43 . . . . 1.0 101.738 168.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.7 t -82.56 116.6 22.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.117 1.767 . . . . 1.0 110.107 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -99.2 110.08 56.78 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 126.228 1.811 . . . . 1.0 107.681 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.14 74.43 5.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.115 1.877 . . . . 1.0 112.249 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.0 t60 . . . . . 0 C--O 1.258 1.541 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 174.04 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.29 130.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 1 N-CA-C 98.039 -4.801 . . . . 1.0 98.039 172.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.72 -155.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.39 52.57 2.01 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.606 2.146 . . . . 1.0 109.311 170.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 115.81 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 171.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 137.65 36.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.916 0.887 . . . . 1.0 109.449 -169.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.92 159.19 42.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.842 1.793 . . . . 1.0 115.842 -167.682 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -103.63 -33.98 8.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.379 -1.737 . . . . 1.0 109.492 154.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -108.98 145.38 31.6 Favored Pre-proline 0 CA--C 1.512 -0.508 0 O-C-N 120.547 -1.346 . . . . 1.0 111.065 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.94 -28.38 50.17 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.403 2.069 . . . . 1.0 111.633 175.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -56.8 -35.99 69.4 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 124.103 0.961 . . . . 1.0 113.461 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.36 -23.33 66.73 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.866 1.266 . . . . 1.0 114.181 177.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -84.04 -23.89 30.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.493 1.117 . . . . 1.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 tp -70.15 -53.72 10.47 Favored Pre-proline 0 C--N 1.355 0.821 0 CA-C-O 116.841 -1.552 . . . . 1.0 114.853 -166.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.58 -35.38 81.61 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-O 113.366 -2.847 . . . . 1.0 115.113 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -69.79 -41.14 4.49 Favored 'Trans proline' 0 CA--C 1.508 -0.817 1 CA-C-N 128.532 4.083 . . . . 1.0 112.799 168.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.21 -50.08 73.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.655 1.693 . . . . 1.0 112.178 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -71.16 -8.51 54.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 115.139 1.533 . . . . 1.0 115.139 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.2 -64.27 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.198 1.952 . . . . 1.0 111.433 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -119.0 -28.81 5.43 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 111.989 -2.369 . . . . 1.0 111.574 -162.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -95.32 -26.95 15.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -166.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.39 171.14 42.5 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 115.884 -3.055 . . . . 1.0 117.605 171.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.87 -53.42 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 125.752 1.621 . . . . 1.0 113.039 -170.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.504 HH22 ' CD2' ' A' ' 39' ' ' HIS . 13.2 ttp180 -124.66 30.92 5.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 148.14 18.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.746 2.128 . . . . 1.0 116.746 -167.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.74 161.27 12.75 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 107.0 -2.44 . . . . 1.0 107.0 -172.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.77 121.17 3.6 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.967 -1.902 . . . . 1.0 108.047 -157.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -148.81 155.0 40.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.163 -1.421 . . . . 1.0 107.163 -168.106 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.2 t -97.4 139.93 32.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 121.249 -0.907 . . . . 1.0 111.23 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -155.52 138.48 15.42 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.29 -1.506 . . . . 1.0 109.583 169.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.5 28.82 13.44 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.161 1.385 . . . . 1.0 110.94 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.52 80.58 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 124.422 1.01 . . . . 1.0 115.186 -173.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -141.86 152.93 44.07 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 119.905 -1.938 . . . . 1.0 110.971 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -68.6 144.09 54.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.864 1.792 . . . . 1.0 114.815 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -140.82 91.83 2.45 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.245 -2.502 . . . . 1.0 104.245 -174.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.3 t -81.4 127.49 32.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.256 2.623 . . . . 1.0 112.106 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -103.04 101.77 23.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 126.574 1.95 . . . . 1.0 105.898 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -84.97 64.87 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.231 1.954 . . . . 1.0 112.382 -164.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.504 ' CD2' HH22 ' A' ' 24' ' ' ARG . 8.9 t-160 . . . . . 0 C--O 1.258 1.536 0 N-CA-C 107.316 -1.365 . . . . 1.0 107.316 171.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.51 2.549 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.8 t -158.71 144.54 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 1 N-CA-C 98.043 -4.799 . . . . 1.0 98.043 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.24 154.68 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 102.305 -3.22 . . . . 1.0 102.305 161.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.38 48.28 1.3 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 124.174 1.94 . . . . 1.0 110.871 177.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.35 129.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.606 -1.998 . . . . 1.0 105.606 171.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -97.06 142.77 28.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.2 152.25 35.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.499 2.037 . . . . 1.0 116.499 -172.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.4 m -100.39 -33.66 10.28 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.747 2.419 . . . . 1.0 109.135 159.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.2 t -120.26 146.6 43.01 Favored Pre-proline 0 CA--C 1.512 -0.483 0 O-C-N 120.951 -1.093 . . . . 1.0 110.295 -173.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.5 -24.47 78.13 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.951 1.767 . . . . 1.0 112.676 165.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.42 -28.71 69.99 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 122.002 0.906 . . . . 1.0 113.076 -176.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.75 -18.61 65.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.54 1.136 . . . . 1.0 114.059 177.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 68.0 m -85.3 -14.59 46.08 Favored 'General case' 0 N--CA 1.425 -1.718 0 O-C-N 120.799 -1.188 . . . . 1.0 113.538 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -49.38 75.28 Favored Pre-proline 0 C--N 1.351 0.655 0 O-C-N 120.603 -1.311 . . . . 1.0 114.444 -170.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.08 -39.35 50.19 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 CA-C-O 113.449 -2.813 . . . . 1.0 115.473 174.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.6 -36.92 10.3 Favored 'Trans proline' 0 CA--C 1.511 -0.667 1 CA-C-N 128.652 4.126 . . . . 1.0 113.096 172.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 m -59.52 -45.25 92.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.239 -1.538 . . . . 1.0 111.714 176.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -71.01 -13.4 61.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 171.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.9 -67.44 0.53 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 124.146 1.927 . . . . 1.0 112.287 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -105.36 -41.64 5.46 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 111.836 -2.438 . . . . 1.0 110.211 -163.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -87.32 -36.69 17.71 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -160.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.05 -177.24 46.65 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 115.934 -3.032 . . . . 1.0 117.922 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.9 -53.57 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 125.97 1.708 . . . . 1.0 113.394 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 16.12 15.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.718 2.407 . . . . 1.0 108.469 -174.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 148.8 10.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 116.946 2.202 . . . . 1.0 116.946 -172.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.71 -170.99 13.08 Favored Glycine 0 CA--C 1.475 -2.432 0 N-CA-C 108.486 -1.846 . . . . 1.0 108.486 -164.186 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.99 6.91 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 120.325 -1.691 . . . . 1.0 108.842 -175.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.31 0.0 OUTLIER -149.53 -177.86 6.1 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.694 143.52 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -115.13 135.78 53.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.896 1.678 . . . . 1.0 109.906 -176.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.09 151.43 21.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.306 -1.738 . . . . 1.0 106.306 168.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.346 0.5 OUTLIER 63.43 18.73 11.25 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.131 1.772 . . . . 1.0 113.439 -173.952 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.85 76.48 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.308 1.432 . . . . 1.0 114.729 -172.545 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -141.79 161.32 38.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.037 -1.861 . . . . 1.0 109.558 -177.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.1 t -69.75 163.83 24.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.952 2.204 . . . . 1.0 116.952 -168.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.88 90.26 1.82 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.212 -2.514 . . . . 1.0 104.212 167.626 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -78.17 140.17 38.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.266 2.226 . . . . 1.0 114.263 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -108.32 106.45 58.66 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 127.692 2.397 . . . . 1.0 107.156 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 76.64 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 122.619 2.213 . . . . 1.0 112.244 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.0 m170 . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -178.222 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 121.089 0.471 . . . . 1.0 110.989 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.2 t -142.18 133.93 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 1 N-CA-C 99.326 -4.324 . . . . 1.0 99.326 179.166 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.2 mt -103.55 -149.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 126.815 2.046 . . . . 1.0 106.368 175.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -132.13 43.71 2.99 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 125.15 2.405 . . . . 1.0 109.644 164.706 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.51 120.02 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 112.81 -1.995 . . . . 1.0 106.014 166.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -94.78 141.12 29.0 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 105.399 -2.074 . . . . 1.0 105.399 172.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -122.48 149.83 43.35 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 117.639 2.459 . . . . 1.0 117.639 -164.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -114.08 -5.93 13.1 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.417 -2.174 . . . . 1.0 110.415 169.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -168.28 155.76 7.61 Favored Pre-proline 0 CA--C 1.504 -0.8 0 N-CA-C 105.129 -2.174 . . . . 1.0 105.129 -174.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.91 -26.87 51.38 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 124.315 2.577 . . . . 1.0 111.457 163.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -64.66 -36.07 83.06 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 113.598 0.962 . . . . 1.0 113.598 -168.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -13.82 62.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 176.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.6 t -96.18 -4.49 42.46 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.932 -1.105 . . . . 1.0 111.781 173.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.13 -50.97 83.65 Favored Pre-proline 0 C--N 1.349 0.578 0 O-C-N 120.303 -1.498 . . . . 1.0 113.5 177.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 -37.66 59.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-O 113.278 -2.884 . . . . 1.0 115.74 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -68.34 -38.18 12.25 Favored 'Trans proline' 0 CA--C 1.506 -0.898 1 CA-C-N 128.604 4.109 . . . . 1.0 112.771 169.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 m -58.37 -47.11 84.86 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.137 1.446 . . . . 1.0 112.745 177.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -4.46 27.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 117.189 2.292 . . . . 1.0 117.189 172.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.45 11.44 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 123.433 1.587 . . . . 1.0 111.257 -178.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.1 -11.5 0.19 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 113.906 -1.497 . . . . 1.0 114.253 -175.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -79.57 -25.58 41.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.797 -1.814 . . . . 1.0 112.751 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.37 159.93 27.29 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 117.188 -2.434 . . . . 1.0 115.317 162.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.94 -33.8 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 120.378 -1.66 . . . . 1.0 112.442 -173.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -115.04 13.66 16.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.906 1.682 . . . . 1.0 110.675 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 162.58 6.98 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 118.233 2.679 . . . . 1.0 118.233 -163.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.81 -171.27 15.92 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 107.187 -2.365 . . . . 1.0 107.187 -176.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.14 154.63 36.24 Favored 'General case' 0 N--CA 1.424 -1.747 0 O-C-N 120.925 -1.338 . . . . 1.0 108.408 -175.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -111.81 146.31 37.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.911 -1.515 . . . . 1.0 106.911 162.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.4 t -94.02 121.26 35.32 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 160.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.6 ttt -149.84 127.38 11.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.717 1.246 . . . . 1.0 111.497 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.17 31.19 17.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 126.824 2.05 . . . . 1.0 110.331 -177.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.95 9.31 79.61 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 115.3 0.88 . . . . 1.0 115.3 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -135.45 143.78 46.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 119.674 -2.074 . . . . 1.0 108.385 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.3 143.38 52.06 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -176.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.48 82.26 2.05 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 102.476 -3.157 . . . . 1.0 102.476 -174.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -71.34 135.41 47.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.388 2.275 . . . . 1.0 114.545 -173.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -120.45 103.46 44.16 Favored Pre-proline 0 N--CA 1.444 -0.766 0 C-N-CA 125.335 1.454 . . . . 1.0 110.038 -165.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.15 61.7 7.82 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.284 1.989 . . . . 1.0 110.137 151.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.578 0 C-N-CA 126.318 1.847 . . . . 1.0 106.399 -164.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 112.832 0.678 . . . . 1.0 112.832 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t -161.55 144.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 1 N-CA-C 96.627 -5.323 . . . . 1.0 96.627 177.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.74 145.76 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 N-CA-C 102.933 -2.988 . . . . 1.0 102.933 172.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.267 13.1 t70 -91.52 45.56 1.24 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.642 2.163 . . . . 1.0 112.551 -173.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.53 107.0 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 164.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -87.99 144.48 26.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.319 1.057 . . . . 1.0 112.556 -164.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.92 142.6 51.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.467 2.395 . . . . 1.0 117.467 -162.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -115.97 1.47 13.31 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.056 2.542 . . . . 1.0 108.231 173.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -173.65 153.95 2.31 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 118.621 -2.549 . . . . 1.0 105.414 -174.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.66 -21.82 38.59 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 123.698 2.357 . . . . 1.0 112.653 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -55.78 -31.4 62.58 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.281 1.432 . . . . 1.0 113.699 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -62.73 -23.13 67.02 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 124.622 1.169 . . . . 1.0 113.784 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.2 t -82.83 -20.99 34.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.005 0.922 . . . . 1.0 112.059 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 tp -68.54 -51.8 21.69 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-O 116.984 -1.484 . . . . 1.0 114.31 -174.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.9 -29.74 58.0 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-O 113.099 -2.959 . . . . 1.0 115.618 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.14 -39.79 2.02 Favored 'Trans proline' 0 CA--C 1.503 -1.031 1 CA-C-N 129.374 4.384 . . . . 1.0 112.456 166.101 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 t -62.61 -59.05 5.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.263 1.506 . . . . 1.0 111.617 -178.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 22.04 0.06 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.763 1.625 . . . . 1.0 113.435 165.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.59 -76.76 0.1 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 118.328 -2.733 . . . . 1.0 107.859 158.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -117.68 -34.21 4.3 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 111.498 -2.592 . . . . 1.0 113.189 -159.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -76.85 -30.28 56.24 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 120.823 -1.173 . . . . 1.0 112.535 -166.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.42 156.42 9.9 Favored Glycine 0 CA--C 1.494 -1.262 0 C-N-CA 118.166 -1.969 . . . . 1.0 115.748 166.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -71.14 -25.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.135 1.374 . . . . 1.0 112.075 159.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -81.89 -21.97 37.11 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.398 2.679 . . . . 1.0 110.455 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.46 153.59 42.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 116.036 1.865 . . . . 1.0 116.036 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.79 170.91 16.09 Favored Glycine 0 CA--C 1.489 -1.578 0 N-CA-C 108.351 -1.899 . . . . 1.0 108.351 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.84 129.62 10.12 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 119.421 -2.223 . . . . 1.0 108.841 -159.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.1 12.35 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 120.271 -1.518 . . . . 1.0 111.999 174.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.59 132.27 44.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.568 1.547 . . . . 1.0 109.752 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.2 ttt -161.47 140.23 9.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.136 1.374 . . . . 1.0 110.213 173.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 59.54 34.91 22.58 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 124.489 2.09 . . . . 1.0 110.759 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.92 57.15 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 114.075 -1.421 . . . . 1.0 116.143 -176.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 176.92 8.27 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 120.199 1.999 . . . . 1.0 112.877 -177.508 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.01 145.69 49.84 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 124.763 2.22 . . . . 1.0 114.538 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -137.38 92.9 2.75 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 102.841 -3.022 . . . . 1.0 102.841 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 131.3 40.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.051 -1.431 . . . . 1.0 112.084 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -111.79 82.83 4.2 Favored Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 127.734 2.414 . . . . 1.0 109.254 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.92 70.59 5.2 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 CA-C-N 124.187 2.531 . . . . 1.0 109.049 154.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.286 1.7 m-70 . . . . . 0 N--CA 1.414 -2.271 0 N-CA-C 102.868 -3.012 . . . . 1.0 102.868 -171.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 121.176 0.512 . . . . 1.0 111.723 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.57 132.72 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 1 N-CA-C 99.891 -4.115 . . . . 1.0 99.891 176.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.58 156.24 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 102.244 -3.243 . . . . 1.0 102.244 170.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -94.59 54.01 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 124.156 1.931 . . . . 1.0 109.182 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.59 117.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -87.18 140.84 29.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.54 1.162 . . . . 1.0 109.235 -175.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.78 148.59 50.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 117.327 2.343 . . . . 1.0 117.327 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -114.59 1.13 14.17 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 124.925 2.298 . . . . 1.0 108.416 172.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -174.11 154.43 2.16 Favored Pre-proline 0 N--CA 1.444 -0.742 0 O-C-N 118.744 -2.473 . . . . 1.0 105.774 -174.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.71 -26.41 45.71 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 CA-C-N 123.221 2.186 . . . . 1.0 111.872 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -44.56 -46.7 10.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 128.644 2.778 . . . . 1.0 112.181 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -61.76 -28.42 69.43 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.629 1.572 . . . . 1.0 113.316 -174.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.9 t -94.28 -8.45 39.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.931 0.872 . . . . 1.0 112.412 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.93 -41.71 29.29 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 119.72 -1.863 . . . . 1.0 114.426 -178.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.13 -46.86 22.83 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-O 113.934 -2.611 . . . . 1.0 115.472 168.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.05 -36.03 23.49 Favored 'Trans proline' 0 CA--C 1.51 -0.697 0 CA-C-N 127.795 3.82 . . . . 1.0 112.507 174.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.3 m -63.54 -26.71 68.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 121.033 -1.042 . . . . 1.0 112.698 172.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -33.69 70.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 117.34 2.348 . . . . 1.0 117.34 162.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -66.97 0.56 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 124.687 2.184 . . . . 1.0 112.394 -169.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.8 -38.13 23.53 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 111.826 -2.443 . . . . 1.0 109.407 -172.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -112.78 -3.95 14.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.407 -1.27 . . . . 1.0 113.563 -164.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -178.58 37.49 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 124.34 2.078 . . . . 1.0 116.602 161.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -70.36 -33.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 O-C-N 119.465 -2.197 . . . . 1.0 114.108 -165.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -77.06 -33.86 57.17 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 120.913 -1.117 . . . . 1.0 110.439 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 137.51 58.09 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 116.548 2.055 . . . . 1.0 116.548 -161.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.67 174.4 25.69 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -175.101 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.83 131.43 8.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 120.556 -1.555 . . . . 1.0 108.901 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.1 168.96 21.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.713 -1.242 . . . . 1.0 109.87 174.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.22 129.73 55.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.617 0.767 . . . . 1.0 112.306 -168.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 125.06 43.43 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 126.904 2.082 . . . . 1.0 111.371 166.339 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.53 25.88 15.4 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 123.405 1.574 . . . . 1.0 112.128 170.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.21 77.42 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.624 -1.171 . . . . 1.0 115.682 -175.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -136.52 155.25 50.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 120.358 2.079 . . . . 1.0 108.946 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -70.55 160.63 32.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 118.557 2.799 . . . . 1.0 118.557 -175.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -148.24 99.75 3.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 104.144 -2.539 . . . . 1.0 104.144 165.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.6 t -80.78 130.79 35.26 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.515 2.726 . . . . 1.0 111.53 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -98.98 138.94 20.7 Favored Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 119.479 -2.013 . . . . 1.0 107.64 -178.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -87.08 33.82 0.43 Allowed 'Trans proline' 0 CA--C 1.507 -0.834 0 CA-C-N 123.96 2.45 . . . . 1.0 111.802 171.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 N--CA 1.417 -2.1 0 C-N-CA 129.02 2.928 . . . . 1.0 107.291 -179.166 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.433 -1.321 1 N-CA-C 99.098 -4.408 . . . . 1.0 99.098 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.31 159.95 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 N-CA-C 102.403 -3.184 . . . . 1.0 102.403 169.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.27 49.16 1.58 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 124.651 2.167 . . . . 1.0 110.622 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.14 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 104.648 -2.352 . . . . 1.0 104.648 167.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.72 137.07 32.66 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.06 148.38 52.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 118.798 2.888 . . . . 1.0 118.798 -165.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -101.69 -14.45 17.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 113.283 -1.78 . . . . 1.0 110.902 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -169.95 167.33 5.03 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 -169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 30.0 Cg_endo -64.38 -24.19 64.68 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.75 2.375 . . . . 1.0 114.258 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -47.58 -53.32 14.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 127.351 2.26 . . . . 1.0 112.349 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -70.73 -12.58 61.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.481 1.512 . . . . 1.0 114.547 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 33.9 t -100.68 -9.48 21.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.204 -0.935 . . . . 1.0 112.555 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -67.3 -45.11 49.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 119.94 -1.725 . . . . 1.0 114.148 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.97 -41.33 62.86 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 CA-C-O 114.106 -2.539 . . . . 1.0 115.902 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -68.84 -34.58 17.72 Favored 'Trans proline' 0 CA--C 1.505 -0.926 0 CA-C-N 127.283 3.637 . . . . 1.0 112.758 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -59.38 -51.47 69.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.575 -1.328 . . . . 1.0 112.01 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.272 0.0 OUTLIER -71.7 -2.32 16.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 115.444 1.646 . . . . 1.0 115.444 170.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -69.89 0.36 Allowed 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 118.934 -2.354 . . . . 1.0 111.173 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.63 -29.34 6.49 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 111.627 -2.533 . . . . 1.0 111.965 -160.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -88.48 -32.46 18.24 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.12 1.156 . . . . 1.0 114.12 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.88 178.16 47.43 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 117.958 -2.068 . . . . 1.0 115.811 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.88 -46.72 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 126.215 1.806 . . . . 1.0 113.896 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -122.25 20.57 10.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.511 -1.663 . . . . 1.0 106.511 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.44 143.47 40.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 115.994 1.85 . . . . 1.0 115.994 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.36 172.76 15.08 Favored Glycine 0 CA--C 1.478 -2.264 0 N-CA-C 108.574 -1.81 . . . . 1.0 108.574 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -152.13 138.71 18.69 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -143.78 169.56 17.54 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 117.945 -1.502 . . . . 1.0 109.843 164.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.4 t -106.41 147.68 28.99 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.183 0.993 . . . . 1.0 109.956 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -160.15 148.2 16.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 105.827 -1.916 . . . . 1.0 105.827 159.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.312 0.9 OUTLIER 58.54 27.03 15.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.795 1.638 . . . . 1.0 113.435 177.308 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.36 14.62 77.06 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.134 -1.394 . . . . 1.0 115.936 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -144.85 153.98 42.16 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 119.695 -2.062 . . . . 1.0 109.123 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.1 t -70.55 157.63 37.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 116.552 2.056 . . . . 1.0 116.552 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 94.06 2.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.175 -3.639 . . . . 1.0 101.175 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.03 137.8 32.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.436 2.294 . . . . 1.0 112.313 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -108.11 98.28 25.67 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 125.5 1.52 . . . . 1.0 108.251 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--N 1.326 -0.619 0 C-N-CA 122.14 1.893 . . . . 1.0 112.441 -176.257 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 100.38 -3.933 . . . . 1.0 100.38 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.01 154.83 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 101.486 -3.524 . . . . 1.0 101.486 166.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 45.87 1.21 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.718 2.199 . . . . 1.0 111.16 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.2 t -84.12 113.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 103.766 -2.679 . . . . 1.0 103.766 163.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -93.06 143.02 26.65 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.165 0.983 . . . . 1.0 110.853 -169.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -141.04 158.31 44.11 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 117.57 2.433 . . . . 1.0 117.57 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.1 p -111.65 -16.8 13.16 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 112.939 -1.937 . . . . 1.0 110.799 161.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -135.72 151.23 73.87 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 125.033 1.333 . . . . 1.0 109.516 -171.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.99 -21.32 63.82 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 122.604 1.966 . . . . 1.0 112.289 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -57.51 -49.55 75.96 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 122.188 0.994 . . . . 1.0 112.79 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -70.18 -10.73 59.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.976 1.31 . . . . 1.0 114.323 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.72 -26.05 24.43 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.63 -1.294 . . . . 1.0 108.929 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.62 -49.64 60.14 Favored Pre-proline 0 C--N 1.352 0.682 0 CA-C-O 116.561 -1.685 . . . . 1.0 115.177 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.31 -40.01 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 CA-C-N 125.001 2.822 . . . . 1.0 115.391 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.54 -35.88 16.31 Favored 'Trans proline' 0 CA--C 1.502 -1.114 1 CA-C-N 128.491 4.068 . . . . 1.0 112.244 169.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -58.05 -43.21 86.76 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.822 1.296 . . . . 1.0 112.617 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -70.61 -11.56 61.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -67.34 0.53 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.967 2.318 . . . . 1.0 112.443 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.19 -27.83 8.54 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.36 -2.654 . . . . 1.0 111.649 -161.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.07 -20.3 18.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.65 149.75 5.11 Favored Glycine 0 CA--C 1.494 -1.271 0 O-C-N 120.53 -1.356 . . . . 1.0 114.457 160.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.08 -37.21 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 119.962 -1.904 . . . . 1.0 112.057 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -81.88 -24.02 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.737 -1.852 . . . . 1.0 111.578 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.7 161.76 1.02 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 117.868 2.544 . . . . 1.0 117.868 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.45 167.5 12.49 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 109.318 -1.513 . . . . 1.0 109.318 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.19 134.03 16.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.045 -1.268 . . . . 1.0 108.51 -167.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 156.77 41.44 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 120.913 -1.117 . . . . 1.0 110.427 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.4 t -98.98 129.17 45.26 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 161.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -158.63 134.5 8.97 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 121.137 -0.977 . . . . 1.0 110.558 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 56.54 40.76 29.32 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.741 2.016 . . . . 1.0 110.354 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.77 15.04 57.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 113.809 -1.542 . . . . 1.0 115.704 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.52 157.92 45.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 119.885 -1.95 . . . . 1.0 109.214 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.1 t -65.66 153.59 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 123.358 1.552 . . . . 1.0 113.056 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.68 78.22 1.19 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 123.03 1.395 . . . . 1.0 108.45 -166.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.63 138.29 44.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.957 1.836 . . . . 1.0 115.957 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -105.79 95.13 9.97 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 105.828 -1.916 . . . . 1.0 105.828 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.464 -0.263 0 C-N-CA 122.963 2.442 . . . . 1.0 112.282 -172.08 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 N--CA 1.435 -1.219 1 N-CA-C 99.979 -4.082 . . . . 1.0 99.979 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.06 159.6 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 C-N-CA 129.495 3.118 . . . . 1.0 102.736 170.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.14 46.46 1.35 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 124.428 2.061 . . . . 1.0 110.919 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.17 128.66 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.69 135.83 53.72 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.72 0.772 . . . . 1.0 109.285 -163.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.09 161.77 41.72 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 115.848 1.796 . . . . 1.0 115.848 -164.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -107.17 -26.11 11.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 113.693 -1.594 . . . . 1.0 109.852 157.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -119.21 146.33 40.41 Favored Pre-proline 0 CA--C 1.512 -0.511 0 O-C-N 120.603 -1.311 . . . . 1.0 111.466 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.06 -19.49 63.44 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 122.032 1.821 . . . . 1.0 112.687 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.72 -41.23 85.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 121.423 -0.798 . . . . 1.0 112.742 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.32 -22.14 64.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.135 1.774 . . . . 1.0 113.879 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 1.6 m -91.61 -16.05 27.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.07 0.948 . . . . 1.0 111.899 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 tp -66.87 -51.59 37.34 Favored Pre-proline 0 C--N 1.35 0.607 0 CA-C-O 117.176 -1.393 . . . . 1.0 114.014 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.39 -36.98 52.33 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-O 113.1 -2.959 . . . . 1.0 115.623 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.62 -42.48 2.48 Favored 'Trans proline' 0 CA--C 1.502 -1.109 1 CA-C-N 129.232 4.333 . . . . 1.0 113.176 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.23 -48.42 81.7 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.783 -1.198 . . . . 1.0 110.956 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -70.84 -9.8 58.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 116.61 2.078 . . . . 1.0 116.61 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.76 -74.65 0.16 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 124.792 2.234 . . . . 1.0 112.353 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.5 -35.22 68.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 111.518 -2.583 . . . . 1.0 110.052 -164.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -107.82 -8.92 15.87 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.896 -1.502 . . . . 1.0 110.544 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 -161.9 26.83 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 124.539 2.188 . . . . 1.0 117.262 156.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -68.67 -28.24 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 119.715 -2.05 . . . . 1.0 112.591 -167.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -78.48 -30.59 47.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 120.631 -1.293 . . . . 1.0 110.72 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.49 43.65 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 117.447 2.388 . . . . 1.0 117.447 -164.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.18 179.23 16.49 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -154.93 127.7 8.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 120.547 -1.561 . . . . 1.0 111.203 -157.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.78 161.59 27.02 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 121.076 -1.015 . . . . 1.0 108.582 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.8 t -108.49 135.38 49.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.57 -1.195 . . . . 1.0 108.089 161.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -156.41 138.43 14.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.289 -0.882 . . . . 1.0 109.563 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.32 19.27 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.282 1.833 . . . . 1.0 110.447 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.96 8.56 69.17 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 124.557 1.075 . . . . 1.0 115.604 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -140.97 164.89 29.04 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 119.974 -1.898 . . . . 1.0 109.138 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -69.84 161.14 30.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 117.041 2.238 . . . . 1.0 117.041 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -150.82 82.25 1.34 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.1 m -75.09 129.13 37.05 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.629 -1.295 . . . . 1.0 114.138 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.84 150.68 36.92 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.788 1.235 . . . . 1.0 108.383 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 C--N 1.328 -0.502 0 CA-C-N 123.22 2.186 . . . . 1.0 111.85 162.606 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 101.767 -3.419 . . . . 1.0 101.767 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER -100.86 -143.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 126.855 2.062 . . . . 1.0 108.043 177.557 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 3' ' ' ILE . 16.7 t70 -139.29 48.19 1.87 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 124.782 2.229 . . . . 1.0 110.15 163.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.78 118.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 113.251 -1.795 . . . . 1.0 106.31 163.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -95.77 141.99 28.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.088 -1.449 . . . . 1.0 107.088 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.65 165.37 35.65 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -164.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -105.62 -32.8 8.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 123.421 1.581 . . . . 1.0 109.896 151.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -102.94 153.83 37.98 Favored Pre-proline 0 N--CA 1.452 -0.345 0 O-C-N 120.512 -1.368 . . . . 1.0 111.891 -166.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.73 -31.8 68.73 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 121.784 1.656 . . . . 1.0 112.812 159.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -62.42 -37.58 86.36 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.924 0.784 . . . . 1.0 112.981 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -57.22 -27.87 62.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.945 1.698 . . . . 1.0 113.922 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 t -96.41 -13.83 22.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.301 -0.874 . . . . 1.0 112.245 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.47 -46.87 69.64 Favored Pre-proline 0 C--N 1.345 0.401 0 CA-C-O 116.807 -1.568 . . . . 1.0 113.936 -164.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.15 -48.78 14.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-N 124.121 2.507 . . . . 1.0 115.895 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.85 -37.96 10.75 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 127.254 3.627 . . . . 1.0 112.648 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -59.48 -37.29 77.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 120.514 -1.367 . . . . 1.0 112.183 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -26.43 63.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.413 1.634 . . . . 1.0 115.413 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.89 -67.3 0.54 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 124.811 2.243 . . . . 1.0 113.14 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -84.86 -37.42 20.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.417 -2.629 . . . . 1.0 109.485 -166.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.61 -12.28 13.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.447 1.647 . . . . 1.0 115.447 -160.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.66 149.28 5.04 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 120.593 -1.317 . . . . 1.0 114.631 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.36 -40.5 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 O-C-N 119.845 -1.973 . . . . 1.0 112.837 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -84.14 -22.4 31.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.713 -1.867 . . . . 1.0 110.881 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.8 159.22 0.57 Allowed 'General case' 0 C--N 1.351 0.644 0 N-CA-C 117.788 2.514 . . . . 1.0 117.788 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.03 164.64 12.07 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.54 133.37 20.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.23 -1.767 . . . . 1.0 106.23 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -148.06 154.36 40.13 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.59 144.25 28.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.259 -1.525 . . . . 1.0 112.134 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -163.13 144.11 9.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.628 -1.295 . . . . 1.0 110.917 170.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.48 37.06 19.98 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.308 1.443 . . . . 1.0 110.419 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.01 -8.96 48.67 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.598 -1.183 . . . . 1.0 115.891 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -146.95 168.99 20.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.855 2.327 . . . . 1.0 111.63 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.47 162.51 17.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.336 1.976 . . . . 1.0 116.336 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -146.12 89.8 1.91 Allowed 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 130.113 3.365 . . . . 1.0 102.778 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.7 m -77.89 132.85 38.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.153 1.781 . . . . 1.0 112.195 173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -108.56 97.16 21.89 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.456 -0.724 0 C-N-CA 122.996 2.464 . . . . 1.0 111.338 -175.161 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.0 t . . . . . 0 N--CA 1.431 -1.411 1 N-CA-C 98.763 -4.532 . . . . 1.0 98.763 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.45 160.64 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 102.703 -3.073 . . . . 1.0 102.703 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 42.46 1.1 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 124.959 2.314 . . . . 1.0 110.831 172.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.2 t -87.11 115.1 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -101.94 139.92 36.93 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 122.182 0.991 . . . . 1.0 108.479 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 153.86 40.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 116.652 2.093 . . . . 1.0 116.652 -160.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -111.14 0.83 16.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 127.017 2.127 . . . . 1.0 110.449 172.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 m -171.18 153.68 3.8 Favored Pre-proline 0 CA--C 1.51 -0.594 0 O-C-N 120.714 -1.241 . . . . 1.0 108.782 -171.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.78 -32.08 47.25 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.009 2.472 . . . . 1.0 111.919 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -46.68 -45.76 19.6 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.403 2.281 . . . . 1.0 112.947 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -67.39 -17.59 64.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.761 1.224 . . . . 1.0 114.013 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.7 t -101.55 -7.32 22.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.405 -0.81 . . . . 1.0 112.698 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.93 -46.43 64.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 120.032 -1.667 . . . . 1.0 113.524 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.17 -45.7 29.88 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 CA-C-O 114.019 -2.576 . . . . 1.0 115.814 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.51 -35.86 21.71 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 CA-C-N 127.408 3.681 . . . . 1.0 112.722 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 m -56.93 -46.39 82.09 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.955 1.36 . . . . 1.0 112.119 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -9.84 58.77 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.315 2.339 . . . . 1.0 117.315 172.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -65.84 0.7 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 124.287 1.994 . . . . 1.0 110.58 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -114.8 -33.84 5.34 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 112.316 -2.22 . . . . 1.0 111.377 -169.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -94.08 -18.05 22.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.796 1.406 . . . . 1.0 114.796 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.76 168.09 41.05 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 116.662 -2.685 . . . . 1.0 116.234 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 tt -70.19 -50.07 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.339 1.456 . . . . 1.0 111.191 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -127.8 32.23 4.99 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.57 152.18 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 119.219 3.044 . . . . 1.0 119.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.47 12.34 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 108.713 -1.755 . . . . 1.0 108.713 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.19 130.74 9.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.294 -1.373 . . . . 1.0 107.294 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 166.69 26.69 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 120.455 -1.403 . . . . 1.0 109.361 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 t -120.78 135.99 55.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.242 0.617 . . . . 1.0 110.897 -164.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.23 145.67 19.51 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.39 1.076 . . . . 1.0 108.272 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.63 32.08 20.29 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 126.307 1.843 . . . . 1.0 110.419 -173.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.67 19.46 62.81 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 124.855 1.217 . . . . 1.0 115.468 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.53 151.87 37.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.662 -2.081 . . . . 1.0 108.876 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -69.17 162.7 26.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.069 2.248 . . . . 1.0 117.069 -169.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.74 95.7 2.55 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.324 -3.213 . . . . 1.0 102.324 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.34 132.68 33.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.557 2.343 . . . . 1.0 112.426 -174.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -102.67 111.57 64.9 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.458 -0.595 0 C-N-CA 122.382 2.054 . . . . 1.0 112.389 -167.352 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 102.019 -3.326 . . . . 1.0 102.019 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.64 154.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 101.472 -3.529 . . . . 1.0 101.472 160.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.64 41.9 1.06 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 124.369 2.033 . . . . 1.0 112.191 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.54 115.26 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.574 -2.38 . . . . 1.0 104.574 167.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -103.09 137.02 41.82 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -163.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 p -140.5 150.81 44.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 118.159 2.651 . . . . 1.0 118.159 -163.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 p -115.15 9.46 15.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 128.002 2.521 . . . . 1.0 109.639 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -167.49 150.31 5.72 Favored Pre-proline 0 CA--C 1.511 -0.534 0 O-C-N 119.608 -1.933 . . . . 1.0 108.536 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.65 -24.58 35.16 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.509 2.139 . . . . 1.0 111.93 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -48.86 -44.46 39.79 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.521 1.929 . . . . 1.0 112.84 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -65.86 -18.3 65.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.026 1.331 . . . . 1.0 113.553 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 40.1 t -83.64 -25.19 30.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.265 1.026 . . . . 1.0 111.344 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.06 -52.48 30.66 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 117.16 -1.4 . . . . 1.0 114.331 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.58 -38.79 39.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-O 113.127 -2.947 . . . . 1.0 115.433 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.94 -37.26 8.97 Favored 'Trans proline' 0 CA--C 1.502 -1.103 1 CA-C-N 129.365 4.38 . . . . 1.0 112.265 172.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.07 -44.3 82.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.379 1.085 . . . . 1.0 111.793 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -70.72 -17.73 62.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.461 2.023 . . . . 1.0 116.461 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -68.25 0.48 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 124.899 2.285 . . . . 1.0 113.005 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -102.08 -38.57 7.67 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.05 -2.796 . . . . 1.0 110.142 -161.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.06 -45.11 7.37 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.564 -166.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.94 142.87 4.41 Favored Glycine 0 CA--C 1.491 -1.426 0 C-N-CA 118.556 -1.783 . . . . 1.0 114.795 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.11 -38.03 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 120.082 -1.834 . . . . 1.0 112.393 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -81.49 -23.62 37.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.307 -1.496 . . . . 1.0 111.663 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.76 156.38 0.2 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 118.624 2.824 . . . . 1.0 118.624 -167.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.85 162.4 14.72 Favored Glycine 0 CA--C 1.475 -2.418 0 N-CA-C 107.854 -2.098 . . . . 1.0 107.854 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.66 6.05 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 119.911 -1.935 . . . . 1.0 107.56 -163.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.14 21.45 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.76 -1.576 . . . . 1.0 110.792 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.0 t -94.81 133.8 38.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.1 ttt -153.61 133.74 13.32 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 121.025 -1.047 . . . . 1.0 109.598 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.367 1.0 OUTLIER 53.48 32.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 128.473 2.709 . . . . 1.0 112.863 -172.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.74 10.02 86.56 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 113.712 -1.585 . . . . 1.0 115.403 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -136.85 157.31 47.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 120.298 2.049 . . . . 1.0 109.708 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.7 t -70.65 141.62 51.65 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 123.926 1.822 . . . . 1.0 113.819 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.72 84.25 2.09 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 102.125 -3.287 . . . . 1.0 102.125 -171.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.19 132.78 37.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.531 1.533 . . . . 1.0 110.551 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.98 95.05 19.31 Favored Pre-proline 0 N--CA 1.434 -1.238 0 C-N-CA 126.119 1.768 . . . . 1.0 106.248 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 N--CA 1.46 -0.461 0 C-N-CA 122.77 2.313 . . . . 1.0 112.389 -175.66 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 0 N--CA 1.431 -1.403 1 N-CA-C 97.697 -4.927 . . . . 1.0 97.697 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.84 156.27 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 101.547 -3.501 . . . . 1.0 101.547 176.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.71 51.31 1.55 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 125.08 2.372 . . . . 1.0 110.718 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -90.29 102.79 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 162.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER -74.36 136.12 42.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 123.765 1.745 . . . . 1.0 112.606 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.49 154.15 18.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.144 1.926 . . . . 1.0 114.165 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 3.18 5.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.6 1.96 . . . . 1.0 107.862 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -177.14 157.02 1.28 Allowed Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 104.032 -2.581 . . . . 1.0 104.032 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.4 -23.18 28.17 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 CA-C-N 123.277 2.206 . . . . 1.0 111.999 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -57.67 -42.15 82.96 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 122.082 0.944 . . . . 1.0 113.057 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -70.58 -7.41 43.79 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 114.973 1.472 . . . . 1.0 114.973 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -82.44 -25.71 33.38 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.95 -1.094 . . . . 1.0 110.297 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.86 -48.23 62.77 Favored Pre-proline 0 C--N 1.354 0.777 0 O-C-N 119.628 -1.92 . . . . 1.0 114.446 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.76 -37.5 55.62 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 CA-C-O 113.216 -2.91 . . . . 1.0 115.237 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -37.06 17.66 Favored 'Trans proline' 0 CA--C 1.503 -1.043 1 CA-C-N 129.054 4.269 . . . . 1.0 112.48 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.92 -39.17 77.35 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.81 -1.181 . . . . 1.0 112.335 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -13.34 62.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 116.917 2.192 . . . . 1.0 116.917 174.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.96 72.31 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 123.158 1.456 . . . . 1.0 113.558 -170.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -164.08 -27.79 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.074 -1.421 . . . . 1.0 111.719 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.79 -17.74 52.67 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 120.228 -1.545 . . . . 1.0 113.004 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 154.35 7.29 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 121.058 -1.026 . . . . 1.0 112.861 154.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.21 -43.17 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 O-C-N 119.914 -1.933 . . . . 1.0 112.554 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -75.91 -28.31 57.99 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.664 -1.897 . . . . 1.0 111.134 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.4 151.46 0.37 Allowed 'General case' 0 C--N 1.35 0.589 0 N-CA-C 118.811 2.893 . . . . 1.0 118.811 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.69 175.62 21.74 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.16 131.95 11.55 Favored 'General case' 0 N--CA 1.434 -1.255 0 O-C-N 121.33 -1.1 . . . . 1.0 110.06 -166.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 154.24 45.72 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.902 -1.123 . . . . 1.0 111.308 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.31 117.04 34.18 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 164.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -147.32 136.36 22.31 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.519 -1.363 . . . . 1.0 110.296 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.417 0.9 OUTLIER 53.23 30.4 9.92 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 128.106 2.562 . . . . 1.0 112.955 -170.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.45 6.28 89.0 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 113.744 -1.571 . . . . 1.0 115.647 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.58 152.4 51.89 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.855 1.827 . . . . 1.0 108.995 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.72 143.09 51.41 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 116.333 1.975 . . . . 1.0 116.333 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -137.98 81.59 1.87 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.34 2.256 . . . . 1.0 107.365 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.6 m -70.11 132.1 45.31 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.206 1.558 . . . . 1.0 115.206 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -96.63 101.08 8.23 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 CA-C-N 122.719 2.007 . . . . 1.0 111.745 -173.602 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 100.773 -3.788 . . . . 1.0 100.773 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.81 -149.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 126.279 1.832 . . . . 1.0 106.822 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -142.38 37.37 1.52 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 124.896 2.284 . . . . 1.0 110.389 167.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.14 119.03 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 112.241 -2.254 . . . . 1.0 106.622 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -102.23 143.16 32.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.828 0.823 . . . . 1.0 109.13 -170.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.5 149.67 41.19 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 117.574 2.435 . . . . 1.0 117.574 -162.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -110.44 3.31 19.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 127.642 2.377 . . . . 1.0 109.73 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -177.55 146.35 0.61 Allowed Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 105.723 -1.954 . . . . 1.0 105.723 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.03 -26.85 57.99 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 123.871 2.418 . . . . 1.0 112.846 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -54.74 -30.84 57.36 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.789 1.636 . . . . 1.0 113.802 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -62.32 -26.38 68.4 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.052 -1.03 . . . . 1.0 113.439 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -100.13 -1.15 37.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.302 -0.874 . . . . 1.0 112.567 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.52 -49.39 83.58 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 120.295 -1.503 . . . . 1.0 113.695 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.28 -34.13 56.91 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-O 113.15 -2.938 . . . . 1.0 115.477 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.38 -36.41 9.2 Favored 'Trans proline' 0 CA--C 1.507 -0.874 1 CA-C-N 129.094 4.284 . . . . 1.0 112.91 169.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.6 -52.37 65.93 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.542 -1.349 . . . . 1.0 111.558 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -71.76 -1.98 15.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.235 1.569 . . . . 1.0 115.235 171.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.67 -69.32 0.39 Allowed 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 118.981 -2.325 . . . . 1.0 111.003 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -115.41 -29.89 6.4 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 111.547 -2.569 . . . . 1.0 112.056 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -92.74 -23.38 18.92 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 115.063 1.505 . . . . 1.0 115.063 -167.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.33 47.91 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 119.842 -1.787 . . . . 1.0 115.231 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.53 -45.44 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.224 1.81 . . . . 1.0 114.136 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -120.61 13.61 11.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.736 1.614 . . . . 1.0 107.034 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 145.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.143 1.905 . . . . 1.0 116.143 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.57 178.17 22.64 Favored Glycine 0 CA--C 1.479 -2.158 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -163.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.42 141.89 31.02 Favored 'General case' 0 N--CA 1.423 -1.817 0 O-C-N 120.569 -1.548 . . . . 1.0 110.116 -163.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -111.85 139.91 46.94 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.5 t -101.14 130.76 47.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.4 ttt -150.06 137.82 20.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 120.751 -1.218 . . . . 1.0 109.59 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.44 27.26 16.22 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.558 1.543 . . . . 1.0 111.23 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.05 86.5 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 114.774 -1.103 . . . . 1.0 115.652 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.36 151.54 43.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.681 2.24 . . . . 1.0 110.536 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.4 t -70.32 153.75 42.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 118.025 2.602 . . . . 1.0 118.025 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -144.6 92.06 2.25 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 127.394 2.278 . . . . 1.0 105.016 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -77.96 137.35 38.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 128.55 2.74 . . . . 1.0 114.782 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -100.2 102.1 16.94 Favored Pre-proline 0 N--CA 1.441 -0.888 0 C-N-CA 126.595 1.958 . . . . 1.0 106.324 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo . . . . . 0 N--CA 1.448 -1.158 0 CA-C-N 121.978 1.742 . . . . 1.0 111.859 -173.102 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 N--CA 1.43 -1.461 1 N-CA-C 98.671 -4.566 . . . . 1.0 98.671 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 155.9 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 101.377 -3.564 . . . . 1.0 101.377 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.61 47.36 1.23 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 124.353 2.025 . . . . 1.0 110.946 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.96 122.88 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -93.8 144.24 25.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.137 0.97 . . . . 1.0 110.81 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.47 155.66 42.12 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.729 1.728 . . . . 1.0 115.395 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -110.71 -24.92 10.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.849 156.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -118.06 146.99 40.44 Favored Pre-proline 0 CA--C 1.512 -0.498 0 O-C-N 120.178 -1.576 . . . . 1.0 110.296 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.14 -17.0 57.67 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 C-N-CA 122.219 1.946 . . . . 1.0 112.049 166.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -59.41 -42.4 91.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.626 -1.296 . . . . 1.0 112.504 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.45 -16.78 63.03 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.04 1.736 . . . . 1.0 113.986 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.638 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -83.34 -28.25 29.13 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 121.114 -0.991 . . . . 1.0 111.063 176.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.3 -53.61 10.22 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 114.471 1.286 . . . . 1.0 114.471 -160.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -57.35 -46.11 30.13 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 CA-C-O 114.344 -2.44 . . . . 1.0 115.406 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -67.11 -37.48 18.61 Favored 'Trans proline' 0 CA--C 1.504 -1.017 0 CA-C-N 127.007 3.538 . . . . 1.0 112.398 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 t -64.41 -37.36 87.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 120.323 -1.485 . . . . 1.0 112.771 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -70.73 -11.63 61.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 116.827 2.158 . . . . 1.0 116.827 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.82 71.59 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 123.148 1.451 . . . . 1.0 113.416 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -164.4 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.911 -1.495 . . . . 1.0 111.378 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -78.5 -14.92 59.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.176 -1.578 . . . . 1.0 113.291 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.11 154.79 7.2 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 122.336 0.965 . . . . 1.0 113.108 149.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -70.19 -41.88 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 O-C-N 120.742 -1.446 . . . . 1.0 112.603 -174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -91.02 -18.56 24.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.961 -1.087 . . . . 1.0 110.978 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.78 144.35 1.76 Allowed 'General case' 0 C--N 1.352 0.703 0 N-CA-C 117.612 2.449 . . . . 1.0 117.612 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.35 25.9 Favored Glycine 0 CA--C 1.475 -2.407 0 N-CA-C 107.47 -2.252 . . . . 1.0 107.47 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -159.95 125.2 4.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.225 -1.162 . . . . 1.0 109.595 -168.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 169.65 22.04 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.723 -1.235 . . . . 1.0 109.65 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.8 t -100.2 139.29 36.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.609 -0.682 . . . . 1.0 112.443 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.8 ttt -162.94 148.4 11.91 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.343 1.057 . . . . 1.0 108.565 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 63.2 28.78 15.97 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 123.226 1.489 . . . . 1.0 110.208 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.16 12.38 57.73 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.602 1.096 . . . . 1.0 115.53 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.3 165.19 32.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 120.023 1.911 . . . . 1.0 110.536 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -69.52 153.96 42.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.144 1.535 . . . . 1.0 115.144 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 85.4 1.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.582 -2.747 . . . . 1.0 103.582 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.56 127.42 32.78 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.262 1.825 . . . . 1.0 112.681 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.56 102.41 14.57 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 105.729 -1.952 . . . . 1.0 105.729 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 N--CA 1.456 -0.71 0 C-N-CA 122.216 1.944 . . . . 1.0 112.141 -166.469 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.44 -0.944 1 N-CA-C 100.15 -4.019 . . . . 1.0 100.15 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 152.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 N-CA-C 100.824 -3.769 . . . . 1.0 100.824 154.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -99.23 50.11 0.95 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 124.268 1.985 . . . . 1.0 111.382 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.73 117.28 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 105.012 -2.218 . . . . 1.0 105.012 163.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.74 143.77 26.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.584 0.707 . . . . 1.0 111.291 -167.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.98 153.57 40.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 116.36 1.985 . . . . 1.0 116.36 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -94.0 -41.69 9.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 112.146 -2.297 . . . . 1.0 109.027 156.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -108.94 148.4 37.82 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.451 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.73 -23.92 74.61 Favored 'Trans proline' 0 CA--C 1.51 -0.704 0 C-N-CA 121.775 1.65 . . . . 1.0 112.656 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.95 -33.96 76.91 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 121.064 -1.023 . . . . 1.0 113.223 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -64.36 -15.32 60.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.549 1.14 . . . . 1.0 113.848 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -89.14 -21.68 23.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.841 -1.162 . . . . 1.0 111.477 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.95 -52.85 46.64 Favored Pre-proline 0 N--CA 1.439 -0.996 0 O-C-N 120.441 -1.412 . . . . 1.0 113.804 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.23 -36.59 45.63 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-O 112.877 -3.051 . . . . 1.0 115.263 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -69.86 -39.7 6.0 Favored 'Trans proline' 0 CA--C 1.504 -0.979 1 CA-C-N 129.456 4.413 . . . . 1.0 112.426 170.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.2 -49.73 75.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 123.71 1.719 . . . . 1.0 111.861 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -71.54 -8.78 56.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 115.905 1.817 . . . . 1.0 115.905 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -68.46 0.45 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 124.237 1.97 . . . . 1.0 110.986 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -106.83 -44.73 4.36 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 111.997 -2.365 . . . . 1.0 110.594 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -87.84 -24.89 23.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.427 0.899 . . . . 1.0 113.427 -154.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.0 167.22 39.99 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 115.297 -3.335 . . . . 1.0 118.314 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.21 -61.0 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 C-N-CA 124.772 1.229 . . . . 1.0 112.3 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -105.18 10.44 33.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.465 1.106 . . . . 1.0 109.659 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 146.2 39.25 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -168.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.86 167.25 19.62 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 107.754 -2.139 . . . . 1.0 107.754 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.18 127.02 4.96 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.963 -1.904 . . . . 1.0 109.674 -162.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 173.41 14.56 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 120.615 -1.303 . . . . 1.0 111.351 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -101.46 139.89 36.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.679 0.792 . . . . 1.0 110.112 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.5 ttt -164.68 145.9 7.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.249 1.42 . . . . 1.0 108.629 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 62.84 28.15 16.3 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 123.161 1.458 . . . . 1.0 110.368 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.72 62.25 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 124.246 0.927 . . . . 1.0 115.252 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.93 162.88 39.48 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 120.228 -1.748 . . . . 1.0 110.916 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 t -64.58 152.36 42.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.918 1.818 . . . . 1.0 115.023 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -142.89 85.88 1.9 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 104.357 -2.46 . . . . 1.0 104.357 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.91 128.28 33.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.075 0.95 . . . . 1.0 111.568 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -110.96 95.72 25.84 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.206 1.802 . . . . 1.0 109.125 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--N 1.33 -0.423 0 C-N-CA 122.776 2.318 . . . . 1.0 111.597 167.139 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.431 -1.406 1 N-CA-C 99.17 -4.382 . . . . 1.0 99.17 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.07 153.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 N-CA-C 100.7 -3.815 . . . . 1.0 100.7 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.27 52.01 1.12 Allowed 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 124.64 2.162 . . . . 1.0 110.308 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.55 123.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 105.399 -2.075 . . . . 1.0 105.399 163.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -80.15 142.91 34.32 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.728 0.775 . . . . 1.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -140.47 149.95 43.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 124.184 1.945 . . . . 1.0 116.088 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 m -114.25 -9.22 12.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 129.424 3.09 . . . . 1.0 107.97 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -174.18 158.15 2.66 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.568 1.547 . . . . 1.0 107.285 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.28 -28.76 33.18 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 C-N-CA 122.296 1.997 . . . . 1.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -55.0 -40.01 69.68 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.311 1.444 . . . . 1.0 113.313 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.2 -29.0 67.17 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.145 1.378 . . . . 1.0 114.079 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 t -99.21 -3.48 34.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.121 -0.987 . . . . 1.0 113.094 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.75 -51.55 75.3 Favored Pre-proline 0 N--CA 1.451 -0.418 0 O-C-N 120.247 -1.533 . . . . 1.0 113.851 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.99 -37.94 50.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-O 113.187 -2.922 . . . . 1.0 115.712 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -68.74 -38.31 10.58 Favored 'Trans proline' 0 CA--C 1.508 -0.825 1 CA-C-N 129.134 4.298 . . . . 1.0 112.701 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.1 t -58.63 -50.7 72.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.351 1.548 . . . . 1.0 111.747 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -0.9 12.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 116.762 2.134 . . . . 1.0 116.762 172.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.02 70.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 123.463 1.602 . . . . 1.0 112.316 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -156.26 -26.55 0.1 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.686 -1.597 . . . . 1.0 112.174 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.93 -19.75 51.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 119.959 -1.713 . . . . 1.0 113.19 -169.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.4 157.5 26.23 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 117.851 -2.119 . . . . 1.0 114.622 157.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -69.53 -35.45 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 O-C-N 120.511 -1.582 . . . . 1.0 112.249 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -112.76 10.76 19.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.695 1.598 . . . . 1.0 110.882 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.03 155.52 34.43 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 115.931 1.826 . . . . 1.0 115.931 -166.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.56 166.05 27.83 Favored Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.942 -2.463 . . . . 1.0 106.942 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.31 154.5 50.85 Favored 'General case' 0 N--CA 1.418 -2.027 0 O-C-N 120.568 -1.548 . . . . 1.0 107.792 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -149.36 165.8 30.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.984 167.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.5 t -97.39 140.53 31.7 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 113.445 0.905 . . . . 1.0 113.445 -169.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 ttt -155.83 136.72 13.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.888 -1.132 . . . . 1.0 109.66 167.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.01 31.08 18.09 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.294 1.521 . . . . 1.0 110.269 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.27 15.62 65.85 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 124.611 1.1 . . . . 1.0 115.012 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -146.91 158.14 43.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.319 -1.695 . . . . 1.0 110.081 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.68 156.62 38.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.677 2.473 . . . . 1.0 117.677 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -141.64 89.59 2.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 103.556 -2.757 . . . . 1.0 103.556 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.9 t -85.91 126.56 34.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.513 2.325 . . . . 1.0 112.854 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -115.8 108.07 47.34 Favored Pre-proline 0 N--CA 1.437 -1.089 0 C-N-CA 126.512 1.925 . . . . 1.0 108.501 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 C--N 1.317 -1.1 0 C-N-CA 122.608 2.206 . . . . 1.0 110.323 159.696 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.433 -1.315 1 N-CA-C 98.602 -4.592 . . . . 1.0 98.602 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.95 160.48 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.495 0 N-CA-C 103.787 -2.671 . . . . 1.0 103.787 172.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.51 44.05 1.18 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 124.672 2.177 . . . . 1.0 110.67 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.2 113.17 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 103.979 -2.6 . . . . 1.0 103.979 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -98.49 133.5 42.77 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -161.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 p -135.63 156.94 48.05 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 118.48 2.771 . . . . 1.0 118.48 -165.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -109.65 -23.43 11.45 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.972 -1.922 . . . . 1.0 110.404 156.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 t -131.59 151.82 79.35 Favored Pre-proline 0 CA--C 1.508 -0.661 0 O-C-N 120.192 -1.567 . . . . 1.0 109.655 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.42 -25.22 56.22 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 122.763 2.022 . . . . 1.0 111.953 164.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -58.49 -41.28 84.97 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 122.37 1.081 . . . . 1.0 113.482 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.42 -13.89 62.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.523 1.129 . . . . 1.0 113.445 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -90.59 -8.31 50.5 Favored 'General case' 0 N--CA 1.417 -2.087 0 O-C-N 120.629 -1.294 . . . . 1.0 111.72 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.08 -44.18 59.22 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 116.759 -1.591 . . . . 1.0 113.23 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.84 -46.77 21.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 124.13 2.511 . . . . 1.0 115.683 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.07 -34.91 21.36 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 CA-C-N 127.557 3.735 . . . . 1.0 112.722 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.3 m -58.95 -35.79 73.72 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.704 -1.248 . . . . 1.0 112.3 172.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -20.1 62.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 116.843 2.164 . . . . 1.0 116.843 172.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -69.88 0.36 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 125.074 2.369 . . . . 1.0 111.903 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -93.5 -38.4 11.43 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.35 -2.659 . . . . 1.0 110.254 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.4 -11.72 20.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 -167.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 174.04 18.53 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 123.202 1.445 . . . . 1.0 115.21 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -69.08 -33.61 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 119.452 -2.205 . . . . 1.0 113.123 -167.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -86.98 -12.66 46.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.457 -1.402 . . . . 1.0 112.027 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.44 158.12 18.48 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 116.737 2.125 . . . . 1.0 116.737 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.17 14.46 Favored Glycine 0 CA--C 1.492 -1.377 0 O-C-N 120.912 -1.117 . . . . 1.0 111.184 -170.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.38 149.08 27.44 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.565 -1.55 . . . . 1.0 111.19 -171.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.63 136.22 54.82 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 125.786 1.634 . . . . 1.0 108.362 167.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 t -89.7 130.05 36.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.393 -0.817 . . . . 1.0 110.597 167.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.9 ttt -155.13 137.24 14.71 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 121.049 -1.032 . . . . 1.0 109.612 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.27 29.03 18.66 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.232 1.813 . . . . 1.0 110.992 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.83 10.9 62.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 116.568 1.387 . . . . 1.0 116.568 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -143.91 127.31 16.83 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.739 2.269 . . . . 1.0 109.153 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 153.39 42.7 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 119.437 3.125 . . . . 1.0 119.437 -162.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -123.21 78.95 1.62 Allowed 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 128.579 2.752 . . . . 1.0 104.218 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 t -70.21 132.98 46.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.406 1.482 . . . . 1.0 114.122 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.98 103.86 46.57 Favored Pre-proline 0 N--CA 1.434 -1.27 0 C-N-CA 125.847 1.659 . . . . 1.0 106.852 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.324 -0.734 0 CA-C-N 123.194 2.176 . . . . 1.0 109.899 157.527 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 N--CA 1.439 -1.003 1 N-CA-C 99.95 -4.093 . . . . 1.0 99.95 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.4 mt -104.53 -146.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 126.695 1.998 . . . . 1.0 107.738 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 3' ' ' ILE . 1.3 t0 -124.31 46.34 2.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 124.956 2.312 . . . . 1.0 109.011 163.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.39 105.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 112.41 -2.177 . . . . 1.0 105.349 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.56 131.54 38.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.741 -1.577 . . . . 1.0 106.741 171.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.79 161.96 39.58 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.051 2.241 . . . . 1.0 117.051 -162.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -46.94 8.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 112.786 -2.006 . . . . 1.0 109.739 154.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 152.97 76.81 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.271 -1.331 . . . . 1.0 111.933 -149.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.29 -33.55 48.01 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.235 2.623 . . . . 1.0 112.034 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -44.85 -48.42 11.09 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 127.282 2.233 . . . . 1.0 112.371 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -63.71 -22.54 66.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.223 1.409 . . . . 1.0 113.978 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.5 t -106.5 -7.47 17.51 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.635 -0.665 . . . . 1.0 112.47 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 tp -64.67 -50.87 62.34 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 116.921 -1.514 . . . . 1.0 113.667 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.77 -41.16 40.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-O 112.918 -3.034 . . . . 1.0 115.543 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -69.03 -40.22 6.77 Favored 'Trans proline' 0 CA--C 1.508 -0.798 1 CA-C-N 129.369 4.382 . . . . 1.0 113.151 173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.1 t -56.89 -44.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.465 1.602 . . . . 1.0 111.627 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -21.01 62.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 174.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.21 -70.89 0.31 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 124.631 2.158 . . . . 1.0 112.89 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -90.58 -42.59 10.71 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.203 -2.726 . . . . 1.0 108.689 -159.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -96.53 -30.19 13.46 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.599 -1.637 . . . . 1.0 113.756 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.98 159.18 22.78 Favored Glycine 0 CA--C 1.484 -1.89 0 C-N-CA 114.798 -3.572 . . . . 1.0 115.016 165.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 tt -70.28 -34.51 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 C-N-CA 126.295 1.838 . . . . 1.0 113.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -98.12 -11.26 23.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.313 0.645 . . . . 1.0 111.801 172.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.39 152.12 11.91 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.812 2.523 . . . . 1.0 117.812 -167.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.4 167.92 29.68 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 109.039 -1.625 . . . . 1.0 109.039 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.98 154.43 42.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 123.286 1.517 . . . . 1.0 110.161 -164.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 175.7 10.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 107.485 -1.302 . . . . 1.0 107.485 166.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.3 t -107.53 147.08 31.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.782 -0.574 . . . . 1.0 110.513 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.1 ttt -164.01 142.01 7.26 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.378 1.471 . . . . 1.0 109.803 169.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.32 35.78 20.66 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 126.157 1.783 . . . . 1.0 110.48 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.87 -5.04 55.27 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 116.231 1.252 . . . . 1.0 116.231 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -135.39 165.26 25.88 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.686 2.243 . . . . 1.0 109.766 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.55 160.89 10.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 115.043 1.497 . . . . 1.0 115.043 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -142.74 90.53 2.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 100.289 -3.967 . . . . 1.0 100.289 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -92.46 128.68 38.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 126.261 1.824 . . . . 1.0 109.034 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.11 98.06 41.12 Favored Pre-proline 0 N--CA 1.436 -1.141 0 C-N-CA 125.212 1.405 . . . . 1.0 107.336 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 121.696 1.597 . . . . 1.0 111.078 173.793 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 98.543 -4.614 . . . . 1.0 98.543 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.79 158.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 101.68 -3.452 . . . . 1.0 101.68 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.85 42.06 1.09 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 124.091 1.901 . . . . 1.0 112.122 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.52 126.67 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 170.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -108.22 140.13 41.9 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.906 0.86 . . . . 1.0 110.958 -157.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.3 156.26 47.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -168.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.4 m -108.77 -26.55 10.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.709 1.719 . . . . 1.0 109.636 162.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -123.17 154.15 65.01 Favored Pre-proline 0 CA--C 1.515 -0.371 0 O-C-N 120.578 -1.326 . . . . 1.0 110.563 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.48 -27.11 54.43 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 121.816 1.677 . . . . 1.0 112.474 160.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.9 -49.63 74.05 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.623 -1.298 . . . . 1.0 112.651 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.93 -5.45 17.03 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.093 1.357 . . . . 1.0 113.633 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -88.56 -27.79 21.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.113 1.435 . . . . 1.0 109.533 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.9 tp -70.15 -47.3 21.29 Favored Pre-proline 0 C--N 1.355 0.835 0 CA-C-O 116.298 -1.811 . . . . 1.0 114.681 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.13 -35.87 61.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-O 113.23 -2.904 . . . . 1.0 115.288 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.43 -39.93 11.66 Favored 'Trans proline' 0 CA--C 1.502 -1.113 1 CA-C-N 128.98 4.243 . . . . 1.0 112.308 170.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.6 m -61.17 -33.47 73.49 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.744 -1.223 . . . . 1.0 113.379 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -12.2 61.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 116.417 2.006 . . . . 1.0 116.417 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.26 71.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 123.272 1.511 . . . . 1.0 113.518 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -163.05 -30.05 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.782 -1.554 . . . . 1.0 111.33 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.9 -15.46 59.0 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 120.23 -1.544 . . . . 1.0 113.038 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.23 153.3 6.3 Favored Glycine 0 CA--C 1.492 -1.394 0 CA-C-O 122.329 0.961 . . . . 1.0 113.887 150.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.3 -35.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 119.877 -1.955 . . . . 1.0 111.818 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -70.17 -37.44 75.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.996 1.718 . . . . 1.0 109.772 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.07 155.68 1.81 Allowed 'General case' 0 C--N 1.348 0.524 0 N-CA-C 118.163 2.653 . . . . 1.0 118.163 -162.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.18 174.13 15.09 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.361 -1.895 . . . . 1.0 108.361 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -160.35 137.59 9.34 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 120.879 -1.365 . . . . 1.0 109.386 -165.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -155.48 166.27 34.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.301 -0.96 . . . . 1.0 110.259 165.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.5 141.58 29.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.778 -0.576 . . . . 1.0 112.338 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -155.56 135.96 13.21 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.186 -0.946 . . . . 1.0 109.868 168.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.98 34.03 21.47 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.77 2.028 . . . . 1.0 110.42 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.47 15.27 68.06 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.76 -1.109 . . . . 1.0 115.669 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -145.85 150.76 36.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 119.8 -2.0 . . . . 1.0 110.057 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.0 156.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 -164.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.18 86.8 2.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.734 -2.691 . . . . 1.0 103.734 -175.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 62.1 m -75.31 131.03 40.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 125.967 1.707 . . . . 1.0 113.554 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.74 126.26 28.85 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 106.075 -1.824 . . . . 1.0 106.075 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 CA--C 1.509 -0.765 0 CA-C-N 124.641 2.693 . . . . 1.0 113.466 -168.92 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.433 -1.312 1 N-CA-C 98.686 -4.561 . . . . 1.0 98.686 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.53 158.76 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 103.284 -2.858 . . . . 1.0 103.284 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.23 50.85 1.56 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.115 2.166 . . . . 1.0 110.358 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.11 118.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 105.373 -2.084 . . . . 1.0 105.373 165.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 134.19 36.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -134.66 146.63 49.69 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 116.967 2.21 . . . . 1.0 116.967 -165.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -110.63 -17.78 13.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 112.433 -2.167 . . . . 1.0 109.176 167.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -140.3 147.62 50.69 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 56.7 Cg_endo -60.71 -24.15 77.97 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 122.401 2.067 . . . . 1.0 112.88 167.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -37.67 70.72 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 122.716 1.246 . . . . 1.0 112.416 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -60.4 -24.66 65.32 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.543 1.537 . . . . 1.0 114.228 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 38.5 t -103.46 -5.02 23.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.164 0.983 . . . . 1.0 112.609 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.25 -48.65 75.89 Favored Pre-proline 0 C--N 1.345 0.411 0 O-C-N 120.186 -1.571 . . . . 1.0 114.299 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.61 -34.3 64.12 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-O 113.402 -2.832 . . . . 1.0 115.44 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.59 -36.55 14.5 Favored 'Trans proline' 0 CA--C 1.506 -0.89 1 CA-C-N 128.867 4.202 . . . . 1.0 112.54 169.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 m -59.29 -51.05 71.63 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.122 1.439 . . . . 1.0 112.37 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 2.36 5.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 116.777 2.14 . . . . 1.0 116.777 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.8 -50.93 30.38 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.752 1.739 . . . . 1.0 111.502 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 -12.71 0.24 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.447 -1.706 . . . . 1.0 113.036 -173.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -84.98 -20.74 30.09 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 120.031 -1.668 . . . . 1.0 113.384 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.88 -166.2 33.51 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 115.344 -3.312 . . . . 1.0 119.154 163.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.3 -62.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 C-N-CA 125.098 1.359 . . . . 1.0 112.295 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.69 13.51 14.23 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.906 1.682 . . . . 1.0 107.437 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.09 145.49 0.75 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 118.282 2.697 . . . . 1.0 118.282 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.8 170.8 21.07 Favored Glycine 0 CA--C 1.477 -2.311 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -162.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -145.16 135.44 24.05 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 -170.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -144.04 149.28 36.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.05 137.7 34.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 121.221 -0.924 . . . . 1.0 111.902 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -155.69 139.96 16.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 120.819 -1.176 . . . . 1.0 109.68 167.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.8 33.95 19.9 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 126.356 1.862 . . . . 1.0 110.141 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.12 16.7 60.3 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 124.382 0.991 . . . . 1.0 115.525 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -144.84 154.38 42.59 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 119.708 -2.054 . . . . 1.0 107.919 -173.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.35 158.49 31.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 119.675 -1.891 . . . . 1.0 115.987 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -144.09 89.69 2.05 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 101.625 -3.472 . . . . 1.0 101.625 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.2 t -85.64 129.3 34.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.798 2.039 . . . . 1.0 112.398 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -103.89 102.9 34.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 122.149 1.9 . . . . 1.0 111.865 -166.644 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t . . . . . 0 N--CA 1.43 -1.425 1 N-CA-C 98.551 -4.611 . . . . 1.0 98.551 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.21 157.39 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 167.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.61 41.6 1.03 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 125.401 2.525 . . . . 1.0 111.653 176.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -92.84 110.74 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.077 -1.874 . . . . 1.0 106.033 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 137.88 52.63 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.556 -1.34 . . . . 1.0 110.669 171.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -104.53 169.69 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.567 -1.333 . . . . 1.0 113.18 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 p -133.24 -0.75 3.28 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 126.803 2.041 . . . . 1.0 108.825 161.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -177.72 155.48 1.08 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 102.993 -2.966 . . . . 1.0 102.993 -167.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.71 -27.16 68.38 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 123.669 2.346 . . . . 1.0 111.748 163.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.37 -42.57 99.52 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.452 1.12 . . . . 1.0 112.893 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -7.05 41.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 t -99.89 -6.02 27.43 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.651 -1.28 . . . . 1.0 111.483 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.83 -39.59 54.92 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 119.703 -1.873 . . . . 1.0 114.303 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.85 -47.35 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 CA-C-O 113.8 -2.667 . . . . 1.0 115.792 169.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.31 -35.67 23.33 Favored 'Trans proline' 0 CA--C 1.507 -0.836 0 CA-C-N 127.995 3.891 . . . . 1.0 112.516 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.3 m -59.25 -34.36 72.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.954 -1.092 . . . . 1.0 112.5 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -25.25 63.05 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 117.01 2.226 . . . . 1.0 117.01 170.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -67.05 0.57 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 124.775 2.226 . . . . 1.0 113.256 -174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.48 -39.04 10.62 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 111.548 -2.569 . . . . 1.0 109.99 -166.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.19 -27.39 13.83 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.527 -1.215 . . . . 1.0 114.267 -162.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.45 171.27 19.83 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 119.98 -1.7 . . . . 1.0 115.758 163.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 23' ' ' ILE . 4.7 mp -69.51 -46.35 76.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 120.007 -1.878 . . . . 1.0 111.818 -175.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -83.83 -15.78 46.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.581 -1.324 . . . . 1.0 111.509 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.59 160.2 1.34 Allowed 'General case' 0 C--N 1.355 0.818 0 N-CA-C 117.833 2.531 . . . . 1.0 117.833 -166.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.01 177.4 20.95 Favored Glycine 0 CA--C 1.49 -1.469 0 O-C-N 120.718 -1.239 . . . . 1.0 111.881 -166.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.21 144.77 31.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.769 -1.43 . . . . 1.0 109.436 -170.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 153.46 35.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.39 1.076 . . . . 1.0 108.191 163.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.98 122.19 43.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.666 0.786 . . . . 1.0 110.346 167.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.7 tpp -154.95 140.71 18.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.847 -1.158 . . . . 1.0 112.034 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 33.37 17.35 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.143 1.777 . . . . 1.0 109.908 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.18 1.36 41.43 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 115.897 1.119 . . . . 1.0 115.897 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -132.6 151.61 51.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 120.021 -1.87 . . . . 1.0 107.831 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.0 t -67.33 156.95 35.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.358 -2.088 . . . . 1.0 114.713 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.16 81.15 1.84 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.435 -2.802 . . . . 1.0 103.435 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 t -81.56 140.67 34.36 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.448 1.099 . . . . 1.0 113.964 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.86 99.5 45.56 Favored Pre-proline 0 N--CA 1.437 -1.108 0 C-N-CA 125.554 1.542 . . . . 1.0 107.11 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--N 1.329 -0.466 0 C-N-CA 122.778 2.318 . . . . 1.0 110.841 169.369 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.4 t . . . . . 0 N--CA 1.429 -1.517 1 N-CA-C 98.241 -4.726 . . . . 1.0 98.241 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.75 158.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 102.49 -3.152 . . . . 1.0 102.49 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 39.03 0.91 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.635 2.636 . . . . 1.0 112.1 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -91.56 103.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.725 -1.58 . . . . 1.0 107.419 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 142.87 51.96 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.776 -1.202 . . . . 1.0 110.717 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.51 166.33 14.85 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.687 -1.258 . . . . 1.0 114.081 -170.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.41 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 32.9 p -126.7 -6.35 6.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.748 2.019 . . . . 1.0 109.325 150.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -178.98 154.91 0.81 Allowed Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 101.107 -3.664 . . . . 1.0 101.107 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.51 -28.37 77.58 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 CA-C-N 123.874 2.419 . . . . 1.0 112.189 162.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.8 -29.13 68.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.733 0.778 . . . . 1.0 112.801 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -70.47 -9.93 57.82 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 120.723 -1.236 . . . . 1.0 114.3 175.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 45.3 t -93.36 -7.78 43.77 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.583 -1.323 . . . . 1.0 112.16 171.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -49.32 88.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 119.941 -1.724 . . . . 1.0 113.958 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.08 -32.92 63.5 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 CA-C-O 113.293 -2.878 . . . . 1.0 115.929 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.11 -36.3 10.11 Favored 'Trans proline' 0 CA--C 1.504 -0.976 1 CA-C-N 129.074 4.277 . . . . 1.0 112.632 167.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.83 -61.55 2.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.949 1.357 . . . . 1.0 111.749 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 21.24 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.921 -1.112 . . . . 1.0 113.873 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.07 -69.93 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 118.092 -2.88 . . . . 1.0 107.973 159.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.81 -20.89 2.21 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 127.435 2.294 . . . . 1.0 114.08 -163.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -87.97 -16.7 33.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.293 -1.505 . . . . 1.0 114.576 -165.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.26 178.67 38.8 Favored Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.226 -1.464 . . . . 1.0 111.35 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.01 -55.65 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 122.481 1.134 . . . . 1.0 112.776 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -122.89 25.08 8.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 123.45 1.595 . . . . 1.0 107.267 -175.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.48 143.89 0.19 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 119.166 3.025 . . . . 1.0 119.166 -163.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.09 163.59 13.23 Favored Glycine 0 CA--C 1.476 -2.368 0 N-CA-C 108.366 -1.893 . . . . 1.0 108.366 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -152.14 126.66 9.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.746 -1.205 . . . . 1.0 107.746 -172.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 150.95 39.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -96.61 139.66 32.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.951 -1.093 . . . . 1.0 112.115 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -156.93 144.81 19.24 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 166.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.341 0.7 OUTLIER 62.67 20.31 11.97 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.414 1.885 . . . . 1.0 113.381 -174.007 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.6 9.51 86.15 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 114.998 -1.001 . . . . 1.0 114.661 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.25 159.0 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.424 -1.633 . . . . 1.0 108.007 -170.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 t -70.05 159.04 34.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.214 -2.179 . . . . 1.0 116.409 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -144.48 90.35 2.08 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 102.034 -3.321 . . . . 1.0 102.034 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.3 t -84.45 130.26 34.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.734 2.014 . . . . 1.0 112.962 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -102.45 107.49 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.452 -0.932 0 C-N-CA 121.768 1.645 . . . . 1.0 112.365 -166.852 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.443 -0.815 0 N-CA-C 103.135 -2.913 . . . . 1.0 103.135 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.38 161.1 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 161.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.44 65.23 0.61 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.981 1.713 . . . . 1.0 107.508 160.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.9 t -84.64 109.2 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.673 -1.973 . . . . 1.0 105.673 160.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -97.29 124.17 41.32 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.9 1.28 . . . . 1.0 108.96 -176.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -145.11 163.02 35.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.357 1.984 . . . . 1.0 116.357 -155.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -99.32 -36.15 9.71 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 123.646 1.688 . . . . 1.0 109.758 154.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -116.97 150.66 46.32 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.445 -1.252 . . . . 1.0 111.536 -156.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.8 -34.24 31.59 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.026 1.817 . . . . 1.0 111.776 170.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -54.85 -41.72 71.11 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.974 1.31 . . . . 1.0 113.021 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -54.75 -30.6 56.86 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.759 1.223 . . . . 1.0 114.149 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t -100.57 -9.37 22.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . 0.267 2.8 tm? -68.42 -49.21 32.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 120.402 -1.436 . . . . 1.0 113.192 -170.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.43 -44.29 43.85 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 CA-C-O 114.267 -2.472 . . . . 1.0 115.95 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.17 -37.73 13.78 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 CA-C-N 127.194 3.605 . . . . 1.0 112.981 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.93 -49.0 78.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.864 1.792 . . . . 1.0 111.414 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -71.31 -8.2 52.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.64 -54.92 10.06 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.605 1.669 . . . . 1.0 111.775 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.11 -23.26 1.03 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 113.146 -1.843 . . . . 1.0 112.597 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -84.64 -20.22 31.69 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 120.162 -1.586 . . . . 1.0 113.55 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.7 179.49 45.04 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 116.462 -2.78 . . . . 1.0 116.978 157.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 tt -70.72 -55.75 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 125.782 1.633 . . . . 1.0 112.434 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -121.31 19.19 11.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.476 1.911 . . . . 1.0 107.035 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.01 145.75 16.01 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.27 1.952 . . . . 1.0 116.27 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.35 162.29 22.68 Favored Glycine 0 CA--C 1.471 -2.659 0 N-CA-C 107.952 -2.059 . . . . 1.0 107.952 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.46 131.71 24.96 Favored 'General case' 0 N--CA 1.425 -1.701 0 O-C-N 120.678 -1.484 . . . . 1.0 107.456 -163.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -141.9 148.2 38.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -99.12 144.82 27.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.246 -1.533 . . . . 1.0 111.146 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -162.2 144.14 11.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.718 -1.239 . . . . 1.0 109.662 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.55 32.29 18.71 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.77 1.628 . . . . 1.0 110.855 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.11 65.98 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 114.636 -1.166 . . . . 1.0 115.885 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -142.67 153.27 43.26 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 120.175 1.987 . . . . 1.0 109.284 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.81 161.61 29.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 115.78 1.77 . . . . 1.0 115.78 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.45 95.38 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 101.738 -3.43 . . . . 1.0 101.738 168.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.7 t -82.56 116.6 22.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.117 1.767 . . . . 1.0 110.107 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -99.2 110.08 56.78 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 126.228 1.811 . . . . 1.0 107.681 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 122.115 1.877 . . . . 1.0 112.249 -175.739 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 N--CA 1.436 -1.127 1 N-CA-C 98.039 -4.801 . . . . 1.0 98.039 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.72 -155.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.39 52.57 2.01 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.606 2.146 . . . . 1.0 109.311 170.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 115.81 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 171.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 137.65 36.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.916 0.887 . . . . 1.0 109.449 -169.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.92 159.19 42.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.842 1.793 . . . . 1.0 115.842 -167.682 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -103.63 -33.98 8.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.379 -1.737 . . . . 1.0 109.492 154.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -108.98 145.38 31.6 Favored Pre-proline 0 CA--C 1.512 -0.508 0 O-C-N 120.547 -1.346 . . . . 1.0 111.065 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.94 -28.38 50.17 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.403 2.069 . . . . 1.0 111.633 175.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -56.8 -35.99 69.4 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 124.103 0.961 . . . . 1.0 113.461 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.36 -23.33 66.73 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.866 1.266 . . . . 1.0 114.181 177.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -84.04 -23.89 30.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.493 1.117 . . . . 1.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 tp -70.15 -53.72 10.47 Favored Pre-proline 0 C--N 1.355 0.821 0 CA-C-O 116.841 -1.552 . . . . 1.0 114.853 -166.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.58 -35.38 81.61 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-O 113.366 -2.847 . . . . 1.0 115.113 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -69.79 -41.14 4.49 Favored 'Trans proline' 0 CA--C 1.508 -0.817 1 CA-C-N 128.532 4.083 . . . . 1.0 112.799 168.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.21 -50.08 73.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.655 1.693 . . . . 1.0 112.178 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -71.16 -8.51 54.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 115.139 1.533 . . . . 1.0 115.139 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.2 -64.27 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.198 1.952 . . . . 1.0 111.433 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -119.0 -28.81 5.43 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 111.989 -2.369 . . . . 1.0 111.574 -162.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -95.32 -26.95 15.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -166.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.39 171.14 42.5 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 115.884 -3.055 . . . . 1.0 117.605 171.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.87 -53.42 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 125.752 1.621 . . . . 1.0 113.039 -170.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -124.66 30.92 5.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 148.14 18.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.746 2.128 . . . . 1.0 116.746 -167.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.74 161.27 12.75 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 107.0 -2.44 . . . . 1.0 107.0 -172.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.77 121.17 3.6 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.967 -1.902 . . . . 1.0 108.047 -157.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -148.81 155.0 40.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.163 -1.421 . . . . 1.0 107.163 -168.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.2 t -97.4 139.93 32.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 121.249 -0.907 . . . . 1.0 111.23 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -155.52 138.48 15.42 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.29 -1.506 . . . . 1.0 109.583 169.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.5 28.82 13.44 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.161 1.385 . . . . 1.0 110.94 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.52 80.58 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 124.422 1.01 . . . . 1.0 115.186 -173.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -141.86 152.93 44.07 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 119.905 -1.938 . . . . 1.0 110.971 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -68.6 144.09 54.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.864 1.792 . . . . 1.0 114.815 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -140.82 91.83 2.45 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.245 -2.502 . . . . 1.0 104.245 -174.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.3 t -81.4 127.49 32.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.256 2.623 . . . . 1.0 112.106 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -103.04 101.77 23.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 126.574 1.95 . . . . 1.0 105.898 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 122.231 1.954 . . . . 1.0 112.382 -164.527 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.441 -0.893 1 N-CA-C 98.043 -4.799 . . . . 1.0 98.043 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.24 154.68 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 102.305 -3.22 . . . . 1.0 102.305 161.033 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.38 48.28 1.3 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 124.174 1.94 . . . . 1.0 110.871 177.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.35 129.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.606 -1.998 . . . . 1.0 105.606 171.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -97.06 142.77 28.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.2 152.25 35.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.499 2.037 . . . . 1.0 116.499 -172.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.4 m -100.39 -33.66 10.28 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.747 2.419 . . . . 1.0 109.135 159.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.2 t -120.26 146.6 43.01 Favored Pre-proline 0 CA--C 1.512 -0.483 0 O-C-N 120.951 -1.093 . . . . 1.0 110.295 -173.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.5 -24.47 78.13 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.951 1.767 . . . . 1.0 112.676 165.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.42 -28.71 69.99 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 122.002 0.906 . . . . 1.0 113.076 -176.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.75 -18.61 65.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.54 1.136 . . . . 1.0 114.059 177.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 68.0 m -85.3 -14.59 46.08 Favored 'General case' 0 N--CA 1.425 -1.718 0 O-C-N 120.799 -1.188 . . . . 1.0 113.538 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -49.38 75.28 Favored Pre-proline 0 C--N 1.351 0.655 0 O-C-N 120.603 -1.311 . . . . 1.0 114.444 -170.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.08 -39.35 50.19 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 CA-C-O 113.449 -2.813 . . . . 1.0 115.473 174.201 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.6 -36.92 10.3 Favored 'Trans proline' 0 CA--C 1.511 -0.667 1 CA-C-N 128.652 4.126 . . . . 1.0 113.096 172.195 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 m -59.52 -45.25 92.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.239 -1.538 . . . . 1.0 111.714 176.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -71.01 -13.4 61.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 171.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.9 -67.44 0.53 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 124.146 1.927 . . . . 1.0 112.287 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -105.36 -41.64 5.46 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 111.836 -2.438 . . . . 1.0 110.211 -163.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -87.32 -36.69 17.71 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -160.111 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.05 -177.24 46.65 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 115.934 -3.032 . . . . 1.0 117.922 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.9 -53.57 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 125.97 1.708 . . . . 1.0 113.394 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 16.12 15.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.718 2.407 . . . . 1.0 108.469 -174.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 148.8 10.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 116.946 2.202 . . . . 1.0 116.946 -172.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.71 -170.99 13.08 Favored Glycine 0 CA--C 1.475 -2.432 0 N-CA-C 108.486 -1.846 . . . . 1.0 108.486 -164.186 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.99 6.91 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 120.325 -1.691 . . . . 1.0 108.842 -175.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.31 0.0 OUTLIER -149.53 -177.86 6.1 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.694 143.52 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -115.13 135.78 53.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.896 1.678 . . . . 1.0 109.906 -176.257 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.09 151.43 21.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.306 -1.738 . . . . 1.0 106.306 168.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.346 0.5 OUTLIER 63.43 18.73 11.25 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.131 1.772 . . . . 1.0 113.439 -173.952 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.85 76.48 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.308 1.432 . . . . 1.0 114.729 -172.545 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -141.79 161.32 38.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.037 -1.861 . . . . 1.0 109.558 -177.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.1 t -69.75 163.83 24.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.952 2.204 . . . . 1.0 116.952 -168.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.88 90.26 1.82 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.212 -2.514 . . . . 1.0 104.212 167.626 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -78.17 140.17 38.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.266 2.226 . . . . 1.0 114.263 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -108.32 106.45 58.66 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 127.692 2.397 . . . . 1.0 107.156 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo . . . . . 0 C--N 1.324 -0.715 0 C-N-CA 122.619 2.213 . . . . 1.0 112.244 -179.073 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.439 -0.999 1 N-CA-C 99.326 -4.324 . . . . 1.0 99.326 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.2 mt -103.55 -149.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 126.815 2.046 . . . . 1.0 106.368 175.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -132.13 43.71 2.99 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 125.15 2.405 . . . . 1.0 109.644 164.706 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.51 120.02 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 112.81 -1.995 . . . . 1.0 106.014 166.164 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -94.78 141.12 29.0 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 105.399 -2.074 . . . . 1.0 105.399 172.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -122.48 149.83 43.35 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 117.639 2.459 . . . . 1.0 117.639 -164.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -114.08 -5.93 13.1 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.417 -2.174 . . . . 1.0 110.415 169.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -168.28 155.76 7.61 Favored Pre-proline 0 CA--C 1.504 -0.8 0 N-CA-C 105.129 -2.174 . . . . 1.0 105.129 -174.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.91 -26.87 51.38 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 124.315 2.577 . . . . 1.0 111.457 163.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -64.66 -36.07 83.06 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 113.598 0.962 . . . . 1.0 113.598 -168.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -13.82 62.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 176.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.6 t -96.18 -4.49 42.46 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.932 -1.105 . . . . 1.0 111.781 173.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.13 -50.97 83.65 Favored Pre-proline 0 C--N 1.349 0.578 0 O-C-N 120.303 -1.498 . . . . 1.0 113.5 177.113 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 -37.66 59.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-O 113.278 -2.884 . . . . 1.0 115.74 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -68.34 -38.18 12.25 Favored 'Trans proline' 0 CA--C 1.506 -0.898 1 CA-C-N 128.604 4.109 . . . . 1.0 112.771 169.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 m -58.37 -47.11 84.86 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.137 1.446 . . . . 1.0 112.745 177.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -4.46 27.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 117.189 2.292 . . . . 1.0 117.189 172.017 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.45 11.44 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 123.433 1.587 . . . . 1.0 111.257 -178.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.1 -11.5 0.19 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 113.906 -1.497 . . . . 1.0 114.253 -175.567 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -79.57 -25.58 41.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.797 -1.814 . . . . 1.0 112.751 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.37 159.93 27.29 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 117.188 -2.434 . . . . 1.0 115.317 162.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.94 -33.8 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 120.378 -1.66 . . . . 1.0 112.442 -173.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -115.04 13.66 16.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.906 1.682 . . . . 1.0 110.675 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 162.58 6.98 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 118.233 2.679 . . . . 1.0 118.233 -163.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.81 -171.27 15.92 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 107.187 -2.365 . . . . 1.0 107.187 -176.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.14 154.63 36.24 Favored 'General case' 0 N--CA 1.424 -1.747 0 O-C-N 120.925 -1.338 . . . . 1.0 108.408 -175.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -111.81 146.31 37.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.911 -1.515 . . . . 1.0 106.911 162.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.4 t -94.02 121.26 35.32 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 160.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.6 ttt -149.84 127.38 11.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.717 1.246 . . . . 1.0 111.497 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.17 31.19 17.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 126.824 2.05 . . . . 1.0 110.331 -177.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.95 9.31 79.61 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 115.3 0.88 . . . . 1.0 115.3 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -135.45 143.78 46.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 119.674 -2.074 . . . . 1.0 108.385 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.3 143.38 52.06 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -176.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.48 82.26 2.05 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 102.476 -3.157 . . . . 1.0 102.476 -174.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -71.34 135.41 47.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.388 2.275 . . . . 1.0 114.545 -173.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -120.45 103.46 44.16 Favored Pre-proline 0 N--CA 1.444 -0.766 0 C-N-CA 125.335 1.454 . . . . 1.0 110.038 -165.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo . . . . . 0 C--N 1.319 -1.018 0 C-N-CA 122.284 1.989 . . . . 1.0 110.137 151.732 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.446 -0.629 1 N-CA-C 96.627 -5.323 . . . . 1.0 96.627 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.74 145.76 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 N-CA-C 102.933 -2.988 . . . . 1.0 102.933 172.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.267 13.1 t70 -91.52 45.56 1.24 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.642 2.163 . . . . 1.0 112.551 -173.306 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.53 107.0 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 164.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -87.99 144.48 26.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.319 1.057 . . . . 1.0 112.556 -164.055 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.92 142.6 51.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.467 2.395 . . . . 1.0 117.467 -162.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -115.97 1.47 13.31 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.056 2.542 . . . . 1.0 108.231 173.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -173.65 153.95 2.31 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 118.621 -2.549 . . . . 1.0 105.414 -174.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.66 -21.82 38.59 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 123.698 2.357 . . . . 1.0 112.653 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -55.78 -31.4 62.58 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.281 1.432 . . . . 1.0 113.699 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -62.73 -23.13 67.02 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 124.622 1.169 . . . . 1.0 113.784 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.2 t -82.83 -20.99 34.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.005 0.922 . . . . 1.0 112.059 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 tp -68.54 -51.8 21.69 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-O 116.984 -1.484 . . . . 1.0 114.31 -174.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.9 -29.74 58.0 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-O 113.099 -2.959 . . . . 1.0 115.618 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.14 -39.79 2.02 Favored 'Trans proline' 0 CA--C 1.503 -1.031 1 CA-C-N 129.374 4.384 . . . . 1.0 112.456 166.101 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 t -62.61 -59.05 5.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.263 1.506 . . . . 1.0 111.617 -178.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 22.04 0.06 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.763 1.625 . . . . 1.0 113.435 165.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.59 -76.76 0.1 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 118.328 -2.733 . . . . 1.0 107.859 158.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -117.68 -34.21 4.3 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 111.498 -2.592 . . . . 1.0 113.189 -159.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -76.85 -30.28 56.24 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 120.823 -1.173 . . . . 1.0 112.535 -166.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.42 156.42 9.9 Favored Glycine 0 CA--C 1.494 -1.262 0 C-N-CA 118.166 -1.969 . . . . 1.0 115.748 166.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -71.14 -25.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.135 1.374 . . . . 1.0 112.075 159.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -81.89 -21.97 37.11 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.398 2.679 . . . . 1.0 110.455 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.46 153.59 42.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 116.036 1.865 . . . . 1.0 116.036 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.79 170.91 16.09 Favored Glycine 0 CA--C 1.489 -1.578 0 N-CA-C 108.351 -1.899 . . . . 1.0 108.351 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.84 129.62 10.12 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 119.421 -2.223 . . . . 1.0 108.841 -159.005 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.1 12.35 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 120.271 -1.518 . . . . 1.0 111.999 174.07 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.59 132.27 44.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.568 1.547 . . . . 1.0 109.752 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.2 ttt -161.47 140.23 9.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.136 1.374 . . . . 1.0 110.213 173.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 59.54 34.91 22.58 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 124.489 2.09 . . . . 1.0 110.759 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.92 57.15 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 114.075 -1.421 . . . . 1.0 116.143 -176.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 176.92 8.27 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 120.199 1.999 . . . . 1.0 112.877 -177.508 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.01 145.69 49.84 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 124.763 2.22 . . . . 1.0 114.538 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -137.38 92.9 2.75 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 102.841 -3.022 . . . . 1.0 102.841 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 131.3 40.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.051 -1.431 . . . . 1.0 112.084 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -111.79 82.83 4.2 Favored Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 127.734 2.414 . . . . 1.0 109.254 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 C--N 1.33 -0.397 0 CA-C-N 124.187 2.531 . . . . 1.0 109.049 154.162 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.432 -1.365 1 N-CA-C 99.891 -4.115 . . . . 1.0 99.891 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.58 156.24 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 102.244 -3.243 . . . . 1.0 102.244 170.075 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -94.59 54.01 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 124.156 1.931 . . . . 1.0 109.182 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.59 117.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -87.18 140.84 29.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.54 1.162 . . . . 1.0 109.235 -175.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.78 148.59 50.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 117.327 2.343 . . . . 1.0 117.327 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -114.59 1.13 14.17 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 124.925 2.298 . . . . 1.0 108.416 172.404 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -174.11 154.43 2.16 Favored Pre-proline 0 N--CA 1.444 -0.742 0 O-C-N 118.744 -2.473 . . . . 1.0 105.774 -174.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.71 -26.41 45.71 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 CA-C-N 123.221 2.186 . . . . 1.0 111.872 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -44.56 -46.7 10.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 128.644 2.778 . . . . 1.0 112.181 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -61.76 -28.42 69.43 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.629 1.572 . . . . 1.0 113.316 -174.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.9 t -94.28 -8.45 39.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.931 0.872 . . . . 1.0 112.412 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.93 -41.71 29.29 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 119.72 -1.863 . . . . 1.0 114.426 -178.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.13 -46.86 22.83 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-O 113.934 -2.611 . . . . 1.0 115.472 168.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.05 -36.03 23.49 Favored 'Trans proline' 0 CA--C 1.51 -0.697 0 CA-C-N 127.795 3.82 . . . . 1.0 112.507 174.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.3 m -63.54 -26.71 68.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 121.033 -1.042 . . . . 1.0 112.698 172.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -33.69 70.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 117.34 2.348 . . . . 1.0 117.34 162.279 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -66.97 0.56 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 124.687 2.184 . . . . 1.0 112.394 -169.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.8 -38.13 23.53 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 111.826 -2.443 . . . . 1.0 109.407 -172.262 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -112.78 -3.95 14.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.407 -1.27 . . . . 1.0 113.563 -164.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -178.58 37.49 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 124.34 2.078 . . . . 1.0 116.602 161.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -70.36 -33.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 O-C-N 119.465 -2.197 . . . . 1.0 114.108 -165.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -77.06 -33.86 57.17 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 120.913 -1.117 . . . . 1.0 110.439 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 137.51 58.09 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 116.548 2.055 . . . . 1.0 116.548 -161.215 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.67 174.4 25.69 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -175.101 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.83 131.43 8.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 120.556 -1.555 . . . . 1.0 108.901 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.1 168.96 21.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.713 -1.242 . . . . 1.0 109.87 174.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.22 129.73 55.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.617 0.767 . . . . 1.0 112.306 -168.482 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 125.06 43.43 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 126.904 2.082 . . . . 1.0 111.371 166.339 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.53 25.88 15.4 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 123.405 1.574 . . . . 1.0 112.128 170.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.21 77.42 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.624 -1.171 . . . . 1.0 115.682 -175.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -136.52 155.25 50.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 120.358 2.079 . . . . 1.0 108.946 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -70.55 160.63 32.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 118.557 2.799 . . . . 1.0 118.557 -175.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -148.24 99.75 3.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 104.144 -2.539 . . . . 1.0 104.144 165.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.6 t -80.78 130.79 35.26 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.515 2.726 . . . . 1.0 111.53 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -98.98 138.94 20.7 Favored Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 119.479 -2.013 . . . . 1.0 107.64 -178.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo . . . . . 0 CA--C 1.507 -0.834 0 CA-C-N 123.96 2.45 . . . . 1.0 111.802 171.679 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.513 2.714 0 CA-C-O 121.113 0.482 . . . . 1.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -138.95 137.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 1 N-CA-C 99.098 -4.408 . . . . 1.0 99.098 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.31 159.95 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 N-CA-C 102.403 -3.184 . . . . 1.0 102.403 169.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.27 49.16 1.58 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 124.651 2.167 . . . . 1.0 110.622 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.14 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 104.648 -2.352 . . . . 1.0 104.648 167.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.72 137.07 32.66 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.06 148.38 52.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 118.798 2.888 . . . . 1.0 118.798 -165.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -101.69 -14.45 17.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 113.283 -1.78 . . . . 1.0 110.902 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -169.95 167.33 5.03 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 -169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 30.0 Cg_endo -64.38 -24.19 64.68 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.75 2.375 . . . . 1.0 114.258 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -47.58 -53.32 14.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 127.351 2.26 . . . . 1.0 112.349 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -70.73 -12.58 61.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.481 1.512 . . . . 1.0 114.547 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 33.9 t -100.68 -9.48 21.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.204 -0.935 . . . . 1.0 112.555 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -67.3 -45.11 49.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 119.94 -1.725 . . . . 1.0 114.148 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.97 -41.33 62.86 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 CA-C-O 114.106 -2.539 . . . . 1.0 115.902 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -68.84 -34.58 17.72 Favored 'Trans proline' 0 CA--C 1.505 -0.926 0 CA-C-N 127.283 3.637 . . . . 1.0 112.758 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -59.38 -51.47 69.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.575 -1.328 . . . . 1.0 112.01 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.272 0.0 OUTLIER -71.7 -2.32 16.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 115.444 1.646 . . . . 1.0 115.444 170.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -69.89 0.36 Allowed 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 118.934 -2.354 . . . . 1.0 111.173 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.63 -29.34 6.49 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 111.627 -2.533 . . . . 1.0 111.965 -160.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -88.48 -32.46 18.24 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.12 1.156 . . . . 1.0 114.12 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.88 178.16 47.43 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 117.958 -2.068 . . . . 1.0 115.811 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.88 -46.72 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 126.215 1.806 . . . . 1.0 113.896 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' NH2' ' CD2' ' A' ' 39' ' ' HIS . 35.6 ttp180 -122.25 20.57 10.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.511 -1.663 . . . . 1.0 106.511 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.44 143.47 40.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 115.994 1.85 . . . . 1.0 115.994 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.36 172.76 15.08 Favored Glycine 0 CA--C 1.478 -2.264 0 N-CA-C 108.574 -1.81 . . . . 1.0 108.574 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -152.13 138.71 18.69 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -143.78 169.56 17.54 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 117.945 -1.502 . . . . 1.0 109.843 164.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.4 t -106.41 147.68 28.99 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.183 0.993 . . . . 1.0 109.956 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -160.15 148.2 16.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 105.827 -1.916 . . . . 1.0 105.827 159.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.312 0.9 OUTLIER 58.54 27.03 15.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.795 1.638 . . . . 1.0 113.435 177.308 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.36 14.62 77.06 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.134 -1.394 . . . . 1.0 115.936 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -144.85 153.98 42.16 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 119.695 -2.062 . . . . 1.0 109.123 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.1 t -70.55 157.63 37.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 116.552 2.056 . . . . 1.0 116.552 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 94.06 2.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.175 -3.639 . . . . 1.0 101.175 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.03 137.8 32.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.436 2.294 . . . . 1.0 112.313 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -108.11 98.28 25.67 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 125.5 1.52 . . . . 1.0 108.251 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.69 76.56 4.43 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.14 1.893 . . . . 1.0 112.441 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.438 ' CD2' ' NH2' ' A' ' 24' ' ' ARG . 35.0 t60 . . . . . 0 C--O 1.262 1.754 0 O-C-N 121.656 -0.652 . . . . 1.0 112.443 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.508 2.428 0 CA-C-O 121.044 0.45 . . . . 1.0 111.494 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.43 134.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 100.38 -3.933 . . . . 1.0 100.38 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.01 154.83 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 101.486 -3.524 . . . . 1.0 101.486 166.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 45.87 1.21 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.718 2.199 . . . . 1.0 111.16 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.2 t -84.12 113.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 103.766 -2.679 . . . . 1.0 103.766 163.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -93.06 143.02 26.65 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.165 0.983 . . . . 1.0 110.853 -169.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -141.04 158.31 44.11 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 117.57 2.433 . . . . 1.0 117.57 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.1 p -111.65 -16.8 13.16 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 112.939 -1.937 . . . . 1.0 110.799 161.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -135.72 151.23 73.87 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 125.033 1.333 . . . . 1.0 109.516 -171.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.99 -21.32 63.82 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 122.604 1.966 . . . . 1.0 112.289 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -57.51 -49.55 75.96 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 122.188 0.994 . . . . 1.0 112.79 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -70.18 -10.73 59.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.976 1.31 . . . . 1.0 114.323 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.72 -26.05 24.43 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.63 -1.294 . . . . 1.0 108.929 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.62 -49.64 60.14 Favored Pre-proline 0 C--N 1.352 0.682 0 CA-C-O 116.561 -1.685 . . . . 1.0 115.177 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.31 -40.01 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 CA-C-N 125.001 2.822 . . . . 1.0 115.391 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.54 -35.88 16.31 Favored 'Trans proline' 0 CA--C 1.502 -1.114 1 CA-C-N 128.491 4.068 . . . . 1.0 112.244 169.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -58.05 -43.21 86.76 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.822 1.296 . . . . 1.0 112.617 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -70.61 -11.56 61.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -67.34 0.53 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.967 2.318 . . . . 1.0 112.443 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.19 -27.83 8.54 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.36 -2.654 . . . . 1.0 111.649 -161.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.07 -20.3 18.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.65 149.75 5.11 Favored Glycine 0 CA--C 1.494 -1.271 0 O-C-N 120.53 -1.356 . . . . 1.0 114.457 160.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.08 -37.21 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 119.962 -1.904 . . . . 1.0 112.057 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -81.88 -24.02 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.737 -1.852 . . . . 1.0 111.578 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.7 161.76 1.02 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 117.868 2.544 . . . . 1.0 117.868 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.45 167.5 12.49 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 109.318 -1.513 . . . . 1.0 109.318 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.19 134.03 16.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.045 -1.268 . . . . 1.0 108.51 -167.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 156.77 41.44 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 120.913 -1.117 . . . . 1.0 110.427 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.4 t -98.98 129.17 45.26 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 161.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -158.63 134.5 8.97 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 121.137 -0.977 . . . . 1.0 110.558 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 56.54 40.76 29.32 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.741 2.016 . . . . 1.0 110.354 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.77 15.04 57.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 113.809 -1.542 . . . . 1.0 115.704 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.52 157.92 45.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 119.885 -1.95 . . . . 1.0 109.214 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.1 t -65.66 153.59 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 123.358 1.552 . . . . 1.0 113.056 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.68 78.22 1.19 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 123.03 1.395 . . . . 1.0 108.45 -166.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.63 138.29 44.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.957 1.836 . . . . 1.0 115.957 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -105.79 95.13 9.97 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 105.828 -1.916 . . . . 1.0 105.828 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.76 70.2 7.49 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.963 2.442 . . . . 1.0 112.282 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 t60 . . . . . 0 C--O 1.258 1.508 0 C-N-CA 124.327 1.051 . . . . 1.0 108.716 176.352 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.507 2.396 0 CA-C-O 120.96 0.41 . . . . 1.0 111.447 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.2 t -143.87 137.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 1 N-CA-C 99.979 -4.082 . . . . 1.0 99.979 -176.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.06 159.6 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 C-N-CA 129.495 3.118 . . . . 1.0 102.736 170.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.14 46.46 1.35 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 124.428 2.061 . . . . 1.0 110.919 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.17 128.66 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.69 135.83 53.72 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.72 0.772 . . . . 1.0 109.285 -163.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.09 161.77 41.72 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 115.848 1.796 . . . . 1.0 115.848 -164.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -107.17 -26.11 11.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 113.693 -1.594 . . . . 1.0 109.852 157.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -119.21 146.33 40.41 Favored Pre-proline 0 CA--C 1.512 -0.511 0 O-C-N 120.603 -1.311 . . . . 1.0 111.466 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.06 -19.49 63.44 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 122.032 1.821 . . . . 1.0 112.687 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.72 -41.23 85.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 121.423 -0.798 . . . . 1.0 112.742 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.32 -22.14 64.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.135 1.774 . . . . 1.0 113.879 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 1.6 m -91.61 -16.05 27.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.07 0.948 . . . . 1.0 111.899 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 tp -66.87 -51.59 37.34 Favored Pre-proline 0 C--N 1.35 0.607 0 CA-C-O 117.176 -1.393 . . . . 1.0 114.014 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.39 -36.98 52.33 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-O 113.1 -2.959 . . . . 1.0 115.623 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.62 -42.48 2.48 Favored 'Trans proline' 0 CA--C 1.502 -1.109 1 CA-C-N 129.232 4.333 . . . . 1.0 113.176 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.23 -48.42 81.7 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.783 -1.198 . . . . 1.0 110.956 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -70.84 -9.8 58.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 116.61 2.078 . . . . 1.0 116.61 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.76 -74.65 0.16 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 124.792 2.234 . . . . 1.0 112.353 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.5 -35.22 68.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 111.518 -2.583 . . . . 1.0 110.052 -164.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -107.82 -8.92 15.87 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.896 -1.502 . . . . 1.0 110.544 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 -161.9 26.83 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 124.539 2.188 . . . . 1.0 117.262 156.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -68.67 -28.24 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 119.715 -2.05 . . . . 1.0 112.591 -167.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -78.48 -30.59 47.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 120.631 -1.293 . . . . 1.0 110.72 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.49 43.65 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 117.447 2.388 . . . . 1.0 117.447 -164.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.18 179.23 16.49 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -154.93 127.7 8.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 120.547 -1.561 . . . . 1.0 111.203 -157.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.78 161.59 27.02 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 121.076 -1.015 . . . . 1.0 108.582 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.8 t -108.49 135.38 49.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.57 -1.195 . . . . 1.0 108.089 161.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -156.41 138.43 14.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.289 -0.882 . . . . 1.0 109.563 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.32 19.27 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.282 1.833 . . . . 1.0 110.447 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.96 8.56 69.17 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 124.557 1.075 . . . . 1.0 115.604 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -140.97 164.89 29.04 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 119.974 -1.898 . . . . 1.0 109.138 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -69.84 161.14 30.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 117.041 2.238 . . . . 1.0 117.041 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -150.82 82.25 1.34 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.1 m -75.09 129.13 37.05 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.629 -1.295 . . . . 1.0 114.138 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.84 150.68 36.92 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.788 1.235 . . . . 1.0 108.383 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -84.24 45.3 1.7 Allowed 'Trans proline' 0 C--N 1.328 -0.502 0 CA-C-N 123.22 2.186 . . . . 1.0 111.85 162.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.4 t60 . . . . . 0 C--O 1.258 1.525 0 C-N-CA 126.482 1.913 . . . . 1.0 109.189 -177.569 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 121.089 0.471 . . . . 1.0 111.445 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t -144.61 133.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 101.767 -3.419 . . . . 1.0 101.767 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER -100.86 -143.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 126.855 2.062 . . . . 1.0 108.043 177.557 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 3' ' ' ILE . 16.7 t70 -139.29 48.19 1.87 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 124.782 2.229 . . . . 1.0 110.15 163.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.78 118.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 113.251 -1.795 . . . . 1.0 106.31 163.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -95.77 141.99 28.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.088 -1.449 . . . . 1.0 107.088 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.65 165.37 35.65 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -164.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -105.62 -32.8 8.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 123.421 1.581 . . . . 1.0 109.896 151.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -102.94 153.83 37.98 Favored Pre-proline 0 N--CA 1.452 -0.345 0 O-C-N 120.512 -1.368 . . . . 1.0 111.891 -166.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.73 -31.8 68.73 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 121.784 1.656 . . . . 1.0 112.812 159.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -62.42 -37.58 86.36 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.924 0.784 . . . . 1.0 112.981 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -57.22 -27.87 62.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.945 1.698 . . . . 1.0 113.922 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 t -96.41 -13.83 22.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.301 -0.874 . . . . 1.0 112.245 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.47 -46.87 69.64 Favored Pre-proline 0 C--N 1.345 0.401 0 CA-C-O 116.807 -1.568 . . . . 1.0 113.936 -164.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.15 -48.78 14.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-N 124.121 2.507 . . . . 1.0 115.895 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.85 -37.96 10.75 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 127.254 3.627 . . . . 1.0 112.648 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -59.48 -37.29 77.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 120.514 -1.367 . . . . 1.0 112.183 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -26.43 63.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.413 1.634 . . . . 1.0 115.413 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.89 -67.3 0.54 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 124.811 2.243 . . . . 1.0 113.14 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -84.86 -37.42 20.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.417 -2.629 . . . . 1.0 109.485 -166.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.61 -12.28 13.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.447 1.647 . . . . 1.0 115.447 -160.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.66 149.28 5.04 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 120.593 -1.317 . . . . 1.0 114.631 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.36 -40.5 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 O-C-N 119.845 -1.973 . . . . 1.0 112.837 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -84.14 -22.4 31.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.713 -1.867 . . . . 1.0 110.881 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.8 159.22 0.57 Allowed 'General case' 0 C--N 1.351 0.644 0 N-CA-C 117.788 2.514 . . . . 1.0 117.788 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.03 164.64 12.07 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.54 133.37 20.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.23 -1.767 . . . . 1.0 106.23 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -148.06 154.36 40.13 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.59 144.25 28.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.259 -1.525 . . . . 1.0 112.134 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -163.13 144.11 9.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.628 -1.295 . . . . 1.0 110.917 170.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.48 37.06 19.98 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.308 1.443 . . . . 1.0 110.419 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.01 -8.96 48.67 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.598 -1.183 . . . . 1.0 115.891 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -146.95 168.99 20.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.855 2.327 . . . . 1.0 111.63 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.47 162.51 17.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.336 1.976 . . . . 1.0 116.336 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -146.12 89.8 1.91 Allowed 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 130.113 3.365 . . . . 1.0 102.778 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.7 m -77.89 132.85 38.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.153 1.781 . . . . 1.0 112.195 173.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -108.56 97.16 21.89 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.68 69.95 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.996 2.464 . . . . 1.0 111.338 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 . . . . . 0 C--O 1.257 1.487 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 170.655 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 121.507 0.67 . . . . 1.0 111.674 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.3 134.73 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 1 N-CA-C 98.763 -4.532 . . . . 1.0 98.763 169.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.45 160.64 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 102.703 -3.073 . . . . 1.0 102.703 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 42.46 1.1 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 124.959 2.314 . . . . 1.0 110.831 172.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.2 t -87.11 115.1 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -101.94 139.92 36.93 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 122.182 0.991 . . . . 1.0 108.479 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 153.86 40.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 116.652 2.093 . . . . 1.0 116.652 -160.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -111.14 0.83 16.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 127.017 2.127 . . . . 1.0 110.449 172.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 m -171.18 153.68 3.8 Favored Pre-proline 0 CA--C 1.51 -0.594 0 O-C-N 120.714 -1.241 . . . . 1.0 108.782 -171.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.78 -32.08 47.25 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.009 2.472 . . . . 1.0 111.919 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -46.68 -45.76 19.6 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.403 2.281 . . . . 1.0 112.947 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -67.39 -17.59 64.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.761 1.224 . . . . 1.0 114.013 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.7 t -101.55 -7.32 22.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.405 -0.81 . . . . 1.0 112.698 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.93 -46.43 64.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 120.032 -1.667 . . . . 1.0 113.524 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.17 -45.7 29.88 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 CA-C-O 114.019 -2.576 . . . . 1.0 115.814 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.51 -35.86 21.71 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 CA-C-N 127.408 3.681 . . . . 1.0 112.722 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 m -56.93 -46.39 82.09 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.955 1.36 . . . . 1.0 112.119 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -9.84 58.77 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.315 2.339 . . . . 1.0 117.315 172.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -65.84 0.7 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 124.287 1.994 . . . . 1.0 110.58 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -114.8 -33.84 5.34 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 112.316 -2.22 . . . . 1.0 111.377 -169.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -94.08 -18.05 22.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.796 1.406 . . . . 1.0 114.796 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.76 168.09 41.05 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 116.662 -2.685 . . . . 1.0 116.234 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 tt -70.19 -50.07 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.339 1.456 . . . . 1.0 111.191 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.585 HH12 ' CD2' ' A' ' 39' ' ' HIS . 3.7 ttp-105 -127.8 32.23 4.99 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.57 152.18 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 119.219 3.044 . . . . 1.0 119.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.47 12.34 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 108.713 -1.755 . . . . 1.0 108.713 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.19 130.74 9.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.294 -1.373 . . . . 1.0 107.294 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 166.69 26.69 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 120.455 -1.403 . . . . 1.0 109.361 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 t -120.78 135.99 55.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.242 0.617 . . . . 1.0 110.897 -164.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.23 145.67 19.51 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.39 1.076 . . . . 1.0 108.272 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.63 32.08 20.29 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 126.307 1.843 . . . . 1.0 110.419 -173.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.67 19.46 62.81 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 124.855 1.217 . . . . 1.0 115.468 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.53 151.87 37.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.662 -2.081 . . . . 1.0 108.876 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -69.17 162.7 26.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.069 2.248 . . . . 1.0 117.069 -169.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.74 95.7 2.55 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.324 -3.213 . . . . 1.0 102.324 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.34 132.68 33.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.557 2.343 . . . . 1.0 112.426 -174.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -102.67 111.57 64.9 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -86.98 59.36 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.382 2.054 . . . . 1.0 112.389 -167.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.585 ' CD2' HH12 ' A' ' 24' ' ' ARG . 35.4 t60 . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.942 1.697 . . . . 1.0 106.669 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.506 2.352 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -161.04 155.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 102.019 -3.326 . . . . 1.0 102.019 171.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.64 154.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 101.472 -3.529 . . . . 1.0 101.472 160.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.64 41.9 1.06 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 124.369 2.033 . . . . 1.0 112.191 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.54 115.26 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.574 -2.38 . . . . 1.0 104.574 167.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -103.09 137.02 41.82 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -163.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 p -140.5 150.81 44.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 118.159 2.651 . . . . 1.0 118.159 -163.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 p -115.15 9.46 15.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 128.002 2.521 . . . . 1.0 109.639 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -167.49 150.31 5.72 Favored Pre-proline 0 CA--C 1.511 -0.534 0 O-C-N 119.608 -1.933 . . . . 1.0 108.536 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.65 -24.58 35.16 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.509 2.139 . . . . 1.0 111.93 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -48.86 -44.46 39.79 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.521 1.929 . . . . 1.0 112.84 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -65.86 -18.3 65.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.026 1.331 . . . . 1.0 113.553 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 40.1 t -83.64 -25.19 30.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.265 1.026 . . . . 1.0 111.344 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.06 -52.48 30.66 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 117.16 -1.4 . . . . 1.0 114.331 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.58 -38.79 39.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-O 113.127 -2.947 . . . . 1.0 115.433 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.94 -37.26 8.97 Favored 'Trans proline' 0 CA--C 1.502 -1.103 1 CA-C-N 129.365 4.38 . . . . 1.0 112.265 172.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.07 -44.3 82.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.379 1.085 . . . . 1.0 111.793 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -70.72 -17.73 62.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.461 2.023 . . . . 1.0 116.461 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -68.25 0.48 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 124.899 2.285 . . . . 1.0 113.005 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -102.08 -38.57 7.67 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.05 -2.796 . . . . 1.0 110.142 -161.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.06 -45.11 7.37 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.564 -166.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.94 142.87 4.41 Favored Glycine 0 CA--C 1.491 -1.426 0 C-N-CA 118.556 -1.783 . . . . 1.0 114.795 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.11 -38.03 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 120.082 -1.834 . . . . 1.0 112.393 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HE ' ' C ' ' A' ' 39' ' ' HIS . 6.9 tmm_? -81.49 -23.62 37.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.307 -1.496 . . . . 1.0 111.663 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.76 156.38 0.2 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 118.624 2.824 . . . . 1.0 118.624 -167.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.85 162.4 14.72 Favored Glycine 0 CA--C 1.475 -2.418 0 N-CA-C 107.854 -2.098 . . . . 1.0 107.854 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.66 6.05 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 119.911 -1.935 . . . . 1.0 107.56 -163.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.14 21.45 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.76 -1.576 . . . . 1.0 110.792 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.0 t -94.81 133.8 38.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.1 ttt -153.61 133.74 13.32 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 121.025 -1.047 . . . . 1.0 109.598 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.367 1.0 OUTLIER 53.48 32.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 128.473 2.709 . . . . 1.0 112.863 -172.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.74 10.02 86.56 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 113.712 -1.585 . . . . 1.0 115.403 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -136.85 157.31 47.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 120.298 2.049 . . . . 1.0 109.708 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.7 t -70.65 141.62 51.65 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 123.926 1.822 . . . . 1.0 113.819 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.72 84.25 2.09 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 102.125 -3.287 . . . . 1.0 102.125 -171.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.19 132.78 37.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.531 1.533 . . . . 1.0 110.551 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.98 95.05 19.31 Favored Pre-proline 0 N--CA 1.434 -1.238 0 C-N-CA 126.119 1.768 . . . . 1.0 106.248 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.19 73.1 5.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.77 2.313 . . . . 1.0 112.389 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' C ' ' HE ' ' A' ' 24' ' ' ARG . 11.5 t-160 . . . . . 0 C--O 1.259 1.592 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.51 2.525 0 CA-C-O 120.786 0.327 . . . . 1.0 111.168 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.0 t -134.53 138.56 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 1 N-CA-C 97.697 -4.927 . . . . 1.0 97.697 173.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.84 156.27 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 101.547 -3.501 . . . . 1.0 101.547 176.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.71 51.31 1.55 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 125.08 2.372 . . . . 1.0 110.718 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -90.29 102.79 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 162.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER -74.36 136.12 42.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 123.765 1.745 . . . . 1.0 112.606 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.49 154.15 18.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.144 1.926 . . . . 1.0 114.165 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 3.18 5.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.6 1.96 . . . . 1.0 107.862 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -177.14 157.02 1.28 Allowed Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 104.032 -2.581 . . . . 1.0 104.032 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.4 -23.18 28.17 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 CA-C-N 123.277 2.206 . . . . 1.0 111.999 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -57.67 -42.15 82.96 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 122.082 0.944 . . . . 1.0 113.057 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -70.58 -7.41 43.79 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 114.973 1.472 . . . . 1.0 114.973 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -82.44 -25.71 33.38 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.95 -1.094 . . . . 1.0 110.297 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.86 -48.23 62.77 Favored Pre-proline 0 C--N 1.354 0.777 0 O-C-N 119.628 -1.92 . . . . 1.0 114.446 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.76 -37.5 55.62 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 CA-C-O 113.216 -2.91 . . . . 1.0 115.237 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -37.06 17.66 Favored 'Trans proline' 0 CA--C 1.503 -1.043 1 CA-C-N 129.054 4.269 . . . . 1.0 112.48 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.92 -39.17 77.35 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.81 -1.181 . . . . 1.0 112.335 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -13.34 62.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 116.917 2.192 . . . . 1.0 116.917 174.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.96 72.31 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 123.158 1.456 . . . . 1.0 113.558 -170.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -164.08 -27.79 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.074 -1.421 . . . . 1.0 111.719 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.79 -17.74 52.67 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 120.228 -1.545 . . . . 1.0 113.004 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 154.35 7.29 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 121.058 -1.026 . . . . 1.0 112.861 154.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.21 -43.17 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 O-C-N 119.914 -1.933 . . . . 1.0 112.554 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -75.91 -28.31 57.99 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.664 -1.897 . . . . 1.0 111.134 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.4 151.46 0.37 Allowed 'General case' 0 C--N 1.35 0.589 0 N-CA-C 118.811 2.893 . . . . 1.0 118.811 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.69 175.62 21.74 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.16 131.95 11.55 Favored 'General case' 0 N--CA 1.434 -1.255 0 O-C-N 121.33 -1.1 . . . . 1.0 110.06 -166.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 154.24 45.72 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.902 -1.123 . . . . 1.0 111.308 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.31 117.04 34.18 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 164.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -147.32 136.36 22.31 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.519 -1.363 . . . . 1.0 110.296 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.417 0.9 OUTLIER 53.23 30.4 9.92 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 128.106 2.562 . . . . 1.0 112.955 -170.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.45 6.28 89.0 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 113.744 -1.571 . . . . 1.0 115.647 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.58 152.4 51.89 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.855 1.827 . . . . 1.0 108.995 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.72 143.09 51.41 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 116.333 1.975 . . . . 1.0 116.333 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -137.98 81.59 1.87 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.34 2.256 . . . . 1.0 107.365 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.6 m -70.11 132.1 45.31 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.206 1.558 . . . . 1.0 115.206 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -96.63 101.08 8.23 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.93 73.4 6.04 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 122.719 2.007 . . . . 1.0 111.745 -173.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.8 t60 . . . . . 0 C--O 1.261 1.703 0 CA-C-O 118.719 -0.658 . . . . 1.0 109.262 173.215 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 121.073 0.463 . . . . 1.0 110.499 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -135.65 127.42 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 100.773 -3.788 . . . . 1.0 100.773 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.81 -149.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 126.279 1.832 . . . . 1.0 106.822 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -142.38 37.37 1.52 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 124.896 2.284 . . . . 1.0 110.389 167.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.14 119.03 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 112.241 -2.254 . . . . 1.0 106.622 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -102.23 143.16 32.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.828 0.823 . . . . 1.0 109.13 -170.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.5 149.67 41.19 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 117.574 2.435 . . . . 1.0 117.574 -162.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -110.44 3.31 19.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 127.642 2.377 . . . . 1.0 109.73 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -177.55 146.35 0.61 Allowed Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 105.723 -1.954 . . . . 1.0 105.723 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.03 -26.85 57.99 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 123.871 2.418 . . . . 1.0 112.846 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -54.74 -30.84 57.36 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.789 1.636 . . . . 1.0 113.802 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -62.32 -26.38 68.4 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.052 -1.03 . . . . 1.0 113.439 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -100.13 -1.15 37.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.302 -0.874 . . . . 1.0 112.567 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.52 -49.39 83.58 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 120.295 -1.503 . . . . 1.0 113.695 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.28 -34.13 56.91 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-O 113.15 -2.938 . . . . 1.0 115.477 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.38 -36.41 9.2 Favored 'Trans proline' 0 CA--C 1.507 -0.874 1 CA-C-N 129.094 4.284 . . . . 1.0 112.91 169.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.6 -52.37 65.93 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.542 -1.349 . . . . 1.0 111.558 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -71.76 -1.98 15.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.235 1.569 . . . . 1.0 115.235 171.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.67 -69.32 0.39 Allowed 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 118.981 -2.325 . . . . 1.0 111.003 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -115.41 -29.89 6.4 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 111.547 -2.569 . . . . 1.0 112.056 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -92.74 -23.38 18.92 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 115.063 1.505 . . . . 1.0 115.063 -167.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.33 47.91 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 119.842 -1.787 . . . . 1.0 115.231 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.53 -45.44 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.224 1.81 . . . . 1.0 114.136 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' NH2' ' CD2' ' A' ' 39' ' ' HIS . 29.7 ttp180 -120.61 13.61 11.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.736 1.614 . . . . 1.0 107.034 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 145.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.143 1.905 . . . . 1.0 116.143 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.57 178.17 22.64 Favored Glycine 0 CA--C 1.479 -2.158 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -163.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.42 141.89 31.02 Favored 'General case' 0 N--CA 1.423 -1.817 0 O-C-N 120.569 -1.548 . . . . 1.0 110.116 -163.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -111.85 139.91 46.94 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.5 t -101.14 130.76 47.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.4 ttt -150.06 137.82 20.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 120.751 -1.218 . . . . 1.0 109.59 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.44 27.26 16.22 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.558 1.543 . . . . 1.0 111.23 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.05 86.5 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 114.774 -1.103 . . . . 1.0 115.652 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.36 151.54 43.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.681 2.24 . . . . 1.0 110.536 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.4 t -70.32 153.75 42.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 118.025 2.602 . . . . 1.0 118.025 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -144.6 92.06 2.25 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 127.394 2.278 . . . . 1.0 105.016 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -77.96 137.35 38.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 128.55 2.74 . . . . 1.0 114.782 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -100.2 102.1 16.94 Favored Pre-proline 0 N--CA 1.441 -0.888 0 C-N-CA 126.595 1.958 . . . . 1.0 106.324 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -85.12 72.38 4.62 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 121.978 1.742 . . . . 1.0 111.859 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.444 ' CD2' ' NH2' ' A' ' 24' ' ' ARG . 35.4 t60 . . . . . 0 C--O 1.259 1.601 0 O-C-N 121.59 -0.694 . . . . 1.0 112.468 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 121.173 0.511 . . . . 1.0 111.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.9 t -133.89 136.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 N-CA-C 98.671 -4.566 . . . . 1.0 98.671 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 155.9 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 101.377 -3.564 . . . . 1.0 101.377 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.61 47.36 1.23 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 124.353 2.025 . . . . 1.0 110.946 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.96 122.88 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -93.8 144.24 25.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.137 0.97 . . . . 1.0 110.81 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.47 155.66 42.12 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.729 1.728 . . . . 1.0 115.395 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -110.71 -24.92 10.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.849 156.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -118.06 146.99 40.44 Favored Pre-proline 0 CA--C 1.512 -0.498 0 O-C-N 120.178 -1.576 . . . . 1.0 110.296 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.14 -17.0 57.67 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 C-N-CA 122.219 1.946 . . . . 1.0 112.049 166.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -59.41 -42.4 91.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.626 -1.296 . . . . 1.0 112.504 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.45 -16.78 63.03 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.04 1.736 . . . . 1.0 113.986 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.638 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -83.34 -28.25 29.13 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 121.114 -0.991 . . . . 1.0 111.063 176.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.3 -53.61 10.22 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 114.471 1.286 . . . . 1.0 114.471 -160.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -57.35 -46.11 30.13 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 CA-C-O 114.344 -2.44 . . . . 1.0 115.406 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -67.11 -37.48 18.61 Favored 'Trans proline' 0 CA--C 1.504 -1.017 0 CA-C-N 127.007 3.538 . . . . 1.0 112.398 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 t -64.41 -37.36 87.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 120.323 -1.485 . . . . 1.0 112.771 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -70.73 -11.63 61.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 116.827 2.158 . . . . 1.0 116.827 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.82 71.59 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 123.148 1.451 . . . . 1.0 113.416 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -164.4 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.911 -1.495 . . . . 1.0 111.378 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -78.5 -14.92 59.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.176 -1.578 . . . . 1.0 113.291 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.11 154.79 7.2 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 122.336 0.965 . . . . 1.0 113.108 149.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -70.19 -41.88 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 O-C-N 120.742 -1.446 . . . . 1.0 112.603 -174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -91.02 -18.56 24.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.961 -1.087 . . . . 1.0 110.978 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.78 144.35 1.76 Allowed 'General case' 0 C--N 1.352 0.703 0 N-CA-C 117.612 2.449 . . . . 1.0 117.612 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.35 25.9 Favored Glycine 0 CA--C 1.475 -2.407 0 N-CA-C 107.47 -2.252 . . . . 1.0 107.47 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -159.95 125.2 4.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.225 -1.162 . . . . 1.0 109.595 -168.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 169.65 22.04 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.723 -1.235 . . . . 1.0 109.65 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.8 t -100.2 139.29 36.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.609 -0.682 . . . . 1.0 112.443 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.8 ttt -162.94 148.4 11.91 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.343 1.057 . . . . 1.0 108.565 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 63.2 28.78 15.97 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 123.226 1.489 . . . . 1.0 110.208 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.16 12.38 57.73 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.602 1.096 . . . . 1.0 115.53 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.3 165.19 32.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 120.023 1.911 . . . . 1.0 110.536 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -69.52 153.96 42.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.144 1.535 . . . . 1.0 115.144 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 85.4 1.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.582 -2.747 . . . . 1.0 103.582 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.56 127.42 32.78 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.262 1.825 . . . . 1.0 112.681 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.56 102.41 14.57 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 105.729 -1.952 . . . . 1.0 105.729 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.95 66.14 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.216 1.944 . . . . 1.0 112.141 -166.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.7 t60 . . . . . 0 C--O 1.259 1.602 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 170.618 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.256 0.551 . . . . 1.0 111.38 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.59 136.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -83.64 42.19 1.19 Allowed 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 . . . . . 0 N--CA 1.429 -1.525 0 C-N-CA 126.935 2.094 . . . . 1.0 109.715 -172.724 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.256 0.551 . . . . 1.0 111.38 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.59 136.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -83.64 42.19 1.19 Allowed 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 . . . . . 0 N--CA 1.429 -1.525 0 C-N-CA 126.935 2.094 . . . . 1.0 109.715 -172.724 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.517 2.879 0 N-CA-C 110.744 -0.095 . . . . 1.0 110.744 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -155.89 137.91 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 1 N-CA-C 100.15 -4.019 . . . . 1.0 100.15 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 152.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 N-CA-C 100.824 -3.769 . . . . 1.0 100.824 154.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -99.23 50.11 0.95 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 124.268 1.985 . . . . 1.0 111.382 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.73 117.28 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 105.012 -2.218 . . . . 1.0 105.012 163.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.74 143.77 26.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.584 0.707 . . . . 1.0 111.291 -167.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.98 153.57 40.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 116.36 1.985 . . . . 1.0 116.36 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -94.0 -41.69 9.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 112.146 -2.297 . . . . 1.0 109.027 156.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -108.94 148.4 37.82 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.451 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.73 -23.92 74.61 Favored 'Trans proline' 0 CA--C 1.51 -0.704 0 C-N-CA 121.775 1.65 . . . . 1.0 112.656 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.95 -33.96 76.91 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 121.064 -1.023 . . . . 1.0 113.223 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -64.36 -15.32 60.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.549 1.14 . . . . 1.0 113.848 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -89.14 -21.68 23.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.841 -1.162 . . . . 1.0 111.477 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.95 -52.85 46.64 Favored Pre-proline 0 N--CA 1.439 -0.996 0 O-C-N 120.441 -1.412 . . . . 1.0 113.804 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.23 -36.59 45.63 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-O 112.877 -3.051 . . . . 1.0 115.263 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -69.86 -39.7 6.0 Favored 'Trans proline' 0 CA--C 1.504 -0.979 1 CA-C-N 129.456 4.413 . . . . 1.0 112.426 170.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.2 -49.73 75.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 123.71 1.719 . . . . 1.0 111.861 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -71.54 -8.78 56.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 115.905 1.817 . . . . 1.0 115.905 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -68.46 0.45 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 124.237 1.97 . . . . 1.0 110.986 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -106.83 -44.73 4.36 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 111.997 -2.365 . . . . 1.0 110.594 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -87.84 -24.89 23.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.427 0.899 . . . . 1.0 113.427 -154.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.0 167.22 39.99 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 115.297 -3.335 . . . . 1.0 118.314 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.21 -61.0 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 C-N-CA 124.772 1.229 . . . . 1.0 112.3 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -105.18 10.44 33.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.465 1.106 . . . . 1.0 109.659 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 146.2 39.25 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -168.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.86 167.25 19.62 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 107.754 -2.139 . . . . 1.0 107.754 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.18 127.02 4.96 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.963 -1.904 . . . . 1.0 109.674 -162.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 173.41 14.56 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 120.615 -1.303 . . . . 1.0 111.351 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -101.46 139.89 36.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.679 0.792 . . . . 1.0 110.112 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.5 ttt -164.68 145.9 7.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.249 1.42 . . . . 1.0 108.629 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 62.84 28.15 16.3 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 123.161 1.458 . . . . 1.0 110.368 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.72 62.25 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 124.246 0.927 . . . . 1.0 115.252 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.93 162.88 39.48 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 120.228 -1.748 . . . . 1.0 110.916 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 t -64.58 152.36 42.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.918 1.818 . . . . 1.0 115.023 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -142.89 85.88 1.9 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 104.357 -2.46 . . . . 1.0 104.357 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.91 128.28 33.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.075 0.95 . . . . 1.0 111.568 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -110.96 95.72 25.84 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.206 1.802 . . . . 1.0 109.125 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.71 67.3 8.47 Favored 'Trans proline' 0 C--N 1.33 -0.423 0 C-N-CA 122.776 2.318 . . . . 1.0 111.597 167.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 . . . . . 0 C--O 1.26 1.631 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 176.698 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.512 2.642 0 CA-C-O 121.767 0.794 . . . . 1.0 112.285 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.44 127.9 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 N-CA-C 99.17 -4.382 . . . . 1.0 99.17 168.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.07 153.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 N-CA-C 100.7 -3.815 . . . . 1.0 100.7 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.27 52.01 1.12 Allowed 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 124.64 2.162 . . . . 1.0 110.308 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.55 123.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 105.399 -2.075 . . . . 1.0 105.399 163.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -80.15 142.91 34.32 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.728 0.775 . . . . 1.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -140.47 149.95 43.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 124.184 1.945 . . . . 1.0 116.088 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 m -114.25 -9.22 12.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 129.424 3.09 . . . . 1.0 107.97 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -174.18 158.15 2.66 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.568 1.547 . . . . 1.0 107.285 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.28 -28.76 33.18 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 C-N-CA 122.296 1.997 . . . . 1.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -55.0 -40.01 69.68 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.311 1.444 . . . . 1.0 113.313 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.2 -29.0 67.17 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.145 1.378 . . . . 1.0 114.079 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 t -99.21 -3.48 34.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.121 -0.987 . . . . 1.0 113.094 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.75 -51.55 75.3 Favored Pre-proline 0 N--CA 1.451 -0.418 0 O-C-N 120.247 -1.533 . . . . 1.0 113.851 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.99 -37.94 50.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-O 113.187 -2.922 . . . . 1.0 115.712 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -68.74 -38.31 10.58 Favored 'Trans proline' 0 CA--C 1.508 -0.825 1 CA-C-N 129.134 4.298 . . . . 1.0 112.701 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.1 t -58.63 -50.7 72.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.351 1.548 . . . . 1.0 111.747 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -0.9 12.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 116.762 2.134 . . . . 1.0 116.762 172.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.02 70.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 123.463 1.602 . . . . 1.0 112.316 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -156.26 -26.55 0.1 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.686 -1.597 . . . . 1.0 112.174 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.93 -19.75 51.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 119.959 -1.713 . . . . 1.0 113.19 -169.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.4 157.5 26.23 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 117.851 -2.119 . . . . 1.0 114.622 157.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -69.53 -35.45 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 O-C-N 120.511 -1.582 . . . . 1.0 112.249 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -112.76 10.76 19.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.695 1.598 . . . . 1.0 110.882 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.03 155.52 34.43 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 115.931 1.826 . . . . 1.0 115.931 -166.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.56 166.05 27.83 Favored Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.942 -2.463 . . . . 1.0 106.942 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.31 154.5 50.85 Favored 'General case' 0 N--CA 1.418 -2.027 0 O-C-N 120.568 -1.548 . . . . 1.0 107.792 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -149.36 165.8 30.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.984 167.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.5 t -97.39 140.53 31.7 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 113.445 0.905 . . . . 1.0 113.445 -169.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 ttt -155.83 136.72 13.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.888 -1.132 . . . . 1.0 109.66 167.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.01 31.08 18.09 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.294 1.521 . . . . 1.0 110.269 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.27 15.62 65.85 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 124.611 1.1 . . . . 1.0 115.012 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -146.91 158.14 43.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.319 -1.695 . . . . 1.0 110.081 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.68 156.62 38.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.677 2.473 . . . . 1.0 117.677 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -141.64 89.59 2.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 103.556 -2.757 . . . . 1.0 103.556 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.9 t -85.91 126.56 34.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.513 2.325 . . . . 1.0 112.854 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -115.8 108.07 47.34 Favored Pre-proline 0 N--CA 1.437 -1.089 0 C-N-CA 126.512 1.925 . . . . 1.0 108.501 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.94 56.7 5.96 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.608 2.206 . . . . 1.0 110.323 159.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.719 2.008 . . . . 1.0 105.661 -170.727 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.508 2.431 0 CA-C-O 120.604 0.24 . . . . 1.0 111.175 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 1' ' ' THR . 60.1 t -138.16 136.1 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 1 N-CA-C 98.602 -4.592 . . . . 1.0 98.602 173.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.95 160.48 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.495 0 N-CA-C 103.787 -2.671 . . . . 1.0 103.787 172.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.51 44.05 1.18 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 124.672 2.177 . . . . 1.0 110.67 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.2 113.17 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 103.979 -2.6 . . . . 1.0 103.979 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -98.49 133.5 42.77 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -161.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 p -135.63 156.94 48.05 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 118.48 2.771 . . . . 1.0 118.48 -165.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -109.65 -23.43 11.45 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.972 -1.922 . . . . 1.0 110.404 156.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 t -131.59 151.82 79.35 Favored Pre-proline 0 CA--C 1.508 -0.661 0 O-C-N 120.192 -1.567 . . . . 1.0 109.655 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.42 -25.22 56.22 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 122.763 2.022 . . . . 1.0 111.953 164.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -58.49 -41.28 84.97 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 122.37 1.081 . . . . 1.0 113.482 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.42 -13.89 62.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.523 1.129 . . . . 1.0 113.445 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -90.59 -8.31 50.5 Favored 'General case' 0 N--CA 1.417 -2.087 0 O-C-N 120.629 -1.294 . . . . 1.0 111.72 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.08 -44.18 59.22 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 116.759 -1.591 . . . . 1.0 113.23 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.84 -46.77 21.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 124.13 2.511 . . . . 1.0 115.683 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.07 -34.91 21.36 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 CA-C-N 127.557 3.735 . . . . 1.0 112.722 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.3 m -58.95 -35.79 73.72 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.704 -1.248 . . . . 1.0 112.3 172.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -20.1 62.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 116.843 2.164 . . . . 1.0 116.843 172.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -69.88 0.36 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 125.074 2.369 . . . . 1.0 111.903 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -93.5 -38.4 11.43 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.35 -2.659 . . . . 1.0 110.254 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.4 -11.72 20.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 -167.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 174.04 18.53 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 123.202 1.445 . . . . 1.0 115.21 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -69.08 -33.61 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 119.452 -2.205 . . . . 1.0 113.123 -167.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -86.98 -12.66 46.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.457 -1.402 . . . . 1.0 112.027 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.44 158.12 18.48 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 116.737 2.125 . . . . 1.0 116.737 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.17 14.46 Favored Glycine 0 CA--C 1.492 -1.377 0 O-C-N 120.912 -1.117 . . . . 1.0 111.184 -170.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.38 149.08 27.44 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.565 -1.55 . . . . 1.0 111.19 -171.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.63 136.22 54.82 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 125.786 1.634 . . . . 1.0 108.362 167.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 t -89.7 130.05 36.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.393 -0.817 . . . . 1.0 110.597 167.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.9 ttt -155.13 137.24 14.71 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 121.049 -1.032 . . . . 1.0 109.612 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.27 29.03 18.66 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.232 1.813 . . . . 1.0 110.992 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.83 10.9 62.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 116.568 1.387 . . . . 1.0 116.568 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -143.91 127.31 16.83 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.739 2.269 . . . . 1.0 109.153 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 153.39 42.7 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 119.437 3.125 . . . . 1.0 119.437 -162.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -123.21 78.95 1.62 Allowed 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 128.579 2.752 . . . . 1.0 104.218 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 t -70.21 132.98 46.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.406 1.482 . . . . 1.0 114.122 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.98 103.86 46.57 Favored Pre-proline 0 N--CA 1.434 -1.27 0 C-N-CA 125.847 1.659 . . . . 1.0 106.852 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.44 91.71 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.734 0 CA-C-N 123.194 2.176 . . . . 1.0 109.899 157.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 . . . . . 0 C--O 1.263 1.811 0 C-N-CA 124.318 1.047 . . . . 1.0 109.56 171.26 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.31 134.93 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 1 N-CA-C 99.95 -4.093 . . . . 1.0 99.95 175.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.4 mt -104.53 -146.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 126.695 1.998 . . . . 1.0 107.738 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 3' ' ' ILE . 1.3 t0 -124.31 46.34 2.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 124.956 2.312 . . . . 1.0 109.011 163.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.39 105.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 112.41 -2.177 . . . . 1.0 105.349 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.56 131.54 38.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.741 -1.577 . . . . 1.0 106.741 171.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.79 161.96 39.58 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.051 2.241 . . . . 1.0 117.051 -162.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -46.94 8.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 112.786 -2.006 . . . . 1.0 109.739 154.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 152.97 76.81 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.271 -1.331 . . . . 1.0 111.933 -149.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.29 -33.55 48.01 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.235 2.623 . . . . 1.0 112.034 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -44.85 -48.42 11.09 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 127.282 2.233 . . . . 1.0 112.371 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -63.71 -22.54 66.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.223 1.409 . . . . 1.0 113.978 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.5 t -106.5 -7.47 17.51 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.635 -0.665 . . . . 1.0 112.47 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 tp -64.67 -50.87 62.34 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 116.921 -1.514 . . . . 1.0 113.667 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.77 -41.16 40.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-O 112.918 -3.034 . . . . 1.0 115.543 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -69.03 -40.22 6.77 Favored 'Trans proline' 0 CA--C 1.508 -0.798 1 CA-C-N 129.369 4.382 . . . . 1.0 113.151 173.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.1 t -56.89 -44.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.465 1.602 . . . . 1.0 111.627 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -21.01 62.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 174.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.21 -70.89 0.31 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 124.631 2.158 . . . . 1.0 112.89 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -90.58 -42.59 10.71 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.203 -2.726 . . . . 1.0 108.689 -159.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -96.53 -30.19 13.46 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.599 -1.637 . . . . 1.0 113.756 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.98 159.18 22.78 Favored Glycine 0 CA--C 1.484 -1.89 0 C-N-CA 114.798 -3.572 . . . . 1.0 115.016 165.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 tt -70.28 -34.51 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 C-N-CA 126.295 1.838 . . . . 1.0 113.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -98.12 -11.26 23.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.313 0.645 . . . . 1.0 111.801 172.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.39 152.12 11.91 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.812 2.523 . . . . 1.0 117.812 -167.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.4 167.92 29.68 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 109.039 -1.625 . . . . 1.0 109.039 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.98 154.43 42.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 123.286 1.517 . . . . 1.0 110.161 -164.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 175.7 10.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 107.485 -1.302 . . . . 1.0 107.485 166.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.3 t -107.53 147.08 31.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.782 -0.574 . . . . 1.0 110.513 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.1 ttt -164.01 142.01 7.26 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.378 1.471 . . . . 1.0 109.803 169.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.32 35.78 20.66 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 126.157 1.783 . . . . 1.0 110.48 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.87 -5.04 55.27 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 116.231 1.252 . . . . 1.0 116.231 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -135.39 165.26 25.88 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.686 2.243 . . . . 1.0 109.766 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.55 160.89 10.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 115.043 1.497 . . . . 1.0 115.043 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -142.74 90.53 2.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 100.289 -3.967 . . . . 1.0 100.289 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -92.46 128.68 38.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 126.261 1.824 . . . . 1.0 109.034 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.11 98.06 41.12 Favored Pre-proline 0 N--CA 1.436 -1.141 0 C-N-CA 125.212 1.405 . . . . 1.0 107.336 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.94 78.29 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.696 1.597 . . . . 1.0 111.078 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.7 t60 . . . . . 0 C--O 1.26 1.606 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 167.197 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.194 0.521 . . . . 1.0 112.067 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t -136.63 138.07 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 98.543 -4.614 . . . . 1.0 98.543 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.79 158.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 101.68 -3.452 . . . . 1.0 101.68 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.85 42.06 1.09 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 124.091 1.901 . . . . 1.0 112.122 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.52 126.67 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 170.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -108.22 140.13 41.9 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.906 0.86 . . . . 1.0 110.958 -157.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.3 156.26 47.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -168.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.4 m -108.77 -26.55 10.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.709 1.719 . . . . 1.0 109.636 162.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -123.17 154.15 65.01 Favored Pre-proline 0 CA--C 1.515 -0.371 0 O-C-N 120.578 -1.326 . . . . 1.0 110.563 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.48 -27.11 54.43 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 121.816 1.677 . . . . 1.0 112.474 160.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.9 -49.63 74.05 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.623 -1.298 . . . . 1.0 112.651 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.93 -5.45 17.03 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.093 1.357 . . . . 1.0 113.633 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -88.56 -27.79 21.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.113 1.435 . . . . 1.0 109.533 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.9 tp -70.15 -47.3 21.29 Favored Pre-proline 0 C--N 1.355 0.835 0 CA-C-O 116.298 -1.811 . . . . 1.0 114.681 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.13 -35.87 61.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-O 113.23 -2.904 . . . . 1.0 115.288 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.43 -39.93 11.66 Favored 'Trans proline' 0 CA--C 1.502 -1.113 1 CA-C-N 128.98 4.243 . . . . 1.0 112.308 170.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.6 m -61.17 -33.47 73.49 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.744 -1.223 . . . . 1.0 113.379 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -12.2 61.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 116.417 2.006 . . . . 1.0 116.417 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.26 71.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 123.272 1.511 . . . . 1.0 113.518 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -163.05 -30.05 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.782 -1.554 . . . . 1.0 111.33 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.9 -15.46 59.0 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 120.23 -1.544 . . . . 1.0 113.038 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.23 153.3 6.3 Favored Glycine 0 CA--C 1.492 -1.394 0 CA-C-O 122.329 0.961 . . . . 1.0 113.887 150.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.3 -35.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 119.877 -1.955 . . . . 1.0 111.818 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -70.17 -37.44 75.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.996 1.718 . . . . 1.0 109.772 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.07 155.68 1.81 Allowed 'General case' 0 C--N 1.348 0.524 0 N-CA-C 118.163 2.653 . . . . 1.0 118.163 -162.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.18 174.13 15.09 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.361 -1.895 . . . . 1.0 108.361 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -160.35 137.59 9.34 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 120.879 -1.365 . . . . 1.0 109.386 -165.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -155.48 166.27 34.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.301 -0.96 . . . . 1.0 110.259 165.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.5 141.58 29.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.778 -0.576 . . . . 1.0 112.338 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -155.56 135.96 13.21 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.186 -0.946 . . . . 1.0 109.868 168.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.98 34.03 21.47 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.77 2.028 . . . . 1.0 110.42 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.47 15.27 68.06 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.76 -1.109 . . . . 1.0 115.669 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -145.85 150.76 36.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 119.8 -2.0 . . . . 1.0 110.057 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.0 156.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 -164.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.18 86.8 2.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.734 -2.691 . . . . 1.0 103.734 -175.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 62.1 m -75.31 131.03 40.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 125.967 1.707 . . . . 1.0 113.554 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.74 126.26 28.85 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 106.075 -1.824 . . . . 1.0 106.075 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.34 38.71 0.54 Allowed 'Trans proline' 0 CA--C 1.509 -0.765 0 CA-C-N 124.641 2.693 . . . . 1.0 113.466 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 t60 . . . . . 0 N--CA 1.426 -1.644 0 C-N-CA 125.965 1.706 . . . . 1.0 109.601 171.05 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.407 0 CA-C-O 121.033 0.444 . . . . 1.0 111.937 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.25 132.89 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 1 N-CA-C 98.686 -4.561 . . . . 1.0 98.686 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.53 158.76 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 103.284 -2.858 . . . . 1.0 103.284 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.23 50.85 1.56 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.115 2.166 . . . . 1.0 110.358 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.11 118.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 105.373 -2.084 . . . . 1.0 105.373 165.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 134.19 36.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -134.66 146.63 49.69 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 116.967 2.21 . . . . 1.0 116.967 -165.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -110.63 -17.78 13.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 112.433 -2.167 . . . . 1.0 109.176 167.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -140.3 147.62 50.69 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 56.7 Cg_endo -60.71 -24.15 77.97 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 122.401 2.067 . . . . 1.0 112.88 167.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -37.67 70.72 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 122.716 1.246 . . . . 1.0 112.416 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -60.4 -24.66 65.32 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.543 1.537 . . . . 1.0 114.228 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 38.5 t -103.46 -5.02 23.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.164 0.983 . . . . 1.0 112.609 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.25 -48.65 75.89 Favored Pre-proline 0 C--N 1.345 0.411 0 O-C-N 120.186 -1.571 . . . . 1.0 114.299 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.61 -34.3 64.12 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-O 113.402 -2.832 . . . . 1.0 115.44 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.59 -36.55 14.5 Favored 'Trans proline' 0 CA--C 1.506 -0.89 1 CA-C-N 128.867 4.202 . . . . 1.0 112.54 169.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 m -59.29 -51.05 71.63 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.122 1.439 . . . . 1.0 112.37 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 2.36 5.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 116.777 2.14 . . . . 1.0 116.777 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.8 -50.93 30.38 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.752 1.739 . . . . 1.0 111.502 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 -12.71 0.24 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.447 -1.706 . . . . 1.0 113.036 -173.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -84.98 -20.74 30.09 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 120.031 -1.668 . . . . 1.0 113.384 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.88 -166.2 33.51 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 115.344 -3.312 . . . . 1.0 119.154 163.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.3 -62.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 C-N-CA 125.098 1.359 . . . . 1.0 112.295 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.462 HH21 ' C ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -117.69 13.51 14.23 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.906 1.682 . . . . 1.0 107.437 -176.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.09 145.49 0.75 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 118.282 2.697 . . . . 1.0 118.282 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.8 170.8 21.07 Favored Glycine 0 CA--C 1.477 -2.311 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -162.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -145.16 135.44 24.05 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 -170.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -144.04 149.28 36.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.05 137.7 34.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 121.221 -0.924 . . . . 1.0 111.902 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -155.69 139.96 16.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 120.819 -1.176 . . . . 1.0 109.68 167.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.8 33.95 19.9 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 126.356 1.862 . . . . 1.0 110.141 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.12 16.7 60.3 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 124.382 0.991 . . . . 1.0 115.525 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -144.84 154.38 42.59 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 119.708 -2.054 . . . . 1.0 107.919 -173.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.35 158.49 31.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 119.675 -1.891 . . . . 1.0 115.987 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -144.09 89.69 2.05 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 101.625 -3.472 . . . . 1.0 101.625 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.2 t -85.64 129.3 34.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.798 2.039 . . . . 1.0 112.398 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -103.89 102.9 34.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -87.0 63.4 4.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.149 1.9 . . . . 1.0 111.865 -166.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.462 ' C ' HH21 ' A' ' 24' ' ' ARG . 58.2 t60 . . . . . 0 C--O 1.253 1.271 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.307 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 121.48 0.657 . . . . 1.0 111.011 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t -138.7 138.09 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 98.551 -4.611 . . . . 1.0 98.551 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.21 157.39 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 167.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.61 41.6 1.03 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 125.401 2.525 . . . . 1.0 111.653 176.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -92.84 110.74 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.077 -1.874 . . . . 1.0 106.033 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 137.88 52.63 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.556 -1.34 . . . . 1.0 110.669 171.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -104.53 169.69 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.567 -1.333 . . . . 1.0 113.18 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 p -133.24 -0.75 3.28 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 126.803 2.041 . . . . 1.0 108.825 161.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -177.72 155.48 1.08 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 102.993 -2.966 . . . . 1.0 102.993 -167.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.71 -27.16 68.38 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 123.669 2.346 . . . . 1.0 111.748 163.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.37 -42.57 99.52 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.452 1.12 . . . . 1.0 112.893 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -7.05 41.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 t -99.89 -6.02 27.43 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.651 -1.28 . . . . 1.0 111.483 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.83 -39.59 54.92 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 119.703 -1.873 . . . . 1.0 114.303 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.85 -47.35 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 CA-C-O 113.8 -2.667 . . . . 1.0 115.792 169.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.31 -35.67 23.33 Favored 'Trans proline' 0 CA--C 1.507 -0.836 0 CA-C-N 127.995 3.891 . . . . 1.0 112.516 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.3 m -59.25 -34.36 72.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.954 -1.092 . . . . 1.0 112.5 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -25.25 63.05 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 117.01 2.226 . . . . 1.0 117.01 170.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -67.05 0.57 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 124.775 2.226 . . . . 1.0 113.256 -174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.48 -39.04 10.62 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 111.548 -2.569 . . . . 1.0 109.99 -166.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.19 -27.39 13.83 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.527 -1.215 . . . . 1.0 114.267 -162.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.45 171.27 19.83 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 119.98 -1.7 . . . . 1.0 115.758 163.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 23' ' ' ILE . 4.7 mp -69.51 -46.35 76.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 120.007 -1.878 . . . . 1.0 111.818 -175.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -83.83 -15.78 46.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.581 -1.324 . . . . 1.0 111.509 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.59 160.2 1.34 Allowed 'General case' 0 C--N 1.355 0.818 0 N-CA-C 117.833 2.531 . . . . 1.0 117.833 -166.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.01 177.4 20.95 Favored Glycine 0 CA--C 1.49 -1.469 0 O-C-N 120.718 -1.239 . . . . 1.0 111.881 -166.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.21 144.77 31.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.769 -1.43 . . . . 1.0 109.436 -170.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 153.46 35.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.39 1.076 . . . . 1.0 108.191 163.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.98 122.19 43.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.666 0.786 . . . . 1.0 110.346 167.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.7 tpp -154.95 140.71 18.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.847 -1.158 . . . . 1.0 112.034 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 33.37 17.35 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.143 1.777 . . . . 1.0 109.908 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.18 1.36 41.43 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 115.897 1.119 . . . . 1.0 115.897 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -132.6 151.61 51.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 120.021 -1.87 . . . . 1.0 107.831 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.0 t -67.33 156.95 35.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.358 -2.088 . . . . 1.0 114.713 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.16 81.15 1.84 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.435 -2.802 . . . . 1.0 103.435 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 t -81.56 140.67 34.36 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.448 1.099 . . . . 1.0 113.964 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.86 99.5 45.56 Favored Pre-proline 0 N--CA 1.437 -1.108 0 C-N-CA 125.554 1.542 . . . . 1.0 107.11 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.27 73.28 4.53 Favored 'Trans proline' 0 C--N 1.329 -0.466 0 C-N-CA 122.778 2.318 . . . . 1.0 110.841 169.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.9 t60 . . . . . 0 N--CA 1.43 -1.438 0 C-N-CA 124.629 1.171 . . . . 1.0 108.242 -176.779 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.511 2.591 0 CA-C-O 121.566 0.698 . . . . 1.0 111.485 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.56 135.12 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 1 N-CA-C 98.241 -4.726 . . . . 1.0 98.241 167.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.75 158.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 102.49 -3.152 . . . . 1.0 102.49 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 39.03 0.91 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.635 2.636 . . . . 1.0 112.1 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -91.56 103.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.725 -1.58 . . . . 1.0 107.419 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 142.87 51.96 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.776 -1.202 . . . . 1.0 110.717 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.51 166.33 14.85 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.687 -1.258 . . . . 1.0 114.081 -170.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.41 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 32.9 p -126.7 -6.35 6.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.748 2.019 . . . . 1.0 109.325 150.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -178.98 154.91 0.81 Allowed Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 101.107 -3.664 . . . . 1.0 101.107 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.51 -28.37 77.58 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 CA-C-N 123.874 2.419 . . . . 1.0 112.189 162.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.8 -29.13 68.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.733 0.778 . . . . 1.0 112.801 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -70.47 -9.93 57.82 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 120.723 -1.236 . . . . 1.0 114.3 175.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 45.3 t -93.36 -7.78 43.77 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.583 -1.323 . . . . 1.0 112.16 171.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -49.32 88.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 119.941 -1.724 . . . . 1.0 113.958 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.08 -32.92 63.5 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 CA-C-O 113.293 -2.878 . . . . 1.0 115.929 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.11 -36.3 10.11 Favored 'Trans proline' 0 CA--C 1.504 -0.976 1 CA-C-N 129.074 4.277 . . . . 1.0 112.632 167.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.83 -61.55 2.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.949 1.357 . . . . 1.0 111.749 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 21.24 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.921 -1.112 . . . . 1.0 113.873 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.07 -69.93 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 118.092 -2.88 . . . . 1.0 107.973 159.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.81 -20.89 2.21 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 127.435 2.294 . . . . 1.0 114.08 -163.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -87.97 -16.7 33.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.293 -1.505 . . . . 1.0 114.576 -165.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.26 178.67 38.8 Favored Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.226 -1.464 . . . . 1.0 111.35 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.01 -55.65 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 122.481 1.134 . . . . 1.0 112.776 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' NH2' ' CD2' ' A' ' 39' ' ' HIS 0.258 0.0 OUTLIER -122.89 25.08 8.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 123.45 1.595 . . . . 1.0 107.267 -175.42 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.48 143.89 0.19 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 119.166 3.025 . . . . 1.0 119.166 -163.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.09 163.59 13.23 Favored Glycine 0 CA--C 1.476 -2.368 0 N-CA-C 108.366 -1.893 . . . . 1.0 108.366 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -152.14 126.66 9.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.746 -1.205 . . . . 1.0 107.746 -172.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 150.95 39.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -96.61 139.66 32.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.951 -1.093 . . . . 1.0 112.115 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -156.93 144.81 19.24 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 166.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.341 0.7 OUTLIER 62.67 20.31 11.97 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.414 1.885 . . . . 1.0 113.381 -174.007 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.6 9.51 86.15 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 114.998 -1.001 . . . . 1.0 114.661 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.25 159.0 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.424 -1.633 . . . . 1.0 108.007 -170.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 t -70.05 159.04 34.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.214 -2.179 . . . . 1.0 116.409 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -144.48 90.35 2.08 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 102.034 -3.321 . . . . 1.0 102.034 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.3 t -84.45 130.26 34.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.734 2.014 . . . . 1.0 112.962 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -102.45 107.49 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.31 64.84 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.768 1.645 . . . . 1.0 112.365 -166.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.409 ' CD2' ' NH2' ' A' ' 24' ' ' ARG . 16.2 t-160 . . . . . 0 C--O 1.26 1.613 0 O-C-N 122.168 -0.332 . . . . 1.0 110.422 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.514 2.769 0 CA-C-O 118.852 -0.594 . . . . 1.0 109.664 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -154.92 127.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 103.135 -2.913 . . . . 1.0 103.135 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.38 161.1 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 161.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.44 65.23 0.61 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.981 1.713 . . . . 1.0 107.508 160.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.9 t -84.64 109.2 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.673 -1.973 . . . . 1.0 105.673 160.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -97.29 124.17 41.32 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.9 1.28 . . . . 1.0 108.96 -176.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -145.11 163.02 35.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.357 1.984 . . . . 1.0 116.357 -155.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -99.32 -36.15 9.71 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 123.646 1.688 . . . . 1.0 109.758 154.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -116.97 150.66 46.32 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.445 -1.252 . . . . 1.0 111.536 -156.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.8 -34.24 31.59 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.026 1.817 . . . . 1.0 111.776 170.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -54.85 -41.72 71.11 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.974 1.31 . . . . 1.0 113.021 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -54.75 -30.6 56.86 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.759 1.223 . . . . 1.0 114.149 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t -100.57 -9.37 22.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . 0.267 2.8 tm? -68.42 -49.21 32.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 120.402 -1.436 . . . . 1.0 113.192 -170.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.43 -44.29 43.85 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 CA-C-O 114.267 -2.472 . . . . 1.0 115.95 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.17 -37.73 13.78 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 CA-C-N 127.194 3.605 . . . . 1.0 112.981 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.93 -49.0 78.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.864 1.792 . . . . 1.0 111.414 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -71.31 -8.2 52.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.64 -54.92 10.06 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.605 1.669 . . . . 1.0 111.775 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.11 -23.26 1.03 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 113.146 -1.843 . . . . 1.0 112.597 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -84.64 -20.22 31.69 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 120.162 -1.586 . . . . 1.0 113.55 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.7 179.49 45.04 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 116.462 -2.78 . . . . 1.0 116.978 157.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 tt -70.72 -55.75 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 125.782 1.633 . . . . 1.0 112.434 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -121.31 19.19 11.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.476 1.911 . . . . 1.0 107.035 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.01 145.75 16.01 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.27 1.952 . . . . 1.0 116.27 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.35 162.29 22.68 Favored Glycine 0 CA--C 1.471 -2.659 0 N-CA-C 107.952 -2.059 . . . . 1.0 107.952 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.46 131.71 24.96 Favored 'General case' 0 N--CA 1.425 -1.701 0 O-C-N 120.678 -1.484 . . . . 1.0 107.456 -163.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -141.9 148.2 38.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -99.12 144.82 27.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.246 -1.533 . . . . 1.0 111.146 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -162.2 144.14 11.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.718 -1.239 . . . . 1.0 109.662 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.55 32.29 18.71 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.77 1.628 . . . . 1.0 110.855 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.11 65.98 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 114.636 -1.166 . . . . 1.0 115.885 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -142.67 153.27 43.26 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 120.175 1.987 . . . . 1.0 109.284 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.81 161.61 29.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 115.78 1.77 . . . . 1.0 115.78 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.45 95.38 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 101.738 -3.43 . . . . 1.0 101.738 168.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.7 t -82.56 116.6 22.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.117 1.767 . . . . 1.0 110.107 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -99.2 110.08 56.78 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 126.228 1.811 . . . . 1.0 107.681 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.14 74.43 5.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.115 1.877 . . . . 1.0 112.249 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.0 t60 . . . . . 0 C--O 1.258 1.541 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 174.04 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.29 130.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 1 N-CA-C 98.039 -4.801 . . . . 1.0 98.039 172.191 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.72 -155.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.39 52.57 2.01 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.606 2.146 . . . . 1.0 109.311 170.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 115.81 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 171.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 137.65 36.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.916 0.887 . . . . 1.0 109.449 -169.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.92 159.19 42.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.842 1.793 . . . . 1.0 115.842 -167.682 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -103.63 -33.98 8.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.379 -1.737 . . . . 1.0 109.492 154.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -108.98 145.38 31.6 Favored Pre-proline 0 CA--C 1.512 -0.508 0 O-C-N 120.547 -1.346 . . . . 1.0 111.065 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.94 -28.38 50.17 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.403 2.069 . . . . 1.0 111.633 175.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -56.8 -35.99 69.4 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 124.103 0.961 . . . . 1.0 113.461 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.36 -23.33 66.73 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.866 1.266 . . . . 1.0 114.181 177.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -84.04 -23.89 30.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.493 1.117 . . . . 1.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 tp -70.15 -53.72 10.47 Favored Pre-proline 0 C--N 1.355 0.821 0 CA-C-O 116.841 -1.552 . . . . 1.0 114.853 -166.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.58 -35.38 81.61 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-O 113.366 -2.847 . . . . 1.0 115.113 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -69.79 -41.14 4.49 Favored 'Trans proline' 0 CA--C 1.508 -0.817 1 CA-C-N 128.532 4.083 . . . . 1.0 112.799 168.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.21 -50.08 73.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.655 1.693 . . . . 1.0 112.178 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -71.16 -8.51 54.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 115.139 1.533 . . . . 1.0 115.139 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.2 -64.27 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.198 1.952 . . . . 1.0 111.433 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -119.0 -28.81 5.43 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 111.989 -2.369 . . . . 1.0 111.574 -162.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -95.32 -26.95 15.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -166.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.39 171.14 42.5 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 115.884 -3.055 . . . . 1.0 117.605 171.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.87 -53.42 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 125.752 1.621 . . . . 1.0 113.039 -170.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -124.66 30.92 5.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 148.14 18.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.746 2.128 . . . . 1.0 116.746 -167.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.74 161.27 12.75 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 107.0 -2.44 . . . . 1.0 107.0 -172.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.77 121.17 3.6 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.967 -1.902 . . . . 1.0 108.047 -157.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -148.81 155.0 40.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.163 -1.421 . . . . 1.0 107.163 -168.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.2 t -97.4 139.93 32.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 121.249 -0.907 . . . . 1.0 111.23 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -155.52 138.48 15.42 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.29 -1.506 . . . . 1.0 109.583 169.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.5 28.82 13.44 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.161 1.385 . . . . 1.0 110.94 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.52 80.58 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 124.422 1.01 . . . . 1.0 115.186 -173.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -141.86 152.93 44.07 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 119.905 -1.938 . . . . 1.0 110.971 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -68.6 144.09 54.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.864 1.792 . . . . 1.0 114.815 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -140.82 91.83 2.45 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.245 -2.502 . . . . 1.0 104.245 -174.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.3 t -81.4 127.49 32.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.256 2.623 . . . . 1.0 112.106 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -103.04 101.77 23.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 126.574 1.95 . . . . 1.0 105.898 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -84.97 64.87 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.231 1.954 . . . . 1.0 112.382 -164.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 . . . . . 0 C--O 1.258 1.536 0 N-CA-C 107.316 -1.365 . . . . 1.0 107.316 171.269 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.51 2.549 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.8 t -158.71 144.54 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 1 N-CA-C 98.043 -4.799 . . . . 1.0 98.043 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.24 154.68 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 102.305 -3.22 . . . . 1.0 102.305 161.033 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.38 48.28 1.3 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 124.174 1.94 . . . . 1.0 110.871 177.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.35 129.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.606 -1.998 . . . . 1.0 105.606 171.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -97.06 142.77 28.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.2 152.25 35.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.499 2.037 . . . . 1.0 116.499 -172.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.4 m -100.39 -33.66 10.28 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.747 2.419 . . . . 1.0 109.135 159.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.2 t -120.26 146.6 43.01 Favored Pre-proline 0 CA--C 1.512 -0.483 0 O-C-N 120.951 -1.093 . . . . 1.0 110.295 -173.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.5 -24.47 78.13 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.951 1.767 . . . . 1.0 112.676 165.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.42 -28.71 69.99 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 122.002 0.906 . . . . 1.0 113.076 -176.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.75 -18.61 65.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.54 1.136 . . . . 1.0 114.059 177.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 68.0 m -85.3 -14.59 46.08 Favored 'General case' 0 N--CA 1.425 -1.718 0 O-C-N 120.799 -1.188 . . . . 1.0 113.538 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -49.38 75.28 Favored Pre-proline 0 C--N 1.351 0.655 0 O-C-N 120.603 -1.311 . . . . 1.0 114.444 -170.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.08 -39.35 50.19 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 CA-C-O 113.449 -2.813 . . . . 1.0 115.473 174.201 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.6 -36.92 10.3 Favored 'Trans proline' 0 CA--C 1.511 -0.667 1 CA-C-N 128.652 4.126 . . . . 1.0 113.096 172.195 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 m -59.52 -45.25 92.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.239 -1.538 . . . . 1.0 111.714 176.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -71.01 -13.4 61.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 171.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.9 -67.44 0.53 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 124.146 1.927 . . . . 1.0 112.287 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -105.36 -41.64 5.46 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 111.836 -2.438 . . . . 1.0 110.211 -163.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -87.32 -36.69 17.71 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -160.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.05 -177.24 46.65 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 115.934 -3.032 . . . . 1.0 117.922 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.9 -53.57 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 125.97 1.708 . . . . 1.0 113.394 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 16.12 15.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.718 2.407 . . . . 1.0 108.469 -174.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 148.8 10.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 116.946 2.202 . . . . 1.0 116.946 -172.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.71 -170.99 13.08 Favored Glycine 0 CA--C 1.475 -2.432 0 N-CA-C 108.486 -1.846 . . . . 1.0 108.486 -164.186 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.99 6.91 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 120.325 -1.691 . . . . 1.0 108.842 -175.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.31 0.0 OUTLIER -149.53 -177.86 6.1 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.694 143.52 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -115.13 135.78 53.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.896 1.678 . . . . 1.0 109.906 -176.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.09 151.43 21.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.306 -1.738 . . . . 1.0 106.306 168.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.346 0.5 OUTLIER 63.43 18.73 11.25 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.131 1.772 . . . . 1.0 113.439 -173.952 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.85 76.48 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.308 1.432 . . . . 1.0 114.729 -172.545 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -141.79 161.32 38.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.037 -1.861 . . . . 1.0 109.558 -177.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.1 t -69.75 163.83 24.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.952 2.204 . . . . 1.0 116.952 -168.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.88 90.26 1.82 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.212 -2.514 . . . . 1.0 104.212 167.626 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -78.17 140.17 38.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.266 2.226 . . . . 1.0 114.263 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -108.32 106.45 58.66 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 127.692 2.397 . . . . 1.0 107.156 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 76.64 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 122.619 2.213 . . . . 1.0 112.244 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.0 m170 . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -178.222 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 121.089 0.471 . . . . 1.0 110.989 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.2 t -142.18 133.93 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 1 N-CA-C 99.326 -4.324 . . . . 1.0 99.326 179.166 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.2 mt -103.55 -149.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 126.815 2.046 . . . . 1.0 106.368 175.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -132.13 43.71 2.99 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 125.15 2.405 . . . . 1.0 109.644 164.706 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.51 120.02 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 112.81 -1.995 . . . . 1.0 106.014 166.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -94.78 141.12 29.0 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 105.399 -2.074 . . . . 1.0 105.399 172.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -122.48 149.83 43.35 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 117.639 2.459 . . . . 1.0 117.639 -164.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -114.08 -5.93 13.1 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.417 -2.174 . . . . 1.0 110.415 169.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -168.28 155.76 7.61 Favored Pre-proline 0 CA--C 1.504 -0.8 0 N-CA-C 105.129 -2.174 . . . . 1.0 105.129 -174.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.91 -26.87 51.38 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 124.315 2.577 . . . . 1.0 111.457 163.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -64.66 -36.07 83.06 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 113.598 0.962 . . . . 1.0 113.598 -168.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -13.82 62.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 176.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.6 t -96.18 -4.49 42.46 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.932 -1.105 . . . . 1.0 111.781 173.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.13 -50.97 83.65 Favored Pre-proline 0 C--N 1.349 0.578 0 O-C-N 120.303 -1.498 . . . . 1.0 113.5 177.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 -37.66 59.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-O 113.278 -2.884 . . . . 1.0 115.74 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -68.34 -38.18 12.25 Favored 'Trans proline' 0 CA--C 1.506 -0.898 1 CA-C-N 128.604 4.109 . . . . 1.0 112.771 169.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 m -58.37 -47.11 84.86 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.137 1.446 . . . . 1.0 112.745 177.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -4.46 27.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 117.189 2.292 . . . . 1.0 117.189 172.017 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.45 11.44 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 123.433 1.587 . . . . 1.0 111.257 -178.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.1 -11.5 0.19 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 113.906 -1.497 . . . . 1.0 114.253 -175.567 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -79.57 -25.58 41.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.797 -1.814 . . . . 1.0 112.751 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.37 159.93 27.29 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 117.188 -2.434 . . . . 1.0 115.317 162.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.94 -33.8 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 120.378 -1.66 . . . . 1.0 112.442 -173.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -115.04 13.66 16.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.906 1.682 . . . . 1.0 110.675 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 162.58 6.98 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 118.233 2.679 . . . . 1.0 118.233 -163.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.81 -171.27 15.92 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 107.187 -2.365 . . . . 1.0 107.187 -176.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.14 154.63 36.24 Favored 'General case' 0 N--CA 1.424 -1.747 0 O-C-N 120.925 -1.338 . . . . 1.0 108.408 -175.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -111.81 146.31 37.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.911 -1.515 . . . . 1.0 106.911 162.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.4 t -94.02 121.26 35.32 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 160.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.6 ttt -149.84 127.38 11.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.717 1.246 . . . . 1.0 111.497 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.17 31.19 17.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 126.824 2.05 . . . . 1.0 110.331 -177.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.95 9.31 79.61 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 115.3 0.88 . . . . 1.0 115.3 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -135.45 143.78 46.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 119.674 -2.074 . . . . 1.0 108.385 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.3 143.38 52.06 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -176.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.48 82.26 2.05 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 102.476 -3.157 . . . . 1.0 102.476 -174.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -71.34 135.41 47.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.388 2.275 . . . . 1.0 114.545 -173.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -120.45 103.46 44.16 Favored Pre-proline 0 N--CA 1.444 -0.766 0 C-N-CA 125.335 1.454 . . . . 1.0 110.038 -165.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.15 61.7 7.82 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.284 1.989 . . . . 1.0 110.137 151.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.578 0 C-N-CA 126.318 1.847 . . . . 1.0 106.399 -164.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 112.832 0.678 . . . . 1.0 112.832 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t -161.55 144.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 1 N-CA-C 96.627 -5.323 . . . . 1.0 96.627 177.276 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.74 145.76 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 N-CA-C 102.933 -2.988 . . . . 1.0 102.933 172.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.267 13.1 t70 -91.52 45.56 1.24 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.642 2.163 . . . . 1.0 112.551 -173.306 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.53 107.0 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 164.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -87.99 144.48 26.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.319 1.057 . . . . 1.0 112.556 -164.055 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.92 142.6 51.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.467 2.395 . . . . 1.0 117.467 -162.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -115.97 1.47 13.31 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.056 2.542 . . . . 1.0 108.231 173.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -173.65 153.95 2.31 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 118.621 -2.549 . . . . 1.0 105.414 -174.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.66 -21.82 38.59 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 123.698 2.357 . . . . 1.0 112.653 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -55.78 -31.4 62.58 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.281 1.432 . . . . 1.0 113.699 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -62.73 -23.13 67.02 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 124.622 1.169 . . . . 1.0 113.784 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.2 t -82.83 -20.99 34.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.005 0.922 . . . . 1.0 112.059 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 tp -68.54 -51.8 21.69 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-O 116.984 -1.484 . . . . 1.0 114.31 -174.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.9 -29.74 58.0 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-O 113.099 -2.959 . . . . 1.0 115.618 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.14 -39.79 2.02 Favored 'Trans proline' 0 CA--C 1.503 -1.031 1 CA-C-N 129.374 4.384 . . . . 1.0 112.456 166.101 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 t -62.61 -59.05 5.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.263 1.506 . . . . 1.0 111.617 -178.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 22.04 0.06 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.763 1.625 . . . . 1.0 113.435 165.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.59 -76.76 0.1 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 118.328 -2.733 . . . . 1.0 107.859 158.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -117.68 -34.21 4.3 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 111.498 -2.592 . . . . 1.0 113.189 -159.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -76.85 -30.28 56.24 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 120.823 -1.173 . . . . 1.0 112.535 -166.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.42 156.42 9.9 Favored Glycine 0 CA--C 1.494 -1.262 0 C-N-CA 118.166 -1.969 . . . . 1.0 115.748 166.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -71.14 -25.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.135 1.374 . . . . 1.0 112.075 159.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -81.89 -21.97 37.11 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.398 2.679 . . . . 1.0 110.455 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.46 153.59 42.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 116.036 1.865 . . . . 1.0 116.036 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.79 170.91 16.09 Favored Glycine 0 CA--C 1.489 -1.578 0 N-CA-C 108.351 -1.899 . . . . 1.0 108.351 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.84 129.62 10.12 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 119.421 -2.223 . . . . 1.0 108.841 -159.005 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.1 12.35 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 120.271 -1.518 . . . . 1.0 111.999 174.07 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.59 132.27 44.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.568 1.547 . . . . 1.0 109.752 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.2 ttt -161.47 140.23 9.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.136 1.374 . . . . 1.0 110.213 173.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 59.54 34.91 22.58 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 124.489 2.09 . . . . 1.0 110.759 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.92 57.15 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 114.075 -1.421 . . . . 1.0 116.143 -176.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 176.92 8.27 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 120.199 1.999 . . . . 1.0 112.877 -177.508 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.01 145.69 49.84 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 124.763 2.22 . . . . 1.0 114.538 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -137.38 92.9 2.75 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 102.841 -3.022 . . . . 1.0 102.841 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 131.3 40.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.051 -1.431 . . . . 1.0 112.084 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -111.79 82.83 4.2 Favored Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 127.734 2.414 . . . . 1.0 109.254 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.92 70.59 5.2 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 CA-C-N 124.187 2.531 . . . . 1.0 109.049 154.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.286 1.7 m-70 . . . . . 0 N--CA 1.414 -2.271 0 N-CA-C 102.868 -3.012 . . . . 1.0 102.868 -171.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 121.176 0.512 . . . . 1.0 111.723 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.57 132.72 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 1 N-CA-C 99.891 -4.115 . . . . 1.0 99.891 176.281 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.58 156.24 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 102.244 -3.243 . . . . 1.0 102.244 170.075 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -94.59 54.01 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 124.156 1.931 . . . . 1.0 109.182 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.59 117.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -87.18 140.84 29.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.54 1.162 . . . . 1.0 109.235 -175.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.78 148.59 50.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 117.327 2.343 . . . . 1.0 117.327 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -114.59 1.13 14.17 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 124.925 2.298 . . . . 1.0 108.416 172.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -174.11 154.43 2.16 Favored Pre-proline 0 N--CA 1.444 -0.742 0 O-C-N 118.744 -2.473 . . . . 1.0 105.774 -174.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.71 -26.41 45.71 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 CA-C-N 123.221 2.186 . . . . 1.0 111.872 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -44.56 -46.7 10.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 128.644 2.778 . . . . 1.0 112.181 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -61.76 -28.42 69.43 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.629 1.572 . . . . 1.0 113.316 -174.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.9 t -94.28 -8.45 39.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.931 0.872 . . . . 1.0 112.412 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.93 -41.71 29.29 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 119.72 -1.863 . . . . 1.0 114.426 -178.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.13 -46.86 22.83 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-O 113.934 -2.611 . . . . 1.0 115.472 168.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.05 -36.03 23.49 Favored 'Trans proline' 0 CA--C 1.51 -0.697 0 CA-C-N 127.795 3.82 . . . . 1.0 112.507 174.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.3 m -63.54 -26.71 68.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 121.033 -1.042 . . . . 1.0 112.698 172.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -33.69 70.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 117.34 2.348 . . . . 1.0 117.34 162.279 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -66.97 0.56 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 124.687 2.184 . . . . 1.0 112.394 -169.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.8 -38.13 23.53 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 111.826 -2.443 . . . . 1.0 109.407 -172.262 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -112.78 -3.95 14.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.407 -1.27 . . . . 1.0 113.563 -164.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -178.58 37.49 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 124.34 2.078 . . . . 1.0 116.602 161.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -70.36 -33.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 O-C-N 119.465 -2.197 . . . . 1.0 114.108 -165.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -77.06 -33.86 57.17 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 120.913 -1.117 . . . . 1.0 110.439 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 137.51 58.09 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 116.548 2.055 . . . . 1.0 116.548 -161.215 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.67 174.4 25.69 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -175.101 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.83 131.43 8.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 120.556 -1.555 . . . . 1.0 108.901 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.1 168.96 21.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.713 -1.242 . . . . 1.0 109.87 174.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.22 129.73 55.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.617 0.767 . . . . 1.0 112.306 -168.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 125.06 43.43 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 126.904 2.082 . . . . 1.0 111.371 166.339 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.53 25.88 15.4 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 123.405 1.574 . . . . 1.0 112.128 170.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.21 77.42 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.624 -1.171 . . . . 1.0 115.682 -175.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -136.52 155.25 50.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 120.358 2.079 . . . . 1.0 108.946 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -70.55 160.63 32.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 118.557 2.799 . . . . 1.0 118.557 -175.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -148.24 99.75 3.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 104.144 -2.539 . . . . 1.0 104.144 165.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.6 t -80.78 130.79 35.26 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.515 2.726 . . . . 1.0 111.53 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -98.98 138.94 20.7 Favored Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 119.479 -2.013 . . . . 1.0 107.64 -178.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -87.08 33.82 0.43 Allowed 'Trans proline' 0 CA--C 1.507 -0.834 0 CA-C-N 123.96 2.45 . . . . 1.0 111.802 171.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 N--CA 1.417 -2.1 0 C-N-CA 129.02 2.928 . . . . 1.0 107.291 -179.166 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.433 -1.321 1 N-CA-C 99.098 -4.408 . . . . 1.0 99.098 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.31 159.95 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 N-CA-C 102.403 -3.184 . . . . 1.0 102.403 169.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.27 49.16 1.58 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 124.651 2.167 . . . . 1.0 110.622 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.14 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 104.648 -2.352 . . . . 1.0 104.648 167.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.72 137.07 32.66 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.06 148.38 52.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 118.798 2.888 . . . . 1.0 118.798 -165.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -101.69 -14.45 17.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 113.283 -1.78 . . . . 1.0 110.902 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -169.95 167.33 5.03 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 -169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 30.0 Cg_endo -64.38 -24.19 64.68 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.75 2.375 . . . . 1.0 114.258 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -47.58 -53.32 14.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 127.351 2.26 . . . . 1.0 112.349 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -70.73 -12.58 61.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.481 1.512 . . . . 1.0 114.547 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 33.9 t -100.68 -9.48 21.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.204 -0.935 . . . . 1.0 112.555 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -67.3 -45.11 49.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 119.94 -1.725 . . . . 1.0 114.148 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.97 -41.33 62.86 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 CA-C-O 114.106 -2.539 . . . . 1.0 115.902 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -68.84 -34.58 17.72 Favored 'Trans proline' 0 CA--C 1.505 -0.926 0 CA-C-N 127.283 3.637 . . . . 1.0 112.758 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -59.38 -51.47 69.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.575 -1.328 . . . . 1.0 112.01 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.272 0.0 OUTLIER -71.7 -2.32 16.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 115.444 1.646 . . . . 1.0 115.444 170.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -69.89 0.36 Allowed 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 118.934 -2.354 . . . . 1.0 111.173 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.63 -29.34 6.49 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 111.627 -2.533 . . . . 1.0 111.965 -160.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -88.48 -32.46 18.24 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.12 1.156 . . . . 1.0 114.12 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.88 178.16 47.43 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 117.958 -2.068 . . . . 1.0 115.811 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.88 -46.72 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 126.215 1.806 . . . . 1.0 113.896 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 35.6 ttp180 -122.25 20.57 10.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.511 -1.663 . . . . 1.0 106.511 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.44 143.47 40.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 115.994 1.85 . . . . 1.0 115.994 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.36 172.76 15.08 Favored Glycine 0 CA--C 1.478 -2.264 0 N-CA-C 108.574 -1.81 . . . . 1.0 108.574 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -152.13 138.71 18.69 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -143.78 169.56 17.54 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 117.945 -1.502 . . . . 1.0 109.843 164.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.4 t -106.41 147.68 28.99 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.183 0.993 . . . . 1.0 109.956 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -160.15 148.2 16.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 105.827 -1.916 . . . . 1.0 105.827 159.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.312 0.9 OUTLIER 58.54 27.03 15.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.795 1.638 . . . . 1.0 113.435 177.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.36 14.62 77.06 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.134 -1.394 . . . . 1.0 115.936 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -144.85 153.98 42.16 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 119.695 -2.062 . . . . 1.0 109.123 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.1 t -70.55 157.63 37.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 116.552 2.056 . . . . 1.0 116.552 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 94.06 2.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.175 -3.639 . . . . 1.0 101.175 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.03 137.8 32.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.436 2.294 . . . . 1.0 112.313 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -108.11 98.28 25.67 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 125.5 1.52 . . . . 1.0 108.251 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--N 1.326 -0.619 0 C-N-CA 122.14 1.893 . . . . 1.0 112.441 -176.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 100.38 -3.933 . . . . 1.0 100.38 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.01 154.83 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 101.486 -3.524 . . . . 1.0 101.486 166.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 45.87 1.21 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.718 2.199 . . . . 1.0 111.16 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.2 t -84.12 113.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 103.766 -2.679 . . . . 1.0 103.766 163.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -93.06 143.02 26.65 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.165 0.983 . . . . 1.0 110.853 -169.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -141.04 158.31 44.11 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 117.57 2.433 . . . . 1.0 117.57 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.1 p -111.65 -16.8 13.16 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 112.939 -1.937 . . . . 1.0 110.799 161.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -135.72 151.23 73.87 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 125.033 1.333 . . . . 1.0 109.516 -171.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.99 -21.32 63.82 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 122.604 1.966 . . . . 1.0 112.289 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -57.51 -49.55 75.96 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 122.188 0.994 . . . . 1.0 112.79 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -70.18 -10.73 59.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.976 1.31 . . . . 1.0 114.323 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.72 -26.05 24.43 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.63 -1.294 . . . . 1.0 108.929 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.62 -49.64 60.14 Favored Pre-proline 0 C--N 1.352 0.682 0 CA-C-O 116.561 -1.685 . . . . 1.0 115.177 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.31 -40.01 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 CA-C-N 125.001 2.822 . . . . 1.0 115.391 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.54 -35.88 16.31 Favored 'Trans proline' 0 CA--C 1.502 -1.114 1 CA-C-N 128.491 4.068 . . . . 1.0 112.244 169.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -58.05 -43.21 86.76 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.822 1.296 . . . . 1.0 112.617 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -70.61 -11.56 61.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -67.34 0.53 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.967 2.318 . . . . 1.0 112.443 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.19 -27.83 8.54 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.36 -2.654 . . . . 1.0 111.649 -161.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.07 -20.3 18.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.65 149.75 5.11 Favored Glycine 0 CA--C 1.494 -1.271 0 O-C-N 120.53 -1.356 . . . . 1.0 114.457 160.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.08 -37.21 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 119.962 -1.904 . . . . 1.0 112.057 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -81.88 -24.02 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.737 -1.852 . . . . 1.0 111.578 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.7 161.76 1.02 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 117.868 2.544 . . . . 1.0 117.868 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.45 167.5 12.49 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 109.318 -1.513 . . . . 1.0 109.318 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.19 134.03 16.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.045 -1.268 . . . . 1.0 108.51 -167.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 156.77 41.44 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 120.913 -1.117 . . . . 1.0 110.427 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.4 t -98.98 129.17 45.26 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 161.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -158.63 134.5 8.97 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 121.137 -0.977 . . . . 1.0 110.558 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 56.54 40.76 29.32 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.741 2.016 . . . . 1.0 110.354 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.77 15.04 57.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 113.809 -1.542 . . . . 1.0 115.704 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.52 157.92 45.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 119.885 -1.95 . . . . 1.0 109.214 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.1 t -65.66 153.59 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 123.358 1.552 . . . . 1.0 113.056 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.68 78.22 1.19 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 123.03 1.395 . . . . 1.0 108.45 -166.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.63 138.29 44.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.957 1.836 . . . . 1.0 115.957 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -105.79 95.13 9.97 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 105.828 -1.916 . . . . 1.0 105.828 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.464 -0.263 0 C-N-CA 122.963 2.442 . . . . 1.0 112.282 -172.08 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 N--CA 1.435 -1.219 1 N-CA-C 99.979 -4.082 . . . . 1.0 99.979 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.06 159.6 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 C-N-CA 129.495 3.118 . . . . 1.0 102.736 170.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.14 46.46 1.35 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 124.428 2.061 . . . . 1.0 110.919 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.17 128.66 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.69 135.83 53.72 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.72 0.772 . . . . 1.0 109.285 -163.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.09 161.77 41.72 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 115.848 1.796 . . . . 1.0 115.848 -164.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -107.17 -26.11 11.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 113.693 -1.594 . . . . 1.0 109.852 157.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -119.21 146.33 40.41 Favored Pre-proline 0 CA--C 1.512 -0.511 0 O-C-N 120.603 -1.311 . . . . 1.0 111.466 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.06 -19.49 63.44 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 122.032 1.821 . . . . 1.0 112.687 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.72 -41.23 85.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 121.423 -0.798 . . . . 1.0 112.742 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.32 -22.14 64.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.135 1.774 . . . . 1.0 113.879 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 1.6 m -91.61 -16.05 27.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.07 0.948 . . . . 1.0 111.899 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 tp -66.87 -51.59 37.34 Favored Pre-proline 0 C--N 1.35 0.607 0 CA-C-O 117.176 -1.393 . . . . 1.0 114.014 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.39 -36.98 52.33 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-O 113.1 -2.959 . . . . 1.0 115.623 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.62 -42.48 2.48 Favored 'Trans proline' 0 CA--C 1.502 -1.109 1 CA-C-N 129.232 4.333 . . . . 1.0 113.176 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.23 -48.42 81.7 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.783 -1.198 . . . . 1.0 110.956 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -70.84 -9.8 58.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 116.61 2.078 . . . . 1.0 116.61 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.76 -74.65 0.16 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 124.792 2.234 . . . . 1.0 112.353 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.5 -35.22 68.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 111.518 -2.583 . . . . 1.0 110.052 -164.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -107.82 -8.92 15.87 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.896 -1.502 . . . . 1.0 110.544 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 -161.9 26.83 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 124.539 2.188 . . . . 1.0 117.262 156.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -68.67 -28.24 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 119.715 -2.05 . . . . 1.0 112.591 -167.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -78.48 -30.59 47.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 120.631 -1.293 . . . . 1.0 110.72 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.49 43.65 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 117.447 2.388 . . . . 1.0 117.447 -164.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.18 179.23 16.49 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -154.93 127.7 8.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 120.547 -1.561 . . . . 1.0 111.203 -157.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.78 161.59 27.02 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 121.076 -1.015 . . . . 1.0 108.582 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.8 t -108.49 135.38 49.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.57 -1.195 . . . . 1.0 108.089 161.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -156.41 138.43 14.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.289 -0.882 . . . . 1.0 109.563 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.32 19.27 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.282 1.833 . . . . 1.0 110.447 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.96 8.56 69.17 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 124.557 1.075 . . . . 1.0 115.604 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -140.97 164.89 29.04 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 119.974 -1.898 . . . . 1.0 109.138 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -69.84 161.14 30.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 117.041 2.238 . . . . 1.0 117.041 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -150.82 82.25 1.34 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.1 m -75.09 129.13 37.05 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.629 -1.295 . . . . 1.0 114.138 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.84 150.68 36.92 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.788 1.235 . . . . 1.0 108.383 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 C--N 1.328 -0.502 0 CA-C-N 123.22 2.186 . . . . 1.0 111.85 162.606 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.438 -1.035 0 N-CA-C 101.767 -3.419 . . . . 1.0 101.767 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER -100.86 -143.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 126.855 2.062 . . . . 1.0 108.043 177.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 3' ' ' ILE . 16.7 t70 -139.29 48.19 1.87 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 124.782 2.229 . . . . 1.0 110.15 163.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.78 118.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 113.251 -1.795 . . . . 1.0 106.31 163.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -95.77 141.99 28.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.088 -1.449 . . . . 1.0 107.088 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.65 165.37 35.65 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -164.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -105.62 -32.8 8.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 123.421 1.581 . . . . 1.0 109.896 151.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -102.94 153.83 37.98 Favored Pre-proline 0 N--CA 1.452 -0.345 0 O-C-N 120.512 -1.368 . . . . 1.0 111.891 -166.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.73 -31.8 68.73 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 121.784 1.656 . . . . 1.0 112.812 159.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -62.42 -37.58 86.36 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.924 0.784 . . . . 1.0 112.981 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -57.22 -27.87 62.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.945 1.698 . . . . 1.0 113.922 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 t -96.41 -13.83 22.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.301 -0.874 . . . . 1.0 112.245 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.47 -46.87 69.64 Favored Pre-proline 0 C--N 1.345 0.401 0 CA-C-O 116.807 -1.568 . . . . 1.0 113.936 -164.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.15 -48.78 14.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-N 124.121 2.507 . . . . 1.0 115.895 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.85 -37.96 10.75 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 127.254 3.627 . . . . 1.0 112.648 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -59.48 -37.29 77.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 120.514 -1.367 . . . . 1.0 112.183 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -26.43 63.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.413 1.634 . . . . 1.0 115.413 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.89 -67.3 0.54 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 124.811 2.243 . . . . 1.0 113.14 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -84.86 -37.42 20.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.417 -2.629 . . . . 1.0 109.485 -166.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.61 -12.28 13.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.447 1.647 . . . . 1.0 115.447 -160.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.66 149.28 5.04 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 120.593 -1.317 . . . . 1.0 114.631 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.36 -40.5 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 O-C-N 119.845 -1.973 . . . . 1.0 112.837 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -84.14 -22.4 31.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.713 -1.867 . . . . 1.0 110.881 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.8 159.22 0.57 Allowed 'General case' 0 C--N 1.351 0.644 0 N-CA-C 117.788 2.514 . . . . 1.0 117.788 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.03 164.64 12.07 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.54 133.37 20.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.23 -1.767 . . . . 1.0 106.23 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -148.06 154.36 40.13 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.59 144.25 28.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.259 -1.525 . . . . 1.0 112.134 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -163.13 144.11 9.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.628 -1.295 . . . . 1.0 110.917 170.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.48 37.06 19.98 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.308 1.443 . . . . 1.0 110.419 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.01 -8.96 48.67 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.598 -1.183 . . . . 1.0 115.891 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -146.95 168.99 20.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.855 2.327 . . . . 1.0 111.63 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.47 162.51 17.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.336 1.976 . . . . 1.0 116.336 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -146.12 89.8 1.91 Allowed 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 130.113 3.365 . . . . 1.0 102.778 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.7 m -77.89 132.85 38.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.153 1.781 . . . . 1.0 112.195 173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -108.56 97.16 21.89 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.456 -0.724 0 C-N-CA 122.996 2.464 . . . . 1.0 111.338 -175.161 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.0 t . . . . . 0 N--CA 1.431 -1.411 1 N-CA-C 98.763 -4.532 . . . . 1.0 98.763 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.45 160.64 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 102.703 -3.073 . . . . 1.0 102.703 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 42.46 1.1 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 124.959 2.314 . . . . 1.0 110.831 172.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.2 t -87.11 115.1 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -101.94 139.92 36.93 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 122.182 0.991 . . . . 1.0 108.479 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 153.86 40.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 116.652 2.093 . . . . 1.0 116.652 -160.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -111.14 0.83 16.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 127.017 2.127 . . . . 1.0 110.449 172.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 m -171.18 153.68 3.8 Favored Pre-proline 0 CA--C 1.51 -0.594 0 O-C-N 120.714 -1.241 . . . . 1.0 108.782 -171.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.78 -32.08 47.25 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.009 2.472 . . . . 1.0 111.919 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -46.68 -45.76 19.6 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.403 2.281 . . . . 1.0 112.947 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -67.39 -17.59 64.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.761 1.224 . . . . 1.0 114.013 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.7 t -101.55 -7.32 22.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.405 -0.81 . . . . 1.0 112.698 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.93 -46.43 64.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 120.032 -1.667 . . . . 1.0 113.524 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.17 -45.7 29.88 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 CA-C-O 114.019 -2.576 . . . . 1.0 115.814 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.51 -35.86 21.71 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 CA-C-N 127.408 3.681 . . . . 1.0 112.722 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 m -56.93 -46.39 82.09 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.955 1.36 . . . . 1.0 112.119 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -9.84 58.77 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.315 2.339 . . . . 1.0 117.315 172.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -65.84 0.7 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 124.287 1.994 . . . . 1.0 110.58 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -114.8 -33.84 5.34 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 112.316 -2.22 . . . . 1.0 111.377 -169.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -94.08 -18.05 22.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.796 1.406 . . . . 1.0 114.796 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.76 168.09 41.05 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 116.662 -2.685 . . . . 1.0 116.234 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 tt -70.19 -50.07 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.339 1.456 . . . . 1.0 111.191 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 ttp-105 -127.8 32.23 4.99 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.57 152.18 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 119.219 3.044 . . . . 1.0 119.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.47 12.34 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 108.713 -1.755 . . . . 1.0 108.713 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.19 130.74 9.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.294 -1.373 . . . . 1.0 107.294 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 166.69 26.69 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 120.455 -1.403 . . . . 1.0 109.361 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 t -120.78 135.99 55.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.242 0.617 . . . . 1.0 110.897 -164.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.23 145.67 19.51 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.39 1.076 . . . . 1.0 108.272 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.63 32.08 20.29 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 126.307 1.843 . . . . 1.0 110.419 -173.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.67 19.46 62.81 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 124.855 1.217 . . . . 1.0 115.468 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.53 151.87 37.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.662 -2.081 . . . . 1.0 108.876 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -69.17 162.7 26.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.069 2.248 . . . . 1.0 117.069 -169.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.74 95.7 2.55 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.324 -3.213 . . . . 1.0 102.324 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.34 132.68 33.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.557 2.343 . . . . 1.0 112.426 -174.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -102.67 111.57 64.9 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo . . . . . 0 N--CA 1.458 -0.595 0 C-N-CA 122.382 2.054 . . . . 1.0 112.389 -167.352 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 102.019 -3.326 . . . . 1.0 102.019 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.64 154.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 101.472 -3.529 . . . . 1.0 101.472 160.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.64 41.9 1.06 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 124.369 2.033 . . . . 1.0 112.191 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.54 115.26 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.574 -2.38 . . . . 1.0 104.574 167.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -103.09 137.02 41.82 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -163.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 p -140.5 150.81 44.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 118.159 2.651 . . . . 1.0 118.159 -163.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 p -115.15 9.46 15.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 128.002 2.521 . . . . 1.0 109.639 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -167.49 150.31 5.72 Favored Pre-proline 0 CA--C 1.511 -0.534 0 O-C-N 119.608 -1.933 . . . . 1.0 108.536 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.65 -24.58 35.16 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.509 2.139 . . . . 1.0 111.93 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -48.86 -44.46 39.79 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.521 1.929 . . . . 1.0 112.84 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -65.86 -18.3 65.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.026 1.331 . . . . 1.0 113.553 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 40.1 t -83.64 -25.19 30.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.265 1.026 . . . . 1.0 111.344 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.06 -52.48 30.66 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 117.16 -1.4 . . . . 1.0 114.331 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.58 -38.79 39.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-O 113.127 -2.947 . . . . 1.0 115.433 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.94 -37.26 8.97 Favored 'Trans proline' 0 CA--C 1.502 -1.103 1 CA-C-N 129.365 4.38 . . . . 1.0 112.265 172.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.07 -44.3 82.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.379 1.085 . . . . 1.0 111.793 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -70.72 -17.73 62.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.461 2.023 . . . . 1.0 116.461 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -68.25 0.48 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 124.899 2.285 . . . . 1.0 113.005 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -102.08 -38.57 7.67 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.05 -2.796 . . . . 1.0 110.142 -161.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.06 -45.11 7.37 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.564 -166.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.94 142.87 4.41 Favored Glycine 0 CA--C 1.491 -1.426 0 C-N-CA 118.556 -1.783 . . . . 1.0 114.795 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.11 -38.03 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 120.082 -1.834 . . . . 1.0 112.393 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -81.49 -23.62 37.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.307 -1.496 . . . . 1.0 111.663 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.76 156.38 0.2 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 118.624 2.824 . . . . 1.0 118.624 -167.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.85 162.4 14.72 Favored Glycine 0 CA--C 1.475 -2.418 0 N-CA-C 107.854 -2.098 . . . . 1.0 107.854 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.66 6.05 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 119.911 -1.935 . . . . 1.0 107.56 -163.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.14 21.45 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.76 -1.576 . . . . 1.0 110.792 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.0 t -94.81 133.8 38.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.1 ttt -153.61 133.74 13.32 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 121.025 -1.047 . . . . 1.0 109.598 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.367 1.0 OUTLIER 53.48 32.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 128.473 2.709 . . . . 1.0 112.863 -172.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.74 10.02 86.56 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 113.712 -1.585 . . . . 1.0 115.403 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -136.85 157.31 47.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 120.298 2.049 . . . . 1.0 109.708 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.7 t -70.65 141.62 51.65 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 123.926 1.822 . . . . 1.0 113.819 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.72 84.25 2.09 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 102.125 -3.287 . . . . 1.0 102.125 -171.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.19 132.78 37.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.531 1.533 . . . . 1.0 110.551 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.98 95.05 19.31 Favored Pre-proline 0 N--CA 1.434 -1.238 0 C-N-CA 126.119 1.768 . . . . 1.0 106.248 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 N--CA 1.46 -0.461 0 C-N-CA 122.77 2.313 . . . . 1.0 112.389 -175.66 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 0 N--CA 1.431 -1.403 1 N-CA-C 97.697 -4.927 . . . . 1.0 97.697 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.84 156.27 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 101.547 -3.501 . . . . 1.0 101.547 176.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.71 51.31 1.55 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 125.08 2.372 . . . . 1.0 110.718 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -90.29 102.79 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 162.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER -74.36 136.12 42.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 123.765 1.745 . . . . 1.0 112.606 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.49 154.15 18.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.144 1.926 . . . . 1.0 114.165 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 3.18 5.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.6 1.96 . . . . 1.0 107.862 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -177.14 157.02 1.28 Allowed Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 104.032 -2.581 . . . . 1.0 104.032 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.4 -23.18 28.17 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 CA-C-N 123.277 2.206 . . . . 1.0 111.999 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -57.67 -42.15 82.96 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 122.082 0.944 . . . . 1.0 113.057 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -70.58 -7.41 43.79 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 114.973 1.472 . . . . 1.0 114.973 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -82.44 -25.71 33.38 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.95 -1.094 . . . . 1.0 110.297 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.86 -48.23 62.77 Favored Pre-proline 0 C--N 1.354 0.777 0 O-C-N 119.628 -1.92 . . . . 1.0 114.446 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.76 -37.5 55.62 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 CA-C-O 113.216 -2.91 . . . . 1.0 115.237 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -37.06 17.66 Favored 'Trans proline' 0 CA--C 1.503 -1.043 1 CA-C-N 129.054 4.269 . . . . 1.0 112.48 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.92 -39.17 77.35 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.81 -1.181 . . . . 1.0 112.335 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -13.34 62.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 116.917 2.192 . . . . 1.0 116.917 174.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.96 72.31 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 123.158 1.456 . . . . 1.0 113.558 -170.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -164.08 -27.79 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.074 -1.421 . . . . 1.0 111.719 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.79 -17.74 52.67 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 120.228 -1.545 . . . . 1.0 113.004 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 154.35 7.29 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 121.058 -1.026 . . . . 1.0 112.861 154.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.21 -43.17 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 O-C-N 119.914 -1.933 . . . . 1.0 112.554 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -75.91 -28.31 57.99 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.664 -1.897 . . . . 1.0 111.134 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.4 151.46 0.37 Allowed 'General case' 0 C--N 1.35 0.589 0 N-CA-C 118.811 2.893 . . . . 1.0 118.811 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.69 175.62 21.74 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.16 131.95 11.55 Favored 'General case' 0 N--CA 1.434 -1.255 0 O-C-N 121.33 -1.1 . . . . 1.0 110.06 -166.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 154.24 45.72 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.902 -1.123 . . . . 1.0 111.308 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.31 117.04 34.18 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 164.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -147.32 136.36 22.31 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.519 -1.363 . . . . 1.0 110.296 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.417 0.9 OUTLIER 53.23 30.4 9.92 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 128.106 2.562 . . . . 1.0 112.955 -170.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.45 6.28 89.0 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 113.744 -1.571 . . . . 1.0 115.647 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.58 152.4 51.89 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.855 1.827 . . . . 1.0 108.995 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.72 143.09 51.41 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 116.333 1.975 . . . . 1.0 116.333 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -137.98 81.59 1.87 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.34 2.256 . . . . 1.0 107.365 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.6 m -70.11 132.1 45.31 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.206 1.558 . . . . 1.0 115.206 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -96.63 101.08 8.23 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 CA-C-N 122.719 2.007 . . . . 1.0 111.745 -173.602 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 100.773 -3.788 . . . . 1.0 100.773 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.81 -149.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 126.279 1.832 . . . . 1.0 106.822 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -142.38 37.37 1.52 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 124.896 2.284 . . . . 1.0 110.389 167.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.14 119.03 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 112.241 -2.254 . . . . 1.0 106.622 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -102.23 143.16 32.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.828 0.823 . . . . 1.0 109.13 -170.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.5 149.67 41.19 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 117.574 2.435 . . . . 1.0 117.574 -162.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -110.44 3.31 19.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 127.642 2.377 . . . . 1.0 109.73 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -177.55 146.35 0.61 Allowed Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 105.723 -1.954 . . . . 1.0 105.723 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.03 -26.85 57.99 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 123.871 2.418 . . . . 1.0 112.846 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -54.74 -30.84 57.36 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.789 1.636 . . . . 1.0 113.802 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -62.32 -26.38 68.4 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.052 -1.03 . . . . 1.0 113.439 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -100.13 -1.15 37.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.302 -0.874 . . . . 1.0 112.567 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.52 -49.39 83.58 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 120.295 -1.503 . . . . 1.0 113.695 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.28 -34.13 56.91 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-O 113.15 -2.938 . . . . 1.0 115.477 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.38 -36.41 9.2 Favored 'Trans proline' 0 CA--C 1.507 -0.874 1 CA-C-N 129.094 4.284 . . . . 1.0 112.91 169.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.6 -52.37 65.93 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.542 -1.349 . . . . 1.0 111.558 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -71.76 -1.98 15.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.235 1.569 . . . . 1.0 115.235 171.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.67 -69.32 0.39 Allowed 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 118.981 -2.325 . . . . 1.0 111.003 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -115.41 -29.89 6.4 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 111.547 -2.569 . . . . 1.0 112.056 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -92.74 -23.38 18.92 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 115.063 1.505 . . . . 1.0 115.063 -167.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.33 47.91 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 119.842 -1.787 . . . . 1.0 115.231 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.53 -45.44 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.224 1.81 . . . . 1.0 114.136 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -120.61 13.61 11.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.736 1.614 . . . . 1.0 107.034 -176.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 145.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.143 1.905 . . . . 1.0 116.143 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.57 178.17 22.64 Favored Glycine 0 CA--C 1.479 -2.158 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -163.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.42 141.89 31.02 Favored 'General case' 0 N--CA 1.423 -1.817 0 O-C-N 120.569 -1.548 . . . . 1.0 110.116 -163.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -111.85 139.91 46.94 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.5 t -101.14 130.76 47.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.4 ttt -150.06 137.82 20.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 120.751 -1.218 . . . . 1.0 109.59 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.44 27.26 16.22 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.558 1.543 . . . . 1.0 111.23 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.05 86.5 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 114.774 -1.103 . . . . 1.0 115.652 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.36 151.54 43.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.681 2.24 . . . . 1.0 110.536 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.4 t -70.32 153.75 42.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 118.025 2.602 . . . . 1.0 118.025 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -144.6 92.06 2.25 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 127.394 2.278 . . . . 1.0 105.016 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -77.96 137.35 38.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 128.55 2.74 . . . . 1.0 114.782 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -100.2 102.1 16.94 Favored Pre-proline 0 N--CA 1.441 -0.888 0 C-N-CA 126.595 1.958 . . . . 1.0 106.324 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo . . . . . 0 N--CA 1.448 -1.158 0 CA-C-N 121.978 1.742 . . . . 1.0 111.859 -173.102 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.9 t . . . . . 0 N--CA 1.43 -1.461 1 N-CA-C 98.671 -4.566 . . . . 1.0 98.671 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 155.9 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 101.377 -3.564 . . . . 1.0 101.377 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.61 47.36 1.23 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 124.353 2.025 . . . . 1.0 110.946 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.96 122.88 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -93.8 144.24 25.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.137 0.97 . . . . 1.0 110.81 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.47 155.66 42.12 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.729 1.728 . . . . 1.0 115.395 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -110.71 -24.92 10.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.849 156.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -118.06 146.99 40.44 Favored Pre-proline 0 CA--C 1.512 -0.498 0 O-C-N 120.178 -1.576 . . . . 1.0 110.296 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.14 -17.0 57.67 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 C-N-CA 122.219 1.946 . . . . 1.0 112.049 166.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -59.41 -42.4 91.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.626 -1.296 . . . . 1.0 112.504 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.45 -16.78 63.03 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.04 1.736 . . . . 1.0 113.986 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.638 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -83.34 -28.25 29.13 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 121.114 -0.991 . . . . 1.0 111.063 176.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.3 -53.61 10.22 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 114.471 1.286 . . . . 1.0 114.471 -160.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -57.35 -46.11 30.13 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 CA-C-O 114.344 -2.44 . . . . 1.0 115.406 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -67.11 -37.48 18.61 Favored 'Trans proline' 0 CA--C 1.504 -1.017 0 CA-C-N 127.007 3.538 . . . . 1.0 112.398 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 t -64.41 -37.36 87.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 120.323 -1.485 . . . . 1.0 112.771 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -70.73 -11.63 61.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 116.827 2.158 . . . . 1.0 116.827 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.82 71.59 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 123.148 1.451 . . . . 1.0 113.416 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -164.4 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.911 -1.495 . . . . 1.0 111.378 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -78.5 -14.92 59.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.176 -1.578 . . . . 1.0 113.291 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.11 154.79 7.2 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 122.336 0.965 . . . . 1.0 113.108 149.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -70.19 -41.88 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 O-C-N 120.742 -1.446 . . . . 1.0 112.603 -174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -91.02 -18.56 24.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.961 -1.087 . . . . 1.0 110.978 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.78 144.35 1.76 Allowed 'General case' 0 C--N 1.352 0.703 0 N-CA-C 117.612 2.449 . . . . 1.0 117.612 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.35 25.9 Favored Glycine 0 CA--C 1.475 -2.407 0 N-CA-C 107.47 -2.252 . . . . 1.0 107.47 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -159.95 125.2 4.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.225 -1.162 . . . . 1.0 109.595 -168.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 169.65 22.04 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.723 -1.235 . . . . 1.0 109.65 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.8 t -100.2 139.29 36.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.609 -0.682 . . . . 1.0 112.443 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.8 ttt -162.94 148.4 11.91 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.343 1.057 . . . . 1.0 108.565 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 63.2 28.78 15.97 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 123.226 1.489 . . . . 1.0 110.208 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.16 12.38 57.73 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.602 1.096 . . . . 1.0 115.53 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.3 165.19 32.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 120.023 1.911 . . . . 1.0 110.536 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -69.52 153.96 42.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.144 1.535 . . . . 1.0 115.144 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 85.4 1.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.582 -2.747 . . . . 1.0 103.582 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.56 127.42 32.78 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.262 1.825 . . . . 1.0 112.681 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.56 102.41 14.57 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 105.729 -1.952 . . . . 1.0 105.729 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo . . . . . 0 N--CA 1.456 -0.71 0 C-N-CA 122.216 1.944 . . . . 1.0 112.141 -166.469 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.44 -0.944 1 N-CA-C 100.15 -4.019 . . . . 1.0 100.15 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 152.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 N-CA-C 100.824 -3.769 . . . . 1.0 100.824 154.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -99.23 50.11 0.95 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 124.268 1.985 . . . . 1.0 111.382 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.73 117.28 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 105.012 -2.218 . . . . 1.0 105.012 163.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.74 143.77 26.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.584 0.707 . . . . 1.0 111.291 -167.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.98 153.57 40.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 116.36 1.985 . . . . 1.0 116.36 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -94.0 -41.69 9.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 112.146 -2.297 . . . . 1.0 109.027 156.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -108.94 148.4 37.82 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.451 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.73 -23.92 74.61 Favored 'Trans proline' 0 CA--C 1.51 -0.704 0 C-N-CA 121.775 1.65 . . . . 1.0 112.656 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.95 -33.96 76.91 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 121.064 -1.023 . . . . 1.0 113.223 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -64.36 -15.32 60.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.549 1.14 . . . . 1.0 113.848 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -89.14 -21.68 23.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.841 -1.162 . . . . 1.0 111.477 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.95 -52.85 46.64 Favored Pre-proline 0 N--CA 1.439 -0.996 0 O-C-N 120.441 -1.412 . . . . 1.0 113.804 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.23 -36.59 45.63 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-O 112.877 -3.051 . . . . 1.0 115.263 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -69.86 -39.7 6.0 Favored 'Trans proline' 0 CA--C 1.504 -0.979 1 CA-C-N 129.456 4.413 . . . . 1.0 112.426 170.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.2 -49.73 75.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 123.71 1.719 . . . . 1.0 111.861 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -71.54 -8.78 56.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 115.905 1.817 . . . . 1.0 115.905 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -68.46 0.45 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 124.237 1.97 . . . . 1.0 110.986 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -106.83 -44.73 4.36 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 111.997 -2.365 . . . . 1.0 110.594 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -87.84 -24.89 23.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.427 0.899 . . . . 1.0 113.427 -154.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.0 167.22 39.99 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 115.297 -3.335 . . . . 1.0 118.314 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.21 -61.0 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 C-N-CA 124.772 1.229 . . . . 1.0 112.3 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -105.18 10.44 33.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.465 1.106 . . . . 1.0 109.659 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 146.2 39.25 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -168.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.86 167.25 19.62 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 107.754 -2.139 . . . . 1.0 107.754 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.18 127.02 4.96 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.963 -1.904 . . . . 1.0 109.674 -162.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 173.41 14.56 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 120.615 -1.303 . . . . 1.0 111.351 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -101.46 139.89 36.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.679 0.792 . . . . 1.0 110.112 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.5 ttt -164.68 145.9 7.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.249 1.42 . . . . 1.0 108.629 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 62.84 28.15 16.3 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 123.161 1.458 . . . . 1.0 110.368 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.72 62.25 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 124.246 0.927 . . . . 1.0 115.252 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.93 162.88 39.48 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 120.228 -1.748 . . . . 1.0 110.916 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 t -64.58 152.36 42.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.918 1.818 . . . . 1.0 115.023 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -142.89 85.88 1.9 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 104.357 -2.46 . . . . 1.0 104.357 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.91 128.28 33.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.075 0.95 . . . . 1.0 111.568 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -110.96 95.72 25.84 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.206 1.802 . . . . 1.0 109.125 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 C--N 1.33 -0.423 0 C-N-CA 122.776 2.318 . . . . 1.0 111.597 167.139 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 N--CA 1.431 -1.406 1 N-CA-C 99.17 -4.382 . . . . 1.0 99.17 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.07 153.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 N-CA-C 100.7 -3.815 . . . . 1.0 100.7 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.27 52.01 1.12 Allowed 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 124.64 2.162 . . . . 1.0 110.308 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.55 123.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 105.399 -2.075 . . . . 1.0 105.399 163.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -80.15 142.91 34.32 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.728 0.775 . . . . 1.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -140.47 149.95 43.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 124.184 1.945 . . . . 1.0 116.088 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 m -114.25 -9.22 12.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 129.424 3.09 . . . . 1.0 107.97 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -174.18 158.15 2.66 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.568 1.547 . . . . 1.0 107.285 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.28 -28.76 33.18 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 C-N-CA 122.296 1.997 . . . . 1.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -55.0 -40.01 69.68 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.311 1.444 . . . . 1.0 113.313 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.2 -29.0 67.17 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.145 1.378 . . . . 1.0 114.079 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 t -99.21 -3.48 34.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.121 -0.987 . . . . 1.0 113.094 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.75 -51.55 75.3 Favored Pre-proline 0 N--CA 1.451 -0.418 0 O-C-N 120.247 -1.533 . . . . 1.0 113.851 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.99 -37.94 50.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-O 113.187 -2.922 . . . . 1.0 115.712 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -68.74 -38.31 10.58 Favored 'Trans proline' 0 CA--C 1.508 -0.825 1 CA-C-N 129.134 4.298 . . . . 1.0 112.701 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.1 t -58.63 -50.7 72.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.351 1.548 . . . . 1.0 111.747 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -0.9 12.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 116.762 2.134 . . . . 1.0 116.762 172.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.02 70.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 123.463 1.602 . . . . 1.0 112.316 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -156.26 -26.55 0.1 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.686 -1.597 . . . . 1.0 112.174 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.93 -19.75 51.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 119.959 -1.713 . . . . 1.0 113.19 -169.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.4 157.5 26.23 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 117.851 -2.119 . . . . 1.0 114.622 157.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -69.53 -35.45 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 O-C-N 120.511 -1.582 . . . . 1.0 112.249 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -112.76 10.76 19.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.695 1.598 . . . . 1.0 110.882 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.03 155.52 34.43 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 115.931 1.826 . . . . 1.0 115.931 -166.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.56 166.05 27.83 Favored Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.942 -2.463 . . . . 1.0 106.942 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.31 154.5 50.85 Favored 'General case' 0 N--CA 1.418 -2.027 0 O-C-N 120.568 -1.548 . . . . 1.0 107.792 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -149.36 165.8 30.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.984 167.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.5 t -97.39 140.53 31.7 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 113.445 0.905 . . . . 1.0 113.445 -169.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 ttt -155.83 136.72 13.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.888 -1.132 . . . . 1.0 109.66 167.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.01 31.08 18.09 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.294 1.521 . . . . 1.0 110.269 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.27 15.62 65.85 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 124.611 1.1 . . . . 1.0 115.012 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -146.91 158.14 43.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.319 -1.695 . . . . 1.0 110.081 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.68 156.62 38.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.677 2.473 . . . . 1.0 117.677 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -141.64 89.59 2.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 103.556 -2.757 . . . . 1.0 103.556 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.9 t -85.91 126.56 34.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.513 2.325 . . . . 1.0 112.854 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -115.8 108.07 47.34 Favored Pre-proline 0 N--CA 1.437 -1.089 0 C-N-CA 126.512 1.925 . . . . 1.0 108.501 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 C--N 1.317 -1.1 0 C-N-CA 122.608 2.206 . . . . 1.0 110.323 159.696 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.433 -1.315 1 N-CA-C 98.602 -4.592 . . . . 1.0 98.602 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.95 160.48 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.495 0 N-CA-C 103.787 -2.671 . . . . 1.0 103.787 172.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.51 44.05 1.18 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 124.672 2.177 . . . . 1.0 110.67 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.2 113.17 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 103.979 -2.6 . . . . 1.0 103.979 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -98.49 133.5 42.77 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -161.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 p -135.63 156.94 48.05 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 118.48 2.771 . . . . 1.0 118.48 -165.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -109.65 -23.43 11.45 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.972 -1.922 . . . . 1.0 110.404 156.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 t -131.59 151.82 79.35 Favored Pre-proline 0 CA--C 1.508 -0.661 0 O-C-N 120.192 -1.567 . . . . 1.0 109.655 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.42 -25.22 56.22 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 122.763 2.022 . . . . 1.0 111.953 164.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -58.49 -41.28 84.97 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 122.37 1.081 . . . . 1.0 113.482 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.42 -13.89 62.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.523 1.129 . . . . 1.0 113.445 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -90.59 -8.31 50.5 Favored 'General case' 0 N--CA 1.417 -2.087 0 O-C-N 120.629 -1.294 . . . . 1.0 111.72 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.08 -44.18 59.22 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 116.759 -1.591 . . . . 1.0 113.23 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.84 -46.77 21.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 124.13 2.511 . . . . 1.0 115.683 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.07 -34.91 21.36 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 CA-C-N 127.557 3.735 . . . . 1.0 112.722 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.3 m -58.95 -35.79 73.72 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.704 -1.248 . . . . 1.0 112.3 172.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -20.1 62.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 116.843 2.164 . . . . 1.0 116.843 172.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -69.88 0.36 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 125.074 2.369 . . . . 1.0 111.903 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -93.5 -38.4 11.43 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.35 -2.659 . . . . 1.0 110.254 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.4 -11.72 20.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 -167.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 174.04 18.53 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 123.202 1.445 . . . . 1.0 115.21 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -69.08 -33.61 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 119.452 -2.205 . . . . 1.0 113.123 -167.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -86.98 -12.66 46.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.457 -1.402 . . . . 1.0 112.027 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.44 158.12 18.48 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 116.737 2.125 . . . . 1.0 116.737 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.17 14.46 Favored Glycine 0 CA--C 1.492 -1.377 0 O-C-N 120.912 -1.117 . . . . 1.0 111.184 -170.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.38 149.08 27.44 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.565 -1.55 . . . . 1.0 111.19 -171.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.63 136.22 54.82 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 125.786 1.634 . . . . 1.0 108.362 167.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 t -89.7 130.05 36.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.393 -0.817 . . . . 1.0 110.597 167.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.9 ttt -155.13 137.24 14.71 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 121.049 -1.032 . . . . 1.0 109.612 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.27 29.03 18.66 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.232 1.813 . . . . 1.0 110.992 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.83 10.9 62.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 116.568 1.387 . . . . 1.0 116.568 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -143.91 127.31 16.83 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.739 2.269 . . . . 1.0 109.153 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 153.39 42.7 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 119.437 3.125 . . . . 1.0 119.437 -162.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -123.21 78.95 1.62 Allowed 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 128.579 2.752 . . . . 1.0 104.218 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 t -70.21 132.98 46.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.406 1.482 . . . . 1.0 114.122 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.98 103.86 46.57 Favored Pre-proline 0 N--CA 1.434 -1.27 0 C-N-CA 125.847 1.659 . . . . 1.0 106.852 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.324 -0.734 0 CA-C-N 123.194 2.176 . . . . 1.0 109.899 157.527 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 N--CA 1.439 -1.003 1 N-CA-C 99.95 -4.093 . . . . 1.0 99.95 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.4 mt -104.53 -146.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 126.695 1.998 . . . . 1.0 107.738 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 3' ' ' ILE . 1.3 t0 -124.31 46.34 2.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 124.956 2.312 . . . . 1.0 109.011 163.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.39 105.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 112.41 -2.177 . . . . 1.0 105.349 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.56 131.54 38.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.741 -1.577 . . . . 1.0 106.741 171.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.79 161.96 39.58 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.051 2.241 . . . . 1.0 117.051 -162.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -46.94 8.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 112.786 -2.006 . . . . 1.0 109.739 154.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 152.97 76.81 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.271 -1.331 . . . . 1.0 111.933 -149.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.29 -33.55 48.01 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.235 2.623 . . . . 1.0 112.034 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -44.85 -48.42 11.09 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 127.282 2.233 . . . . 1.0 112.371 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -63.71 -22.54 66.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.223 1.409 . . . . 1.0 113.978 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.5 t -106.5 -7.47 17.51 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.635 -0.665 . . . . 1.0 112.47 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 tp -64.67 -50.87 62.34 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 116.921 -1.514 . . . . 1.0 113.667 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.77 -41.16 40.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-O 112.918 -3.034 . . . . 1.0 115.543 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -69.03 -40.22 6.77 Favored 'Trans proline' 0 CA--C 1.508 -0.798 1 CA-C-N 129.369 4.382 . . . . 1.0 113.151 173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.1 t -56.89 -44.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.465 1.602 . . . . 1.0 111.627 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -21.01 62.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 174.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.21 -70.89 0.31 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 124.631 2.158 . . . . 1.0 112.89 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -90.58 -42.59 10.71 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.203 -2.726 . . . . 1.0 108.689 -159.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -96.53 -30.19 13.46 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.599 -1.637 . . . . 1.0 113.756 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.98 159.18 22.78 Favored Glycine 0 CA--C 1.484 -1.89 0 C-N-CA 114.798 -3.572 . . . . 1.0 115.016 165.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 tt -70.28 -34.51 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 C-N-CA 126.295 1.838 . . . . 1.0 113.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -98.12 -11.26 23.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.313 0.645 . . . . 1.0 111.801 172.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.39 152.12 11.91 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.812 2.523 . . . . 1.0 117.812 -167.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.4 167.92 29.68 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 109.039 -1.625 . . . . 1.0 109.039 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.98 154.43 42.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 123.286 1.517 . . . . 1.0 110.161 -164.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 175.7 10.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 107.485 -1.302 . . . . 1.0 107.485 166.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.3 t -107.53 147.08 31.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.782 -0.574 . . . . 1.0 110.513 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.1 ttt -164.01 142.01 7.26 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.378 1.471 . . . . 1.0 109.803 169.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.32 35.78 20.66 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 126.157 1.783 . . . . 1.0 110.48 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.87 -5.04 55.27 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 116.231 1.252 . . . . 1.0 116.231 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -135.39 165.26 25.88 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.686 2.243 . . . . 1.0 109.766 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.55 160.89 10.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 115.043 1.497 . . . . 1.0 115.043 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -142.74 90.53 2.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 100.289 -3.967 . . . . 1.0 100.289 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -92.46 128.68 38.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 126.261 1.824 . . . . 1.0 109.034 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.11 98.06 41.12 Favored Pre-proline 0 N--CA 1.436 -1.141 0 C-N-CA 125.212 1.405 . . . . 1.0 107.336 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 121.696 1.597 . . . . 1.0 111.078 173.793 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t . . . . . 0 N--CA 1.429 -1.516 1 N-CA-C 98.543 -4.614 . . . . 1.0 98.543 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.79 158.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 101.68 -3.452 . . . . 1.0 101.68 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.85 42.06 1.09 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 124.091 1.901 . . . . 1.0 112.122 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.52 126.67 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 170.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -108.22 140.13 41.9 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.906 0.86 . . . . 1.0 110.958 -157.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.3 156.26 47.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -168.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.4 m -108.77 -26.55 10.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.709 1.719 . . . . 1.0 109.636 162.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -123.17 154.15 65.01 Favored Pre-proline 0 CA--C 1.515 -0.371 0 O-C-N 120.578 -1.326 . . . . 1.0 110.563 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.48 -27.11 54.43 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 121.816 1.677 . . . . 1.0 112.474 160.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.9 -49.63 74.05 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.623 -1.298 . . . . 1.0 112.651 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.93 -5.45 17.03 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.093 1.357 . . . . 1.0 113.633 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -88.56 -27.79 21.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.113 1.435 . . . . 1.0 109.533 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.9 tp -70.15 -47.3 21.29 Favored Pre-proline 0 C--N 1.355 0.835 0 CA-C-O 116.298 -1.811 . . . . 1.0 114.681 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.13 -35.87 61.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-O 113.23 -2.904 . . . . 1.0 115.288 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.43 -39.93 11.66 Favored 'Trans proline' 0 CA--C 1.502 -1.113 1 CA-C-N 128.98 4.243 . . . . 1.0 112.308 170.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.6 m -61.17 -33.47 73.49 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.744 -1.223 . . . . 1.0 113.379 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -12.2 61.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 116.417 2.006 . . . . 1.0 116.417 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.26 71.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 123.272 1.511 . . . . 1.0 113.518 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -163.05 -30.05 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.782 -1.554 . . . . 1.0 111.33 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.9 -15.46 59.0 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 120.23 -1.544 . . . . 1.0 113.038 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.23 153.3 6.3 Favored Glycine 0 CA--C 1.492 -1.394 0 CA-C-O 122.329 0.961 . . . . 1.0 113.887 150.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.3 -35.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 119.877 -1.955 . . . . 1.0 111.818 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -70.17 -37.44 75.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.996 1.718 . . . . 1.0 109.772 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.07 155.68 1.81 Allowed 'General case' 0 C--N 1.348 0.524 0 N-CA-C 118.163 2.653 . . . . 1.0 118.163 -162.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.18 174.13 15.09 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.361 -1.895 . . . . 1.0 108.361 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -160.35 137.59 9.34 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 120.879 -1.365 . . . . 1.0 109.386 -165.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -155.48 166.27 34.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.301 -0.96 . . . . 1.0 110.259 165.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.5 141.58 29.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.778 -0.576 . . . . 1.0 112.338 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -155.56 135.96 13.21 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.186 -0.946 . . . . 1.0 109.868 168.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.98 34.03 21.47 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.77 2.028 . . . . 1.0 110.42 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.47 15.27 68.06 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.76 -1.109 . . . . 1.0 115.669 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -145.85 150.76 36.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 119.8 -2.0 . . . . 1.0 110.057 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.0 156.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 -164.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.18 86.8 2.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.734 -2.691 . . . . 1.0 103.734 -175.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 62.1 m -75.31 131.03 40.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 125.967 1.707 . . . . 1.0 113.554 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.74 126.26 28.85 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 106.075 -1.824 . . . . 1.0 106.075 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 CA--C 1.509 -0.765 0 CA-C-N 124.641 2.693 . . . . 1.0 113.466 -168.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 N--CA 1.433 -1.312 1 N-CA-C 98.686 -4.561 . . . . 1.0 98.686 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.53 158.76 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 103.284 -2.858 . . . . 1.0 103.284 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.23 50.85 1.56 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.115 2.166 . . . . 1.0 110.358 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.11 118.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 105.373 -2.084 . . . . 1.0 105.373 165.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 134.19 36.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -134.66 146.63 49.69 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 116.967 2.21 . . . . 1.0 116.967 -165.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -110.63 -17.78 13.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 112.433 -2.167 . . . . 1.0 109.176 167.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -140.3 147.62 50.69 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 56.7 Cg_endo -60.71 -24.15 77.97 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 122.401 2.067 . . . . 1.0 112.88 167.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -37.67 70.72 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 122.716 1.246 . . . . 1.0 112.416 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -60.4 -24.66 65.32 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.543 1.537 . . . . 1.0 114.228 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 38.5 t -103.46 -5.02 23.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.164 0.983 . . . . 1.0 112.609 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.25 -48.65 75.89 Favored Pre-proline 0 C--N 1.345 0.411 0 O-C-N 120.186 -1.571 . . . . 1.0 114.299 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.61 -34.3 64.12 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-O 113.402 -2.832 . . . . 1.0 115.44 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.59 -36.55 14.5 Favored 'Trans proline' 0 CA--C 1.506 -0.89 1 CA-C-N 128.867 4.202 . . . . 1.0 112.54 169.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 m -59.29 -51.05 71.63 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.122 1.439 . . . . 1.0 112.37 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 2.36 5.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 116.777 2.14 . . . . 1.0 116.777 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.8 -50.93 30.38 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.752 1.739 . . . . 1.0 111.502 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 -12.71 0.24 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.447 -1.706 . . . . 1.0 113.036 -173.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -84.98 -20.74 30.09 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 120.031 -1.668 . . . . 1.0 113.384 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.88 -166.2 33.51 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 115.344 -3.312 . . . . 1.0 119.154 163.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.3 -62.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 C-N-CA 125.098 1.359 . . . . 1.0 112.295 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.69 13.51 14.23 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.906 1.682 . . . . 1.0 107.437 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.09 145.49 0.75 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 118.282 2.697 . . . . 1.0 118.282 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.8 170.8 21.07 Favored Glycine 0 CA--C 1.477 -2.311 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -162.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -145.16 135.44 24.05 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 -170.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -144.04 149.28 36.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.05 137.7 34.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 121.221 -0.924 . . . . 1.0 111.902 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -155.69 139.96 16.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 120.819 -1.176 . . . . 1.0 109.68 167.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.8 33.95 19.9 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 126.356 1.862 . . . . 1.0 110.141 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.12 16.7 60.3 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 124.382 0.991 . . . . 1.0 115.525 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -144.84 154.38 42.59 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 119.708 -2.054 . . . . 1.0 107.919 -173.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.35 158.49 31.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 119.675 -1.891 . . . . 1.0 115.987 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -144.09 89.69 2.05 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 101.625 -3.472 . . . . 1.0 101.625 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.2 t -85.64 129.3 34.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.798 2.039 . . . . 1.0 112.398 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -103.89 102.9 34.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo . . . . . 0 N--CA 1.454 -0.836 0 C-N-CA 122.149 1.9 . . . . 1.0 111.865 -166.644 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t . . . . . 0 N--CA 1.43 -1.425 1 N-CA-C 98.551 -4.611 . . . . 1.0 98.551 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.21 157.39 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 167.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.61 41.6 1.03 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 125.401 2.525 . . . . 1.0 111.653 176.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -92.84 110.74 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.077 -1.874 . . . . 1.0 106.033 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 137.88 52.63 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.556 -1.34 . . . . 1.0 110.669 171.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -104.53 169.69 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.567 -1.333 . . . . 1.0 113.18 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 p -133.24 -0.75 3.28 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 126.803 2.041 . . . . 1.0 108.825 161.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -177.72 155.48 1.08 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 102.993 -2.966 . . . . 1.0 102.993 -167.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.71 -27.16 68.38 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 123.669 2.346 . . . . 1.0 111.748 163.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.37 -42.57 99.52 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.452 1.12 . . . . 1.0 112.893 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -7.05 41.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 t -99.89 -6.02 27.43 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.651 -1.28 . . . . 1.0 111.483 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.83 -39.59 54.92 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 119.703 -1.873 . . . . 1.0 114.303 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.85 -47.35 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 CA-C-O 113.8 -2.667 . . . . 1.0 115.792 169.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.31 -35.67 23.33 Favored 'Trans proline' 0 CA--C 1.507 -0.836 0 CA-C-N 127.995 3.891 . . . . 1.0 112.516 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.3 m -59.25 -34.36 72.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.954 -1.092 . . . . 1.0 112.5 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -25.25 63.05 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 117.01 2.226 . . . . 1.0 117.01 170.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -67.05 0.57 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 124.775 2.226 . . . . 1.0 113.256 -174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.48 -39.04 10.62 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 111.548 -2.569 . . . . 1.0 109.99 -166.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.19 -27.39 13.83 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.527 -1.215 . . . . 1.0 114.267 -162.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.45 171.27 19.83 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 119.98 -1.7 . . . . 1.0 115.758 163.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 23' ' ' ILE . 4.7 mp -69.51 -46.35 76.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 120.007 -1.878 . . . . 1.0 111.818 -175.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -83.83 -15.78 46.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.581 -1.324 . . . . 1.0 111.509 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.59 160.2 1.34 Allowed 'General case' 0 C--N 1.355 0.818 0 N-CA-C 117.833 2.531 . . . . 1.0 117.833 -166.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.01 177.4 20.95 Favored Glycine 0 CA--C 1.49 -1.469 0 O-C-N 120.718 -1.239 . . . . 1.0 111.881 -166.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.21 144.77 31.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.769 -1.43 . . . . 1.0 109.436 -170.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 153.46 35.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.39 1.076 . . . . 1.0 108.191 163.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.98 122.19 43.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.666 0.786 . . . . 1.0 110.346 167.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.7 tpp -154.95 140.71 18.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.847 -1.158 . . . . 1.0 112.034 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 33.37 17.35 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.143 1.777 . . . . 1.0 109.908 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.18 1.36 41.43 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 115.897 1.119 . . . . 1.0 115.897 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -132.6 151.61 51.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 120.021 -1.87 . . . . 1.0 107.831 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.0 t -67.33 156.95 35.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.358 -2.088 . . . . 1.0 114.713 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.16 81.15 1.84 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.435 -2.802 . . . . 1.0 103.435 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 t -81.56 140.67 34.36 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.448 1.099 . . . . 1.0 113.964 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.86 99.5 45.56 Favored Pre-proline 0 N--CA 1.437 -1.108 0 C-N-CA 125.554 1.542 . . . . 1.0 107.11 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 C--N 1.329 -0.466 0 C-N-CA 122.778 2.318 . . . . 1.0 110.841 169.369 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.4 t . . . . . 0 N--CA 1.429 -1.517 1 N-CA-C 98.241 -4.726 . . . . 1.0 98.241 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.75 158.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 102.49 -3.152 . . . . 1.0 102.49 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 39.03 0.91 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.635 2.636 . . . . 1.0 112.1 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -91.56 103.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.725 -1.58 . . . . 1.0 107.419 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 142.87 51.96 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.776 -1.202 . . . . 1.0 110.717 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.51 166.33 14.85 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.687 -1.258 . . . . 1.0 114.081 -170.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.41 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 32.9 p -126.7 -6.35 6.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.748 2.019 . . . . 1.0 109.325 150.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -178.98 154.91 0.81 Allowed Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 101.107 -3.664 . . . . 1.0 101.107 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.51 -28.37 77.58 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 CA-C-N 123.874 2.419 . . . . 1.0 112.189 162.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.8 -29.13 68.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.733 0.778 . . . . 1.0 112.801 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -70.47 -9.93 57.82 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 120.723 -1.236 . . . . 1.0 114.3 175.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 45.3 t -93.36 -7.78 43.77 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.583 -1.323 . . . . 1.0 112.16 171.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -49.32 88.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 119.941 -1.724 . . . . 1.0 113.958 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.08 -32.92 63.5 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 CA-C-O 113.293 -2.878 . . . . 1.0 115.929 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.11 -36.3 10.11 Favored 'Trans proline' 0 CA--C 1.504 -0.976 1 CA-C-N 129.074 4.277 . . . . 1.0 112.632 167.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.83 -61.55 2.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.949 1.357 . . . . 1.0 111.749 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 21.24 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.921 -1.112 . . . . 1.0 113.873 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.07 -69.93 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 118.092 -2.88 . . . . 1.0 107.973 159.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.81 -20.89 2.21 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 127.435 2.294 . . . . 1.0 114.08 -163.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -87.97 -16.7 33.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.293 -1.505 . . . . 1.0 114.576 -165.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.26 178.67 38.8 Favored Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.226 -1.464 . . . . 1.0 111.35 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.01 -55.65 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 122.481 1.134 . . . . 1.0 112.776 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -122.89 25.08 8.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 123.45 1.595 . . . . 1.0 107.267 -175.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.48 143.89 0.19 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 119.166 3.025 . . . . 1.0 119.166 -163.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.09 163.59 13.23 Favored Glycine 0 CA--C 1.476 -2.368 0 N-CA-C 108.366 -1.893 . . . . 1.0 108.366 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -152.14 126.66 9.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.746 -1.205 . . . . 1.0 107.746 -172.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 150.95 39.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -96.61 139.66 32.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.951 -1.093 . . . . 1.0 112.115 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -156.93 144.81 19.24 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 166.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.341 0.7 OUTLIER 62.67 20.31 11.97 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.414 1.885 . . . . 1.0 113.381 -174.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.6 9.51 86.15 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 114.998 -1.001 . . . . 1.0 114.661 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.25 159.0 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.424 -1.633 . . . . 1.0 108.007 -170.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 t -70.05 159.04 34.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.214 -2.179 . . . . 1.0 116.409 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -144.48 90.35 2.08 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 102.034 -3.321 . . . . 1.0 102.034 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.3 t -84.45 130.26 34.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.734 2.014 . . . . 1.0 112.962 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -102.45 107.49 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo . . . . . 0 N--CA 1.452 -0.932 0 C-N-CA 121.768 1.645 . . . . 1.0 112.365 -166.852 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.443 -0.815 0 N-CA-C 103.135 -2.913 . . . . 1.0 103.135 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.38 161.1 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 161.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.44 65.23 0.61 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.981 1.713 . . . . 1.0 107.508 160.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.9 t -84.64 109.2 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.673 -1.973 . . . . 1.0 105.673 160.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -97.29 124.17 41.32 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.9 1.28 . . . . 1.0 108.96 -176.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -145.11 163.02 35.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.357 1.984 . . . . 1.0 116.357 -155.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -99.32 -36.15 9.71 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 123.646 1.688 . . . . 1.0 109.758 154.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -116.97 150.66 46.32 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.445 -1.252 . . . . 1.0 111.536 -156.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.8 -34.24 31.59 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.026 1.817 . . . . 1.0 111.776 170.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -54.85 -41.72 71.11 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.974 1.31 . . . . 1.0 113.021 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -54.75 -30.6 56.86 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.759 1.223 . . . . 1.0 114.149 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t -100.57 -9.37 22.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . 0.267 2.8 tm? -68.42 -49.21 32.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 120.402 -1.436 . . . . 1.0 113.192 -170.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.43 -44.29 43.85 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 CA-C-O 114.267 -2.472 . . . . 1.0 115.95 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.17 -37.73 13.78 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 CA-C-N 127.194 3.605 . . . . 1.0 112.981 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.93 -49.0 78.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.864 1.792 . . . . 1.0 111.414 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -71.31 -8.2 52.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.64 -54.92 10.06 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.605 1.669 . . . . 1.0 111.775 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.11 -23.26 1.03 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 113.146 -1.843 . . . . 1.0 112.597 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -84.64 -20.22 31.69 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 120.162 -1.586 . . . . 1.0 113.55 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.7 179.49 45.04 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 116.462 -2.78 . . . . 1.0 116.978 157.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 tt -70.72 -55.75 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 125.782 1.633 . . . . 1.0 112.434 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -121.31 19.19 11.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.476 1.911 . . . . 1.0 107.035 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.01 145.75 16.01 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.27 1.952 . . . . 1.0 116.27 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.35 162.29 22.68 Favored Glycine 0 CA--C 1.471 -2.659 0 N-CA-C 107.952 -2.059 . . . . 1.0 107.952 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.46 131.71 24.96 Favored 'General case' 0 N--CA 1.425 -1.701 0 O-C-N 120.678 -1.484 . . . . 1.0 107.456 -163.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -141.9 148.2 38.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -99.12 144.82 27.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.246 -1.533 . . . . 1.0 111.146 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -162.2 144.14 11.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.718 -1.239 . . . . 1.0 109.662 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.55 32.29 18.71 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.77 1.628 . . . . 1.0 110.855 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.11 65.98 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 114.636 -1.166 . . . . 1.0 115.885 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -142.67 153.27 43.26 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 120.175 1.987 . . . . 1.0 109.284 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.81 161.61 29.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 115.78 1.77 . . . . 1.0 115.78 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.45 95.38 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 101.738 -3.43 . . . . 1.0 101.738 168.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.7 t -82.56 116.6 22.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.117 1.767 . . . . 1.0 110.107 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -99.2 110.08 56.78 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 126.228 1.811 . . . . 1.0 107.681 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.453 -0.855 0 C-N-CA 122.115 1.877 . . . . 1.0 112.249 -175.739 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 N--CA 1.436 -1.127 1 N-CA-C 98.039 -4.801 . . . . 1.0 98.039 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.72 -155.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.39 52.57 2.01 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.606 2.146 . . . . 1.0 109.311 170.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 115.81 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 171.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 137.65 36.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.916 0.887 . . . . 1.0 109.449 -169.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.92 159.19 42.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.842 1.793 . . . . 1.0 115.842 -167.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -103.63 -33.98 8.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.379 -1.737 . . . . 1.0 109.492 154.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -108.98 145.38 31.6 Favored Pre-proline 0 CA--C 1.512 -0.508 0 O-C-N 120.547 -1.346 . . . . 1.0 111.065 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.94 -28.38 50.17 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.403 2.069 . . . . 1.0 111.633 175.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -56.8 -35.99 69.4 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 124.103 0.961 . . . . 1.0 113.461 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.36 -23.33 66.73 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.866 1.266 . . . . 1.0 114.181 177.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -84.04 -23.89 30.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.493 1.117 . . . . 1.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 tp -70.15 -53.72 10.47 Favored Pre-proline 0 C--N 1.355 0.821 0 CA-C-O 116.841 -1.552 . . . . 1.0 114.853 -166.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.58 -35.38 81.61 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-O 113.366 -2.847 . . . . 1.0 115.113 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -69.79 -41.14 4.49 Favored 'Trans proline' 0 CA--C 1.508 -0.817 1 CA-C-N 128.532 4.083 . . . . 1.0 112.799 168.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.21 -50.08 73.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.655 1.693 . . . . 1.0 112.178 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -71.16 -8.51 54.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 115.139 1.533 . . . . 1.0 115.139 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.2 -64.27 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.198 1.952 . . . . 1.0 111.433 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -119.0 -28.81 5.43 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 111.989 -2.369 . . . . 1.0 111.574 -162.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -95.32 -26.95 15.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -166.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.39 171.14 42.5 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 115.884 -3.055 . . . . 1.0 117.605 171.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.87 -53.42 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 125.752 1.621 . . . . 1.0 113.039 -170.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -124.66 30.92 5.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 148.14 18.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.746 2.128 . . . . 1.0 116.746 -167.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.74 161.27 12.75 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 107.0 -2.44 . . . . 1.0 107.0 -172.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.77 121.17 3.6 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.967 -1.902 . . . . 1.0 108.047 -157.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -148.81 155.0 40.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.163 -1.421 . . . . 1.0 107.163 -168.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.2 t -97.4 139.93 32.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 121.249 -0.907 . . . . 1.0 111.23 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -155.52 138.48 15.42 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.29 -1.506 . . . . 1.0 109.583 169.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.5 28.82 13.44 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.161 1.385 . . . . 1.0 110.94 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.52 80.58 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 124.422 1.01 . . . . 1.0 115.186 -173.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -141.86 152.93 44.07 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 119.905 -1.938 . . . . 1.0 110.971 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -68.6 144.09 54.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.864 1.792 . . . . 1.0 114.815 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -140.82 91.83 2.45 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.245 -2.502 . . . . 1.0 104.245 -174.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.3 t -81.4 127.49 32.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.256 2.623 . . . . 1.0 112.106 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -103.04 101.77 23.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 126.574 1.95 . . . . 1.0 105.898 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.457 -0.661 0 C-N-CA 122.231 1.954 . . . . 1.0 112.382 -164.527 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.8 t . . . . . 0 N--CA 1.441 -0.893 1 N-CA-C 98.043 -4.799 . . . . 1.0 98.043 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.24 154.68 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 102.305 -3.22 . . . . 1.0 102.305 161.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.38 48.28 1.3 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 124.174 1.94 . . . . 1.0 110.871 177.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.35 129.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.606 -1.998 . . . . 1.0 105.606 171.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -97.06 142.77 28.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.2 152.25 35.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.499 2.037 . . . . 1.0 116.499 -172.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.4 m -100.39 -33.66 10.28 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.747 2.419 . . . . 1.0 109.135 159.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.2 t -120.26 146.6 43.01 Favored Pre-proline 0 CA--C 1.512 -0.483 0 O-C-N 120.951 -1.093 . . . . 1.0 110.295 -173.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.5 -24.47 78.13 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.951 1.767 . . . . 1.0 112.676 165.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.42 -28.71 69.99 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 122.002 0.906 . . . . 1.0 113.076 -176.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.75 -18.61 65.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.54 1.136 . . . . 1.0 114.059 177.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 68.0 m -85.3 -14.59 46.08 Favored 'General case' 0 N--CA 1.425 -1.718 0 O-C-N 120.799 -1.188 . . . . 1.0 113.538 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -49.38 75.28 Favored Pre-proline 0 C--N 1.351 0.655 0 O-C-N 120.603 -1.311 . . . . 1.0 114.444 -170.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.08 -39.35 50.19 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 CA-C-O 113.449 -2.813 . . . . 1.0 115.473 174.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.6 -36.92 10.3 Favored 'Trans proline' 0 CA--C 1.511 -0.667 1 CA-C-N 128.652 4.126 . . . . 1.0 113.096 172.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 m -59.52 -45.25 92.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.239 -1.538 . . . . 1.0 111.714 176.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -71.01 -13.4 61.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 171.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.9 -67.44 0.53 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 124.146 1.927 . . . . 1.0 112.287 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -105.36 -41.64 5.46 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 111.836 -2.438 . . . . 1.0 110.211 -163.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -87.32 -36.69 17.71 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -160.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.05 -177.24 46.65 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 115.934 -3.032 . . . . 1.0 117.922 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.9 -53.57 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 125.97 1.708 . . . . 1.0 113.394 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 16.12 15.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.718 2.407 . . . . 1.0 108.469 -174.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 148.8 10.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 116.946 2.202 . . . . 1.0 116.946 -172.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.71 -170.99 13.08 Favored Glycine 0 CA--C 1.475 -2.432 0 N-CA-C 108.486 -1.846 . . . . 1.0 108.486 -164.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.99 6.91 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 120.325 -1.691 . . . . 1.0 108.842 -175.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.31 0.0 OUTLIER -149.53 -177.86 6.1 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.694 143.52 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -115.13 135.78 53.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.896 1.678 . . . . 1.0 109.906 -176.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.09 151.43 21.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.306 -1.738 . . . . 1.0 106.306 168.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.346 0.5 OUTLIER 63.43 18.73 11.25 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.131 1.772 . . . . 1.0 113.439 -173.952 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.85 76.48 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.308 1.432 . . . . 1.0 114.729 -172.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -141.79 161.32 38.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.037 -1.861 . . . . 1.0 109.558 -177.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.1 t -69.75 163.83 24.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.952 2.204 . . . . 1.0 116.952 -168.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.88 90.26 1.82 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.212 -2.514 . . . . 1.0 104.212 167.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -78.17 140.17 38.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.266 2.226 . . . . 1.0 114.263 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -108.32 106.45 58.66 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 127.692 2.397 . . . . 1.0 107.156 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo . . . . . 0 C--N 1.324 -0.715 0 C-N-CA 122.619 2.213 . . . . 1.0 112.244 -179.073 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.439 -0.999 1 N-CA-C 99.326 -4.324 . . . . 1.0 99.326 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.2 mt -103.55 -149.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 126.815 2.046 . . . . 1.0 106.368 175.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -132.13 43.71 2.99 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 125.15 2.405 . . . . 1.0 109.644 164.706 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.51 120.02 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 112.81 -1.995 . . . . 1.0 106.014 166.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -94.78 141.12 29.0 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 105.399 -2.074 . . . . 1.0 105.399 172.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -122.48 149.83 43.35 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 117.639 2.459 . . . . 1.0 117.639 -164.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -114.08 -5.93 13.1 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.417 -2.174 . . . . 1.0 110.415 169.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -168.28 155.76 7.61 Favored Pre-proline 0 CA--C 1.504 -0.8 0 N-CA-C 105.129 -2.174 . . . . 1.0 105.129 -174.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.91 -26.87 51.38 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 124.315 2.577 . . . . 1.0 111.457 163.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -64.66 -36.07 83.06 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 113.598 0.962 . . . . 1.0 113.598 -168.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -13.82 62.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 176.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.6 t -96.18 -4.49 42.46 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.932 -1.105 . . . . 1.0 111.781 173.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.13 -50.97 83.65 Favored Pre-proline 0 C--N 1.349 0.578 0 O-C-N 120.303 -1.498 . . . . 1.0 113.5 177.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 -37.66 59.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-O 113.278 -2.884 . . . . 1.0 115.74 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -68.34 -38.18 12.25 Favored 'Trans proline' 0 CA--C 1.506 -0.898 1 CA-C-N 128.604 4.109 . . . . 1.0 112.771 169.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 m -58.37 -47.11 84.86 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.137 1.446 . . . . 1.0 112.745 177.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -4.46 27.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 117.189 2.292 . . . . 1.0 117.189 172.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.45 11.44 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 123.433 1.587 . . . . 1.0 111.257 -178.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.1 -11.5 0.19 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 113.906 -1.497 . . . . 1.0 114.253 -175.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -79.57 -25.58 41.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.797 -1.814 . . . . 1.0 112.751 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.37 159.93 27.29 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 117.188 -2.434 . . . . 1.0 115.317 162.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.94 -33.8 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 120.378 -1.66 . . . . 1.0 112.442 -173.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -115.04 13.66 16.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.906 1.682 . . . . 1.0 110.675 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 162.58 6.98 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 118.233 2.679 . . . . 1.0 118.233 -163.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.81 -171.27 15.92 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 107.187 -2.365 . . . . 1.0 107.187 -176.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.14 154.63 36.24 Favored 'General case' 0 N--CA 1.424 -1.747 0 O-C-N 120.925 -1.338 . . . . 1.0 108.408 -175.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -111.81 146.31 37.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.911 -1.515 . . . . 1.0 106.911 162.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.4 t -94.02 121.26 35.32 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 160.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.6 ttt -149.84 127.38 11.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.717 1.246 . . . . 1.0 111.497 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.17 31.19 17.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 126.824 2.05 . . . . 1.0 110.331 -177.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.95 9.31 79.61 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 115.3 0.88 . . . . 1.0 115.3 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -135.45 143.78 46.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 119.674 -2.074 . . . . 1.0 108.385 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.3 143.38 52.06 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -176.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.48 82.26 2.05 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 102.476 -3.157 . . . . 1.0 102.476 -174.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -71.34 135.41 47.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.388 2.275 . . . . 1.0 114.545 -173.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -120.45 103.46 44.16 Favored Pre-proline 0 N--CA 1.444 -0.766 0 C-N-CA 125.335 1.454 . . . . 1.0 110.038 -165.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo . . . . . 0 C--N 1.319 -1.018 0 C-N-CA 122.284 1.989 . . . . 1.0 110.137 151.732 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.446 -0.629 1 N-CA-C 96.627 -5.323 . . . . 1.0 96.627 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.74 145.76 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 N-CA-C 102.933 -2.988 . . . . 1.0 102.933 172.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.267 13.1 t70 -91.52 45.56 1.24 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.642 2.163 . . . . 1.0 112.551 -173.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.53 107.0 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 164.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -87.99 144.48 26.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.319 1.057 . . . . 1.0 112.556 -164.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.92 142.6 51.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.467 2.395 . . . . 1.0 117.467 -162.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -115.97 1.47 13.31 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.056 2.542 . . . . 1.0 108.231 173.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -173.65 153.95 2.31 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 118.621 -2.549 . . . . 1.0 105.414 -174.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.66 -21.82 38.59 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 123.698 2.357 . . . . 1.0 112.653 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -55.78 -31.4 62.58 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.281 1.432 . . . . 1.0 113.699 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -62.73 -23.13 67.02 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 124.622 1.169 . . . . 1.0 113.784 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.2 t -82.83 -20.99 34.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.005 0.922 . . . . 1.0 112.059 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 tp -68.54 -51.8 21.69 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-O 116.984 -1.484 . . . . 1.0 114.31 -174.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.9 -29.74 58.0 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-O 113.099 -2.959 . . . . 1.0 115.618 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.14 -39.79 2.02 Favored 'Trans proline' 0 CA--C 1.503 -1.031 1 CA-C-N 129.374 4.384 . . . . 1.0 112.456 166.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 t -62.61 -59.05 5.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.263 1.506 . . . . 1.0 111.617 -178.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 22.04 0.06 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.763 1.625 . . . . 1.0 113.435 165.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.59 -76.76 0.1 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 118.328 -2.733 . . . . 1.0 107.859 158.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -117.68 -34.21 4.3 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 111.498 -2.592 . . . . 1.0 113.189 -159.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -76.85 -30.28 56.24 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 120.823 -1.173 . . . . 1.0 112.535 -166.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.42 156.42 9.9 Favored Glycine 0 CA--C 1.494 -1.262 0 C-N-CA 118.166 -1.969 . . . . 1.0 115.748 166.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -71.14 -25.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.135 1.374 . . . . 1.0 112.075 159.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -81.89 -21.97 37.11 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.398 2.679 . . . . 1.0 110.455 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.46 153.59 42.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 116.036 1.865 . . . . 1.0 116.036 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.79 170.91 16.09 Favored Glycine 0 CA--C 1.489 -1.578 0 N-CA-C 108.351 -1.899 . . . . 1.0 108.351 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.84 129.62 10.12 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 119.421 -2.223 . . . . 1.0 108.841 -159.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.1 12.35 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 120.271 -1.518 . . . . 1.0 111.999 174.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.59 132.27 44.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.568 1.547 . . . . 1.0 109.752 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.2 ttt -161.47 140.23 9.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.136 1.374 . . . . 1.0 110.213 173.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 59.54 34.91 22.58 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 124.489 2.09 . . . . 1.0 110.759 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.92 57.15 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 114.075 -1.421 . . . . 1.0 116.143 -176.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 176.92 8.27 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 120.199 1.999 . . . . 1.0 112.877 -177.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.01 145.69 49.84 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 124.763 2.22 . . . . 1.0 114.538 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -137.38 92.9 2.75 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 102.841 -3.022 . . . . 1.0 102.841 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 131.3 40.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.051 -1.431 . . . . 1.0 112.084 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -111.79 82.83 4.2 Favored Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 127.734 2.414 . . . . 1.0 109.254 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 C--N 1.33 -0.397 0 CA-C-N 124.187 2.531 . . . . 1.0 109.049 154.162 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.432 -1.365 1 N-CA-C 99.891 -4.115 . . . . 1.0 99.891 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.58 156.24 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 102.244 -3.243 . . . . 1.0 102.244 170.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -94.59 54.01 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 124.156 1.931 . . . . 1.0 109.182 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.59 117.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -87.18 140.84 29.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.54 1.162 . . . . 1.0 109.235 -175.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.78 148.59 50.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 117.327 2.343 . . . . 1.0 117.327 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -114.59 1.13 14.17 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 124.925 2.298 . . . . 1.0 108.416 172.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -174.11 154.43 2.16 Favored Pre-proline 0 N--CA 1.444 -0.742 0 O-C-N 118.744 -2.473 . . . . 1.0 105.774 -174.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.71 -26.41 45.71 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 CA-C-N 123.221 2.186 . . . . 1.0 111.872 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -44.56 -46.7 10.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 128.644 2.778 . . . . 1.0 112.181 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -61.76 -28.42 69.43 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.629 1.572 . . . . 1.0 113.316 -174.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.9 t -94.28 -8.45 39.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.931 0.872 . . . . 1.0 112.412 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.93 -41.71 29.29 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 119.72 -1.863 . . . . 1.0 114.426 -178.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.13 -46.86 22.83 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-O 113.934 -2.611 . . . . 1.0 115.472 168.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.05 -36.03 23.49 Favored 'Trans proline' 0 CA--C 1.51 -0.697 0 CA-C-N 127.795 3.82 . . . . 1.0 112.507 174.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.3 m -63.54 -26.71 68.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 121.033 -1.042 . . . . 1.0 112.698 172.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -33.69 70.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 117.34 2.348 . . . . 1.0 117.34 162.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -66.97 0.56 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 124.687 2.184 . . . . 1.0 112.394 -169.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.8 -38.13 23.53 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 111.826 -2.443 . . . . 1.0 109.407 -172.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -112.78 -3.95 14.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.407 -1.27 . . . . 1.0 113.563 -164.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -178.58 37.49 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 124.34 2.078 . . . . 1.0 116.602 161.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -70.36 -33.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 O-C-N 119.465 -2.197 . . . . 1.0 114.108 -165.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -77.06 -33.86 57.17 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 120.913 -1.117 . . . . 1.0 110.439 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 137.51 58.09 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 116.548 2.055 . . . . 1.0 116.548 -161.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.67 174.4 25.69 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -175.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.83 131.43 8.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 120.556 -1.555 . . . . 1.0 108.901 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.1 168.96 21.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.713 -1.242 . . . . 1.0 109.87 174.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.22 129.73 55.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.617 0.767 . . . . 1.0 112.306 -168.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 125.06 43.43 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 126.904 2.082 . . . . 1.0 111.371 166.339 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.53 25.88 15.4 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 123.405 1.574 . . . . 1.0 112.128 170.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.21 77.42 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.624 -1.171 . . . . 1.0 115.682 -175.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -136.52 155.25 50.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 120.358 2.079 . . . . 1.0 108.946 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -70.55 160.63 32.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 118.557 2.799 . . . . 1.0 118.557 -175.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -148.24 99.75 3.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 104.144 -2.539 . . . . 1.0 104.144 165.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.6 t -80.78 130.79 35.26 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.515 2.726 . . . . 1.0 111.53 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -98.98 138.94 20.7 Favored Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 119.479 -2.013 . . . . 1.0 107.64 -178.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo . . . . . 0 CA--C 1.507 -0.834 0 CA-C-N 123.96 2.45 . . . . 1.0 111.802 171.679 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.513 2.714 0 CA-C-O 121.113 0.482 . . . . 1.0 110.985 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.9 t -138.95 137.85 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 1 N-CA-C 99.098 -4.408 . . . . 1.0 99.098 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.31 159.95 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.408 0 N-CA-C 102.403 -3.184 . . . . 1.0 102.403 169.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.27 49.16 1.58 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 124.651 2.167 . . . . 1.0 110.622 173.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 83.6 t -92.14 112.85 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 104.648 -2.352 . . . . 1.0 104.648 167.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -87.72 137.07 32.66 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 107.89 -1.152 . . . . 1.0 107.89 -177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 p -133.06 148.38 52.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 118.798 2.888 . . . . 1.0 118.798 -165.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.4 p -101.69 -14.45 17.37 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 113.283 -1.78 . . . . 1.0 110.902 168.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.0 m -169.95 167.33 5.03 Favored Pre-proline 0 N--CA 1.441 -0.9 0 N-CA-C 106.421 -1.696 . . . . 1.0 106.421 -169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 30.0 Cg_endo -64.38 -24.19 64.68 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 CA-C-N 123.75 2.375 . . . . 1.0 114.258 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -47.58 -53.32 14.95 Favored 'General case' 0 C--N 1.347 0.499 0 C-N-CA 127.351 2.26 . . . . 1.0 112.349 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -70.73 -12.58 61.64 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.481 1.512 . . . . 1.0 114.547 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.408 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 33.9 t -100.68 -9.48 21.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 121.204 -0.935 . . . . 1.0 112.555 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 30.6 tp -67.3 -45.11 49.45 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 119.94 -1.725 . . . . 1.0 114.148 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.97 -41.33 62.86 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 CA-C-O 114.106 -2.539 . . . . 1.0 115.902 169.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -68.84 -34.58 17.72 Favored 'Trans proline' 0 CA--C 1.505 -0.926 0 CA-C-N 127.283 3.637 . . . . 1.0 112.758 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.6 m -59.38 -51.47 69.77 Favored 'General case' 0 N--CA 1.444 -0.742 0 O-C-N 120.575 -1.328 . . . . 1.0 112.01 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.272 0.0 OUTLIER -71.7 -2.32 16.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 115.444 1.646 . . . . 1.0 115.444 170.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.7 -69.89 0.36 Allowed 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 118.934 -2.354 . . . . 1.0 111.173 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -115.63 -29.34 6.49 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 111.627 -2.533 . . . . 1.0 111.965 -160.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -88.48 -32.46 18.24 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 114.12 1.156 . . . . 1.0 114.12 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.88 178.16 47.43 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 117.958 -2.068 . . . . 1.0 115.811 173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -70.88 -46.72 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 C-N-CA 126.215 1.806 . . . . 1.0 113.896 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' NH2' ' CD2' ' A' ' 39' ' ' HIS . 35.6 ttp180 -122.25 20.57 10.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.511 -1.663 . . . . 1.0 106.511 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.44 143.47 40.26 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 115.994 1.85 . . . . 1.0 115.994 -172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -120.36 172.76 15.08 Favored Glycine 0 CA--C 1.478 -2.264 0 N-CA-C 108.574 -1.81 . . . . 1.0 108.574 -165.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -152.13 138.71 18.69 Favored 'General case' 0 N--CA 1.421 -1.921 0 N-CA-C 107.082 -1.451 . . . . 1.0 107.082 -169.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -143.78 169.56 17.54 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 117.945 -1.502 . . . . 1.0 109.843 164.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.4 t -106.41 147.68 28.99 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 124.183 0.993 . . . . 1.0 109.956 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.7 ttt -160.15 148.2 16.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 105.827 -1.916 . . . . 1.0 105.827 159.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.312 0.9 OUTLIER 58.54 27.03 15.09 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.795 1.638 . . . . 1.0 113.435 177.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.36 14.62 77.06 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.134 -1.394 . . . . 1.0 115.936 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -144.85 153.98 42.16 Favored 'General case' 0 N--CA 1.439 -0.994 0 O-C-N 119.695 -2.062 . . . . 1.0 109.123 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.1 t -70.55 157.63 37.55 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 116.552 2.056 . . . . 1.0 116.552 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 94.06 2.6 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.175 -3.639 . . . . 1.0 101.175 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 20.0 t -86.03 137.8 32.43 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 127.436 2.294 . . . . 1.0 112.313 -175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -108.11 98.28 25.67 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 125.5 1.52 . . . . 1.0 108.251 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.69 76.56 4.43 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.14 1.893 . . . . 1.0 112.441 -176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.438 ' CD2' ' NH2' ' A' ' 24' ' ' ARG . 35.0 t60 . . . . . 0 C--O 1.262 1.754 0 O-C-N 121.656 -0.652 . . . . 1.0 112.443 171.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.508 2.428 0 CA-C-O 121.044 0.45 . . . . 1.0 111.494 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 t -142.43 134.82 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 100.38 -3.933 . . . . 1.0 100.38 -175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.01 154.83 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 101.486 -3.524 . . . . 1.0 101.486 166.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.72 45.87 1.21 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.718 2.199 . . . . 1.0 111.16 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.2 t -84.12 113.78 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 103.766 -2.679 . . . . 1.0 103.766 163.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.4 mtmm -93.06 143.02 26.65 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.165 0.983 . . . . 1.0 110.853 -169.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 p -141.04 158.31 44.11 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 117.57 2.433 . . . . 1.0 117.57 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.1 p -111.65 -16.8 13.16 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 112.939 -1.937 . . . . 1.0 110.799 161.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.7 t -135.72 151.23 73.87 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 125.033 1.333 . . . . 1.0 109.516 -171.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.99 -21.32 63.82 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 CA-C-N 122.604 1.966 . . . . 1.0 112.289 165.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -57.51 -49.55 75.96 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-O 122.188 0.994 . . . . 1.0 112.79 -175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -70.18 -10.73 59.74 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.976 1.31 . . . . 1.0 114.323 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.4 t -86.72 -26.05 24.43 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.63 -1.294 . . . . 1.0 108.929 173.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 18.1 tp -65.62 -49.64 60.14 Favored Pre-proline 0 C--N 1.352 0.682 0 CA-C-O 116.561 -1.685 . . . . 1.0 115.177 -169.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -63.31 -40.01 34.49 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 CA-C-N 125.001 2.822 . . . . 1.0 115.391 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.54 -35.88 16.31 Favored 'Trans proline' 0 CA--C 1.502 -1.114 1 CA-C-N 128.491 4.068 . . . . 1.0 112.244 169.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -58.05 -43.21 86.76 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.822 1.296 . . . . 1.0 112.617 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -70.61 -11.56 61.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 116.038 1.866 . . . . 1.0 116.038 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -67.34 0.53 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 124.967 2.318 . . . . 1.0 112.443 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.19 -27.83 8.54 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 111.36 -2.654 . . . . 1.0 111.649 -161.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -96.07 -20.3 18.76 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 113.701 1.0 . . . . 1.0 113.701 -177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.65 149.75 5.11 Favored Glycine 0 CA--C 1.494 -1.271 0 O-C-N 120.53 -1.356 . . . . 1.0 114.457 160.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.08 -37.21 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 O-C-N 119.962 -1.904 . . . . 1.0 112.057 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -81.88 -24.02 35.97 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 119.737 -1.852 . . . . 1.0 111.578 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.7 161.76 1.02 Allowed 'General case' 0 C--N 1.352 0.692 0 N-CA-C 117.868 2.544 . . . . 1.0 117.868 -166.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.45 167.5 12.49 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 109.318 -1.513 . . . . 1.0 109.318 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -150.19 134.03 16.83 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.045 -1.268 . . . . 1.0 108.51 -167.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 156.77 41.44 Favored 'General case' 0 CA--C 1.499 -0.996 0 O-C-N 120.913 -1.117 . . . . 1.0 110.427 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.4 t -98.98 129.17 45.26 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 161.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -158.63 134.5 8.97 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 121.137 -0.977 . . . . 1.0 110.558 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.9 t30 56.54 40.76 29.32 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 126.741 2.016 . . . . 1.0 110.354 -174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.77 15.04 57.24 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 113.809 -1.542 . . . . 1.0 115.704 -175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -138.52 157.92 45.24 Favored 'General case' 0 N--CA 1.437 -1.091 0 O-C-N 119.885 -1.95 . . . . 1.0 109.214 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 45.1 t -65.66 153.59 41.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 123.358 1.552 . . . . 1.0 113.056 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.68 78.22 1.19 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 123.03 1.395 . . . . 1.0 108.45 -166.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 67.9 m -73.63 138.29 44.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 115.957 1.836 . . . . 1.0 115.957 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -105.79 95.13 9.97 Favored Pre-proline 0 N--CA 1.437 -1.106 0 N-CA-C 105.828 -1.916 . . . . 1.0 105.828 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.76 70.2 7.49 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.963 2.442 . . . . 1.0 112.282 -172.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.7 t60 . . . . . 0 C--O 1.258 1.508 0 C-N-CA 124.327 1.051 . . . . 1.0 108.716 176.352 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.507 2.396 0 CA-C-O 120.96 0.41 . . . . 1.0 111.447 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.2 t -143.87 137.79 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 1 N-CA-C 99.979 -4.082 . . . . 1.0 99.979 -176.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.06 159.6 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 C-N-CA 129.495 3.118 . . . . 1.0 102.736 170.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.14 46.46 1.35 Allowed 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 124.428 2.061 . . . . 1.0 110.919 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.17 128.66 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 165.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -114.69 135.83 53.72 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.72 0.772 . . . . 1.0 109.285 -163.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.2 p -150.09 161.77 41.72 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 115.848 1.796 . . . . 1.0 115.848 -164.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -107.17 -26.11 11.24 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-N 113.693 -1.594 . . . . 1.0 109.852 157.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 t -119.21 146.33 40.41 Favored Pre-proline 0 CA--C 1.512 -0.511 0 O-C-N 120.603 -1.311 . . . . 1.0 111.466 -172.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.06 -19.49 63.44 Favored 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 122.032 1.821 . . . . 1.0 112.687 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -58.72 -41.23 85.89 Favored 'General case' 0 C--N 1.344 0.342 0 O-C-N 121.423 -0.798 . . . . 1.0 112.742 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -61.32 -22.14 64.62 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 126.135 1.774 . . . . 1.0 113.879 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 1.6 m -91.61 -16.05 27.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 124.07 0.948 . . . . 1.0 111.899 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 tp -66.87 -51.59 37.34 Favored Pre-proline 0 C--N 1.35 0.607 0 CA-C-O 117.176 -1.393 . . . . 1.0 114.014 -172.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.39 -36.98 52.33 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 CA-C-O 113.1 -2.959 . . . . 1.0 115.623 174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.62 -42.48 2.48 Favored 'Trans proline' 0 CA--C 1.502 -1.109 1 CA-C-N 129.232 4.333 . . . . 1.0 113.176 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -59.23 -48.42 81.7 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.783 -1.198 . . . . 1.0 110.956 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -70.84 -9.8 58.3 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 116.61 2.078 . . . . 1.0 116.61 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.76 -74.65 0.16 Allowed 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 124.792 2.234 . . . . 1.0 112.353 171.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -72.5 -35.22 68.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 111.518 -2.583 . . . . 1.0 110.052 -164.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -107.82 -8.92 15.87 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.896 -1.502 . . . . 1.0 110.544 -174.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.21 -161.9 26.83 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-O 124.539 2.188 . . . . 1.0 117.262 156.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -68.67 -28.24 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 119.715 -2.05 . . . . 1.0 112.591 -167.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -78.48 -30.59 47.41 Favored 'General case' 0 N--CA 1.433 -1.303 0 O-C-N 120.631 -1.293 . . . . 1.0 110.72 176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -68.38 153.49 43.65 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 117.447 2.388 . . . . 1.0 117.447 -164.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.18 179.23 16.49 Favored Glycine 0 CA--C 1.491 -1.432 0 N-CA-C 108.968 -1.653 . . . . 1.0 108.968 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -154.93 127.7 8.08 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 120.547 -1.561 . . . . 1.0 111.203 -157.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.78 161.59 27.02 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 121.076 -1.015 . . . . 1.0 108.582 170.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.8 t -108.49 135.38 49.87 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.57 -1.195 . . . . 1.0 108.089 161.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -156.41 138.43 14.5 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.289 -0.882 . . . . 1.0 109.563 172.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.32 19.27 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.282 1.833 . . . . 1.0 110.447 -177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.96 8.56 69.17 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 124.557 1.075 . . . . 1.0 115.604 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -140.97 164.89 29.04 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 119.974 -1.898 . . . . 1.0 109.138 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -69.84 161.14 30.46 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 117.041 2.238 . . . . 1.0 117.041 -168.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -150.82 82.25 1.34 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.248 -1.76 . . . . 1.0 106.248 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.1 m -75.09 129.13 37.05 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.629 -1.295 . . . . 1.0 114.138 177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -98.84 150.68 36.92 Favored Pre-proline 0 N--CA 1.444 -0.773 0 C-N-CA 124.788 1.235 . . . . 1.0 108.383 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -84.24 45.3 1.7 Allowed 'Trans proline' 0 C--N 1.328 -0.502 0 CA-C-N 123.22 2.186 . . . . 1.0 111.85 162.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.4 t60 . . . . . 0 C--O 1.258 1.525 0 C-N-CA 126.482 1.913 . . . . 1.0 109.189 -177.569 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 121.089 0.471 . . . . 1.0 111.445 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.6 t -144.61 133.49 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 101.767 -3.419 . . . . 1.0 101.767 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 4' ' ' ASP . 0.7 OUTLIER -100.86 -143.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 C-N-CA 126.855 2.062 . . . . 1.0 108.043 177.557 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 3' ' ' ILE . 16.7 t70 -139.29 48.19 1.87 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 124.782 2.229 . . . . 1.0 110.15 163.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -86.78 118.0 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 CA-C-N 113.251 -1.795 . . . . 1.0 106.31 163.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -95.77 141.99 28.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.088 -1.449 . . . . 1.0 107.088 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.65 165.37 35.65 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 115.148 1.536 . . . . 1.0 115.148 -164.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -105.62 -32.8 8.3 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 123.421 1.581 . . . . 1.0 109.896 151.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.4 t -102.94 153.83 37.98 Favored Pre-proline 0 N--CA 1.452 -0.345 0 O-C-N 120.512 -1.368 . . . . 1.0 111.891 -166.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.73 -31.8 68.73 Favored 'Trans proline' 0 CA--C 1.511 -0.653 0 C-N-CA 121.784 1.656 . . . . 1.0 112.812 159.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -62.42 -37.58 86.36 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.924 0.784 . . . . 1.0 112.981 -169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -57.22 -27.87 62.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.945 1.698 . . . . 1.0 113.922 175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 t -96.41 -13.83 22.89 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 121.301 -0.874 . . . . 1.0 112.245 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.47 -46.87 69.64 Favored Pre-proline 0 C--N 1.345 0.401 0 CA-C-O 116.807 -1.568 . . . . 1.0 113.936 -164.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.15 -48.78 14.62 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-N 124.121 2.507 . . . . 1.0 115.895 174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.85 -37.96 10.75 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 CA-C-N 127.254 3.627 . . . . 1.0 112.648 174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.7 t -59.48 -37.29 77.86 Favored 'General case' 0 N--CA 1.44 -0.95 0 O-C-N 120.514 -1.367 . . . . 1.0 112.183 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -26.43 63.69 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 115.413 1.634 . . . . 1.0 115.413 174.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.89 -67.3 0.54 Allowed 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 124.811 2.243 . . . . 1.0 113.14 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -84.86 -37.42 20.69 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.417 -2.629 . . . . 1.0 109.485 -166.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.61 -12.28 13.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.447 1.647 . . . . 1.0 115.447 -160.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.66 149.28 5.04 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 120.593 -1.317 . . . . 1.0 114.631 158.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.36 -40.5 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 O-C-N 119.845 -1.973 . . . . 1.0 112.837 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -84.14 -22.4 31.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 119.713 -1.867 . . . . 1.0 110.881 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.8 159.22 0.57 Allowed 'General case' 0 C--N 1.351 0.644 0 N-CA-C 117.788 2.514 . . . . 1.0 117.788 -167.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.03 164.64 12.07 Favored Glycine 0 CA--C 1.48 -2.117 0 N-CA-C 109.346 -1.501 . . . . 1.0 109.346 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.54 133.37 20.1 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 106.23 -1.767 . . . . 1.0 106.23 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -148.06 154.36 40.13 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.782 -1.562 . . . . 1.0 106.782 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.1 t -98.59 144.25 28.1 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.259 -1.525 . . . . 1.0 112.134 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 25.4 ttt -163.13 144.11 9.49 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 120.628 -1.295 . . . . 1.0 110.917 170.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.48 37.06 19.98 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 125.308 1.443 . . . . 1.0 110.419 178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.01 -8.96 48.67 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 114.598 -1.183 . . . . 1.0 115.891 -177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -146.95 168.99 20.12 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 120.855 2.327 . . . . 1.0 111.63 -174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.47 162.51 17.75 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 116.336 1.976 . . . . 1.0 116.336 -168.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -146.12 89.8 1.91 Allowed 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 130.113 3.365 . . . . 1.0 102.778 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.7 m -77.89 132.85 38.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.153 1.781 . . . . 1.0 112.195 173.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -108.56 97.16 21.89 Favored Pre-proline 0 N--CA 1.44 -0.963 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.68 69.95 7.72 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.996 2.464 . . . . 1.0 111.338 -175.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 . . . . . 0 C--O 1.257 1.487 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 170.655 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 N--CA 1.503 2.186 0 CA-C-O 121.507 0.67 . . . . 1.0 111.674 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.0 t -128.3 134.73 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 1 N-CA-C 98.763 -4.532 . . . . 1.0 98.763 169.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.45 160.64 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 N-CA-C 102.703 -3.073 . . . . 1.0 102.703 173.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.9 42.46 1.1 Allowed 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 124.959 2.314 . . . . 1.0 110.831 172.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.2 t -87.11 115.1 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 N-CA-C 104.463 -2.421 . . . . 1.0 104.463 168.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -101.94 139.92 36.93 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 122.182 0.991 . . . . 1.0 108.479 -172.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.87 153.86 40.64 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 116.652 2.093 . . . . 1.0 116.652 -160.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.8 p -111.14 0.83 16.98 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 127.017 2.127 . . . . 1.0 110.449 172.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.8 m -171.18 153.68 3.8 Favored Pre-proline 0 CA--C 1.51 -0.594 0 O-C-N 120.714 -1.241 . . . . 1.0 108.782 -171.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -65.78 -32.08 47.25 Favored 'Trans proline' 0 CA--C 1.517 -0.356 0 C-N-CA 123.009 2.472 . . . . 1.0 111.919 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -46.68 -45.76 19.6 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 127.403 2.281 . . . . 1.0 112.947 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -67.39 -17.59 64.79 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.761 1.224 . . . . 1.0 114.013 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.7 t -101.55 -7.32 22.88 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.405 -0.81 . . . . 1.0 112.698 174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.93 -46.43 64.7 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 120.032 -1.667 . . . . 1.0 113.524 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.17 -45.7 29.88 Favored 'Trans proline' 0 CA--C 1.533 0.459 0 CA-C-O 114.019 -2.576 . . . . 1.0 115.814 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -67.51 -35.86 21.71 Favored 'Trans proline' 0 CA--C 1.506 -0.883 0 CA-C-N 127.408 3.681 . . . . 1.0 112.722 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.3 m -56.93 -46.39 82.09 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 122.955 1.36 . . . . 1.0 112.119 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -9.84 58.77 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 117.315 2.339 . . . . 1.0 117.315 172.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -65.84 0.7 Allowed 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 124.287 1.994 . . . . 1.0 110.58 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -114.8 -33.84 5.34 Favored 'General case' 0 N--CA 1.42 -1.967 0 CA-C-N 112.316 -2.22 . . . . 1.0 111.377 -169.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -94.08 -18.05 22.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.796 1.406 . . . . 1.0 114.796 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.76 168.09 41.05 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 116.662 -2.685 . . . . 1.0 116.234 167.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.2 tt -70.19 -50.07 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 125.339 1.456 . . . . 1.0 111.191 -170.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.585 HH12 ' CD2' ' A' ' 39' ' ' HIS . 3.7 ttp-105 -127.8 32.23 4.99 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.044 -1.465 . . . . 1.0 107.044 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.57 152.18 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 N-CA-C 119.219 3.044 . . . . 1.0 119.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.47 12.34 Favored Glycine 0 CA--C 1.48 -2.103 0 N-CA-C 108.713 -1.755 . . . . 1.0 108.713 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.19 130.74 9.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.294 -1.373 . . . . 1.0 107.294 -170.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 166.69 26.69 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 120.455 -1.403 . . . . 1.0 109.361 172.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 t -120.78 135.99 55.01 Favored 'General case' 0 N--CA 1.442 -0.859 0 C-N-CA 123.242 0.617 . . . . 1.0 110.897 -164.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.23 145.67 19.51 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 124.39 1.076 . . . . 1.0 108.272 169.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.63 32.08 20.29 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 126.307 1.843 . . . . 1.0 110.419 -173.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.67 19.46 62.81 Favored Glycine 0 C--N 1.347 1.148 0 C-N-CA 124.855 1.217 . . . . 1.0 115.468 -174.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -147.53 151.87 37.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 O-C-N 119.662 -2.081 . . . . 1.0 108.876 -173.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -69.17 162.7 26.49 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.069 2.248 . . . . 1.0 117.069 -169.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.74 95.7 2.55 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.324 -3.213 . . . . 1.0 102.324 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.1 t -87.34 132.68 33.87 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.557 2.343 . . . . 1.0 112.426 -174.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -102.67 111.57 64.9 Favored Pre-proline 0 N--CA 1.437 -1.078 0 N-CA-C 106.958 -1.497 . . . . 1.0 106.958 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -86.98 59.36 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.382 2.054 . . . . 1.0 112.389 -167.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.585 ' CD2' HH12 ' A' ' 24' ' ' ARG . 35.4 t60 . . . . . 0 C--O 1.26 1.606 0 C-N-CA 125.942 1.697 . . . . 1.0 106.669 -173.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.506 2.352 0 N-CA-C 112.128 0.418 . . . . 1.0 112.128 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 p -161.04 155.19 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.91 0 N-CA-C 102.019 -3.326 . . . . 1.0 102.019 171.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.64 154.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.623 0 N-CA-C 101.472 -3.529 . . . . 1.0 101.472 160.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.64 41.9 1.06 Allowed 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 124.369 2.033 . . . . 1.0 112.191 -178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.0 t -90.54 115.26 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 104.574 -2.38 . . . . 1.0 104.574 167.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -103.09 137.02 41.82 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 -163.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 p -140.5 150.81 44.22 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 118.159 2.651 . . . . 1.0 118.159 -163.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 p -115.15 9.46 15.86 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 128.002 2.521 . . . . 1.0 109.639 172.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.6 m -167.49 150.31 5.72 Favored Pre-proline 0 CA--C 1.511 -0.534 0 O-C-N 119.608 -1.933 . . . . 1.0 108.536 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.65 -24.58 35.16 Favored 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.509 2.139 . . . . 1.0 111.93 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -48.86 -44.46 39.79 Favored 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.521 1.929 . . . . 1.0 112.84 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -65.86 -18.3 65.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.026 1.331 . . . . 1.0 113.553 -175.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 40.1 t -83.64 -25.19 30.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.265 1.026 . . . . 1.0 111.344 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.06 -52.48 30.66 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-O 117.16 -1.4 . . . . 1.0 114.331 -168.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.58 -38.79 39.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-O 113.127 -2.947 . . . . 1.0 115.433 175.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.94 -37.26 8.97 Favored 'Trans proline' 0 CA--C 1.502 -1.103 1 CA-C-N 129.365 4.38 . . . . 1.0 112.265 172.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.07 -44.3 82.94 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 122.379 1.085 . . . . 1.0 111.793 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -70.72 -17.73 62.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 116.461 2.023 . . . . 1.0 116.461 174.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -68.25 0.48 Allowed 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 124.899 2.285 . . . . 1.0 113.005 -175.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -102.08 -38.57 7.67 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 111.05 -2.796 . . . . 1.0 110.142 -161.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -95.06 -45.11 7.37 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.564 -166.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.94 142.87 4.41 Favored Glycine 0 CA--C 1.491 -1.426 0 C-N-CA 118.556 -1.783 . . . . 1.0 114.795 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.11 -38.03 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 O-C-N 120.082 -1.834 . . . . 1.0 112.393 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.443 ' HE ' ' C ' ' A' ' 39' ' ' HIS . 6.9 tmm_? -81.49 -23.62 37.24 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 120.307 -1.496 . . . . 1.0 111.663 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.76 156.38 0.2 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 118.624 2.824 . . . . 1.0 118.624 -167.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -104.85 162.4 14.72 Favored Glycine 0 CA--C 1.475 -2.418 0 N-CA-C 107.854 -2.098 . . . . 1.0 107.854 -176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.66 6.05 Favored 'General case' 0 N--CA 1.436 -1.155 0 O-C-N 119.911 -1.935 . . . . 1.0 107.56 -163.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.45 170.14 21.45 Favored 'General case' 0 CA--C 1.496 -1.109 0 C-N-CA 117.76 -1.576 . . . . 1.0 110.792 171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.0 t -94.81 133.8 38.13 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.036 -0.728 . . . . 1.0 109.036 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 19.1 ttt -153.61 133.74 13.32 Favored 'General case' 0 N--CA 1.428 -1.564 0 O-C-N 121.025 -1.047 . . . . 1.0 109.598 175.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.367 1.0 OUTLIER 53.48 32.68 14.53 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 128.473 2.709 . . . . 1.0 112.863 -172.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.74 10.02 86.56 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 113.712 -1.585 . . . . 1.0 115.403 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -136.85 157.31 47.04 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 120.298 2.049 . . . . 1.0 109.708 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.7 t -70.65 141.62 51.65 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 123.926 1.822 . . . . 1.0 113.819 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.72 84.25 2.09 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 102.125 -3.287 . . . . 1.0 102.125 -171.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -78.19 132.78 37.75 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.531 1.533 . . . . 1.0 110.551 171.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.98 95.05 19.31 Favored Pre-proline 0 N--CA 1.434 -1.238 0 C-N-CA 126.119 1.768 . . . . 1.0 106.248 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.19 73.1 5.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.77 2.313 . . . . 1.0 112.389 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' C ' ' HE ' ' A' ' 24' ' ' ARG . 11.5 t-160 . . . . . 0 C--O 1.259 1.592 0 N-CA-C 108.304 -0.999 . . . . 1.0 108.304 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.2 p . . . . . 0 N--CA 1.51 2.525 0 CA-C-O 120.786 0.327 . . . . 1.0 111.168 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.0 t -134.53 138.56 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 1 N-CA-C 97.697 -4.927 . . . . 1.0 97.697 173.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.84 156.27 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 101.547 -3.501 . . . . 1.0 101.547 176.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -93.71 51.31 1.55 Allowed 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 125.08 2.372 . . . . 1.0 110.718 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.5 t -90.29 102.79 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 104.885 -2.265 . . . . 1.0 104.885 162.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 0.1 OUTLIER -74.36 136.12 42.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 123.765 1.745 . . . . 1.0 112.606 -176.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -100.49 154.15 18.78 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.144 1.926 . . . . 1.0 114.165 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.52 3.18 5.59 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.6 1.96 . . . . 1.0 107.862 172.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 m -177.14 157.02 1.28 Allowed Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 104.032 -2.581 . . . . 1.0 104.032 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -70.4 -23.18 28.17 Favored 'Trans proline' 0 CA--C 1.51 -0.678 0 CA-C-N 123.277 2.206 . . . . 1.0 111.999 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -57.67 -42.15 82.96 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 122.082 0.944 . . . . 1.0 113.057 -174.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -70.58 -7.41 43.79 Favored 'General case' 0 C--N 1.344 0.337 0 N-CA-C 114.973 1.472 . . . . 1.0 114.973 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 t -82.44 -25.71 33.38 Favored 'General case' 0 C--N 1.348 0.517 0 O-C-N 120.95 -1.094 . . . . 1.0 110.297 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.86 -48.23 62.77 Favored Pre-proline 0 C--N 1.354 0.777 0 O-C-N 119.628 -1.92 . . . . 1.0 114.446 -175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -62.76 -37.5 55.62 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 CA-C-O 113.216 -2.91 . . . . 1.0 115.237 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.6 -37.06 17.66 Favored 'Trans proline' 0 CA--C 1.503 -1.043 1 CA-C-N 129.054 4.269 . . . . 1.0 112.48 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 73.6 m -57.92 -39.17 77.35 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 120.81 -1.181 . . . . 1.0 112.335 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 -13.34 62.02 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 116.917 2.192 . . . . 1.0 116.917 174.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.96 72.31 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 123.158 1.456 . . . . 1.0 113.558 -170.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -164.08 -27.79 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.074 -1.421 . . . . 1.0 111.719 -171.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -79.79 -17.74 52.67 Favored 'General case' 0 N--CA 1.437 -1.114 0 O-C-N 120.228 -1.545 . . . . 1.0 113.004 -174.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.12 154.35 7.29 Favored Glycine 0 C--N 1.348 1.202 0 O-C-N 121.058 -1.026 . . . . 1.0 112.861 154.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 tt -70.21 -43.17 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 O-C-N 119.914 -1.933 . . . . 1.0 112.554 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -75.91 -28.31 57.99 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.664 -1.897 . . . . 1.0 111.134 173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.4 151.46 0.37 Allowed 'General case' 0 C--N 1.35 0.589 0 N-CA-C 118.811 2.893 . . . . 1.0 118.811 -162.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.69 175.62 21.74 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 -169.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.16 131.95 11.55 Favored 'General case' 0 N--CA 1.434 -1.255 0 O-C-N 121.33 -1.1 . . . . 1.0 110.06 -166.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.88 154.24 45.72 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 120.902 -1.123 . . . . 1.0 111.308 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.31 117.04 34.18 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.239 -1.023 . . . . 1.0 108.239 164.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -147.32 136.36 22.31 Favored 'General case' 0 CA--C 1.505 -0.762 0 O-C-N 120.519 -1.363 . . . . 1.0 110.296 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.417 0.9 OUTLIER 53.23 30.4 9.92 Favored 'General case' 0 C--N 1.345 0.371 0 C-N-CA 128.106 2.562 . . . . 1.0 112.955 -170.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.45 6.28 89.0 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 113.744 -1.571 . . . . 1.0 115.647 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.58 152.4 51.89 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 119.855 1.827 . . . . 1.0 108.995 -173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.5 t -70.72 143.09 51.41 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 116.333 1.975 . . . . 1.0 116.333 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -137.98 81.59 1.87 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.34 2.256 . . . . 1.0 107.365 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 82.6 m -70.11 132.1 45.31 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 115.206 1.558 . . . . 1.0 115.206 174.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -96.63 101.08 8.23 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -80.93 73.4 6.04 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 CA-C-N 122.719 2.007 . . . . 1.0 111.745 -173.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.8 t60 . . . . . 0 C--O 1.261 1.703 0 CA-C-O 118.719 -0.658 . . . . 1.0 109.262 173.215 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 121.073 0.463 . . . . 1.0 110.499 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.0 t -135.65 127.42 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 100.773 -3.788 . . . . 1.0 100.773 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.81 -149.24 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 126.279 1.832 . . . . 1.0 106.822 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -142.38 37.37 1.52 Allowed 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 124.896 2.284 . . . . 1.0 110.389 167.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.1 t -83.14 119.03 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 112.241 -2.254 . . . . 1.0 106.622 172.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -102.23 143.16 32.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.828 0.823 . . . . 1.0 109.13 -170.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.5 149.67 41.19 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 117.574 2.435 . . . . 1.0 117.574 -162.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.6 p -110.44 3.31 19.55 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 127.642 2.377 . . . . 1.0 109.73 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 m -177.55 146.35 0.61 Allowed Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 105.723 -1.954 . . . . 1.0 105.723 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -65.03 -26.85 57.99 Favored 'Trans proline' 0 CA--C 1.513 -0.557 0 CA-C-N 123.871 2.418 . . . . 1.0 112.846 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -54.74 -30.84 57.36 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 125.789 1.636 . . . . 1.0 113.802 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -62.32 -26.38 68.4 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 121.052 -1.03 . . . . 1.0 113.439 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 37.4 t -100.13 -1.15 37.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.302 -0.874 . . . . 1.0 112.567 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 48.2 tp -62.52 -49.39 83.58 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 120.295 -1.503 . . . . 1.0 113.695 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -64.28 -34.13 56.91 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-O 113.15 -2.938 . . . . 1.0 115.477 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.38 -36.41 9.2 Favored 'Trans proline' 0 CA--C 1.507 -0.874 1 CA-C-N 129.094 4.284 . . . . 1.0 112.91 169.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.1 m -58.6 -52.37 65.93 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 120.542 -1.349 . . . . 1.0 111.558 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -71.76 -1.98 15.9 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 115.235 1.569 . . . . 1.0 115.235 171.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.67 -69.32 0.39 Allowed 'General case' 0 CA--C 1.508 -0.654 0 O-C-N 118.981 -2.325 . . . . 1.0 111.003 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -115.41 -29.89 6.4 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 111.547 -2.569 . . . . 1.0 112.056 -162.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -92.74 -23.38 18.92 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 115.063 1.505 . . . . 1.0 115.063 -167.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.8 176.33 47.91 Favored Glycine 0 C--N 1.345 1.055 0 O-C-N 119.842 -1.787 . . . . 1.0 115.231 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -70.53 -45.44 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 C-N-CA 126.224 1.81 . . . . 1.0 114.136 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.444 ' NH2' ' CD2' ' A' ' 39' ' ' HIS . 29.7 ttp180 -120.61 13.61 11.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.736 1.614 . . . . 1.0 107.034 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.31 145.77 25.95 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.143 1.905 . . . . 1.0 116.143 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -144.57 178.17 22.64 Favored Glycine 0 CA--C 1.479 -2.158 0 N-CA-C 109.707 -1.357 . . . . 1.0 109.707 -163.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.42 141.89 31.02 Favored 'General case' 0 N--CA 1.423 -1.817 0 O-C-N 120.569 -1.548 . . . . 1.0 110.116 -163.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -111.85 139.91 46.94 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 106.916 -1.513 . . . . 1.0 106.916 167.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.5 t -101.14 130.76 47.26 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.4 ttt -150.06 137.82 20.04 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 120.751 -1.218 . . . . 1.0 109.59 171.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.44 27.26 16.22 Favored 'General case' 0 C--N 1.343 0.322 0 C-N-CA 125.558 1.543 . . . . 1.0 111.23 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 10.05 86.5 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-N 114.774 -1.103 . . . . 1.0 115.652 -175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -141.36 151.54 43.62 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.681 2.24 . . . . 1.0 110.536 -177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.4 t -70.32 153.75 42.68 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 118.025 2.602 . . . . 1.0 118.025 -174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -144.6 92.06 2.25 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 127.394 2.278 . . . . 1.0 105.016 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 t -77.96 137.35 38.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 128.55 2.74 . . . . 1.0 114.782 -172.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-30 -100.2 102.1 16.94 Favored Pre-proline 0 N--CA 1.441 -0.888 0 C-N-CA 126.595 1.958 . . . . 1.0 106.324 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -85.12 72.38 4.62 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 121.978 1.742 . . . . 1.0 111.859 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.444 ' CD2' ' NH2' ' A' ' 24' ' ' ARG . 35.4 t60 . . . . . 0 C--O 1.259 1.601 0 O-C-N 121.59 -0.694 . . . . 1.0 112.468 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.503 2.187 0 CA-C-O 121.173 0.511 . . . . 1.0 111.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 68.9 t -133.89 136.27 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 N-CA-C 98.671 -4.566 . . . . 1.0 98.671 173.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.34 155.9 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.449 0 N-CA-C 101.377 -3.564 . . . . 1.0 101.377 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.61 47.36 1.23 Allowed 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 124.353 2.025 . . . . 1.0 110.946 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.96 122.88 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 170.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -93.8 144.24 25.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.137 0.97 . . . . 1.0 110.81 -169.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -147.47 155.66 42.12 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.729 1.728 . . . . 1.0 115.395 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 t -110.71 -24.92 10.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 113.211 -1.813 . . . . 1.0 109.849 156.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 t -118.06 146.99 40.44 Favored Pre-proline 0 CA--C 1.512 -0.498 0 O-C-N 120.178 -1.576 . . . . 1.0 110.296 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -65.14 -17.0 57.67 Favored 'Trans proline' 0 CA--C 1.515 -0.446 0 C-N-CA 122.219 1.946 . . . . 1.0 112.049 166.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -59.41 -42.4 91.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 120.626 -1.296 . . . . 1.0 112.504 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -64.45 -16.78 63.03 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 126.04 1.736 . . . . 1.0 113.986 176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.638 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -83.34 -28.25 29.13 Favored 'General case' 0 N--CA 1.436 -1.144 0 O-C-N 121.114 -0.991 . . . . 1.0 111.063 176.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.3 -53.61 10.22 Favored Pre-proline 0 C--N 1.351 0.635 0 N-CA-C 114.471 1.286 . . . . 1.0 114.471 -160.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -57.35 -46.11 30.13 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 CA-C-O 114.344 -2.44 . . . . 1.0 115.406 173.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -67.11 -37.48 18.61 Favored 'Trans proline' 0 CA--C 1.504 -1.017 0 CA-C-N 127.007 3.538 . . . . 1.0 112.398 175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 2.6 t -64.41 -37.36 87.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 120.323 -1.485 . . . . 1.0 112.771 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -70.73 -11.63 61.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 116.827 2.158 . . . . 1.0 116.827 170.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.53 -33.82 71.59 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 123.148 1.451 . . . . 1.0 113.416 -168.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -164.4 -27.96 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 113.911 -1.495 . . . . 1.0 111.378 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -78.5 -14.92 59.13 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.176 -1.578 . . . . 1.0 113.291 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.11 154.79 7.2 Favored Glycine 0 CA--C 1.494 -1.238 0 CA-C-O 122.336 0.965 . . . . 1.0 113.108 149.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -70.19 -41.88 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 O-C-N 120.742 -1.446 . . . . 1.0 112.603 -174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -91.02 -18.56 24.41 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.961 -1.087 . . . . 1.0 110.978 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.78 144.35 1.76 Allowed 'General case' 0 C--N 1.352 0.703 0 N-CA-C 117.612 2.449 . . . . 1.0 117.612 -165.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.18 164.35 25.9 Favored Glycine 0 CA--C 1.475 -2.407 0 N-CA-C 107.47 -2.252 . . . . 1.0 107.47 -172.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -159.95 125.2 4.02 Favored 'General case' 0 N--CA 1.434 -1.236 0 O-C-N 121.225 -1.162 . . . . 1.0 109.595 -168.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 169.65 22.04 Favored 'General case' 0 CA--C 1.499 -1.013 0 O-C-N 120.723 -1.235 . . . . 1.0 109.65 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.8 t -100.2 139.29 36.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 121.609 -0.682 . . . . 1.0 112.443 -174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.8 ttt -162.94 148.4 11.91 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.343 1.057 . . . . 1.0 108.565 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 63.2 28.78 15.97 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 123.226 1.489 . . . . 1.0 110.208 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.16 12.38 57.73 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.602 1.096 . . . . 1.0 115.53 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -149.3 165.19 32.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 120.023 1.911 . . . . 1.0 110.536 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.0 t -69.52 153.96 42.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 115.144 1.535 . . . . 1.0 115.144 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.87 85.4 1.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.582 -2.747 . . . . 1.0 103.582 -173.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.4 m -76.56 127.42 32.78 Favored 'General case' 0 N--CA 1.432 -1.348 0 C-N-CA 126.262 1.825 . . . . 1.0 112.681 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.56 102.41 14.57 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 105.729 -1.952 . . . . 1.0 105.729 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -83.95 66.14 7.13 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.216 1.944 . . . . 1.0 112.141 -166.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.7 t60 . . . . . 0 C--O 1.259 1.602 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 170.618 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.256 0.551 . . . . 1.0 111.38 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.59 136.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 -176.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -83.64 42.19 1.19 Allowed 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 . . . . . 0 N--CA 1.429 -1.525 0 C-N-CA 126.935 2.094 . . . . 1.0 109.715 -172.724 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.504 2.269 0 CA-C-O 121.256 0.551 . . . . 1.0 111.38 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.59 136.02 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 1 N-CA-C 100.09 -4.041 . . . . 1.0 100.09 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.51 156.34 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 101.981 -3.341 . . . . 1.0 101.981 164.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.41 45.4 1.23 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 124.16 1.933 . . . . 1.0 111.382 174.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.6 t -84.99 116.65 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.92 -2.252 . . . . 1.0 104.92 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -101.31 139.3 37.18 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.424 1.107 . . . . 1.0 109.257 -170.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 p -154.6 162.87 40.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 116.428 2.01 . . . . 1.0 116.428 -160.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.2 t -109.21 -16.94 13.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 113.612 -1.631 . . . . 1.0 110.204 165.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.4 t -140.21 150.06 60.28 Favored Pre-proline 0 CA--C 1.51 -0.569 0 O-C-N 120.476 -1.39 . . . . 1.0 108.522 -174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.23 -20.36 69.78 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 C-N-CA 122.251 1.968 . . . . 1.0 112.642 167.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -51.09 -45.17 61.4 Favored 'General case' 0 C--N 1.348 0.531 0 C-N-CA 124.817 1.247 . . . . 1.0 113.066 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -64.66 -22.45 66.98 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.928 1.691 . . . . 1.0 113.409 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 15.1 t -97.97 -7.54 29.83 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.48 -0.763 . . . . 1.0 111.799 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.45 -50.12 67.94 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 119.96 -1.713 . . . . 1.0 113.472 -173.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.33 -46.0 33.65 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 CA-C-O 114.198 -2.501 . . . . 1.0 115.94 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -68.39 -37.29 13.77 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-N 126.983 3.53 . . . . 1.0 113.018 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.77 -38.52 90.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 O-C-N 120.503 -1.373 . . . . 1.0 111.905 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.15 -7.57 47.56 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 116.191 1.923 . . . . 1.0 116.191 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.37 -62.69 1.31 Allowed 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 123.952 1.834 . . . . 1.0 113.026 -171.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -26.05 2.01 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 112.924 -1.943 . . . . 1.0 113.134 -166.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.85 -33.74 62.17 Favored 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 120.11 -1.618 . . . . 1.0 108.835 160.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.39 -154.07 16.88 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-O 123.888 1.827 . . . . 1.0 116.987 138.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.05 -33.55 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.932 0 O-C-N 120.041 -1.858 . . . . 1.0 112.944 -163.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -75.56 -36.42 60.4 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 120.793 -1.192 . . . . 1.0 110.171 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.13 163.67 14.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 118.058 2.614 . . . . 1.0 118.058 -159.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.8 168.84 30.59 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 108.085 -2.006 . . . . 1.0 108.085 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -130.84 150.04 52.2 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 120.663 -1.492 . . . . 1.0 109.633 -168.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 152.92 34.94 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 166.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -108.88 125.86 52.44 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 162.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -154.97 144.55 21.38 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.461 -0.775 . . . . 1.0 108.964 174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.43 29.77 18.61 Favored 'General case' 0 C--N 1.349 0.576 0 C-N-CA 126.458 1.903 . . . . 1.0 110.219 -170.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.13 9.9 61.17 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 124.777 1.18 . . . . 1.0 115.764 -173.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -140.55 159.64 41.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 120.41 2.105 . . . . 1.0 108.588 -175.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.8 t -68.84 164.15 22.65 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.131 -1.605 . . . . 1.0 115.219 -171.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.4 mtmm -159.29 96.98 1.33 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.128 2.171 . . . . 1.0 107.449 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m -83.65 134.23 34.79 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 128.511 2.724 . . . . 1.0 113.321 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -104.93 138.41 19.5 Favored Pre-proline 0 N--CA 1.434 -1.255 0 C-N-CA 126.282 1.833 . . . . 1.0 106.258 177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -83.64 42.19 1.19 Allowed 'Trans proline' 0 CA--C 1.511 -0.635 0 CA-C-N 124.416 2.613 . . . . 1.0 111.421 162.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 t-80 . . . . . 0 N--CA 1.429 -1.525 0 C-N-CA 126.935 2.094 . . . . 1.0 109.715 -172.724 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.517 2.879 0 N-CA-C 110.744 -0.095 . . . . 1.0 110.744 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -155.89 137.91 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 1 N-CA-C 100.15 -4.019 . . . . 1.0 100.15 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.05 152.69 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.363 0 N-CA-C 100.824 -3.769 . . . . 1.0 100.824 154.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -99.23 50.11 0.95 Allowed 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 124.268 1.985 . . . . 1.0 111.382 -176.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.73 117.28 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 105.012 -2.218 . . . . 1.0 105.012 163.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.74 143.77 26.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.584 0.707 . . . . 1.0 111.291 -167.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.98 153.57 40.22 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 116.36 1.985 . . . . 1.0 116.36 -171.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.7 m -94.0 -41.69 9.44 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 112.146 -2.297 . . . . 1.0 109.027 156.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -108.94 148.4 37.82 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.451 -165.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -62.73 -23.92 74.61 Favored 'Trans proline' 0 CA--C 1.51 -0.704 0 C-N-CA 121.775 1.65 . . . . 1.0 112.656 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -63.95 -33.96 76.91 Favored 'General case' 0 C--N 1.343 0.296 0 O-C-N 121.064 -1.023 . . . . 1.0 113.223 -178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -64.36 -15.32 60.21 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.549 1.14 . . . . 1.0 113.848 174.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.5 t -89.14 -21.68 23.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.841 -1.162 . . . . 1.0 111.477 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.95 -52.85 46.64 Favored Pre-proline 0 N--CA 1.439 -0.996 0 O-C-N 120.441 -1.412 . . . . 1.0 113.804 -174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.23 -36.59 45.63 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 CA-C-O 112.877 -3.051 . . . . 1.0 115.263 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -69.86 -39.7 6.0 Favored 'Trans proline' 0 CA--C 1.504 -0.979 1 CA-C-N 129.456 4.413 . . . . 1.0 112.426 170.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.9 t -57.2 -49.73 75.07 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 123.71 1.719 . . . . 1.0 111.861 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -71.54 -8.78 56.12 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 115.905 1.817 . . . . 1.0 115.905 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.43 -68.46 0.45 Allowed 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 124.237 1.97 . . . . 1.0 110.986 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -106.83 -44.73 4.36 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-N 111.997 -2.365 . . . . 1.0 110.594 -167.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -87.84 -24.89 23.56 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 113.427 0.899 . . . . 1.0 113.427 -154.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.0 167.22 39.99 Favored Glycine 0 CA--C 1.49 -1.499 0 C-N-CA 115.297 -3.335 . . . . 1.0 118.314 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.21 -61.0 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 C-N-CA 124.772 1.229 . . . . 1.0 112.3 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -105.18 10.44 33.78 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 124.465 1.106 . . . . 1.0 109.659 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 146.2 39.25 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 115.167 1.543 . . . . 1.0 115.167 -168.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.86 167.25 19.62 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 107.754 -2.139 . . . . 1.0 107.754 -176.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.18 127.02 4.96 Favored 'General case' 0 N--CA 1.435 -1.2 0 O-C-N 119.963 -1.904 . . . . 1.0 109.674 -162.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.38 173.41 14.56 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 120.615 -1.303 . . . . 1.0 111.351 175.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -101.46 139.89 36.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.679 0.792 . . . . 1.0 110.112 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.5 ttt -164.68 145.9 7.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.249 1.42 . . . . 1.0 108.629 170.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 62.84 28.15 16.3 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-O 123.161 1.458 . . . . 1.0 110.368 -174.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.72 62.25 Favored Glycine 0 C--N 1.347 1.156 0 C-N-CA 124.246 0.927 . . . . 1.0 115.252 -173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -149.93 162.88 39.48 Favored 'General case' 0 N--CA 1.439 -1.014 0 O-C-N 120.228 -1.748 . . . . 1.0 110.916 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.3 t -64.58 152.36 42.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.918 1.818 . . . . 1.0 115.023 -171.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -142.89 85.88 1.9 Allowed 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 104.357 -2.46 . . . . 1.0 104.357 -176.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.2 t -80.91 128.28 33.5 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.075 0.95 . . . . 1.0 111.568 172.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -110.96 95.72 25.84 Favored Pre-proline 0 N--CA 1.44 -0.956 0 C-N-CA 126.206 1.802 . . . . 1.0 109.125 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.71 67.3 8.47 Favored 'Trans proline' 0 C--N 1.33 -0.423 0 C-N-CA 122.776 2.318 . . . . 1.0 111.597 167.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 . . . . . 0 C--O 1.26 1.631 0 N-CA-C 105.96 -1.867 . . . . 1.0 105.96 176.698 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 N--CA 1.512 2.642 0 CA-C-O 121.767 0.794 . . . . 1.0 112.285 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.44 127.9 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 N-CA-C 99.17 -4.382 . . . . 1.0 99.17 168.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.07 153.59 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.665 0 N-CA-C 100.7 -3.815 . . . . 1.0 100.7 175.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -97.27 52.01 1.12 Allowed 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 124.64 2.162 . . . . 1.0 110.308 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.5 t -80.55 123.7 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 N-CA-C 105.399 -2.075 . . . . 1.0 105.399 163.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -80.15 142.91 34.32 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.728 0.775 . . . . 1.0 110.524 -173.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -140.47 149.95 43.17 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 124.184 1.945 . . . . 1.0 116.088 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.0 m -114.25 -9.22 12.87 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 129.424 3.09 . . . . 1.0 107.97 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -174.18 158.15 2.66 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.568 1.547 . . . . 1.0 107.285 -166.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.28 -28.76 33.18 Favored 'Trans proline' 0 CA--C 1.512 -0.588 0 C-N-CA 122.296 1.997 . . . . 1.0 112.329 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -55.0 -40.01 69.68 Favored 'General case' 0 C--N 1.347 0.494 0 C-N-CA 125.311 1.444 . . . . 1.0 113.313 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -59.2 -29.0 67.17 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 125.145 1.378 . . . . 1.0 114.079 178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 t -99.21 -3.48 34.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.121 -0.987 . . . . 1.0 113.094 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.75 -51.55 75.3 Favored Pre-proline 0 N--CA 1.451 -0.418 0 O-C-N 120.247 -1.533 . . . . 1.0 113.851 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.99 -37.94 50.0 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 CA-C-O 113.187 -2.922 . . . . 1.0 115.712 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -68.74 -38.31 10.58 Favored 'Trans proline' 0 CA--C 1.508 -0.825 1 CA-C-N 129.134 4.298 . . . . 1.0 112.701 171.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.1 t -58.63 -50.7 72.9 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.351 1.548 . . . . 1.0 111.747 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.76 -0.9 12.19 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 116.762 2.134 . . . . 1.0 116.762 172.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.56 -43.02 70.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 123.463 1.602 . . . . 1.0 112.316 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -156.26 -26.55 0.1 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.686 -1.597 . . . . 1.0 112.174 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -78.93 -19.75 51.0 Favored 'General case' 0 N--CA 1.433 -1.282 0 O-C-N 119.959 -1.713 . . . . 1.0 113.19 -169.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.4 157.5 26.23 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 117.851 -2.119 . . . . 1.0 114.622 157.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 tt -69.53 -35.45 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 O-C-N 120.511 -1.582 . . . . 1.0 112.249 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -112.76 10.76 19.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.695 1.598 . . . . 1.0 110.882 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.03 155.52 34.43 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 115.931 1.826 . . . . 1.0 115.931 -166.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.56 166.05 27.83 Favored Glycine 0 CA--C 1.481 -2.084 0 N-CA-C 106.942 -2.463 . . . . 1.0 106.942 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.31 154.5 50.85 Favored 'General case' 0 N--CA 1.418 -2.027 0 O-C-N 120.568 -1.548 . . . . 1.0 107.792 -165.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.289 0.1 OUTLIER -149.36 165.8 30.93 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.479 -0.782 . . . . 1.0 109.984 167.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.5 t -97.39 140.53 31.7 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 113.445 0.905 . . . . 1.0 113.445 -169.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 24.0 ttt -155.83 136.72 13.56 Favored 'General case' 0 CA--C 1.506 -0.75 0 O-C-N 120.888 -1.132 . . . . 1.0 109.66 167.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 62.01 31.08 18.09 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.294 1.521 . . . . 1.0 110.269 -175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.27 15.62 65.85 Favored Glycine 0 C--N 1.346 1.106 0 C-N-CA 124.611 1.1 . . . . 1.0 115.012 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -146.91 158.14 43.84 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 120.319 -1.695 . . . . 1.0 110.081 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 36.7 t -69.68 156.62 38.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.677 2.473 . . . . 1.0 117.677 -162.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -141.64 89.59 2.22 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 103.556 -2.757 . . . . 1.0 103.556 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.9 t -85.91 126.56 34.17 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 127.513 2.325 . . . . 1.0 112.854 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -115.8 108.07 47.34 Favored Pre-proline 0 N--CA 1.437 -1.089 0 C-N-CA 126.512 1.925 . . . . 1.0 108.501 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -81.94 56.7 5.96 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.608 2.206 . . . . 1.0 110.323 159.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.719 2.008 . . . . 1.0 105.661 -170.727 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 2' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.508 2.431 0 CA-C-O 120.604 0.24 . . . . 1.0 111.175 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 1' ' ' THR . 60.1 t -138.16 136.1 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 1 N-CA-C 98.602 -4.592 . . . . 1.0 98.602 173.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.95 160.48 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.495 0 N-CA-C 103.787 -2.671 . . . . 1.0 103.787 172.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -88.51 44.05 1.18 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 124.672 2.177 . . . . 1.0 110.67 173.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.2 t -92.2 113.17 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 103.979 -2.6 . . . . 1.0 103.979 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -98.49 133.5 42.77 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 -161.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.8 p -135.63 156.94 48.05 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 118.48 2.771 . . . . 1.0 118.48 -165.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.5 t -109.65 -23.43 11.45 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.972 -1.922 . . . . 1.0 110.404 156.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 t -131.59 151.82 79.35 Favored Pre-proline 0 CA--C 1.508 -0.661 0 O-C-N 120.192 -1.567 . . . . 1.0 109.655 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.42 -25.22 56.22 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 122.763 2.022 . . . . 1.0 111.953 164.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -58.49 -41.28 84.97 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 122.37 1.081 . . . . 1.0 113.482 -173.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.42 -13.89 62.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.523 1.129 . . . . 1.0 113.445 -178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.6 m -90.59 -8.31 50.5 Favored 'General case' 0 N--CA 1.417 -2.087 0 O-C-N 120.629 -1.294 . . . . 1.0 111.72 177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -66.08 -44.18 59.22 Favored Pre-proline 0 C--N 1.352 0.71 0 CA-C-O 116.759 -1.591 . . . . 1.0 113.23 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.84 -46.77 21.23 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 CA-C-N 124.13 2.511 . . . . 1.0 115.683 170.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.07 -34.91 21.36 Favored 'Trans proline' 0 CA--C 1.51 -0.717 0 CA-C-N 127.557 3.735 . . . . 1.0 112.722 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.3 m -58.95 -35.79 73.72 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.704 -1.248 . . . . 1.0 112.3 172.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -20.1 62.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 116.843 2.164 . . . . 1.0 116.843 172.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -69.88 0.36 Allowed 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 125.074 2.369 . . . . 1.0 111.903 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 tp60 -93.5 -38.4 11.43 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 111.35 -2.659 . . . . 1.0 110.254 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.4 -11.72 20.9 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 113.28 0.844 . . . . 1.0 113.28 -167.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.98 174.04 18.53 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-O 123.202 1.445 . . . . 1.0 115.21 159.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 tt -69.08 -33.61 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 119.452 -2.205 . . . . 1.0 113.123 -167.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -86.98 -12.66 46.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 120.457 -1.402 . . . . 1.0 112.027 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.44 158.12 18.48 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 116.737 2.125 . . . . 1.0 116.737 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -138.9 -176.17 14.46 Favored Glycine 0 CA--C 1.492 -1.377 0 O-C-N 120.912 -1.117 . . . . 1.0 111.184 -170.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.38 149.08 27.44 Favored 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.565 -1.55 . . . . 1.0 111.19 -171.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.63 136.22 54.82 Favored 'General case' 0 CA--C 1.496 -1.132 0 C-N-CA 125.786 1.634 . . . . 1.0 108.362 167.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.9 t -89.7 130.05 36.03 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 121.393 -0.817 . . . . 1.0 110.597 167.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 22.9 ttt -155.13 137.24 14.71 Favored 'General case' 0 CA--C 1.5 -0.971 0 O-C-N 121.049 -1.032 . . . . 1.0 109.612 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.27 29.03 18.66 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.232 1.813 . . . . 1.0 110.992 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.83 10.9 62.11 Favored Glycine 0 C--N 1.343 0.97 0 N-CA-C 116.568 1.387 . . . . 1.0 116.568 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -143.91 127.31 16.83 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 120.739 2.269 . . . . 1.0 109.153 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.96 153.39 42.7 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 119.437 3.125 . . . . 1.0 119.437 -162.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -123.21 78.95 1.62 Allowed 'General case' 0 CA--C 1.492 -1.28 0 C-N-CA 128.579 2.752 . . . . 1.0 104.218 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.7 t -70.21 132.98 46.58 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.406 1.482 . . . . 1.0 114.122 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -105.98 103.86 46.57 Favored Pre-proline 0 N--CA 1.434 -1.27 0 C-N-CA 125.847 1.659 . . . . 1.0 106.852 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.44 91.71 0.4 Allowed 'Trans proline' 0 C--N 1.324 -0.734 0 CA-C-N 123.194 2.176 . . . . 1.0 109.899 157.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.7 t-160 . . . . . 0 C--O 1.263 1.811 0 C-N-CA 124.318 1.047 . . . . 1.0 109.56 171.26 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.401 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -140.31 134.93 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 1 N-CA-C 99.95 -4.093 . . . . 1.0 99.95 175.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.599 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.4 mt -104.53 -146.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 C-N-CA 126.695 1.998 . . . . 1.0 107.738 -177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.599 ' H ' HG22 ' A' ' 3' ' ' ILE . 1.3 t0 -124.31 46.34 2.3 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 124.956 2.312 . . . . 1.0 109.011 163.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -91.39 105.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.146 0 CA-C-N 112.41 -2.177 . . . . 1.0 105.349 160.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.56 131.54 38.72 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 106.741 -1.577 . . . . 1.0 106.741 171.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.79 161.96 39.58 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 117.051 2.241 . . . . 1.0 117.051 -162.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.27 -46.94 8.39 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 112.786 -2.006 . . . . 1.0 109.739 154.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 m -127.22 152.97 76.81 Favored Pre-proline 0 CA--C 1.512 -0.499 0 CA-C-N 114.271 -1.331 . . . . 1.0 111.933 -149.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.29 -33.55 48.01 Favored 'Trans proline' 0 CA--C 1.507 -0.86 0 C-N-CA 123.235 2.623 . . . . 1.0 112.034 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.0 tttm -44.85 -48.42 11.09 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 127.282 2.233 . . . . 1.0 112.371 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -63.71 -22.54 66.96 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.223 1.409 . . . . 1.0 113.978 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.5 t -106.5 -7.47 17.51 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.635 -0.665 . . . . 1.0 112.47 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 tp -64.67 -50.87 62.34 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 116.921 -1.514 . . . . 1.0 113.667 -172.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.77 -41.16 40.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 CA-C-O 112.918 -3.034 . . . . 1.0 115.543 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -69.03 -40.22 6.77 Favored 'Trans proline' 0 CA--C 1.508 -0.798 1 CA-C-N 129.369 4.382 . . . . 1.0 113.151 173.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.1 t -56.89 -44.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.465 1.602 . . . . 1.0 111.627 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -21.01 62.64 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 116.507 2.04 . . . . 1.0 116.507 174.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.21 -70.89 0.31 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 124.631 2.158 . . . . 1.0 112.89 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -90.58 -42.59 10.71 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 111.203 -2.726 . . . . 1.0 108.689 -159.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -96.53 -30.19 13.46 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.599 -1.637 . . . . 1.0 113.756 -160.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.98 159.18 22.78 Favored Glycine 0 CA--C 1.484 -1.89 0 C-N-CA 114.798 -3.572 . . . . 1.0 115.016 165.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 tt -70.28 -34.51 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 C-N-CA 126.295 1.838 . . . . 1.0 113.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -98.12 -11.26 23.04 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.313 0.645 . . . . 1.0 111.801 172.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.39 152.12 11.91 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 117.812 2.523 . . . . 1.0 117.812 -167.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.4 167.92 29.68 Favored Glycine 0 CA--C 1.483 -1.95 0 N-CA-C 109.039 -1.625 . . . . 1.0 109.039 -172.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.98 154.43 42.54 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-O 123.286 1.517 . . . . 1.0 110.161 -164.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 175.7 10.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 107.485 -1.302 . . . . 1.0 107.485 166.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.3 t -107.53 147.08 31.0 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.782 -0.574 . . . . 1.0 110.513 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.1 ttt -164.01 142.01 7.26 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.378 1.471 . . . . 1.0 109.803 169.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.32 35.78 20.66 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 126.157 1.783 . . . . 1.0 110.48 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.87 -5.04 55.27 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 116.231 1.252 . . . . 1.0 116.231 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -135.39 165.26 25.88 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.686 2.243 . . . . 1.0 109.766 -176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.55 160.89 10.47 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 115.043 1.497 . . . . 1.0 115.043 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -142.74 90.53 2.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 100.289 -3.967 . . . . 1.0 100.289 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.2 t -92.46 128.68 38.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 126.261 1.824 . . . . 1.0 109.034 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -112.11 98.06 41.12 Favored Pre-proline 0 N--CA 1.436 -1.141 0 C-N-CA 125.212 1.405 . . . . 1.0 107.336 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.94 78.29 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 121.696 1.597 . . . . 1.0 111.078 173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 80.7 t60 . . . . . 0 C--O 1.26 1.606 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 167.197 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.194 0.521 . . . . 1.0 112.067 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t -136.63 138.07 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.516 1 N-CA-C 98.543 -4.614 . . . . 1.0 98.543 176.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.79 158.98 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.529 0 N-CA-C 101.68 -3.452 . . . . 1.0 101.68 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.85 42.06 1.09 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 124.091 1.901 . . . . 1.0 112.122 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.52 126.67 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 170.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.0 mttm -108.22 140.13 41.9 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.906 0.86 . . . . 1.0 110.958 -157.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -138.3 156.26 47.81 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 115.229 1.566 . . . . 1.0 115.229 -168.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.4 m -108.77 -26.55 10.25 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 123.709 1.719 . . . . 1.0 109.636 162.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -123.17 154.15 65.01 Favored Pre-proline 0 CA--C 1.515 -0.371 0 O-C-N 120.578 -1.326 . . . . 1.0 110.563 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.48 -27.11 54.43 Favored 'Trans proline' 0 CA--C 1.513 -0.558 0 C-N-CA 121.816 1.677 . . . . 1.0 112.474 160.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -62.9 -49.63 74.05 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.623 -1.298 . . . . 1.0 112.651 -173.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.93 -5.45 17.03 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.093 1.357 . . . . 1.0 113.633 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -88.56 -27.79 21.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 123.113 1.435 . . . . 1.0 109.533 177.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.9 tp -70.15 -47.3 21.29 Favored Pre-proline 0 C--N 1.355 0.835 0 CA-C-O 116.298 -1.811 . . . . 1.0 114.681 -172.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -63.13 -35.87 61.78 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 CA-C-O 113.23 -2.904 . . . . 1.0 115.288 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -67.43 -39.93 11.66 Favored 'Trans proline' 0 CA--C 1.502 -1.113 1 CA-C-N 128.98 4.243 . . . . 1.0 112.308 170.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.6 m -61.17 -33.47 73.49 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.744 -1.223 . . . . 1.0 113.379 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -12.2 61.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 116.417 2.006 . . . . 1.0 116.417 173.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.38 -33.26 71.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 123.272 1.511 . . . . 1.0 113.518 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -163.05 -30.05 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.782 -1.554 . . . . 1.0 111.33 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -77.9 -15.46 59.0 Favored 'General case' 0 N--CA 1.438 -1.03 0 O-C-N 120.23 -1.544 . . . . 1.0 113.038 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 153.23 153.3 6.3 Favored Glycine 0 CA--C 1.492 -1.394 0 CA-C-O 122.329 0.961 . . . . 1.0 113.887 150.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 tt -69.3 -35.48 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 119.877 -1.955 . . . . 1.0 111.818 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -70.17 -37.44 75.17 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.996 1.718 . . . . 1.0 109.772 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.07 155.68 1.81 Allowed 'General case' 0 C--N 1.348 0.524 0 N-CA-C 118.163 2.653 . . . . 1.0 118.163 -162.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -116.18 174.13 15.09 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.361 -1.895 . . . . 1.0 108.361 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -160.35 137.59 9.34 Favored 'General case' 0 N--CA 1.426 -1.665 0 O-C-N 120.879 -1.365 . . . . 1.0 109.386 -165.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -155.48 166.27 34.05 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.301 -0.96 . . . . 1.0 110.259 165.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.0 t -96.5 141.58 29.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 121.778 -0.576 . . . . 1.0 112.338 -171.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -155.56 135.96 13.21 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 121.186 -0.946 . . . . 1.0 109.868 168.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.98 34.03 21.47 Favored 'General case' 0 C--N 1.342 0.26 0 C-N-CA 126.77 2.028 . . . . 1.0 110.42 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.47 15.27 68.06 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.76 -1.109 . . . . 1.0 115.669 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -145.85 150.76 36.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 O-C-N 119.8 -2.0 . . . . 1.0 110.057 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.9 t -70.0 156.93 38.42 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 -164.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.18 86.8 2.15 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.734 -2.691 . . . . 1.0 103.734 -175.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 62.1 m -75.31 131.03 40.02 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 125.967 1.707 . . . . 1.0 113.554 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -111.74 126.26 28.85 Favored Pre-proline 0 N--CA 1.443 -0.798 0 N-CA-C 106.075 -1.824 . . . . 1.0 106.075 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.34 38.71 0.54 Allowed 'Trans proline' 0 CA--C 1.509 -0.765 0 CA-C-N 124.641 2.693 . . . . 1.0 113.466 -168.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.6 t60 . . . . . 0 N--CA 1.426 -1.644 0 C-N-CA 125.965 1.706 . . . . 1.0 109.601 171.05 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.407 0 CA-C-O 121.033 0.444 . . . . 1.0 111.937 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.25 132.89 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 1 N-CA-C 98.686 -4.561 . . . . 1.0 98.686 170.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.53 158.76 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 N-CA-C 103.284 -2.858 . . . . 1.0 103.284 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.23 50.85 1.56 Allowed 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 127.115 2.166 . . . . 1.0 110.358 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.9 t -94.11 118.56 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 105.373 -2.084 . . . . 1.0 105.373 165.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 134.19 36.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.121 -1.437 . . . . 1.0 107.121 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -134.66 146.63 49.69 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 116.967 2.21 . . . . 1.0 116.967 -165.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.9 t -110.63 -17.78 13.32 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 112.433 -2.167 . . . . 1.0 109.176 167.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -140.3 147.62 50.69 Favored Pre-proline 0 CA--C 1.505 -0.762 0 N-CA-C 106.253 -1.758 . . . . 1.0 106.253 178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 56.7 Cg_endo -60.71 -24.15 77.97 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 122.401 2.067 . . . . 1.0 112.88 167.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.5 -37.67 70.72 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 122.716 1.246 . . . . 1.0 112.416 -174.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -60.4 -24.66 65.32 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.543 1.537 . . . . 1.0 114.228 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 38.5 t -103.46 -5.02 23.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.164 0.983 . . . . 1.0 112.609 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.25 -48.65 75.89 Favored Pre-proline 0 C--N 1.345 0.411 0 O-C-N 120.186 -1.571 . . . . 1.0 114.299 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.61 -34.3 64.12 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 CA-C-O 113.402 -2.832 . . . . 1.0 115.44 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -68.59 -36.55 14.5 Favored 'Trans proline' 0 CA--C 1.506 -0.89 1 CA-C-N 128.867 4.202 . . . . 1.0 112.54 169.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 m -59.29 -51.05 71.63 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 123.122 1.439 . . . . 1.0 112.37 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 2.36 5.82 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 116.777 2.14 . . . . 1.0 116.777 170.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.8 -50.93 30.38 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.752 1.739 . . . . 1.0 111.502 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 -12.71 0.24 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.447 -1.706 . . . . 1.0 113.036 -173.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -84.98 -20.74 30.09 Favored 'General case' 0 N--CA 1.432 -1.332 0 O-C-N 120.031 -1.668 . . . . 1.0 113.384 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.88 -166.2 33.51 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 115.344 -3.312 . . . . 1.0 119.154 163.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.2 mt -71.3 -62.35 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 C-N-CA 125.098 1.359 . . . . 1.0 112.295 -173.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.462 HH21 ' C ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -117.69 13.51 14.23 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 125.906 1.682 . . . . 1.0 107.437 -176.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -44.09 145.49 0.75 Allowed 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 118.282 2.697 . . . . 1.0 118.282 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.8 170.8 21.07 Favored Glycine 0 CA--C 1.477 -2.311 0 N-CA-C 109.317 -1.513 . . . . 1.0 109.317 -162.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -145.16 135.44 24.05 Favored 'General case' 0 N--CA 1.416 -2.171 0 N-CA-C 106.943 -1.503 . . . . 1.0 106.943 -170.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -144.04 149.28 36.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 107.479 -1.304 . . . . 1.0 107.479 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.05 137.7 34.75 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 121.221 -0.924 . . . . 1.0 111.902 -172.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -155.69 139.96 16.62 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 120.819 -1.176 . . . . 1.0 109.68 167.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.8 33.95 19.9 Favored 'General case' 0 C--N 1.346 0.444 0 C-N-CA 126.356 1.862 . . . . 1.0 110.141 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.12 16.7 60.3 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 124.382 0.991 . . . . 1.0 115.525 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -144.84 154.38 42.59 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 119.708 -2.054 . . . . 1.0 107.919 -173.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.5 t -67.35 158.49 31.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 119.675 -1.891 . . . . 1.0 115.987 -169.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -144.09 89.69 2.05 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 101.625 -3.472 . . . . 1.0 101.625 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.2 t -85.64 129.3 34.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.798 2.039 . . . . 1.0 112.398 -174.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -103.89 102.9 34.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -87.0 63.4 4.32 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.149 1.9 . . . . 1.0 111.865 -166.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.462 ' C ' HH21 ' A' ' 24' ' ' ARG . 58.2 t60 . . . . . 0 C--O 1.253 1.271 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.307 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.503 2.205 0 CA-C-O 121.48 0.657 . . . . 1.0 111.011 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.3 t -138.7 138.09 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 98.551 -4.611 . . . . 1.0 98.551 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.21 157.39 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 102.498 -3.149 . . . . 1.0 102.498 167.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.61 41.6 1.03 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 125.401 2.525 . . . . 1.0 111.653 176.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.3 t -92.84 110.74 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 113.077 -1.874 . . . . 1.0 106.033 170.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.62 137.88 52.63 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 120.556 -1.34 . . . . 1.0 110.669 171.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 p -104.53 169.69 8.32 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.567 -1.333 . . . . 1.0 113.18 -176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 18.5 p -133.24 -0.75 3.28 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 126.803 2.041 . . . . 1.0 108.825 161.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.8 t -177.72 155.48 1.08 Allowed Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 102.993 -2.966 . . . . 1.0 102.993 -167.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.71 -27.16 68.38 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 123.669 2.346 . . . . 1.0 111.748 163.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -62.37 -42.57 99.52 Favored 'General case' 0 C--N 1.346 0.455 0 CA-C-O 122.452 1.12 . . . . 1.0 112.893 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -7.05 41.42 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.9 t -99.89 -6.02 27.43 Favored 'General case' 0 C--N 1.349 0.586 0 O-C-N 120.651 -1.28 . . . . 1.0 111.483 170.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 23.3 tp -62.83 -39.59 54.92 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 119.703 -1.873 . . . . 1.0 114.303 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.85 -47.35 15.99 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 CA-C-O 113.8 -2.667 . . . . 1.0 115.792 169.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -67.31 -35.67 23.33 Favored 'Trans proline' 0 CA--C 1.507 -0.836 0 CA-C-N 127.995 3.891 . . . . 1.0 112.516 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.3 m -59.25 -34.36 72.13 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 120.954 -1.092 . . . . 1.0 112.5 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -25.25 63.05 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 117.01 2.226 . . . . 1.0 117.01 170.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.0 -67.05 0.57 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 124.775 2.226 . . . . 1.0 113.256 -174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -94.48 -39.04 10.62 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 111.548 -2.569 . . . . 1.0 109.99 -166.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -99.19 -27.39 13.83 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 114.527 -1.215 . . . . 1.0 114.267 -162.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 152.45 171.27 19.83 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 119.98 -1.7 . . . . 1.0 115.758 163.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.406 ' H ' HD12 ' A' ' 23' ' ' ILE . 4.7 mp -69.51 -46.35 76.14 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 O-C-N 120.007 -1.878 . . . . 1.0 111.818 -175.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -83.83 -15.78 46.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 120.581 -1.324 . . . . 1.0 111.509 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.59 160.2 1.34 Allowed 'General case' 0 C--N 1.355 0.818 0 N-CA-C 117.833 2.531 . . . . 1.0 117.833 -166.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.01 177.4 20.95 Favored Glycine 0 CA--C 1.49 -1.469 0 O-C-N 120.718 -1.239 . . . . 1.0 111.881 -166.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.21 144.77 31.01 Favored 'General case' 0 N--CA 1.431 -1.39 0 O-C-N 120.769 -1.43 . . . . 1.0 109.436 -170.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.3 153.46 35.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 124.39 1.076 . . . . 1.0 108.191 163.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.2 t -101.98 122.19 43.6 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.666 0.786 . . . . 1.0 110.346 167.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 39.7 tpp -154.95 140.71 18.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.847 -1.158 . . . . 1.0 112.034 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.98 33.37 17.35 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 126.143 1.777 . . . . 1.0 109.908 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.18 1.36 41.43 Favored Glycine 0 C--N 1.346 1.105 0 N-CA-C 115.897 1.119 . . . . 1.0 115.897 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -132.6 151.61 51.89 Favored 'General case' 0 N--CA 1.435 -1.224 0 O-C-N 120.021 -1.87 . . . . 1.0 107.831 -168.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 13.0 t -67.33 156.95 35.18 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.358 -2.088 . . . . 1.0 114.713 -176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.16 81.15 1.84 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.435 -2.802 . . . . 1.0 103.435 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.0 t -81.56 140.67 34.36 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 124.448 1.099 . . . . 1.0 113.964 -170.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -111.86 99.5 45.56 Favored Pre-proline 0 N--CA 1.437 -1.108 0 C-N-CA 125.554 1.542 . . . . 1.0 107.11 -178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.27 73.28 4.53 Favored 'Trans proline' 0 C--N 1.329 -0.466 0 C-N-CA 122.778 2.318 . . . . 1.0 110.841 169.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.9 t60 . . . . . 0 N--CA 1.43 -1.438 0 C-N-CA 124.629 1.171 . . . . 1.0 108.242 -176.779 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 N--CA 1.511 2.591 0 CA-C-O 121.566 0.698 . . . . 1.0 111.485 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.4 t -125.56 135.12 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 1 N-CA-C 98.241 -4.726 . . . . 1.0 98.241 167.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.75 158.33 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.426 0 N-CA-C 102.49 -3.152 . . . . 1.0 102.49 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.85 39.03 0.91 Allowed 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 125.635 2.636 . . . . 1.0 112.1 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -91.56 103.53 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-N 113.725 -1.58 . . . . 1.0 107.419 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 142.87 51.96 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 120.776 -1.202 . . . . 1.0 110.717 170.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -87.51 166.33 14.85 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 120.687 -1.258 . . . . 1.0 114.081 -170.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.41 ' H ' ' HG2' ' A' ' 12' ' ' GLN . 32.9 p -126.7 -6.35 6.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.748 2.019 . . . . 1.0 109.325 150.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -178.98 154.91 0.81 Allowed Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 101.107 -3.664 . . . . 1.0 101.107 -167.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -62.51 -28.37 77.58 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 CA-C-N 123.874 2.419 . . . . 1.0 112.189 162.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -67.8 -29.13 68.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.733 0.778 . . . . 1.0 112.801 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -70.47 -9.93 57.82 Favored 'General case' 0 C--N 1.345 0.409 0 O-C-N 120.723 -1.236 . . . . 1.0 114.3 175.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 45.3 t -93.36 -7.78 43.77 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.583 -1.323 . . . . 1.0 112.16 171.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -49.32 88.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 119.941 -1.724 . . . . 1.0 113.958 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -64.08 -32.92 63.5 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 CA-C-O 113.293 -2.878 . . . . 1.0 115.929 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -70.11 -36.3 10.11 Favored 'Trans proline' 0 CA--C 1.504 -0.976 1 CA-C-N 129.074 4.277 . . . . 1.0 112.632 167.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.83 -61.55 2.54 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 122.949 1.357 . . . . 1.0 111.749 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.92 21.24 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 120.921 -1.112 . . . . 1.0 113.873 168.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.07 -69.93 0.34 Allowed 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 118.092 -2.88 . . . . 1.0 107.973 159.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.81 -20.89 2.21 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 127.435 2.294 . . . . 1.0 114.08 -163.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -87.97 -16.7 33.04 Favored 'General case' 0 N--CA 1.435 -1.19 0 O-C-N 120.293 -1.505 . . . . 1.0 114.576 -165.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.26 178.67 38.8 Favored Glycine 0 CA--C 1.496 -1.125 0 C-N-CA 119.226 -1.464 . . . . 1.0 111.35 167.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.01 -55.65 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 122.481 1.134 . . . . 1.0 112.776 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' NH2' ' CD2' ' A' ' 39' ' ' HIS 0.258 0.0 OUTLIER -122.89 25.08 8.78 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 123.45 1.595 . . . . 1.0 107.267 -175.42 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -39.48 143.89 0.19 Allowed 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 119.166 3.025 . . . . 1.0 119.166 -163.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -107.09 163.59 13.23 Favored Glycine 0 CA--C 1.476 -2.368 0 N-CA-C 108.366 -1.893 . . . . 1.0 108.366 -174.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 13' ' ' CYS . . . -152.14 126.66 9.41 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 107.746 -1.205 . . . . 1.0 107.746 -172.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.84 150.95 39.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.604 -1.258 . . . . 1.0 107.604 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.3 t -96.61 139.66 32.37 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 120.951 -1.093 . . . . 1.0 112.115 -173.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -156.93 144.81 19.24 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.242 -1.392 . . . . 1.0 107.242 166.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.341 0.7 OUTLIER 62.67 20.31 11.97 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 126.414 1.885 . . . . 1.0 113.381 -174.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.6 9.51 86.15 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 114.998 -1.001 . . . . 1.0 114.661 -173.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -141.25 159.0 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 120.424 -1.633 . . . . 1.0 108.007 -170.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.0 t -70.05 159.04 34.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.214 -2.179 . . . . 1.0 116.409 -169.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -144.48 90.35 2.08 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 102.034 -3.321 . . . . 1.0 102.034 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.3 t -84.45 130.26 34.78 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.734 2.014 . . . . 1.0 112.962 -174.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -102.45 107.49 53.89 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 -174.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -85.31 64.84 6.01 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.768 1.645 . . . . 1.0 112.365 -166.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.409 ' CD2' ' NH2' ' A' ' 24' ' ' ARG . 16.2 t-160 . . . . . 0 C--O 1.26 1.613 0 O-C-N 122.168 -0.332 . . . . 1.0 110.422 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.514 2.769 0 CA-C-O 118.852 -0.594 . . . . 1.0 109.664 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -154.92 127.53 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 103.135 -2.913 . . . . 1.0 103.135 176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.38 161.1 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 N-CA-C 103.361 -2.829 . . . . 1.0 103.361 161.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -110.44 65.23 0.61 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.981 1.713 . . . . 1.0 107.508 160.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.9 t -84.64 109.2 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.673 -1.973 . . . . 1.0 105.673 160.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -97.29 124.17 41.32 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 124.9 1.28 . . . . 1.0 108.96 -176.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 p -145.11 163.02 35.58 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 116.357 1.984 . . . . 1.0 116.357 -155.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 74.2 p -99.32 -36.15 9.71 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-O 123.646 1.688 . . . . 1.0 109.758 154.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 75.7 m -116.97 150.66 46.32 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 114.445 -1.252 . . . . 1.0 111.536 -156.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.8 -34.24 31.59 Favored 'Trans proline' 0 CA--C 1.511 -0.636 0 C-N-CA 122.026 1.817 . . . . 1.0 111.776 170.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -54.85 -41.72 71.11 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.974 1.31 . . . . 1.0 113.021 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -54.75 -30.6 56.86 Favored 'General case' 0 C--N 1.346 0.439 0 C-N-CA 124.759 1.223 . . . . 1.0 114.149 177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.3 t -100.57 -9.37 22.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 112.722 0.638 . . . . 1.0 112.722 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . 0.267 2.8 tm? -68.42 -49.21 32.51 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 120.402 -1.436 . . . . 1.0 113.192 -170.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.43 -44.29 43.85 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 CA-C-O 114.267 -2.472 . . . . 1.0 115.95 171.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -68.17 -37.73 13.78 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 CA-C-N 127.194 3.605 . . . . 1.0 112.981 175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 48.7 t -57.93 -49.0 78.27 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.864 1.792 . . . . 1.0 111.414 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -71.31 -8.2 52.14 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 115.563 1.69 . . . . 1.0 115.563 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.64 -54.92 10.06 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.605 1.669 . . . . 1.0 111.775 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -138.11 -23.26 1.03 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 113.146 -1.843 . . . . 1.0 112.597 -173.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -84.64 -20.22 31.69 Favored 'General case' 0 N--CA 1.432 -1.349 0 O-C-N 120.162 -1.586 . . . . 1.0 113.55 -167.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.7 179.49 45.04 Favored Glycine 0 C--N 1.347 1.183 0 C-N-CA 116.462 -2.78 . . . . 1.0 116.978 157.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 tt -70.72 -55.75 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 125.782 1.633 . . . . 1.0 112.434 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -121.31 19.19 11.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.476 1.911 . . . . 1.0 107.035 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.01 145.75 16.01 Favored 'General case' 0 C--N 1.348 0.515 0 N-CA-C 116.27 1.952 . . . . 1.0 116.27 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -129.35 162.29 22.68 Favored Glycine 0 CA--C 1.471 -2.659 0 N-CA-C 107.952 -2.059 . . . . 1.0 107.952 -170.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.46 131.71 24.96 Favored 'General case' 0 N--CA 1.425 -1.701 0 O-C-N 120.678 -1.484 . . . . 1.0 107.456 -163.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -141.9 148.2 38.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.0 t -99.12 144.82 27.82 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 120.246 -1.533 . . . . 1.0 111.146 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 23.4 ttt -162.2 144.14 11.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.718 -1.239 . . . . 1.0 109.662 167.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.55 32.29 18.71 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.77 1.628 . . . . 1.0 110.855 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.9 13.11 65.98 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 114.636 -1.166 . . . . 1.0 115.885 -175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -142.67 153.27 43.26 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 120.175 1.987 . . . . 1.0 109.284 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.1 t -69.81 161.61 29.51 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 115.78 1.77 . . . . 1.0 115.78 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.45 95.38 3.06 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 101.738 -3.43 . . . . 1.0 101.738 168.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 33.7 t -82.56 116.6 22.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.117 1.767 . . . . 1.0 110.107 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -99.2 110.08 56.78 Favored Pre-proline 0 N--CA 1.437 -1.112 0 C-N-CA 126.228 1.811 . . . . 1.0 107.681 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -80.14 74.43 5.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.115 1.877 . . . . 1.0 112.249 -175.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.0 t60 . . . . . 0 C--O 1.258 1.541 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 174.04 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 112.193 0.442 . . . . 1.0 112.193 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.29 130.34 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 1 N-CA-C 98.039 -4.801 . . . . 1.0 98.039 172.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.72 -155.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 -179.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.39 52.57 2.01 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 124.606 2.146 . . . . 1.0 109.311 170.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 115.81 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 171.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.19 137.65 36.63 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.916 0.887 . . . . 1.0 109.449 -169.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.92 159.19 42.99 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 115.842 1.793 . . . . 1.0 115.842 -167.682 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.3 t -103.63 -33.98 8.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 113.379 -1.737 . . . . 1.0 109.492 154.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.5 m -108.98 145.38 31.6 Favored Pre-proline 0 CA--C 1.512 -0.508 0 O-C-N 120.547 -1.346 . . . . 1.0 111.065 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.94 -28.38 50.17 Favored 'Trans proline' 0 CA--C 1.515 -0.443 0 C-N-CA 122.403 2.069 . . . . 1.0 111.633 175.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -56.8 -35.99 69.4 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 124.103 0.961 . . . . 1.0 113.461 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -62.36 -23.33 66.73 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.866 1.266 . . . . 1.0 114.181 177.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.7 t -84.04 -23.89 30.69 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.493 1.117 . . . . 1.0 110.991 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.7 tp -70.15 -53.72 10.47 Favored Pre-proline 0 C--N 1.355 0.821 0 CA-C-O 116.841 -1.552 . . . . 1.0 114.853 -166.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.58 -35.38 81.61 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 CA-C-O 113.366 -2.847 . . . . 1.0 115.113 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -69.79 -41.14 4.49 Favored 'Trans proline' 0 CA--C 1.508 -0.817 1 CA-C-N 128.532 4.083 . . . . 1.0 112.799 168.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 t -57.21 -50.08 73.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.655 1.693 . . . . 1.0 112.178 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 tptp -71.16 -8.51 54.0 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 115.139 1.533 . . . . 1.0 115.139 174.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.2 -64.27 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 124.198 1.952 . . . . 1.0 111.433 -179.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -119.0 -28.81 5.43 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 111.989 -2.369 . . . . 1.0 111.574 -162.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -95.32 -26.95 15.7 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 115.458 1.651 . . . . 1.0 115.458 -166.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.39 171.14 42.5 Favored Glycine 0 CA--C 1.496 -1.111 0 C-N-CA 115.884 -3.055 . . . . 1.0 117.605 171.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.87 -53.42 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 125.752 1.621 . . . . 1.0 113.039 -170.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -124.66 30.92 5.83 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 179.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.13 148.14 18.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 116.746 2.128 . . . . 1.0 116.746 -167.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -112.74 161.27 12.75 Favored Glycine 0 CA--C 1.472 -2.619 0 N-CA-C 107.0 -2.44 . . . . 1.0 107.0 -172.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.77 121.17 3.6 Favored 'General case' 0 N--CA 1.432 -1.372 0 O-C-N 119.967 -1.902 . . . . 1.0 108.047 -157.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -148.81 155.0 40.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.163 -1.421 . . . . 1.0 107.163 -168.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.2 t -97.4 139.93 32.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 121.249 -0.907 . . . . 1.0 111.23 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.8 ttt -155.52 138.48 15.42 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.29 -1.506 . . . . 1.0 109.583 169.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.5 28.82 13.44 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 125.161 1.385 . . . . 1.0 110.94 179.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.68 11.52 80.58 Favored Glycine 0 C--N 1.346 1.093 0 C-N-CA 124.422 1.01 . . . . 1.0 115.186 -173.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -141.86 152.93 44.07 Favored 'General case' 0 N--CA 1.438 -1.056 0 O-C-N 119.905 -1.938 . . . . 1.0 110.971 -173.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.2 t -68.6 144.09 54.64 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 123.864 1.792 . . . . 1.0 114.815 -175.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -140.82 91.83 2.45 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.245 -2.502 . . . . 1.0 104.245 -174.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.3 t -81.4 127.49 32.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.256 2.623 . . . . 1.0 112.106 177.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -103.04 101.77 23.63 Favored Pre-proline 0 N--CA 1.437 -1.081 0 C-N-CA 126.574 1.95 . . . . 1.0 105.898 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -84.97 64.87 6.34 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.231 1.954 . . . . 1.0 112.382 -164.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 . . . . . 0 C--O 1.258 1.536 0 N-CA-C 107.316 -1.365 . . . . 1.0 107.316 171.269 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.51 2.549 0 N-CA-C 112.66 0.615 . . . . 1.0 112.66 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.8 t -158.71 144.54 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 1 N-CA-C 98.043 -4.799 . . . . 1.0 98.043 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.24 154.68 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 102.305 -3.22 . . . . 1.0 102.305 161.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.38 48.28 1.3 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-O 124.174 1.94 . . . . 1.0 110.871 177.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.35 129.76 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 105.606 -1.998 . . . . 1.0 105.606 171.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -97.06 142.77 28.59 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.826 -1.176 . . . . 1.0 107.826 -173.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 p -149.2 152.25 35.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.499 2.037 . . . . 1.0 116.499 -172.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.4 m -100.39 -33.66 10.28 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 127.747 2.419 . . . . 1.0 109.135 159.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.2 t -120.26 146.6 43.01 Favored Pre-proline 0 CA--C 1.512 -0.483 0 O-C-N 120.951 -1.093 . . . . 1.0 110.295 -173.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.5 -24.47 78.13 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.951 1.767 . . . . 1.0 112.676 165.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.42 -28.71 69.99 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 122.002 0.906 . . . . 1.0 113.076 -176.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -65.75 -18.61 65.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.54 1.136 . . . . 1.0 114.059 177.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 68.0 m -85.3 -14.59 46.08 Favored 'General case' 0 N--CA 1.425 -1.718 0 O-C-N 120.799 -1.188 . . . . 1.0 113.538 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -49.38 75.28 Favored Pre-proline 0 C--N 1.351 0.655 0 O-C-N 120.603 -1.311 . . . . 1.0 114.444 -170.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -62.08 -39.35 50.19 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 CA-C-O 113.449 -2.813 . . . . 1.0 115.473 174.201 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -69.6 -36.92 10.3 Favored 'Trans proline' 0 CA--C 1.511 -0.667 1 CA-C-N 128.652 4.126 . . . . 1.0 113.096 172.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 52.1 m -59.52 -45.25 92.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 120.239 -1.538 . . . . 1.0 111.714 176.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.2 tptp -71.01 -13.4 61.98 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 115.751 1.76 . . . . 1.0 115.751 171.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.9 -67.44 0.53 Allowed 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 124.146 1.927 . . . . 1.0 112.287 178.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -105.36 -41.64 5.46 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 111.836 -2.438 . . . . 1.0 110.211 -163.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -87.32 -36.69 17.71 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 113.534 0.939 . . . . 1.0 113.534 -160.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.05 -177.24 46.65 Favored Glycine 0 CA--C 1.495 -1.188 0 C-N-CA 115.934 -3.032 . . . . 1.0 117.922 174.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.8 tt -70.9 -53.57 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 125.97 1.708 . . . . 1.0 113.394 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.08 16.12 15.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.718 2.407 . . . . 1.0 108.469 -174.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.28 148.8 10.87 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 116.946 2.202 . . . . 1.0 116.946 -172.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -142.71 -170.99 13.08 Favored Glycine 0 CA--C 1.475 -2.432 0 N-CA-C 108.486 -1.846 . . . . 1.0 108.486 -164.186 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.99 6.91 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 120.325 -1.691 . . . . 1.0 108.842 -175.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.31 0.0 OUTLIER -149.53 -177.86 6.1 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-N 114.036 -1.438 . . . . 1.0 107.694 143.52 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 10.8 t -115.13 135.78 53.82 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 125.896 1.678 . . . . 1.0 109.906 -176.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.09 151.43 21.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 106.306 -1.738 . . . . 1.0 106.306 168.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . 0.346 0.5 OUTLIER 63.43 18.73 11.25 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 126.131 1.772 . . . . 1.0 113.439 -173.952 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.22 12.85 76.48 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.308 1.432 . . . . 1.0 114.729 -172.545 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -141.79 161.32 38.26 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 120.037 -1.861 . . . . 1.0 109.558 -177.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.1 t -69.75 163.83 24.87 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.952 2.204 . . . . 1.0 116.952 -168.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.88 90.26 1.82 Allowed 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 104.212 -2.514 . . . . 1.0 104.212 167.626 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 10.9 t -78.17 140.17 38.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.266 2.226 . . . . 1.0 114.263 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -108.32 106.45 58.66 Favored Pre-proline 0 N--CA 1.439 -0.986 0 C-N-CA 127.692 2.397 . . . . 1.0 107.156 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 76.64 4.41 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 122.619 2.213 . . . . 1.0 112.244 -179.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 60.0 m170 . . . . . 0 N--CA 1.428 -1.532 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -178.222 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.505 2.284 0 CA-C-O 121.089 0.471 . . . . 1.0 110.989 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.2 t -142.18 133.93 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 1 N-CA-C 99.326 -4.324 . . . . 1.0 99.326 179.166 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.559 HG22 ' H ' ' A' ' 4' ' ' ASP . 1.2 mt -103.55 -149.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.352 0 C-N-CA 126.815 2.046 . . . . 1.0 106.368 175.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.559 ' H ' HG22 ' A' ' 3' ' ' ILE . 0.9 OUTLIER -132.13 43.71 2.99 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 125.15 2.405 . . . . 1.0 109.644 164.706 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.51 120.02 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 CA-C-N 112.81 -1.995 . . . . 1.0 106.014 166.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -94.78 141.12 29.0 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 105.399 -2.074 . . . . 1.0 105.399 172.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -122.48 149.83 43.35 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 117.639 2.459 . . . . 1.0 117.639 -164.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.2 p -114.08 -5.93 13.1 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 112.417 -2.174 . . . . 1.0 110.415 169.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -168.28 155.76 7.61 Favored Pre-proline 0 CA--C 1.504 -0.8 0 N-CA-C 105.129 -2.174 . . . . 1.0 105.129 -174.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -65.91 -26.87 51.38 Favored 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 124.315 2.577 . . . . 1.0 111.457 163.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -64.66 -36.07 83.06 Favored 'General case' 0 C--N 1.346 0.436 0 N-CA-C 113.598 0.962 . . . . 1.0 113.598 -168.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -13.82 62.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 113.903 1.075 . . . . 1.0 113.903 176.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.6 t -96.18 -4.49 42.46 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.932 -1.105 . . . . 1.0 111.781 173.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.13 -50.97 83.65 Favored Pre-proline 0 C--N 1.349 0.578 0 O-C-N 120.303 -1.498 . . . . 1.0 113.5 177.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.34 -37.66 59.38 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 CA-C-O 113.278 -2.884 . . . . 1.0 115.74 176.486 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -68.34 -38.18 12.25 Favored 'Trans proline' 0 CA--C 1.506 -0.898 1 CA-C-N 128.604 4.109 . . . . 1.0 112.771 169.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.7 m -58.37 -47.11 84.86 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 123.137 1.446 . . . . 1.0 112.745 177.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.62 -4.46 27.25 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 117.189 2.292 . . . . 1.0 117.189 172.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.88 -54.45 11.44 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 123.433 1.587 . . . . 1.0 111.257 -178.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.1 -11.5 0.19 Allowed 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 113.906 -1.497 . . . . 1.0 114.253 -175.567 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -79.57 -25.58 41.55 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 119.797 -1.814 . . . . 1.0 112.751 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.37 159.93 27.29 Favored Glycine 0 C--N 1.349 1.291 0 C-N-CA 117.188 -2.434 . . . . 1.0 115.317 162.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 tt -68.94 -33.8 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 120.378 -1.66 . . . . 1.0 112.442 -173.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -115.04 13.66 16.96 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.906 1.682 . . . . 1.0 110.675 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.06 162.58 6.98 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 118.233 2.679 . . . . 1.0 118.233 -163.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -146.81 -171.27 15.92 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 107.187 -2.365 . . . . 1.0 107.187 -176.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.14 154.63 36.24 Favored 'General case' 0 N--CA 1.424 -1.747 0 O-C-N 120.925 -1.338 . . . . 1.0 108.408 -175.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -111.81 146.31 37.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 106.911 -1.515 . . . . 1.0 106.911 162.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.4 t -94.02 121.26 35.32 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 160.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 12.6 ttt -149.84 127.38 11.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.717 1.246 . . . . 1.0 111.497 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.17 31.19 17.76 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 126.824 2.05 . . . . 1.0 110.331 -177.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.95 9.31 79.61 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 115.3 0.88 . . . . 1.0 115.3 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -135.45 143.78 46.09 Favored 'General case' 0 N--CA 1.439 -0.979 0 O-C-N 119.674 -2.074 . . . . 1.0 108.385 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -70.3 143.38 52.06 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -176.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.48 82.26 2.05 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 102.476 -3.157 . . . . 1.0 102.476 -174.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.4 t -71.34 135.41 47.34 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.388 2.275 . . . . 1.0 114.545 -173.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -120.45 103.46 44.16 Favored Pre-proline 0 N--CA 1.444 -0.766 0 C-N-CA 125.335 1.454 . . . . 1.0 110.038 -165.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -78.15 61.7 7.82 Favored 'Trans proline' 0 C--N 1.319 -1.018 0 C-N-CA 122.284 1.989 . . . . 1.0 110.137 151.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.259 1.578 0 C-N-CA 126.318 1.847 . . . . 1.0 106.399 -164.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.8 p . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 112.832 0.678 . . . . 1.0 112.832 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t -161.55 144.02 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 1 N-CA-C 96.627 -5.323 . . . . 1.0 96.627 177.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.74 145.76 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.319 0 N-CA-C 102.933 -2.988 . . . . 1.0 102.933 172.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . 0.267 13.1 t70 -91.52 45.56 1.24 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.642 2.163 . . . . 1.0 112.551 -173.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -84.53 107.0 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 105.416 -2.068 . . . . 1.0 105.416 164.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -87.99 144.48 26.51 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 122.319 1.057 . . . . 1.0 112.556 -164.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.92 142.6 51.0 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 117.467 2.395 . . . . 1.0 117.467 -162.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.6 t -115.97 1.47 13.31 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 128.056 2.542 . . . . 1.0 108.231 173.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 m -173.65 153.95 2.31 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 118.621 -2.549 . . . . 1.0 105.414 -174.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.66 -21.82 38.59 Favored 'Trans proline' 0 CA--C 1.509 -0.766 0 CA-C-N 123.698 2.357 . . . . 1.0 112.653 177.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -55.78 -31.4 62.58 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.281 1.432 . . . . 1.0 113.699 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -62.73 -23.13 67.02 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 124.622 1.169 . . . . 1.0 113.784 177.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.2 t -82.83 -20.99 34.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.005 0.922 . . . . 1.0 112.059 178.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.2 tp -68.54 -51.8 21.69 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-O 116.984 -1.484 . . . . 1.0 114.31 -174.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.9 -29.74 58.0 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 CA-C-O 113.099 -2.959 . . . . 1.0 115.618 176.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -73.14 -39.79 2.02 Favored 'Trans proline' 0 CA--C 1.503 -1.031 1 CA-C-N 129.374 4.384 . . . . 1.0 112.456 166.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 t -62.61 -59.05 5.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-O 123.263 1.506 . . . . 1.0 111.617 -178.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 22.04 0.06 Allowed 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.763 1.625 . . . . 1.0 113.435 165.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.59 -76.76 0.1 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 118.328 -2.733 . . . . 1.0 107.859 158.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -117.68 -34.21 4.3 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 111.498 -2.592 . . . . 1.0 113.189 -159.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -76.85 -30.28 56.24 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 120.823 -1.173 . . . . 1.0 112.535 -166.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.42 156.42 9.9 Favored Glycine 0 CA--C 1.494 -1.262 0 C-N-CA 118.166 -1.969 . . . . 1.0 115.748 166.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -71.14 -25.28 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 125.135 1.374 . . . . 1.0 112.075 159.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -81.89 -21.97 37.11 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.398 2.679 . . . . 1.0 110.455 178.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.46 153.59 42.78 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 116.036 1.865 . . . . 1.0 116.036 -173.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -123.79 170.91 16.09 Favored Glycine 0 CA--C 1.489 -1.578 0 N-CA-C 108.351 -1.899 . . . . 1.0 108.351 175.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.84 129.62 10.12 Favored 'General case' 0 N--CA 1.435 -1.188 0 O-C-N 119.421 -2.223 . . . . 1.0 108.841 -159.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.27 174.1 12.35 Favored 'General case' 0 CA--C 1.504 -0.821 0 O-C-N 120.271 -1.518 . . . . 1.0 111.999 174.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.6 t -98.59 132.27 44.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.568 1.547 . . . . 1.0 109.752 -179.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.2 ttt -161.47 140.23 9.76 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.136 1.374 . . . . 1.0 110.213 173.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 59.54 34.91 22.58 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 124.489 2.09 . . . . 1.0 110.759 -179.432 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.02 1.92 57.15 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 114.075 -1.421 . . . . 1.0 116.143 -176.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 176.92 8.27 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 120.199 1.999 . . . . 1.0 112.877 -177.508 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.01 145.69 49.84 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 124.763 2.22 . . . . 1.0 114.538 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -137.38 92.9 2.75 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 102.841 -3.022 . . . . 1.0 102.841 176.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -74.86 131.3 40.64 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.051 -1.431 . . . . 1.0 112.084 168.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -111.79 82.83 4.2 Favored Pre-proline 0 N--CA 1.439 -1.016 0 C-N-CA 127.734 2.414 . . . . 1.0 109.254 178.742 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.92 70.59 5.2 Favored 'Trans proline' 0 C--N 1.33 -0.397 0 CA-C-N 124.187 2.531 . . . . 1.0 109.049 154.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . 0.286 1.7 m-70 . . . . . 0 N--CA 1.414 -2.271 0 N-CA-C 102.868 -3.012 . . . . 1.0 102.868 -171.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.504 2.229 0 CA-C-O 121.176 0.512 . . . . 1.0 111.723 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.9 t -135.57 132.72 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 1 N-CA-C 99.891 -4.115 . . . . 1.0 99.891 176.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.58 156.24 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.562 0 N-CA-C 102.244 -3.243 . . . . 1.0 102.244 170.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -94.59 54.01 1.73 Allowed 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 124.156 1.931 . . . . 1.0 109.182 170.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.59 117.17 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 105.022 -2.214 . . . . 1.0 105.022 165.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -87.18 140.84 29.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 122.54 1.162 . . . . 1.0 109.235 -175.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.9 p -134.78 148.59 50.26 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 117.327 2.343 . . . . 1.0 117.327 -169.576 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.3 t -114.59 1.13 14.17 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-O 124.925 2.298 . . . . 1.0 108.416 172.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -174.11 154.43 2.16 Favored Pre-proline 0 N--CA 1.444 -0.742 0 O-C-N 118.744 -2.473 . . . . 1.0 105.774 -174.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.71 -26.41 45.71 Favored 'Trans proline' 0 CA--C 1.517 -0.347 0 CA-C-N 123.221 2.186 . . . . 1.0 111.872 178.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -44.56 -46.7 10.06 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 128.644 2.778 . . . . 1.0 112.181 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -61.76 -28.42 69.43 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 125.629 1.572 . . . . 1.0 113.316 -174.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.9 t -94.28 -8.45 39.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.931 0.872 . . . . 1.0 112.412 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 16.9 tp -67.93 -41.71 29.29 Favored Pre-proline 0 N--CA 1.448 -0.554 0 O-C-N 119.72 -1.863 . . . . 1.0 114.426 -178.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -58.13 -46.86 22.83 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 CA-C-O 113.934 -2.611 . . . . 1.0 115.472 168.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.05 -36.03 23.49 Favored 'Trans proline' 0 CA--C 1.51 -0.697 0 CA-C-N 127.795 3.82 . . . . 1.0 112.507 174.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.3 m -63.54 -26.71 68.83 Favored 'General case' 0 N--CA 1.442 -0.846 0 O-C-N 121.033 -1.042 . . . . 1.0 112.698 172.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.97 -33.69 70.7 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 117.34 2.348 . . . . 1.0 117.34 162.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.55 -66.97 0.56 Allowed 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 124.687 2.184 . . . . 1.0 112.394 -169.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -82.8 -38.13 23.53 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 111.826 -2.443 . . . . 1.0 109.407 -172.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -112.78 -3.95 14.11 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 114.407 -1.27 . . . . 1.0 113.563 -164.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -178.58 37.49 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 124.34 2.078 . . . . 1.0 116.602 161.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.3 tt -70.36 -33.19 53.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.865 0 O-C-N 119.465 -2.197 . . . . 1.0 114.108 -165.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -77.06 -33.86 57.17 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 120.913 -1.117 . . . . 1.0 110.439 179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.76 137.51 58.09 Favored 'General case' 0 C--N 1.342 0.277 0 N-CA-C 116.548 2.055 . . . . 1.0 116.548 -161.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.67 174.4 25.69 Favored Glycine 0 CA--C 1.488 -1.609 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -175.101 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -156.83 131.43 8.74 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 120.556 -1.555 . . . . 1.0 108.901 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.1 168.96 21.05 Favored 'General case' 0 CA--C 1.499 -0.998 0 O-C-N 120.713 -1.242 . . . . 1.0 109.87 174.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.22 129.73 55.5 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.617 0.767 . . . . 1.0 112.306 -168.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.78 125.06 43.43 Favored 'General case' 0 N--CA 1.413 -2.298 0 C-N-CA 126.904 2.082 . . . . 1.0 111.371 166.339 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.53 25.88 15.4 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 123.405 1.574 . . . . 1.0 112.128 170.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.14 14.21 77.42 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 114.624 -1.171 . . . . 1.0 115.682 -175.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -136.52 155.25 50.22 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 120.358 2.079 . . . . 1.0 108.946 178.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.3 t -70.55 160.63 32.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 118.557 2.799 . . . . 1.0 118.557 -175.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -148.24 99.75 3.08 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 104.144 -2.539 . . . . 1.0 104.144 165.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.6 t -80.78 130.79 35.26 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.515 2.726 . . . . 1.0 111.53 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -98.98 138.94 20.7 Favored Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 119.479 -2.013 . . . . 1.0 107.64 -178.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -87.08 33.82 0.43 Allowed 'Trans proline' 0 CA--C 1.507 -0.834 0 CA-C-N 123.96 2.45 . . . . 1.0 111.802 171.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 6.0 t60 . . . . . 0 N--CA 1.417 -2.1 0 C-N-CA 129.02 2.928 . . . . 1.0 107.291 -179.166 . . . . . . . . 0 0 . 1 stop_ save_